id	sid	tid	token	lemma	pos
dpc-4600	1	1	dermatology	dermatology	NOUN
dpc-4600	1	2	:	:	PUNCT
dpc-4600	1	3	practical	practical	ADJ
dpc-4600	1	4	and	and	CCONJ
dpc-4600	1	5	conceptual	conceptual	ADJ
dpc-4600	1	6	review	review	NOUN
dpc-4600	1	7	|	|	ADV
dpc-4600	1	8	dermatol	dermatol	ADJ
dpc-4600	1	9	pract	pract	NOUN
dpc-4600	1	10	concept	concept	NOUN
dpc-4600	1	11	.	.	PUNCT
dpc-4600	2	1	2025;15(1):4600	2025;15(1):4600	NUM
dpc-4600	2	2	1	1	NUM
dpc-4600	2	3	treatment	treatment	NOUN
dpc-4600	2	4	advances	advance	NOUN
dpc-4600	2	5	in	in	ADP
dpc-4600	2	6	vitiligo	vitiligo	NOUN
dpc-4600	2	7	:	:	PUNCT
dpc-4600	2	8	an	an	DET
dpc-4600	2	9	updated	update	VERB
dpc-4600	2	10	review	review	NOUN
dpc-4600	2	11	ishrat	ishrat	PROPN
dpc-4600	2	12	binti	binti	PROPN
dpc-4600	2	13	ismail1	ismail1	PROPN
dpc-4600	2	14	,	,	PUNCT
dpc-4600	2	15	yasmeen	yasmeen	PROPN
dpc-4600	2	16	jabeen	jabeen	PROPN
dpc-4600	2	17	bhat1	bhat1	PROPN
dpc-4600	2	18	,	,	PUNCT
dpc-4600	2	19	mohd	mohd	PROPN
dpc-4600	2	20	shurjeel	shurjeel	PROPN
dpc-4600	2	21	ul	ul	INTJ
dpc-4600	2	22	islam1	islam1	PROPN
dpc-4600	2	23	1	1	NUM
dpc-4600	2	24	postgraduate	postgraduate	PROPN
dpc-4600	2	25	department	department	NOUN
dpc-4600	2	26	of	of	ADP
dpc-4600	2	27	dermatology	dermatology	NOUN
dpc-4600	2	28	,	,	PUNCT
dpc-4600	2	29	venereology	venereology	NOUN
dpc-4600	2	30	and	and	CCONJ
dpc-4600	2	31	leprosy	leprosy	NOUN
dpc-4600	2	32	,	,	PUNCT
dpc-4600	2	33	government	government	NOUN
dpc-4600	2	34	medical	medical	PROPN
dpc-4600	2	35	college	college	PROPN
dpc-4600	2	36	,	,	PUNCT
dpc-4600	2	37	srinagar	srinagar	PROPN
dpc-4600	2	38	.	.	PUNCT
dpc-4600	3	1	key	key	ADJ
dpc-4600	3	2	words	word	NOUN
dpc-4600	3	3	:	:	PUNCT
dpc-4600	3	4	active	active	ADJ
dpc-4600	3	5	vitiligo	vitiligo	NOUN
dpc-4600	3	6	,	,	PUNCT
dpc-4600	3	7	janus	janus	PROPN
dpc-4600	3	8	kinase	kinase	PROPN
dpc-4600	3	9	inhibitor	inhibitor	PROPN
dpc-4600	3	10	,	,	PUNCT
dpc-4600	3	11	cxcl10	cxcl10	NOUN
dpc-4600	3	12	,	,	PUNCT
dpc-4600	3	13	wnt	wnt	PROPN
dpc-4600	3	14	agonist	agonist	PROPN
dpc-4600	3	15	,	,	PUNCT
dpc-4600	3	16	il-17/23	il-17/23	PROPN
dpc-4600	3	17	citation	citation	NOUN
dpc-4600	3	18	:	:	PUNCT
dpc-4600	4	1	binti	binti	PROPN
dpc-4600	4	2	ismail	ismail	PROPN
dpc-4600	4	3	i	i	PROPN
dpc-4600	4	4	,	,	PUNCT
dpc-4600	4	5	bhat	bhat	PROPN
dpc-4600	4	6	yj	yj	PROPN
dpc-4600	4	7	,	,	PUNCT
dpc-4600	4	8	ul	ul	INTJ
dpc-4600	4	9	islam	islam	PROPN
dpc-4600	4	10	ms	ms	PROPN
dpc-4600	4	11	.	.	PROPN
dpc-4600	4	12	treatment	treatment	NOUN
dpc-4600	4	13	advances	advance	NOUN
dpc-4600	4	14	in	in	ADP
dpc-4600	4	15	vitiligo	vitiligo	NOUN
dpc-4600	4	16	:	:	PUNCT
dpc-4600	4	17	an	an	DET
dpc-4600	4	18	updated	update	VERB
dpc-4600	4	19	review	review	NOUN
dpc-4600	4	20	.	.	PUNCT
dpc-4600	5	1	dermatol	dermatol	NOUN
dpc-4600	5	2	pract	pract	PROPN
dpc-4600	5	3	concept	concept	NOUN
dpc-4600	5	4	.	.	PUNCT
dpc-4600	6	1	2025;15(1):4600	2025;15(1):4600	NUM
dpc-4600	6	2	.	.	PUNCT
dpc-4600	6	3	doi	doi	NOUN
dpc-4600	6	4	:	:	PUNCT
dpc-4600	6	5	https://doi.org/10.5826/dpc.1501a4600	https://doi.org/10.5826/dpc.1501a4600	PRON
dpc-4600	6	6	accepted	accept	VERB
dpc-4600	6	7	:	:	PUNCT
dpc-4600	6	8	august	august	PROPN
dpc-4600	6	9	23	23	NUM
dpc-4600	6	10	,	,	PUNCT
dpc-4600	6	11	2024	2024	NUM
dpc-4600	6	12	;	;	PUNCT
dpc-4600	6	13	published	publish	VERB
dpc-4600	6	14	:	:	PUNCT
dpc-4600	6	15	january	january	PROPN
dpc-4600	6	16	2025	2025	NUM
dpc-4600	6	17	copyright	copyright	NOUN
dpc-4600	6	18	:	:	PUNCT
dpc-4600	6	19	©	©	PROPN
dpc-4600	6	20	2024	2024	NUM
dpc-4600	6	21	binti	binti	PROPN
dpc-4600	6	22	ismail	ismail	PROPN
dpc-4600	6	23	et	et	PROPN
dpc-4600	6	24	al	al	PROPN
dpc-4600	6	25	.	.	PUNCT
dpc-4600	7	1	this	this	PRON
dpc-4600	7	2	is	be	AUX
dpc-4600	7	3	an	an	DET
dpc-4600	7	4	open	open	ADJ
dpc-4600	7	5	-	-	PUNCT
dpc-4600	7	6	access	access	NOUN
dpc-4600	7	7	article	article	NOUN
dpc-4600	7	8	distributed	distribute	VERB
dpc-4600	7	9	under	under	ADP
dpc-4600	7	10	the	the	DET
dpc-4600	7	11	terms	term	NOUN
dpc-4600	7	12	of	of	ADP
dpc-4600	7	13	the	the	DET
dpc-4600	7	14	creative	creative	ADJ
dpc-4600	7	15	commons	common	NOUN
dpc-4600	7	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-4600	7	17	license	license	NOUN
dpc-4600	7	18	(	(	PUNCT
dpc-4600	7	19	by	by	ADP
dpc-4600	7	20	-	-	PUNCT
dpc-4600	7	21	nc-4.0	nc-4.0	NOUN
dpc-4600	7	22	)	)	PUNCT
dpc-4600	7	23	,	,	PUNCT
dpc-4600	7	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-4600	7	25	,	,	PUNCT
dpc-4600	7	26	which	which	PRON
dpc-4600	7	27	permits	permit	VERB
dpc-4600	7	28	unrestricted	unrestricted	ADJ
dpc-4600	7	29	noncommercial	noncommercial	ADJ
dpc-4600	7	30	use	use	NOUN
dpc-4600	7	31	,	,	PUNCT
dpc-4600	7	32	distribution	distribution	NOUN
dpc-4600	7	33	,	,	PUNCT
dpc-4600	7	34	and	and	CCONJ
dpc-4600	7	35	reproduction	reproduction	NOUN
dpc-4600	7	36	in	in	ADP
dpc-4600	7	37	any	any	DET
dpc-4600	7	38	medium	medium	NOUN
dpc-4600	7	39	,	,	PUNCT
dpc-4600	7	40	provided	provide	VERB
dpc-4600	7	41	the	the	DET
dpc-4600	7	42	original	original	ADJ
dpc-4600	7	43	authors	author	NOUN
dpc-4600	7	44	and	and	CCONJ
dpc-4600	7	45	source	source	NOUN
dpc-4600	7	46	are	be	AUX
dpc-4600	7	47	credited	credit	VERB
dpc-4600	7	48	.	.	PUNCT
dpc-4600	8	1	funding	funding	NOUN
dpc-4600	8	2	:	:	PUNCT
dpc-4600	8	3	none	none	NOUN
dpc-4600	8	4	.	.	PUNCT
dpc-4600	9	1	competing	compete	VERB
dpc-4600	9	2	interests	interest	NOUN
dpc-4600	9	3	:	:	PUNCT
dpc-4600	9	4	none	none	NOUN
dpc-4600	9	5	.	.	PUNCT
dpc-4600	10	1	authorship	authorship	NOUN
dpc-4600	10	2	:	:	PUNCT
dpc-4600	10	3	all	all	DET
dpc-4600	10	4	authors	author	NOUN
dpc-4600	10	5	have	have	AUX
dpc-4600	10	6	contributed	contribute	VERB
dpc-4600	10	7	significantly	significantly	ADV
dpc-4600	10	8	to	to	ADP
dpc-4600	10	9	this	this	DET
dpc-4600	10	10	publication	publication	NOUN
dpc-4600	10	11	.	.	PUNCT
dpc-4600	11	1	corresponding	correspond	VERB
dpc-4600	11	2	author	author	NOUN
dpc-4600	11	3	:	:	PUNCT
dpc-4600	11	4	dr	dr	PROPN
dpc-4600	11	5	.	.	PROPN
dpc-4600	11	6	yasmeen	yasmeen	PROPN
dpc-4600	11	7	jabeen	jabeen	PROPN
dpc-4600	11	8	bhat	bhat	PROPN
dpc-4600	11	9	,	,	PUNCT
dpc-4600	11	10	md	md	PROPN
dpc-4600	11	11	,	,	PUNCT
dpc-4600	11	12	associate	associate	NOUN
dpc-4600	11	13	professor	professor	NOUN
dpc-4600	11	14	&	&	CCONJ
dpc-4600	11	15	head	head	PROPN
dpc-4600	11	16	postgraduate	postgraduate	PROPN
dpc-4600	11	17	department	department	PROPN
dpc-4600	11	18	of	of	ADP
dpc-4600	11	19	dermatology	dermatology	NOUN
dpc-4600	11	20	,	,	PUNCT
dpc-4600	11	21	venereology	venereology	NOUN
dpc-4600	11	22	&	&	CCONJ
dpc-4600	11	23	leprosy	leprosy	NOUN
dpc-4600	11	24	,	,	PUNCT
dpc-4600	11	25	government	government	NOUN
dpc-4600	11	26	medical	medical	PROPN
dpc-4600	11	27	college	college	PROPN
dpc-4600	11	28	,	,	PUNCT
dpc-4600	11	29	srinagar	srinagar	NOUN
dpc-4600	11	30	,	,	PUNCT
dpc-4600	11	31	j&k	j&k	PROPN
dpc-4600	11	32	,	,	PUNCT
dpc-4600	11	33	india	india	PROPN
dpc-4600	11	34	.	.	PUNCT
dpc-4600	12	1	phone	phone	NOUN
dpc-4600	12	2	:	:	PUNCT
dpc-4600	12	3	+91	+91	NOUN
dpc-4600	12	4	-	-	PUNCT
dpc-4600	12	5	9419040771	9419040771	NUM
dpc-4600	12	6	.	.	PUNCT
dpc-4600	13	1	e	e	X
dpc-4600	13	2	-	-	NOUN
dpc-4600	13	3	mail	mail	NOUN
dpc-4600	13	4	address	address	NOUN
dpc-4600	13	5	:	:	PUNCT
dpc-4600	13	6	yasmeenasif76@gmail.com	yasmeenasif76@gmail.com	X
dpc-4600	13	7	introduction	introduction	NOUN
dpc-4600	13	8	:	:	PUNCT
dpc-4600	13	9	vitiligo	vitiligo	PROPN
dpc-4600	13	10	is	be	AUX
dpc-4600	13	11	a	a	DET
dpc-4600	13	12	common	common	ADJ
dpc-4600	13	13	disorder	disorder	NOUN
dpc-4600	13	14	of	of	ADP
dpc-4600	13	15	depigmentation	depigmentation	NOUN
dpc-4600	13	16	caused	cause	VERB
dpc-4600	13	17	by	by	ADP
dpc-4600	13	18	the	the	DET
dpc-4600	13	19	progressive	progressive	ADJ
dpc-4600	13	20	destruction	destruction	NOUN
dpc-4600	13	21	of	of	ADP
dpc-4600	13	22	melanocytes	melanocyte	NOUN
dpc-4600	13	23	that	that	PRON
dpc-4600	13	24	affects	affect	VERB
dpc-4600	13	25	the	the	DET
dpc-4600	13	26	skin	skin	NOUN
dpc-4600	13	27	,	,	PUNCT
dpc-4600	13	28	hair	hair	NOUN
dpc-4600	13	29	,	,	PUNCT
dpc-4600	13	30	and	and	CCONJ
dpc-4600	13	31	mucous	mucous	ADJ
dpc-4600	13	32	membranes	membrane	NOUN
dpc-4600	13	33	,	,	PUNCT
dpc-4600	13	34	clinically	clinically	ADV
dpc-4600	13	35	presenting	present	VERB
dpc-4600	13	36	as	as	ADP
dpc-4600	13	37	depigmented	depigmented	ADJ
dpc-4600	13	38	macules	macule	NOUN
dpc-4600	13	39	and	and	CCONJ
dpc-4600	13	40	leukotrichia	leukotrichia	NOUN
dpc-4600	13	41	.	.	PUNCT
dpc-4600	14	1	this	this	DET
dpc-4600	14	2	condition	condition	NOUN
dpc-4600	14	3	,	,	PUNCT
dpc-4600	14	4	affecting	affect	VERB
dpc-4600	14	5	millions	million	NOUN
dpc-4600	14	6	of	of	ADP
dpc-4600	14	7	people	people	NOUN
dpc-4600	14	8	worldwide	worldwide	ADV
dpc-4600	14	9	,	,	PUNCT
dpc-4600	14	10	has	have	VERB
dpc-4600	14	11	a	a	DET
dpc-4600	14	12	significant	significant	ADJ
dpc-4600	14	13	psychosocial	psychosocial	ADJ
dpc-4600	14	14	burden	burden	NOUN
dpc-4600	14	15	on	on	ADP
dpc-4600	14	16	patients	patient	NOUN
dpc-4600	14	17	’	'	PUNCT
dpc-4600	14	18	quality	quality	NOUN
dpc-4600	14	19	of	of	ADP
dpc-4600	14	20	life	life	NOUN
dpc-4600	14	21	,	,	PUNCT
dpc-4600	14	22	particularly	particularly	ADV
dpc-4600	14	23	in	in	ADP
dpc-4600	14	24	relation	relation	NOUN
dpc-4600	14	25	to	to	ADP
dpc-4600	14	26	skin	skin	NOUN
dpc-4600	14	27	colour	colour	NOUN
dpc-4600	14	28	.	.	PUNCT
dpc-4600	15	1	the	the	DET
dpc-4600	15	2	etiopathogenesis	etiopathogenesis	NOUN
dpc-4600	15	3	of	of	ADP
dpc-4600	15	4	this	this	DET
dpc-4600	15	5	disorder	disorder	NOUN
dpc-4600	15	6	is	be	AUX
dpc-4600	15	7	obscure	obscure	ADJ
dpc-4600	15	8	,	,	PUNCT
dpc-4600	15	9	but	but	CCONJ
dpc-4600	15	10	multiple	multiple	ADJ
dpc-4600	15	11	factors	factor	NOUN
dpc-4600	15	12	contribute	contribute	VERB
dpc-4600	15	13	to	to	ADP
dpc-4600	15	14	the	the	DET
dpc-4600	15	15	loss	loss	NOUN
dpc-4600	15	16	of	of	ADP
dpc-4600	15	17	melanocytes	melanocyte	NOUN
dpc-4600	15	18	in	in	ADP
dpc-4600	15	19	the	the	DET
dpc-4600	15	20	skin	skin	NOUN
dpc-4600	15	21	,	,	PUNCT
dpc-4600	15	22	like	like	ADP
dpc-4600	15	23	oxidative	oxidative	ADJ
dpc-4600	15	24	stress	stress	NOUN
dpc-4600	15	25	,	,	PUNCT
dpc-4600	15	26	inflammation	inflammation	NOUN
dpc-4600	15	27	,	,	PUNCT
dpc-4600	15	28	genetics	genetic	NOUN
dpc-4600	15	29	,	,	PUNCT
dpc-4600	15	30	and	and	CCONJ
dpc-4600	15	31	autoimmunity	autoimmunity	NOUN
dpc-4600	15	32	.	.	PUNCT
dpc-4600	16	1	the	the	DET
dpc-4600	16	2	treatment	treatment	NOUN
dpc-4600	16	3	of	of	ADP
dpc-4600	16	4	vitiligo	vitiligo	NOUN
dpc-4600	16	5	has	have	AUX
dpc-4600	16	6	been	be	AUX
dpc-4600	16	7	challenging	challenge	VERB
dpc-4600	16	8	over	over	ADP
dpc-4600	16	9	the	the	DET
dpc-4600	16	10	past	past	ADJ
dpc-4600	16	11	years	year	NOUN
dpc-4600	16	12	,	,	PUNCT
dpc-4600	16	13	but	but	CCONJ
dpc-4600	16	14	recent	recent	ADJ
dpc-4600	16	15	developments	development	NOUN
dpc-4600	16	16	in	in	ADP
dpc-4600	16	17	understanding	understand	VERB
dpc-4600	16	18	the	the	DET
dpc-4600	16	19	etiopathogenesis	etiopathogenesis	NOUN
dpc-4600	16	20	of	of	ADP
dpc-4600	16	21	the	the	DET
dpc-4600	16	22	disease	disease	NOUN
dpc-4600	16	23	have	have	AUX
dpc-4600	16	24	paved	pave	VERB
dpc-4600	16	25	the	the	DET
dpc-4600	16	26	way	way	NOUN
dpc-4600	16	27	for	for	ADP
dpc-4600	16	28	the	the	DET
dpc-4600	16	29	development	development	NOUN
dpc-4600	16	30	of	of	ADP
dpc-4600	16	31	more	more	ADV
dpc-4600	16	32	effective	effective	ADJ
dpc-4600	16	33	and	and	CCONJ
dpc-4600	16	34	promising	promise	VERB
dpc-4600	16	35	therapeutic	therapeutic	ADJ
dpc-4600	16	36	treatment	treatment	NOUN
dpc-4600	16	37	options	option	NOUN
dpc-4600	16	38	.	.	PUNCT
dpc-4600	17	1	objective	objective	NOUN
dpc-4600	17	2	:	:	PUNCT
dpc-4600	17	3	the	the	DET
dpc-4600	17	4	aim	aim	NOUN
dpc-4600	17	5	of	of	ADP
dpc-4600	17	6	this	this	DET
dpc-4600	17	7	review	review	NOUN
dpc-4600	17	8	was	be	AUX
dpc-4600	17	9	to	to	PART
dpc-4600	17	10	provide	provide	VERB
dpc-4600	17	11	an	an	DET
dpc-4600	17	12	overview	overview	NOUN
dpc-4600	17	13	of	of	ADP
dpc-4600	17	14	the	the	DET
dpc-4600	17	15	underlying	underlying	ADJ
dpc-4600	17	16	mechanisms	mechanism	NOUN
dpc-4600	17	17	and	and	CCONJ
dpc-4600	17	18	highlight	highlight	VERB
dpc-4600	17	19	the	the	DET
dpc-4600	17	20	latest	late	ADJ
dpc-4600	17	21	advances	advance	NOUN
dpc-4600	17	22	in	in	ADP
dpc-4600	17	23	the	the	DET
dpc-4600	17	24	treatment	treatment	NOUN
dpc-4600	17	25	of	of	ADP
dpc-4600	17	26	vitiligo	vitiligo	NOUN
dpc-4600	17	27	.	.	PUNCT
dpc-4600	18	1	methodology	methodology	NOUN
dpc-4600	18	2	:	:	PUNCT
dpc-4600	18	3	this	this	DET
dpc-4600	18	4	review	review	NOUN
dpc-4600	18	5	was	be	AUX
dpc-4600	18	6	performed	perform	VERB
dpc-4600	18	7	according	accord	VERB
dpc-4600	18	8	to	to	ADP
dpc-4600	18	9	prisma	prisma	PROPN
dpc-4600	18	10	(	(	PUNCT
dpc-4600	18	11	preferred	prefer	VERB
dpc-4600	18	12	reporting	reporting	NOUN
dpc-4600	18	13	items	item	NOUN
dpc-4600	18	14	for	for	ADP
dpc-4600	18	15	systematic	systematic	ADJ
dpc-4600	18	16	reviews	review	NOUN
dpc-4600	18	17	and	and	CCONJ
dpc-4600	18	18	metanalyses	metanalyse	NOUN
dpc-4600	18	19	)	)	PUNCT
dpc-4600	18	20	guidelines	guideline	NOUN
dpc-4600	18	21	.	.	PUNCT
dpc-4600	19	1	a	a	DET
dpc-4600	19	2	comprehensive	comprehensive	ADJ
dpc-4600	19	3	search	search	NOUN
dpc-4600	19	4	of	of	ADP
dpc-4600	19	5	the	the	DET
dpc-4600	19	6	literature	literature	NOUN
dpc-4600	19	7	was	be	AUX
dpc-4600	19	8	carried	carry	VERB
dpc-4600	19	9	out	out	ADP
dpc-4600	19	10	through	through	ADP
dpc-4600	19	11	the	the	DET
dpc-4600	19	12	pubmed	pubmed	PROPN
dpc-4600	19	13	electronic	electronic	ADJ
dpc-4600	19	14	database	database	NOUN
dpc-4600	19	15	from	from	ADP
dpc-4600	19	16	inception	inception	NOUN
dpc-4600	19	17	to	to	ADP
dpc-4600	19	18	31	31	NUM
dpc-4600	19	19	december	december	PROPN
dpc-4600	19	20	2023	2023	NUM
dpc-4600	19	21	using	use	VERB
dpc-4600	19	22	the	the	DET
dpc-4600	19	23	following	follow	VERB
dpc-4600	19	24	search	search	NOUN
dpc-4600	19	25	terms	term	NOUN
dpc-4600	19	26	“	"	PUNCT
dpc-4600	19	27	vitiligo	vitiligo	VERB
dpc-4600	19	28	”	"	PUNCT
dpc-4600	19	29	and	and	CCONJ
dpc-4600	19	30	“	"	PUNCT
dpc-4600	19	31	jak	jak	PROPN
dpc-4600	19	32	inhibitors	inhibitor	NOUN
dpc-4600	19	33	”	"	PUNCT
dpc-4600	19	34	,	,	PUNCT
dpc-4600	19	35	“	"	PUNCT
dpc-4600	19	36	vitiligo	vitiligo	VERB
dpc-4600	19	37	”	"	PUNCT
dpc-4600	19	38	and	and	CCONJ
dpc-4600	19	39	“	"	PUNCT
dpc-4600	19	40	prostaglandin	prostaglandin	NOUN
dpc-4600	19	41	”	"	PUNCT
dpc-4600	19	42	,	,	PUNCT
dpc-4600	19	43	“	"	PUNCT
dpc-4600	19	44	vitiligo	vitiligo	VERB
dpc-4600	19	45	”	"	PUNCT
dpc-4600	19	46	and	and	CCONJ
dpc-4600	19	47	“	"	PUNCT
dpc-4600	19	48	afamelanotide	afamelanotide	NOUN
dpc-4600	19	49	”	"	PUNCT
dpc-4600	19	50	,	,	PUNCT
dpc-4600	19	51	“	"	PUNCT
dpc-4600	19	52	vitiligo	vitiligo	VERB
dpc-4600	19	53	”	"	PUNCT
dpc-4600	19	54	and	and	CCONJ
dpc-4600	19	55	“	"	PUNCT
dpc-4600	19	56	antioxidants	antioxidant	NOUN
dpc-4600	19	57	”	"	PUNCT
dpc-4600	19	58	,	,	PUNCT
dpc-4600	19	59	“	"	PUNCT
dpc-4600	19	60	vitiligo	vitiligo	VERB
dpc-4600	19	61	”	"	PUNCT
dpc-4600	19	62	and	and	CCONJ
dpc-4600	19	63	“	"	PUNCT
dpc-4600	19	64	vitamin	vitamin	NOUN
dpc-4600	19	65	d3	d3	PROPN
dpc-4600	19	66	”	"	PUNCT
dpc-4600	19	67	,	,	PUNCT
dpc-4600	19	68	“	"	PUNCT
dpc-4600	19	69	vitiligo	vitiligo	VERB
dpc-4600	19	70	”	"	PUNCT
dpc-4600	19	71	and	and	CCONJ
dpc-4600	19	72	“	"	PUNCT
dpc-4600	19	73	statins	statins	PROPN
dpc-4600	19	74	”	"	PUNCT
dpc-4600	19	75	,	,	PUNCT
dpc-4600	19	76	“	"	PUNCT
dpc-4600	19	77	vitiligo	vitiligo	VERB
dpc-4600	19	78	”	"	PUNCT
dpc-4600	19	79	and	and	CCONJ
dpc-4600	19	80	“	"	PUNCT
dpc-4600	19	81	tnf	tnf	PROPN
dpc-4600	19	82	-	-	PUNCT
dpc-4600	19	83	alpha	alpha	NOUN
dpc-4600	19	84	”	"	PUNCT
dpc-4600	19	85	,	,	PUNCT
dpc-4600	19	86	“	"	PUNCT
dpc-4600	19	87	vitiligo	vitiligo	VERB
dpc-4600	19	88	”	"	PUNCT
dpc-4600	19	89	and	and	CCONJ
dpc-4600	19	90	“	"	PUNCT
dpc-4600	19	91	interleukin	interleukin	NOUN
dpc-4600	19	92	”	"	PUNCT
dpc-4600	19	93	,	,	PUNCT
dpc-4600	19	94	“	"	PUNCT
dpc-4600	19	95	vitiligo	vitiligo	VERB
dpc-4600	19	96	”	"	PUNCT
dpc-4600	19	97	and	and	CCONJ
dpc-4600	19	98	“	"	PUNCT
dpc-4600	19	99	light	light	ADJ
dpc-4600	19	100	therapy	therapy	NOUN
dpc-4600	19	101	”	"	PUNCT
dpc-4600	19	102	.	.	PUNCT
dpc-4600	20	1	two	two	NUM
dpc-4600	20	2	independent	independent	ADJ
dpc-4600	20	3	reviewers	reviewer	NOUN
dpc-4600	20	4	screened	screen	VERB
dpc-4600	20	5	titles	title	NOUN
dpc-4600	20	6	,	,	PUNCT
dpc-4600	20	7	abstracts	abstract	NOUN
dpc-4600	20	8	,	,	PUNCT
dpc-4600	20	9	and	and	CCONJ
dpc-4600	20	10	full	full	ADJ
dpc-4600	20	11	texts	text	NOUN
dpc-4600	20	12	to	to	PART
dpc-4600	20	13	select	select	VERB
dpc-4600	20	14	papers	paper	NOUN
dpc-4600	20	15	dealing	deal	VERB
dpc-4600	20	16	with	with	ADP
dpc-4600	20	17	vitiligo	vitiligo	NOUN
dpc-4600	20	18	and	and	CCONJ
dpc-4600	20	19	its	its	PRON
dpc-4600	20	20	treatment	treatment	NOUN
dpc-4600	20	21	.	.	PUNCT
dpc-4600	21	1	conclusion	conclusion	NOUN
dpc-4600	21	2	:	:	PUNCT
dpc-4600	21	3	the	the	DET
dpc-4600	21	4	advent	advent	NOUN
dpc-4600	21	5	of	of	ADP
dpc-4600	21	6	treatment	treatment	NOUN
dpc-4600	21	7	modalities	modality	NOUN
dpc-4600	21	8	like	like	ADP
dpc-4600	21	9	janus	janus	PROPN
dpc-4600	21	10	kinase	kinase	PROPN
dpc-4600	21	11	inhibitors	inhibitor	NOUN
dpc-4600	21	12	,	,	PUNCT
dpc-4600	21	13	prostaglandin	prostaglandin	NOUN
dpc-4600	21	14	analogues	analogue	NOUN
dpc-4600	21	15	,	,	PUNCT
dpc-4600	21	16	antioxidants	antioxidant	NOUN
dpc-4600	21	17	,	,	PUNCT
dpc-4600	21	18	tnf	tnf	PROPN
dpc-4600	21	19	-	-	PUNCT
dpc-4600	21	20	α	α	PROPN
dpc-4600	21	21	inhibitors	inhibitor	NOUN
dpc-4600	21	22	,	,	PUNCT
dpc-4600	21	23	targeted	target	VERB
dpc-4600	21	24	phototherapy	phototherapy	NOUN
dpc-4600	21	25	,	,	PUNCT
dpc-4600	21	26	and	and	CCONJ
dpc-4600	21	27	excimer	excimer	NOUN
dpc-4600	21	28	lasers	laser	NOUN
dpc-4600	21	29	has	have	AUX
dpc-4600	21	30	revolutionized	revolutionize	VERB
dpc-4600	21	31	the	the	DET
dpc-4600	21	32	therapeutic	therapeutic	ADJ
dpc-4600	21	33	possibilities	possibility	NOUN
dpc-4600	21	34	,	,	PUNCT
dpc-4600	21	35	offering	offer	VERB
dpc-4600	21	36	a	a	DET
dpc-4600	21	37	ray	ray	NOUN
dpc-4600	21	38	of	of	ADP
dpc-4600	21	39	hope	hope	NOUN
dpc-4600	21	40	to	to	ADP
dpc-4600	21	41	the	the	DET
dpc-4600	21	42	individuals	individual	NOUN
dpc-4600	21	43	suffering	suffer	VERB
dpc-4600	21	44	from	from	ADP
dpc-4600	21	45	this	this	DET
dpc-4600	21	46	devastating	devastating	ADJ
dpc-4600	21	47	condition	condition	NOUN
dpc-4600	21	48	.	.	PUNCT
dpc-4600	22	1	abstract	abstract	ADJ
dpc-4600	22	2	2	2	NUM
dpc-4600	22	3	review	review	NOUN
dpc-4600	22	4	|	|	ADV
dpc-4600	22	5	dermatol	dermatol	ADJ
dpc-4600	22	6	pract	pract	NOUN
dpc-4600	22	7	concept	concept	NOUN
dpc-4600	22	8	.	.	PUNCT
dpc-4600	23	1	2025;15(1):4600	2025;15(1):4600	NUM
dpc-4600	23	2	introduction	introduction	NOUN
dpc-4600	23	3	vitiligo	vitiligo	NOUN
dpc-4600	23	4	is	be	AUX
dpc-4600	23	5	a	a	DET
dpc-4600	23	6	chronic	chronic	ADJ
dpc-4600	23	7	autoimmune	autoimmune	ADJ
dpc-4600	23	8	hypomelanotic	hypomelanotic	ADJ
dpc-4600	23	9	disorder	disorder	NOUN
dpc-4600	23	10	presenting	present	VERB
dpc-4600	23	11	as	as	ADP
dpc-4600	23	12	well	well	ADV
dpc-4600	23	13	-	-	PUNCT
dpc-4600	23	14	defined	define	VERB
dpc-4600	23	15	hypopigmented	hypopigmente	VERB
dpc-4600	23	16	macules	macule	NOUN
dpc-4600	23	17	on	on	ADP
dpc-4600	23	18	the	the	DET
dpc-4600	23	19	skin	skin	NOUN
dpc-4600	23	20	and	and	CCONJ
dpc-4600	23	21	mucous	mucous	ADJ
dpc-4600	23	22	membranes	membrane	NOUN
dpc-4600	23	23	along	along	ADP
dpc-4600	23	24	with	with	ADP
dpc-4600	23	25	leukotrichia	leukotrichia	NOUN
dpc-4600	23	26	.	.	PUNCT
dpc-4600	24	1	it	it	PRON
dpc-4600	24	2	is	be	AUX
dpc-4600	24	3	caused	cause	VERB
dpc-4600	24	4	by	by	ADP
dpc-4600	24	5	the	the	DET
dpc-4600	24	6	destruction	destruction	NOUN
dpc-4600	24	7	of	of	ADP
dpc-4600	24	8	melanocytes	melanocyte	NOUN
dpc-4600	24	9	in	in	ADP
dpc-4600	24	10	the	the	DET
dpc-4600	24	11	epidermis	epidermis	NOUN
dpc-4600	24	12	,	,	PUNCT
dpc-4600	24	13	which	which	PRON
dpc-4600	24	14	makes	make	VERB
dpc-4600	24	15	the	the	DET
dpc-4600	24	16	skin	skin	NOUN
dpc-4600	24	17	appear	appear	VERB
dpc-4600	24	18	white	white	ADJ
dpc-4600	24	19	.	.	PUNCT
dpc-4600	25	1	it	it	PRON
dpc-4600	25	2	is	be	AUX
dpc-4600	25	3	quite	quite	DET
dpc-4600	25	4	a	a	DET
dpc-4600	25	5	common	common	ADJ
dpc-4600	25	6	disease	disease	NOUN
dpc-4600	25	7	,	,	PUNCT
dpc-4600	25	8	affecting	affect	VERB
dpc-4600	25	9	nearly	nearly	ADV
dpc-4600	25	10	1	1	NUM
dpc-4600	25	11	%	%	NOUN
dpc-4600	25	12	of	of	ADP
dpc-4600	25	13	people	people	NOUN
dpc-4600	25	14	across	across	ADP
dpc-4600	25	15	the	the	DET
dpc-4600	25	16	globe	globe	NOUN
dpc-4600	26	1	[	[	X
dpc-4600	26	2	1	1	NUM
dpc-4600	26	3	]	]	PUNCT
dpc-4600	26	4	.	.	PUNCT
dpc-4600	27	1	it	it	PRON
dpc-4600	27	2	can	can	AUX
dpc-4600	27	3	affect	affect	VERB
dpc-4600	27	4	anyone	anyone	PRON
dpc-4600	27	5	,	,	PUNCT
dpc-4600	27	6	irrespective	irrespective	ADV
dpc-4600	27	7	of	of	ADP
dpc-4600	27	8	age	age	NOUN
dpc-4600	27	9	,	,	PUNCT
dpc-4600	27	10	sex	sex	NOUN
dpc-4600	27	11	,	,	PUNCT
dpc-4600	27	12	geographical	geographical	ADJ
dpc-4600	27	13	location	location	NOUN
dpc-4600	27	14	,	,	PUNCT
dpc-4600	27	15	ethnicity	ethnicity	NOUN
dpc-4600	27	16	,	,	PUNCT
dpc-4600	27	17	or	or	CCONJ
dpc-4600	27	18	skin	skin	NOUN
dpc-4600	27	19	color	color	NOUN
dpc-4600	27	20	.	.	PUNCT
dpc-4600	28	1	it	it	PRON
dpc-4600	28	2	may	may	AUX
dpc-4600	28	3	cause	cause	VERB
dpc-4600	28	4	the	the	DET
dpc-4600	28	5	patient	patient	ADJ
dpc-4600	28	6	significant	significant	ADJ
dpc-4600	28	7	psychosocial	psychosocial	ADJ
dpc-4600	28	8	distress	distress	NOUN
dpc-4600	28	9	due	due	ADP
dpc-4600	28	10	to	to	ADP
dpc-4600	28	11	the	the	DET
dpc-4600	28	12	stigma	stigma	NOUN
dpc-4600	28	13	associated	associate	VERB
dpc-4600	28	14	with	with	ADP
dpc-4600	28	15	the	the	DET
dpc-4600	28	16	disease	disease	NOUN
dpc-4600	28	17	and	and	CCONJ
dpc-4600	28	18	may	may	AUX
dpc-4600	28	19	result	result	VERB
dpc-4600	28	20	in	in	ADP
dpc-4600	28	21	social	social	ADJ
dpc-4600	28	22	isolation	isolation	NOUN
dpc-4600	28	23	and	and	CCONJ
dpc-4600	28	24	low	low	ADJ
dpc-4600	28	25	self	self	NOUN
dpc-4600	28	26	-	-	PUNCT
dpc-4600	28	27	esteem	esteem	NOUN
dpc-4600	29	1	[	[	X
dpc-4600	29	2	2	2	NUM
dpc-4600	29	3	]	]	PUNCT
dpc-4600	29	4	.	.	PUNCT
dpc-4600	30	1	vitiligo	vitiligo	PROPN
dpc-4600	30	2	is	be	AUX
dpc-4600	30	3	broadly	broadly	ADV
dpc-4600	30	4	classified	classify	VERB
dpc-4600	30	5	into	into	ADP
dpc-4600	30	6	three	three	NUM
dpc-4600	30	7	groups	group	NOUN
dpc-4600	30	8	(	(	PUNCT
dpc-4600	30	9	figure	figure	NOUN
dpc-4600	30	10	1	1	NUM
dpc-4600	30	11	)	)	PUNCT
dpc-4600	31	1	[	[	X
dpc-4600	31	2	3	3	NUM
dpc-4600	31	3	]	]	PUNCT
dpc-4600	31	4	.	.	PUNCT
dpc-4600	31	5	etiopathogenesis	etiopathogenesis	VERB
dpc-4600	31	6	the	the	DET
dpc-4600	31	7	etiopathogenesis	etiopathogenesis	NOUN
dpc-4600	31	8	of	of	ADP
dpc-4600	31	9	vitiligo	vitiligo	NOUN
dpc-4600	31	10	is	be	AUX
dpc-4600	31	11	complex	complex	ADJ
dpc-4600	31	12	and	and	CCONJ
dpc-4600	31	13	is	be	AUX
dpc-4600	31	14	not	not	PART
dpc-4600	31	15	fully	fully	ADV
dpc-4600	31	16	elucidated	elucidated	ADJ
dpc-4600	31	17	.	.	PUNCT
dpc-4600	32	1	genetics	genetic	NOUN
dpc-4600	32	2	,	,	PUNCT
dpc-4600	32	3	autoimmunity	autoimmunity	NOUN
dpc-4600	32	4	,	,	PUNCT
dpc-4600	32	5	oxidative	oxidative	ADJ
dpc-4600	32	6	stress	stress	NOUN
dpc-4600	32	7	,	,	PUNCT
dpc-4600	32	8	and	and	CCONJ
dpc-4600	32	9	neurological	neurological	ADJ
dpc-4600	32	10	dysfunction	dysfunction	NOUN
dpc-4600	32	11	are	be	AUX
dpc-4600	32	12	some	some	PRON
dpc-4600	32	13	of	of	ADP
dpc-4600	32	14	the	the	DET
dpc-4600	32	15	theories	theory	NOUN
dpc-4600	32	16	and	and	CCONJ
dpc-4600	32	17	pathogenetic	pathogenetic	ADJ
dpc-4600	32	18	mechanisms	mechanism	NOUN
dpc-4600	32	19	that	that	PRON
dpc-4600	32	20	have	have	AUX
dpc-4600	32	21	been	be	AUX
dpc-4600	32	22	put	put	VERB
dpc-4600	32	23	forward	forward	ADV
dpc-4600	32	24	.	.	PUNCT
dpc-4600	33	1	however	however	ADV
dpc-4600	33	2	,	,	PUNCT
dpc-4600	33	3	none	none	NOUN
dpc-4600	33	4	of	of	ADP
dpc-4600	33	5	these	these	PRON
dpc-4600	33	6	can	can	AUX
dpc-4600	33	7	explain	explain	VERB
dpc-4600	33	8	the	the	DET
dpc-4600	33	9	different	different	ADJ
dpc-4600	33	10	types	type	NOUN
dpc-4600	33	11	of	of	ADP
dpc-4600	33	12	vitiligo	vitiligo	NOUN
dpc-4600	33	13	that	that	PRON
dpc-4600	33	14	have	have	AUX
dpc-4600	33	15	been	be	AUX
dpc-4600	33	16	seen	see	VERB
dpc-4600	33	17	[	[	PUNCT
dpc-4600	33	18	4	4	NUM
dpc-4600	33	19	]	]	PUNCT
dpc-4600	33	20	.	.	PUNCT
dpc-4600	34	1	this	this	PRON
dpc-4600	34	2	has	have	AUX
dpc-4600	34	3	led	lead	VERB
dpc-4600	34	4	to	to	ADP
dpc-4600	34	5	the	the	DET
dpc-4600	34	6	development	development	NOUN
dpc-4600	34	7	of	of	ADP
dpc-4600	34	8	the	the	DET
dpc-4600	34	9	convergence	convergence	NOUN
dpc-4600	34	10	theory	theory	NOUN
dpc-4600	34	11	,	,	PUNCT
dpc-4600	34	12	which	which	PRON
dpc-4600	34	13	states	state	VERB
dpc-4600	34	14	that	that	SCONJ
dpc-4600	34	15	there	there	PRON
dpc-4600	34	16	are	be	VERB
dpc-4600	34	17	several	several	ADJ
dpc-4600	34	18	mechanisms	mechanism	NOUN
dpc-4600	34	19	contributing	contribute	VERB
dpc-4600	34	20	to	to	ADP
dpc-4600	34	21	the	the	DET
dpc-4600	34	22	loss	loss	NOUN
dpc-4600	34	23	of	of	ADP
dpc-4600	34	24	melanocytes	melanocyte	NOUN
dpc-4600	34	25	;	;	PUNCT
dpc-4600	34	26	among	among	ADP
dpc-4600	34	27	these	these	PRON
dpc-4600	34	28	,	,	PUNCT
dpc-4600	34	29	autoimmunity	autoimmunity	NOUN
dpc-4600	34	30	and	and	CCONJ
dpc-4600	34	31	oxidative	oxidative	ADJ
dpc-4600	34	32	stress	stress	NOUN
dpc-4600	34	33	theories	theory	NOUN
dpc-4600	34	34	are	be	AUX
dpc-4600	34	35	regarded	regard	VERB
dpc-4600	34	36	as	as	ADP
dpc-4600	34	37	the	the	DET
dpc-4600	34	38	major	major	ADJ
dpc-4600	34	39	ones	one	NOUN
dpc-4600	34	40	in	in	ADP
dpc-4600	34	41	the	the	DET
dpc-4600	34	42	pathogenesis	pathogenesis	NOUN
dpc-4600	34	43	of	of	ADP
dpc-4600	34	44	vitiligo	vitiligo	NOUN
dpc-4600	34	45	(	(	PUNCT
dpc-4600	34	46	figure	figure	NOUN
dpc-4600	34	47	2	2	NUM
dpc-4600	34	48	)	)	PUNCT
dpc-4600	35	1	[	[	X
dpc-4600	35	2	5	5	NUM
dpc-4600	35	3	]	]	PUNCT
dpc-4600	35	4	.	.	PUNCT
dpc-4600	36	1	the	the	DET
dpc-4600	36	2	etiopathogenesis	etiopathogenesis	NOUN
dpc-4600	36	3	of	of	ADP
dpc-4600	36	4	this	this	DET
dpc-4600	36	5	disease	disease	NOUN
dpc-4600	36	6	is	be	AUX
dpc-4600	36	7	summarized	summarize	VERB
dpc-4600	36	8	below	below	ADP
dpc-4600	36	9	(	(	PUNCT
dpc-4600	36	10	table	table	NOUN
dpc-4600	36	11	1	1	NUM
dpc-4600	36	12	)	)	PUNCT
dpc-4600	37	1	[	[	X
dpc-4600	37	2	6	6	NUM
dpc-4600	37	3	-	-	SYM
dpc-4600	37	4	17	17	NUM
dpc-4600	37	5	]	]	PUNCT
dpc-4600	37	6	.	.	PUNCT
dpc-4600	38	1	methodology	methodology	NOUN
dpc-4600	38	2	this	this	DET
dpc-4600	38	3	review	review	NOUN
dpc-4600	38	4	was	be	AUX
dpc-4600	38	5	performed	perform	VERB
dpc-4600	38	6	according	accord	VERB
dpc-4600	38	7	to	to	ADP
dpc-4600	38	8	prisma	prisma	PROPN
dpc-4600	38	9	(	(	PUNCT
dpc-4600	38	10	preferred	prefer	VERB
dpc-4600	38	11	reporting	reporting	NOUN
dpc-4600	38	12	items	item	NOUN
dpc-4600	38	13	for	for	ADP
dpc-4600	38	14	systematic	systematic	ADJ
dpc-4600	38	15	reviews	review	NOUN
dpc-4600	38	16	and	and	CCONJ
dpc-4600	38	17	metanalyses	metanalyse	NOUN
dpc-4600	38	18	)	)	PUNCT
dpc-4600	38	19	guidelines	guideline	NOUN
dpc-4600	38	20	.	.	PUNCT
dpc-4600	39	1	a	a	DET
dpc-4600	39	2	comprehensive	comprehensive	ADJ
dpc-4600	39	3	search	search	NOUN
dpc-4600	39	4	of	of	ADP
dpc-4600	39	5	the	the	DET
dpc-4600	39	6	literature	literature	NOUN
dpc-4600	39	7	was	be	AUX
dpc-4600	39	8	carried	carry	VERB
dpc-4600	39	9	out	out	ADP
dpc-4600	39	10	through	through	ADP
dpc-4600	39	11	the	the	DET
dpc-4600	39	12	pubmed	pubmed	PROPN
dpc-4600	39	13	electronic	electronic	ADJ
dpc-4600	39	14	database	database	NOUN
dpc-4600	39	15	from	from	ADP
dpc-4600	39	16	inception	inception	NOUN
dpc-4600	39	17	to	to	ADP
dpc-4600	39	18	31	31	NUM
dpc-4600	39	19	december	december	PROPN
dpc-4600	39	20	2023	2023	NUM
dpc-4600	39	21	using	use	VERB
dpc-4600	39	22	the	the	DET
dpc-4600	39	23	following	follow	VERB
dpc-4600	39	24	search	search	NOUN
dpc-4600	39	25	terms	term	NOUN
dpc-4600	39	26	“	"	PUNCT
dpc-4600	39	27	vitiligo	vitiligo	VERB
dpc-4600	39	28	”	"	PUNCT
dpc-4600	39	29	and	and	CCONJ
dpc-4600	39	30	“	"	PUNCT
dpc-4600	39	31	jak	jak	PROPN
dpc-4600	39	32	inhibitors	inhibitor	NOUN
dpc-4600	39	33	”	"	PUNCT
dpc-4600	39	34	,	,	PUNCT
dpc-4600	39	35	“	"	PUNCT
dpc-4600	39	36	vitiligo	vitiligo	VERB
dpc-4600	39	37	”	"	PUNCT
dpc-4600	39	38	and	and	CCONJ
dpc-4600	39	39	“	"	PUNCT
dpc-4600	39	40	prostaglandin	prostaglandin	NOUN
dpc-4600	39	41	”	"	PUNCT
dpc-4600	39	42	,	,	PUNCT
dpc-4600	39	43	“	"	PUNCT
dpc-4600	39	44	vitiligo	vitiligo	VERB
dpc-4600	39	45	”	"	PUNCT
dpc-4600	39	46	and	and	CCONJ
dpc-4600	39	47	“	"	PUNCT
dpc-4600	39	48	afamelanotide	afamelanotide	NOUN
dpc-4600	39	49	”	"	PUNCT
dpc-4600	39	50	,	,	PUNCT
dpc-4600	39	51	“	"	PUNCT
dpc-4600	39	52	vitiligo	vitiligo	VERB
dpc-4600	39	53	”	"	PUNCT
dpc-4600	39	54	and	and	CCONJ
dpc-4600	39	55	“	"	PUNCT
dpc-4600	39	56	antioxidants	antioxidant	NOUN
dpc-4600	39	57	”	"	PUNCT
dpc-4600	39	58	,	,	PUNCT
dpc-4600	39	59	“	"	PUNCT
dpc-4600	39	60	vitiligo	vitiligo	VERB
dpc-4600	39	61	”	"	PUNCT
dpc-4600	39	62	and	and	CCONJ
dpc-4600	39	63	“	"	PUNCT
dpc-4600	39	64	vitamin	vitamin	NOUN
dpc-4600	39	65	d3	d3	PROPN
dpc-4600	39	66	”	"	PUNCT
dpc-4600	39	67	,	,	PUNCT
dpc-4600	39	68	“	"	PUNCT
dpc-4600	39	69	vitiligo	vitiligo	VERB
dpc-4600	39	70	”	"	PUNCT
dpc-4600	39	71	and	and	CCONJ
dpc-4600	39	72	“	"	PUNCT
dpc-4600	39	73	statins	statins	PROPN
dpc-4600	39	74	”	"	PUNCT
dpc-4600	39	75	,	,	PUNCT
dpc-4600	39	76	“	"	PUNCT
dpc-4600	39	77	vitiligo	vitiligo	VERB
dpc-4600	39	78	”	"	PUNCT
dpc-4600	39	79	and	and	CCONJ
dpc-4600	39	80	“	"	PUNCT
dpc-4600	39	81	tnf	tnf	PROPN
dpc-4600	39	82	-	-	PUNCT
dpc-4600	39	83	alpha	alpha	NOUN
dpc-4600	39	84	”	"	PUNCT
dpc-4600	39	85	,	,	PUNCT
dpc-4600	39	86	“	"	PUNCT
dpc-4600	39	87	vitiligo	vitiligo	VERB
dpc-4600	39	88	”	"	PUNCT
dpc-4600	39	89	and	and	CCONJ
dpc-4600	39	90	“	"	PUNCT
dpc-4600	39	91	interleukin	interleukin	NOUN
dpc-4600	39	92	”	"	PUNCT
dpc-4600	39	93	,	,	PUNCT
dpc-4600	39	94	“	"	PUNCT
dpc-4600	39	95	vitiligo	vitiligo	VERB
dpc-4600	39	96	”	"	PUNCT
dpc-4600	39	97	and	and	CCONJ
dpc-4600	39	98	“	"	PUNCT
dpc-4600	39	99	light	light	ADJ
dpc-4600	39	100	therapy	therapy	NOUN
dpc-4600	39	101	”	"	PUNCT
dpc-4600	39	102	.	.	PUNCT
dpc-4600	40	1	a	a	DET
dpc-4600	40	2	manual	manual	ADJ
dpc-4600	40	3	search	search	NOUN
dpc-4600	40	4	was	be	AUX
dpc-4600	40	5	also	also	ADV
dpc-4600	40	6	performed	perform	VERB
dpc-4600	40	7	by	by	ADP
dpc-4600	40	8	analyzing	analyze	VERB
dpc-4600	40	9	the	the	DET
dpc-4600	40	10	reference	reference	NOUN
dpc-4600	40	11	sections	section	NOUN
dpc-4600	40	12	of	of	ADP
dpc-4600	40	13	all	all	DET
dpc-4600	40	14	relevant	relevant	ADJ
dpc-4600	40	15	studies	study	NOUN
dpc-4600	40	16	or	or	CCONJ
dpc-4600	40	17	reviews	review	NOUN
dpc-4600	40	18	on	on	ADP
dpc-4600	40	19	the	the	DET
dpc-4600	40	20	topic	topic	NOUN
dpc-4600	40	21	.	.	PUNCT
dpc-4600	41	1	titles	title	NOUN
dpc-4600	41	2	,	,	PUNCT
dpc-4600	41	3	abstracts	abstract	NOUN
dpc-4600	41	4	,	,	PUNCT
dpc-4600	41	5	and	and	CCONJ
dpc-4600	41	6	full	full	ADJ
dpc-4600	41	7	texts	text	NOUN
dpc-4600	41	8	were	be	AUX
dpc-4600	41	9	screened	screen	VERB
dpc-4600	41	10	by	by	ADP
dpc-4600	41	11	two	two	NUM
dpc-4600	41	12	independent	independent	ADJ
dpc-4600	41	13	reviewers	reviewer	NOUN
dpc-4600	41	14	to	to	PART
dpc-4600	41	15	select	select	VERB
dpc-4600	41	16	papers	paper	NOUN
dpc-4600	41	17	dealing	deal	VERB
dpc-4600	41	18	with	with	ADP
dpc-4600	41	19	vitiligo	vitiligo	NOUN
dpc-4600	41	20	and	and	CCONJ
dpc-4600	41	21	its	its	PRON
dpc-4600	41	22	treatment	treatment	NOUN
dpc-4600	41	23	.	.	PUNCT
dpc-4600	42	1	inclusion	inclusion	NOUN
dpc-4600	42	2	criteria	criterion	NOUN
dpc-4600	42	3	were	be	AUX
dpc-4600	42	4	(	(	PUNCT
dpc-4600	42	5	i	i	NOUN
dpc-4600	42	6	)	)	PUNCT
dpc-4600	42	7	articles	article	NOUN
dpc-4600	42	8	discussing	discuss	VERB
dpc-4600	42	9	vitiligo	vitiligo	ADJ
dpc-4600	42	10	treatment	treatment	NOUN
dpc-4600	42	11	,	,	PUNCT
dpc-4600	42	12	(	(	PUNCT
dpc-4600	42	13	ii	ii	NOUN
dpc-4600	42	14	)	)	PUNCT
dpc-4600	42	15	all	all	DET
dpc-4600	42	16	types	type	NOUN
dpc-4600	42	17	of	of	ADP
dpc-4600	42	18	articles	article	NOUN
dpc-4600	42	19	,	,	PUNCT
dpc-4600	42	20	and	and	CCONJ
dpc-4600	42	21	(	(	PUNCT
dpc-4600	42	22	iii	iii	NOUN
dpc-4600	42	23	)	)	PUNCT
dpc-4600	42	24	no	no	DET
dpc-4600	42	25	sample	sample	NOUN
dpc-4600	42	26	size	size	NOUN
dpc-4600	42	27	limitation	limitation	NOUN
dpc-4600	42	28	.	.	PUNCT
dpc-4600	43	1	exclusion	exclusion	NOUN
dpc-4600	43	2	criteria	criterion	NOUN
dpc-4600	43	3	were	be	AUX
dpc-4600	43	4	(	(	PUNCT
dpc-4600	43	5	i	i	NOUN
dpc-4600	43	6	)	)	PUNCT
dpc-4600	43	7	non	non	ADJ
dpc-4600	43	8	-	-	ADJ
dpc-4600	43	9	english	english	ADJ
dpc-4600	43	10	articles	article	NOUN
dpc-4600	43	11	,	,	PUNCT
dpc-4600	43	12	(	(	PUNCT
dpc-4600	43	13	ii	ii	NOUN
dpc-4600	43	14	)	)	PUNCT
dpc-4600	43	15	irrelevant	irrelevant	ADJ
dpc-4600	43	16	review	review	NOUN
dpc-4600	43	17	articles	article	NOUN
dpc-4600	43	18	,	,	PUNCT
dpc-4600	43	19	personal	personal	ADJ
dpc-4600	43	20	opinions/	opinions/	NUM
dpc-4600	43	21	editorials	editorial	NOUN
dpc-4600	43	22	and	and	CCONJ
dpc-4600	43	23	duplicates	duplicate	NOUN
dpc-4600	43	24	,	,	PUNCT
dpc-4600	43	25	and	and	CCONJ
dpc-4600	43	26	(	(	PUNCT
dpc-4600	43	27	iii	iii	X
dpc-4600	43	28	)	)	PUNCT
dpc-4600	43	29	articles	article	NOUN
dpc-4600	43	30	published	publish	VERB
dpc-4600	43	31	before	before	ADP
dpc-4600	43	32	the	the	DET
dpc-4600	43	33	year	year	NOUN
dpc-4600	43	34	2010	2010	NUM
dpc-4600	43	35	(	(	PUNCT
dpc-4600	43	36	figure	figure	NOUN
dpc-4600	43	37	3	3	NUM
dpc-4600	43	38	)	)	PUNCT
dpc-4600	43	39	.	.	PUNCT
dpc-4600	44	1	treatment	treatment	NOUN
dpc-4600	44	2	vitiligo	vitiligo	NOUN
dpc-4600	44	3	treatment	treatment	NOUN
dpc-4600	44	4	is	be	AUX
dpc-4600	44	5	difficult	difficult	ADJ
dpc-4600	44	6	and	and	CCONJ
dpc-4600	44	7	frequently	frequently	ADV
dpc-4600	44	8	distressing	distressing	ADJ
dpc-4600	44	9	for	for	ADP
dpc-4600	44	10	patients	patient	NOUN
dpc-4600	44	11	.	.	PUNCT
dpc-4600	45	1	since	since	SCONJ
dpc-4600	45	2	it	it	PRON
dpc-4600	45	3	impairs	impair	VERB
dpc-4600	45	4	one	one	NUM
dpc-4600	45	5	’s	’s	PART
dpc-4600	45	6	quality	quality	NOUN
dpc-4600	45	7	of	of	ADP
dpc-4600	45	8	life	life	NOUN
dpc-4600	45	9	(	(	PUNCT
dpc-4600	45	10	qol	qol	NOUN
dpc-4600	45	11	)	)	PUNCT
dpc-4600	45	12	,	,	PUNCT
dpc-4600	45	13	treatment	treatment	NOUN
dpc-4600	45	14	must	must	AUX
dpc-4600	45	15	be	be	AUX
dpc-4600	45	16	swift	swift	ADJ
dpc-4600	45	17	and	and	CCONJ
dpc-4600	45	18	aggressive	aggressive	ADJ
dpc-4600	45	19	.	.	PUNCT
dpc-4600	46	1	the	the	DET
dpc-4600	46	2	goal	goal	NOUN
dpc-4600	46	3	of	of	ADP
dpc-4600	46	4	vitiligo	vitiligo	ADJ
dpc-4600	46	5	treatment	treatment	NOUN
dpc-4600	46	6	is	be	AUX
dpc-4600	46	7	to	to	PART
dpc-4600	46	8	limit	limit	VERB
dpc-4600	46	9	disease	disease	NOUN
dpc-4600	46	10	development	development	NOUN
dpc-4600	46	11	,	,	PUNCT
dpc-4600	46	12	induce	induce	VERB
dpc-4600	46	13	pigmentation	pigmentation	NOUN
dpc-4600	46	14	,	,	PUNCT
dpc-4600	46	15	and	and	CCONJ
dpc-4600	46	16	retain	retain	VERB
dpc-4600	46	17	repigmentation	repigmentation	NOUN
dpc-4600	46	18	,	,	PUNCT
dpc-4600	46	19	thereby	thereby	ADV
dpc-4600	46	20	minimizing	minimize	VERB
dpc-4600	46	21	the	the	DET
dpc-4600	46	22	psychological	psychological	ADJ
dpc-4600	46	23	stress	stress	NOUN
dpc-4600	46	24	.	.	PUNCT
dpc-4600	47	1	janus	janus	PROPN
dpc-4600	47	2	kinase	kinase	PROPN
dpc-4600	47	3	inhibitors	inhibitors	PROPN
dpc-4600	47	4	janus	janus	PROPN
dpc-4600	47	5	kinases	kinases	PROPN
dpc-4600	47	6	(	(	PUNCT
dpc-4600	47	7	jak	jak	PROPN
dpc-4600	47	8	)	)	PUNCT
dpc-4600	47	9	like	like	ADP
dpc-4600	47	10	jak1	jak1	PROPN
dpc-4600	47	11	,	,	PUNCT
dpc-4600	47	12	jak2	jak2	NOUN
dpc-4600	47	13	,	,	PUNCT
dpc-4600	47	14	and	and	CCONJ
dpc-4600	47	15	tyk2	tyk2	NOUN
dpc-4600	47	16	(	(	PUNCT
dpc-4600	47	17	tyrosine	tyrosine	NOUN
dpc-4600	47	18	kinase	kinase	NOUN
dpc-4600	47	19	2	2	NUM
dpc-4600	47	20	)	)	PUNCT
dpc-4600	47	21	are	be	AUX
dpc-4600	47	22	a	a	DET
dpc-4600	47	23	class	class	NOUN
dpc-4600	47	24	of	of	ADP
dpc-4600	47	25	cytoplasmic	cytoplasmic	ADJ
dpc-4600	47	26	tyrosine	tyrosine	NOUN
dpc-4600	47	27	kinases	kinase	NOUN
dpc-4600	47	28	that	that	PRON
dpc-4600	47	29	contribute	contribute	VERB
dpc-4600	47	30	to	to	ADP
dpc-4600	47	31	cytokine	cytokine	NOUN
dpc-4600	47	32	-	-	PUNCT
dpc-4600	47	33	mediated	mediate	VERB
dpc-4600	47	34	signal	signal	NOUN
dpc-4600	47	35	transduction	transduction	NOUN
dpc-4600	47	36	via	via	ADP
dpc-4600	47	37	the	the	DET
dpc-4600	47	38	jak/	jak/	ADJ
dpc-4600	47	39	stat	stat	NOUN
dpc-4600	47	40	(	(	PUNCT
dpc-4600	47	41	jak	jak	PROPN
dpc-4600	47	42	/	/	SYM
dpc-4600	47	43	signal	signal	NOUN
dpc-4600	47	44	transducer	transducer	NOUN
dpc-4600	47	45	and	and	CCONJ
dpc-4600	47	46	activating	activate	VERB
dpc-4600	47	47	protein	protein	NOUN
dpc-4600	47	48	)	)	PUNCT
dpc-4600	47	49	pathway	pathway	NOUN
dpc-4600	47	50	.	.	PUNCT
dpc-4600	48	1	the	the	DET
dpc-4600	48	2	cell	cell	NOUN
dpc-4600	48	3	surface	surface	NOUN
dpc-4600	48	4	receptor	receptor	NOUN
dpc-4600	48	5	for	for	ADP
dpc-4600	48	6	interferon	interferon	ADJ
dpc-4600	48	7	-	-	PUNCT
dpc-4600	48	8	γ	γ	NOUN
dpc-4600	48	9	is	be	AUX
dpc-4600	48	10	composed	compose	VERB
dpc-4600	48	11	of	of	ADP
dpc-4600	48	12	two	two	NUM
dpc-4600	48	13	subunits	subunit	NOUN
dpc-4600	48	14	,	,	PUNCT
dpc-4600	48	15	ifngr1	ifngr1	NOUN
dpc-4600	48	16	and	and	CCONJ
dpc-4600	48	17	ifngr2	ifngr2	NOUN
dpc-4600	48	18	,	,	PUNCT
dpc-4600	48	19	which	which	PRON
dpc-4600	48	20	belong	belong	VERB
dpc-4600	48	21	to	to	ADP
dpc-4600	48	22	jak1	jak1	PROPN
dpc-4600	48	23	and	and	CCONJ
dpc-4600	48	24	jak2	jak2	PROPN
dpc-4600	48	25	,	,	PUNCT
dpc-4600	48	26	respectively	respectively	ADV
dpc-4600	48	27	.	.	PUNCT
dpc-4600	49	1	once	once	SCONJ
dpc-4600	49	2	interferonγ	interferonγ	NOUN
dpc-4600	49	3	binds	bind	VERB
dpc-4600	49	4	to	to	ADP
dpc-4600	49	5	its	its	PRON
dpc-4600	49	6	figure	figure	NOUN
dpc-4600	49	7	1	1	NUM
dpc-4600	49	8	.	.	PUNCT
dpc-4600	50	1	classification	classification	NOUN
dpc-4600	50	2	of	of	ADP
dpc-4600	50	3	vitiligo	vitiligo	NOUN
dpc-4600	50	4	.	.	PUNCT
dpc-4600	51	1	review	review	VERB
dpc-4600	51	2	|	|	ADV
dpc-4600	51	3	dermatol	dermatol	ADJ
dpc-4600	51	4	pract	pract	NOUN
dpc-4600	51	5	concept	concept	NOUN
dpc-4600	51	6	.	.	PUNCT
dpc-4600	52	1	2025;15(1):4600	2025;15(1):4600	NUM
dpc-4600	52	2	3	3	NUM
dpc-4600	52	3	figure	figure	NOUN
dpc-4600	52	4	2	2	NUM
dpc-4600	52	5	.	.	PUNCT
dpc-4600	52	6	schematic	schematic	ADJ
dpc-4600	52	7	diagram	diagram	NOUN
dpc-4600	52	8	of	of	ADP
dpc-4600	52	9	the	the	DET
dpc-4600	52	10	pathogenesis	pathogenesis	NOUN
dpc-4600	52	11	with	with	ADP
dpc-4600	52	12	insight	insight	NOUN
dpc-4600	52	13	into	into	ADP
dpc-4600	52	14	current	current	ADJ
dpc-4600	52	15	and	and	CCONJ
dpc-4600	52	16	proposed	propose	VERB
dpc-4600	52	17	treatment	treatment	NOUN
dpc-4600	52	18	of	of	ADP
dpc-4600	52	19	vitiligo	vitiligo	NOUN
dpc-4600	52	20	.	.	PUNCT
dpc-4600	53	1	table	table	NOUN
dpc-4600	53	2	1	1	NUM
dpc-4600	53	3	.	.	PUNCT
dpc-4600	54	1	summary	summary	NOUN
dpc-4600	54	2	of	of	ADP
dpc-4600	54	3	the	the	DET
dpc-4600	54	4	main	main	ADJ
dpc-4600	54	5	pathogenetic	pathogenetic	ADJ
dpc-4600	54	6	mechanisms	mechanism	NOUN
dpc-4600	54	7	in	in	ADP
dpc-4600	54	8	vitiligo	vitiligo	NOUN
dpc-4600	54	9	.	.	PUNCT
dpc-4600	55	1	genetics	genetic	NOUN
dpc-4600	55	2	•	•	ADP
dpc-4600	55	3	many	many	ADJ
dpc-4600	55	4	genetic	genetic	ADJ
dpc-4600	55	5	loci	locus	NOUN
dpc-4600	55	6	have	have	AUX
dpc-4600	55	7	been	be	AUX
dpc-4600	55	8	identified	identify	VERB
dpc-4600	55	9	like	like	ADP
dpc-4600	55	10	nlrp1	nlrp1	NOUN
dpc-4600	55	11	(	(	PUNCT
dpc-4600	55	12	nlr	nlr	PROPN
dpc-4600	55	13	family	family	PROPN
dpc-4600	55	14	pyrin	pyrin	NOUN
dpc-4600	55	15	domain	domain	NOUN
dpc-4600	55	16	containing	contain	VERB
dpc-4600	55	17	1	1	NUM
dpc-4600	55	18	)	)	PUNCT
dpc-4600	55	19	,	,	PUNCT
dpc-4600	55	20	pdgfra	pdgfra	NOUN
dpc-4600	55	21	(	(	PUNCT
dpc-4600	55	22	platelet	platelet	NOUN
dpc-4600	55	23	-	-	PUNCT
dpc-4600	55	24	derived	derive	VERB
dpc-4600	55	25	growth	growth	NOUN
dpc-4600	55	26	factor	factor	NOUN
dpc-4600	55	27	receptor	receptor	NOUN
dpc-4600	55	28	α	α	NOUN
dpc-4600	55	29	)	)	PUNCT
dpc-4600	55	30	,	,	PUNCT
dpc-4600	55	31	ptpn22	ptpn22	NOUN
dpc-4600	55	32	(	(	PUNCT
dpc-4600	55	33	protein	protein	NOUN
dpc-4600	55	34	tyrosinase	tyrosinase	NOUN
dpc-4600	55	35	phosphatase	phosphatase	NOUN
dpc-4600	55	36	non	non	ADJ
dpc-4600	55	37	-	-	ADJ
dpc-4600	55	38	receptor	receptor	ADJ
dpc-4600	55	39	type	type	NOUN
dpc-4600	55	40	22	22	NUM
dpc-4600	55	41	)	)	PUNCT
dpc-4600	55	42	,	,	PUNCT
dpc-4600	55	43	foxd3	foxd3	NOUN
dpc-4600	55	44	(	(	PUNCT
dpc-4600	55	45	forkhead	forkhead	PROPN
dpc-4600	55	46	box	box	PROPN
dpc-4600	55	47	d3	d3	PROPN
dpc-4600	55	48	)	)	PUNCT
dpc-4600	55	49	,	,	PUNCT
dpc-4600	55	50	xbp1	xbp1	PROPN
dpc-4600	56	1	(	(	PUNCT
dpc-4600	56	2	x	x	NOUN
dpc-4600	56	3	-	-	NOUN
dpc-4600	56	4	box	box	NOUN
dpc-4600	56	5	binding	bind	VERB
dpc-4600	56	6	protein	protein	NOUN
dpc-4600	56	7	1	1	NUM
dpc-4600	56	8	)	)	PUNCT
dpc-4600	56	9	,	,	PUNCT
dpc-4600	56	10	ctla-4	ctla-4	X
dpc-4600	56	11	(	(	PUNCT
dpc-4600	56	12	cytotoxic	cytotoxic	ADJ
dpc-4600	56	13	t	t	NOUN
dpc-4600	56	14	-	-	PUNCT
dpc-4600	56	15	lymphocyte	lymphocyte	NOUN
dpc-4600	56	16	antigen	antigen	NOUN
dpc-4600	56	17	4	4	NUM
dpc-4600	56	18	)	)	PUNCT
dpc-4600	56	19	,	,	PUNCT
dpc-4600	56	20	•	•	NUM
dpc-4600	56	21	vitiligo	vitiligo	PROPN
dpc-4600	56	22	has	have	VERB
dpc-4600	56	23	a	a	DET
dpc-4600	56	24	significant	significant	ADJ
dpc-4600	56	25	association	association	NOUN
dpc-4600	56	26	with	with	ADP
dpc-4600	56	27	other	other	ADJ
dpc-4600	56	28	autoimmune	autoimmune	ADJ
dpc-4600	56	29	disorders	disorder	NOUN
dpc-4600	56	30	like	like	ADP
dpc-4600	56	31	type	type	NOUN
dpc-4600	56	32	1	1	NUM
dpc-4600	56	33	diabetes	diabetes	NOUN
dpc-4600	56	34	mellitus	mellitus	NOUN
dpc-4600	56	35	,	,	PUNCT
dpc-4600	56	36	autoimmune	autoimmune	ADJ
dpc-4600	56	37	thyroiditis	thyroiditis	NOUN
dpc-4600	56	38	,	,	PUNCT
dpc-4600	56	39	pernicious	pernicious	ADJ
dpc-4600	56	40	anemia	anemia	NOUN
dpc-4600	56	41	,	,	PUNCT
dpc-4600	56	42	addison	addison	PROPN
dpc-4600	56	43	’s	’s	PART
dpc-4600	56	44	disease	disease	PROPN
dpc-4600	56	45	,	,	PUNCT
dpc-4600	56	46	systemic	systemic	ADJ
dpc-4600	56	47	lupus	lupus	PROPN
dpc-4600	56	48	erythematosus	erythematosus	PROPN
dpc-4600	56	49	,	,	PUNCT
dpc-4600	56	50	and	and	CCONJ
dpc-4600	56	51	alopecia	alopecia	NOUN
dpc-4600	56	52	areata	areata	ADJ
dpc-4600	56	53	.	.	PUNCT
dpc-4600	57	1	•	•	NOUN
dpc-4600	57	2	familial	familial	ADJ
dpc-4600	57	3	vitiligo	vitiligo	NOUN
dpc-4600	57	4	is	be	AUX
dpc-4600	57	5	associated	associate	VERB
dpc-4600	57	6	with	with	ADP
dpc-4600	57	7	polymorphism	polymorphism	NOUN
dpc-4600	57	8	in	in	ADP
dpc-4600	57	9	hla	hla	PROPN
dpc-4600	57	10	-	-	PUNCT
dpc-4600	57	11	drb1	drb1	PROPN
dpc-4600	57	12	/	/	SYM
dpc-4600	57	13	dqa1	dqa1	PROPN
dpc-4600	57	14	.	.	PUNCT
dpc-4600	58	1	autoimmunity	autoimmunity	NOUN
dpc-4600	58	2	•	•	NUM
dpc-4600	58	3	melanocytes	melanocyte	NOUN
dpc-4600	58	4	communicate	communicate	VERB
dpc-4600	58	5	stress	stress	NOUN
dpc-4600	58	6	to	to	ADP
dpc-4600	58	7	antigen	antigen	NOUN
dpc-4600	58	8	-	-	PUNCT
dpc-4600	58	9	presenting	present	VERB
dpc-4600	58	10	cells	cell	NOUN
dpc-4600	58	11	through	through	ADP
dpc-4600	58	12	exosomes	exosome	NOUN
dpc-4600	58	13	,	,	PUNCT
dpc-4600	58	14	extracellular	extracellular	ADJ
dpc-4600	58	15	vesicles	vesicle	NOUN
dpc-4600	58	16	with	with	ADP
dpc-4600	58	17	micro	micro	NOUN
dpc-4600	58	18	-	-	NOUN
dpc-4600	58	19	rnas	rnas	ADJ
dpc-4600	58	20	,	,	PUNCT
dpc-4600	58	21	heat	heat	NOUN
dpc-4600	58	22	shock	shock	NOUN
dpc-4600	58	23	protein	protein	NOUN
dpc-4600	58	24	70	70	NUM
dpc-4600	58	25	(	(	PUNCT
dpc-4600	58	26	hsp	hsp	NOUN
dpc-4600	58	27	70	70	NUM
dpc-4600	58	28	)	)	PUNCT
dpc-4600	58	29	,	,	PUNCT
dpc-4600	58	30	and	and	CCONJ
dpc-4600	58	31	damps	damps	VERB
dpc-4600	58	32	(	(	PUNCT
dpc-4600	58	33	damage	damage	NOUN
dpc-4600	58	34	-	-	PUNCT
dpc-4600	58	35	associated	associate	VERB
dpc-4600	58	36	molecular	molecular	ADJ
dpc-4600	58	37	patterns	pattern	NOUN
dpc-4600	58	38	)	)	PUNCT
dpc-4600	58	39	.	.	PUNCT
dpc-4600	59	1	•	•	INTJ
dpc-4600	59	2	there	there	PRON
dpc-4600	59	3	is	be	VERB
dpc-4600	59	4	production	production	NOUN
dpc-4600	59	5	of	of	ADP
dpc-4600	59	6	interferon	interferon	ADJ
dpc-4600	59	7	-	-	PUNCT
dpc-4600	59	8	γ	γ	NOUN
dpc-4600	59	9	leading	lead	VERB
dpc-4600	59	10	to	to	ADP
dpc-4600	59	11	the	the	DET
dpc-4600	59	12	activation	activation	NOUN
dpc-4600	59	13	of	of	ADP
dpc-4600	59	14	cxc	cxc	NOUN
dpc-4600	59	15	chemokine	chemokine	ADJ
dpc-4600	59	16	ligands	ligand	NOUN
dpc-4600	59	17	(	(	PUNCT
dpc-4600	59	18	cxcl9	cxcl9	NOUN
dpc-4600	59	19	,	,	PUNCT
dpc-4600	59	20	cxcl10	cxcl10	NOUN
dpc-4600	59	21	,	,	PUNCT
dpc-4600	59	22	and	and	CCONJ
dpc-4600	59	23	cxcl11	cxcl11	NOUN
dpc-4600	59	24	)	)	PUNCT
dpc-4600	59	25	and	and	CCONJ
dpc-4600	59	26	attracting	attract	VERB
dpc-4600	59	27	more	more	ADJ
dpc-4600	59	28	cd8+t	cd8+t	NOUN
dpc-4600	59	29	cells	cell	NOUN
dpc-4600	59	30	towards	towards	ADP
dpc-4600	59	31	vitiliginous	vitiliginous	ADJ
dpc-4600	59	32	sites	site	NOUN
dpc-4600	59	33	.	.	PUNCT
dpc-4600	60	1	•	•	NUM
dpc-4600	60	2	dysfunction	dysfunction	NOUN
dpc-4600	60	3	of	of	ADP
dpc-4600	60	4	regulatory	regulatory	ADJ
dpc-4600	60	5	t	t	NOUN
dpc-4600	60	6	cells	cell	NOUN
dpc-4600	60	7	(	(	PUNCT
dpc-4600	60	8	tregs	treg	NOUN
dpc-4600	60	9	)	)	PUNCT
dpc-4600	60	10	and	and	CCONJ
dpc-4600	60	11	cd8	cd8	PROPN
dpc-4600	60	12	+	+	CCONJ
dpc-4600	60	13	tissue	tissue	NOUN
dpc-4600	60	14	-	-	PUNCT
dpc-4600	60	15	resident	resident	NOUN
dpc-4600	60	16	memory	memory	NOUN
dpc-4600	60	17	t	t	PROPN
dpc-4600	60	18	cells	cell	NOUN
dpc-4600	60	19	(	(	PUNCT
dpc-4600	60	20	trm	trm	NOUN
dpc-4600	60	21	)	)	PUNCT
dpc-4600	60	22	is	be	AUX
dpc-4600	60	23	also	also	ADV
dpc-4600	60	24	seen	see	VERB
dpc-4600	60	25	.	.	PUNCT
dpc-4600	61	1	oxidative	oxidative	ADJ
dpc-4600	61	2	stress	stress	NOUN
dpc-4600	61	3	hypothesis	hypothesis	NOUN
dpc-4600	61	4	•	•	NOUN
dpc-4600	61	5	there	there	PRON
dpc-4600	61	6	is	be	VERB
dpc-4600	61	7	excessive	excessive	ADJ
dpc-4600	61	8	production	production	NOUN
dpc-4600	61	9	of	of	ADP
dpc-4600	61	10	oxidative	oxidative	ADJ
dpc-4600	61	11	stress	stress	NOUN
dpc-4600	61	12	markers	marker	NOUN
dpc-4600	61	13	and	and	CCONJ
dpc-4600	61	14	reduction	reduction	NOUN
dpc-4600	61	15	in	in	ADP
dpc-4600	61	16	antioxidants	antioxidant	NOUN
dpc-4600	61	17	.	.	PUNCT
dpc-4600	62	1	•	•	NUM
dpc-4600	62	2	components	component	NOUN
dpc-4600	62	3	of	of	ADP
dpc-4600	62	4	upr	upr	NOUN
dpc-4600	62	5	(	(	PUNCT
dpc-4600	62	6	unfolded	unfold	VERB
dpc-4600	62	7	protein	protein	NOUN
dpc-4600	62	8	response	response	NOUN
dpc-4600	62	9	)	)	PUNCT
dpc-4600	62	10	like	like	ADP
dpc-4600	62	11	encoding	encode	VERB
dpc-4600	62	12	x	x	PROPN
dpc-4600	62	13	-	-	NOUN
dpc-4600	62	14	box	box	NOUN
dpc-4600	62	15	protein	protein	NOUN
dpc-4600	62	16	1	1	NUM
dpc-4600	62	17	(	(	PUNCT
dpc-4600	62	18	xbp1	xbp1	PROPN
dpc-4600	62	19	)	)	PUNCT
dpc-4600	62	20	causes	cause	VERB
dpc-4600	62	21	the	the	DET
dpc-4600	62	22	release	release	NOUN
dpc-4600	62	23	of	of	ADP
dpc-4600	62	24	immune	immune	ADJ
dpc-4600	62	25	mediators	mediator	NOUN
dpc-4600	62	26	like	like	ADP
dpc-4600	62	27	il-6/8	il-6/8	NOUN
dpc-4600	62	28	,	,	PUNCT
dpc-4600	62	29	which	which	PRON
dpc-4600	62	30	halt	halt	VERB
dpc-4600	62	31	t	t	PROPN
dpc-4600	62	32	regulatory	regulatory	ADJ
dpc-4600	62	33	cells	cell	NOUN
dpc-4600	62	34	(	(	PUNCT
dpc-4600	62	35	tregs	treg	NOUN
dpc-4600	62	36	)	)	PUNCT
dpc-4600	62	37	.	.	PUNCT
dpc-4600	63	1	•	•	NOUN
dpc-4600	63	2	significant	significant	ADJ
dpc-4600	63	3	reduction	reduction	NOUN
dpc-4600	63	4	in	in	ADP
dpc-4600	63	5	nuclear	nuclear	ADJ
dpc-4600	63	6	factor	factor	NOUN
dpc-4600	63	7	erythroid	erythroid	NOUN
dpc-4600	63	8	2	2	NUM
dpc-4600	63	9	-	-	PUNCT
dpc-4600	63	10	related	relate	VERB
dpc-4600	63	11	factor	factor	NOUN
dpc-4600	63	12	(	(	PUNCT
dpc-4600	63	13	nrf2	nrf2	PROPN
dpc-4600	63	14	)	)	PUNCT
dpc-4600	63	15	and	and	CCONJ
dpc-4600	63	16	mtorc1	mtorc1	NOUN
dpc-4600	63	17	(	(	PUNCT
dpc-4600	63	18	mammalian	mammalian	ADJ
dpc-4600	63	19	target	target	NOUN
dpc-4600	63	20	of	of	ADP
dpc-4600	63	21	rapamycin	rapamycin	NOUN
dpc-4600	63	22	complex	complex	ADJ
dpc-4600	63	23	1	1	NUM
dpc-4600	63	24	)	)	PUNCT
dpc-4600	63	25	causes	cause	VERB
dpc-4600	63	26	significant	significant	ADJ
dpc-4600	63	27	oxidative	oxidative	ADJ
dpc-4600	63	28	stress	stress	NOUN
dpc-4600	63	29	to	to	ADP
dpc-4600	63	30	melanocytes	melanocyte	NOUN
dpc-4600	63	31	.	.	PUNCT
dpc-4600	64	1	neural	neural	ADJ
dpc-4600	64	2	hypothesis	hypothesis	NOUN
dpc-4600	64	3	•	•	NOUN
dpc-4600	64	4	different	different	ADJ
dpc-4600	64	5	neurochemical	neurochemical	ADJ
dpc-4600	64	6	substances	substance	NOUN
dpc-4600	64	7	released	release	VERB
dpc-4600	64	8	from	from	ADP
dpc-4600	64	9	nerve	nerve	NOUN
dpc-4600	64	10	endings	ending	NOUN
dpc-4600	64	11	in	in	ADP
dpc-4600	64	12	the	the	DET
dpc-4600	64	13	skin	skin	NOUN
dpc-4600	64	14	kill	kill	NOUN
dpc-4600	64	15	melanocytes	melanocyte	NOUN
dpc-4600	64	16	and	and	CCONJ
dpc-4600	64	17	damage	damage	NOUN
dpc-4600	64	18	cells	cell	NOUN
dpc-4600	64	19	.	.	PUNCT
dpc-4600	65	1	•	•	NUM
dpc-4600	65	2	increased	increase	VERB
dpc-4600	65	3	levels	level	NOUN
dpc-4600	65	4	of	of	ADP
dpc-4600	65	5	norepinephrine	norepinephrine	NOUN
dpc-4600	65	6	in	in	ADP
dpc-4600	65	7	plasma	plasma	NOUN
dpc-4600	65	8	and	and	CCONJ
dpc-4600	65	9	catecholamine	catecholamine	NOUN
dpc-4600	65	10	catabolites	catabolite	NOUN
dpc-4600	65	11	in	in	ADP
dpc-4600	65	12	urine	urine	NOUN
dpc-4600	65	13	are	be	AUX
dpc-4600	65	14	observed	observe	VERB
dpc-4600	65	15	.	.	PUNCT
dpc-4600	66	1	•	•	X
dpc-4600	66	2	there	there	PRON
dpc-4600	66	3	is	be	VERB
dpc-4600	66	4	an	an	DET
dpc-4600	66	5	increase	increase	NOUN
dpc-4600	66	6	in	in	ADP
dpc-4600	66	7	neuropeptide	neuropeptide	ADJ
dpc-4600	66	8	y	y	PROPN
dpc-4600	66	9	(	(	PUNCT
dpc-4600	66	10	npy	npy	PROPN
dpc-4600	66	11	)	)	PUNCT
dpc-4600	66	12	in	in	ADP
dpc-4600	66	13	vitiligo	vitiligo	NOUN
dpc-4600	66	14	-	-	PUNCT
dpc-4600	66	15	lesional	lesional	ADJ
dpc-4600	66	16	and	and	CCONJ
dpc-4600	66	17	peri	peri	NOUN
dpc-4600	66	18	-	-	PUNCT
dpc-4600	66	19	lesional	lesional	ADJ
dpc-4600	66	20	skin	skin	NOUN
dpc-4600	66	21	.	.	PUNCT
dpc-4600	67	1	4	4	NUM
dpc-4600	67	2	review	review	NOUN
dpc-4600	67	3	|	|	ADV
dpc-4600	67	4	dermatol	dermatol	ADJ
dpc-4600	67	5	pract	pract	NOUN
dpc-4600	67	6	concept	concept	NOUN
dpc-4600	67	7	.	.	PUNCT
dpc-4600	68	1	2025;15(1):4600	2025;15(1):4600	NUM
dpc-4600	68	2	records	record	NOUN
dpc-4600	68	3	identified	identify	VERB
dpc-4600	68	4	from	from	ADP
dpc-4600	68	5	:	:	PUNCT
dpc-4600	68	6	pubmed	pubmed	PROPN
dpc-4600	68	7	(	(	PUNCT
dpc-4600	68	8	n=1046	n=1046	NOUN
dpc-4600	68	9	)	)	PUNCT
dpc-4600	68	10	other	other	ADJ
dpc-4600	68	11	sources	source	NOUN
dpc-4600	68	12	(	(	PUNCT
dpc-4600	68	13	n=8	n=8	NUM
dpc-4600	68	14	)	)	PUNCT
dpc-4600	68	15	records	record	NOUN
dpc-4600	68	16	screened	screen	VERB
dpc-4600	68	17	(	(	PUNCT
dpc-4600	68	18	n=871	n=871	PROPN
dpc-4600	68	19	)	)	PUNCT
dpc-4600	68	20	records	record	NOUN
dpc-4600	68	21	excluded	exclude	VERB
dpc-4600	68	22	(	(	PUNCT
dpc-4600	68	23	n=248	n=248	NOUN
dpc-4600	68	24	)	)	PUNCT
dpc-4600	68	25	published	publish	VERB
dpc-4600	68	26	before	before	ADP
dpc-4600	68	27	2010	2010	NUM
dpc-4600	68	28	(	(	PUNCT
dpc-4600	68	29	n=226	n=226	NOUN
dpc-4600	68	30	)	)	PUNCT
dpc-4600	68	31	only	only	ADV
dpc-4600	68	32	abstracts	abstract	NOUN
dpc-4600	68	33	available	available	ADJ
dpc-4600	68	34	(	(	PUNCT
dpc-4600	68	35	n=14	n=14	NOUN
dpc-4600	68	36	)	)	PUNCT
dpc-4600	68	37	non	non	ADJ
dpc-4600	68	38	-	-	ADJ
dpc-4600	68	39	english	english	ADJ
dpc-4600	68	40	(	(	PUNCT
dpc-4600	68	41	n=8	n=8	NUM
dpc-4600	68	42	)	)	PUNCT
dpc-4600	68	43	reports	report	NOUN
dpc-4600	68	44	sought	seek	VERB
dpc-4600	68	45	for	for	ADP
dpc-4600	68	46	retrieval	retrieval	NOUN
dpc-4600	68	47	(	(	PUNCT
dpc-4600	68	48	n=623	n=623	PROPN
dpc-4600	68	49	)	)	PUNCT
dpc-4600	68	50	reports	report	NOUN
dpc-4600	68	51	assessed	assess	VERB
dpc-4600	68	52	for	for	ADP
dpc-4600	68	53	eligibility	eligibility	NOUN
dpc-4600	68	54	(	(	PUNCT
dpc-4600	68	55	n=623	n=623	PROPN
dpc-4600	68	56	)	)	PUNCT
dpc-4600	68	57	reports	report	NOUN
dpc-4600	68	58	excluded	exclude	VERB
dpc-4600	68	59	(	(	PUNCT
dpc-4600	68	60	n=570	n=570	NOUN
dpc-4600	68	61	):	):	PUNCT
dpc-4600	68	62	irrelevant	irrelevant	ADJ
dpc-4600	68	63	review	review	NOUN
dpc-4600	68	64	articles	article	NOUN
dpc-4600	68	65	(	(	PUNCT
dpc-4600	68	66	n=137	n=137	NUM
dpc-4600	68	67	)	)	PUNCT
dpc-4600	68	68	other	other	ADJ
dpc-4600	68	69	reasons	reason	NOUN
dpc-4600	68	70	(	(	PUNCT
dpc-4600	68	71	n=433	n=433	NOUN
dpc-4600	68	72	)	)	PUNCT
dpc-4600	68	73	i	i	PROPN
dpc-4600	68	74	d	d	PROPN
dpc-4600	68	75	en	en	PROPN
dpc-4600	68	76	tif	tif	PROPN
dpc-4600	68	77	ic	ic	PROPN
dpc-4600	68	78	at	at	ADP
dpc-4600	68	79	io	io	PROPN
dpc-4600	68	80	n	n	PRON
dpc-4600	68	81	sc	sc	PROPN
dpc-4600	68	82	re	re	X
dpc-4600	68	83	en	en	X
dpc-4600	68	84	in	in	ADP
dpc-4600	68	85	g	g	NOUN
dpc-4600	68	86	identification	identification	NOUN
dpc-4600	68	87	of	of	ADP
dpc-4600	68	88	studies	study	NOUN
dpc-4600	68	89	via	via	ADP
dpc-4600	68	90	databases	database	NOUN
dpc-4600	68	91	and	and	CCONJ
dpc-4600	68	92	registers	register	NOUN
dpc-4600	68	93	studies	study	NOUN
dpc-4600	68	94	included	include	VERB
dpc-4600	68	95	in	in	ADP
dpc-4600	68	96	review	review	NOUN
dpc-4600	68	97	(	(	PUNCT
dpc-4600	68	98	n=53	n=53	ADV
dpc-4600	68	99	)	)	PUNCT
dpc-4600	68	100	meta	meta	ADJ
dpc-4600	68	101	-	-	PUNCT
dpc-4600	68	102	analysis	analysis	NOUN
dpc-4600	68	103	and	and	CCONJ
dpc-4600	68	104	systematic	systematic	ADJ
dpc-4600	68	105	reviews	review	NOUN
dpc-4600	68	106	(	(	PUNCT
dpc-4600	68	107	n=7	n=7	PROPN
dpc-4600	68	108	)	)	PUNCT
dpc-4600	68	109	original	original	ADJ
dpc-4600	68	110	articles	article	NOUN
dpc-4600	68	111	(	(	PUNCT
dpc-4600	68	112	n=18	n=18	ADJ
dpc-4600	68	113	)	)	PUNCT
dpc-4600	68	114	rct	rct	PROPN
dpc-4600	68	115	(	(	PUNCT
dpc-4600	68	116	n=5	n=5	ADJ
dpc-4600	68	117	)	)	PUNCT
dpc-4600	68	118	clinical	clinical	ADJ
dpc-4600	68	119	trials	trial	NOUN
dpc-4600	68	120	(	(	PUNCT
dpc-4600	68	121	n=7	n=7	NOUN
dpc-4600	68	122	)	)	PUNCT
dpc-4600	68	123	case	case	NOUN
dpc-4600	68	124	-	-	PUNCT
dpc-4600	68	125	control	control	NOUN
dpc-4600	68	126	study	study	NOUN
dpc-4600	68	127	(	(	PUNCT
dpc-4600	68	128	n=6	n=6	NOUN
dpc-4600	68	129	)	)	PUNCT
dpc-4600	68	130	narrative	narrative	NOUN
dpc-4600	68	131	reviews	review	NOUN
dpc-4600	68	132	(	(	PUNCT
dpc-4600	68	133	n=22	n=22	NOUN
dpc-4600	68	134	)	)	PUNCT
dpc-4600	68	135	case	case	NOUN
dpc-4600	68	136	series	series	NOUN
dpc-4600	68	137	(	(	PUNCT
dpc-4600	68	138	n=2	n=2	NOUN
dpc-4600	68	139	)	)	PUNCT
dpc-4600	68	140	case	case	NOUN
dpc-4600	68	141	report	report	NOUN
dpc-4600	68	142	(	(	PUNCT
dpc-4600	68	143	n=3	n=3	NOUN
dpc-4600	68	144	)	)	PUNCT
dpc-4600	68	145	editorial	editorial	ADJ
dpc-4600	68	146	review	review	NOUN
dpc-4600	68	147	(	(	PUNCT
dpc-4600	68	148	n=1	n=1	PROPN
dpc-4600	68	149	)	)	PUNCT
dpc-4600	68	150	in	in	ADP
dpc-4600	68	151	cl	cl	NOUN
dpc-4600	68	152	ud	ud	INTJ
dpc-4600	68	153	ed	ed	NOUN
dpc-4600	68	154	duplicates	duplicate	NOUN
dpc-4600	68	155	removed	remove	VERB
dpc-4600	68	156	:	:	PUNCT
dpc-4600	68	157	(	(	PUNCT
dpc-4600	68	158	n=183	n=183	NUM
dpc-4600	68	159	)	)	PUNCT
dpc-4600	68	160	figure	figure	NOUN
dpc-4600	68	161	3	3	NUM
dpc-4600	68	162	.	.	PUNCT
dpc-4600	68	163	metodology	metodology	NOUN
dpc-4600	68	164	of	of	ADP
dpc-4600	68	165	the	the	DET
dpc-4600	68	166	study	study	NOUN
dpc-4600	68	167	.	.	PUNCT
dpc-4600	69	1	receptor	receptor	NOUN
dpc-4600	69	2	,	,	PUNCT
dpc-4600	69	3	there	there	PRON
dpc-4600	69	4	is	be	VERB
dpc-4600	69	5	activation	activation	NOUN
dpc-4600	69	6	and	and	CCONJ
dpc-4600	69	7	phosphorylation	phosphorylation	NOUN
dpc-4600	69	8	of	of	ADP
dpc-4600	69	9	stat1	stat1	PROPN
dpc-4600	69	10	,	,	PUNCT
dpc-4600	69	11	leading	lead	VERB
dpc-4600	69	12	to	to	ADP
dpc-4600	69	13	transcription	transcription	NOUN
dpc-4600	69	14	of	of	ADP
dpc-4600	69	15	ifn	ifn	PROPN
dpc-4600	69	16	-	-	PUNCT
dpc-4600	69	17	γ	γ	NOUN
dpc-4600	69	18	-	-	PUNCT
dpc-4600	69	19	stimulated	stimulated	ADJ
dpc-4600	69	20	genes	gene	NOUN
dpc-4600	69	21	[	[	X
dpc-4600	69	22	18	18	NUM
dpc-4600	69	23	]	]	PUNCT
dpc-4600	69	24	.	.	PUNCT
dpc-4600	70	1	therefore	therefore	ADV
dpc-4600	70	2	,	,	PUNCT
dpc-4600	70	3	inhibition	inhibition	NOUN
dpc-4600	70	4	of	of	ADP
dpc-4600	70	5	the	the	DET
dpc-4600	70	6	jak1	jak1	PROPN
dpc-4600	70	7	/	/	SYM
dpc-4600	70	8	jak2	jak2	PROPN
dpc-4600	70	9	pathway	pathway	NOUN
dpc-4600	70	10	can	can	AUX
dpc-4600	70	11	block	block	VERB
dpc-4600	70	12	ifn	ifn	NOUN
dpc-4600	70	13	-	-	PUNCT
dpc-4600	70	14	γ	γ	NOUN
dpc-4600	70	15	signaling	signal	VERB
dpc-4600	70	16	,	,	PUNCT
dpc-4600	70	17	which	which	PRON
dpc-4600	70	18	makes	make	VERB
dpc-4600	70	19	janus	janus	PROPN
dpc-4600	70	20	kinase	kinase	PROPN
dpc-4600	70	21	inhibitors	inhibitor	VERB
dpc-4600	70	22	an	an	DET
dpc-4600	70	23	attractive	attractive	ADJ
dpc-4600	70	24	treatment	treatment	NOUN
dpc-4600	70	25	option	option	NOUN
dpc-4600	70	26	for	for	ADP
dpc-4600	70	27	the	the	DET
dpc-4600	70	28	management	management	NOUN
dpc-4600	70	29	of	of	ADP
dpc-4600	70	30	vitiligo	vitiligo	NOUN
dpc-4600	70	31	.	.	PUNCT
dpc-4600	71	1	topical	topical	ADJ
dpc-4600	71	2	ruxolitinib	ruxolitinib	NOUN
dpc-4600	71	3	1.5	1.5	NUM
dpc-4600	71	4	%	%	NOUN
dpc-4600	71	5	cream	cream	NOUN
dpc-4600	71	6	,	,	PUNCT
dpc-4600	71	7	a	a	DET
dpc-4600	71	8	jak	jak	PROPN
dpc-4600	71	9	1	1	NUM
dpc-4600	71	10	and	and	CCONJ
dpc-4600	71	11	2	2	NUM
dpc-4600	71	12	inhibitor	inhibitor	NOUN
dpc-4600	71	13	,	,	PUNCT
dpc-4600	71	14	is	be	AUX
dpc-4600	71	15	the	the	DET
dpc-4600	71	16	first	first	PROPN
dpc-4600	71	17	jak	jak	PROPN
dpc-4600	71	18	inhibitor	inhibitor	NOUN
dpc-4600	71	19	approved	approve	VERB
dpc-4600	71	20	by	by	ADP
dpc-4600	71	21	the	the	DET
dpc-4600	71	22	fda	fda	PROPN
dpc-4600	71	23	for	for	ADP
dpc-4600	71	24	the	the	DET
dpc-4600	71	25	treatment	treatment	NOUN
dpc-4600	71	26	of	of	ADP
dpc-4600	71	27	non	non	ADJ
dpc-4600	71	28	-	-	ADJ
dpc-4600	71	29	segmental	segmental	ADJ
dpc-4600	71	30	vitiligo	vitiligo	NOUN
dpc-4600	71	31	(	(	PUNCT
dpc-4600	71	32	nsv	nsv	PROPN
dpc-4600	71	33	)	)	PUNCT
dpc-4600	71	34	in	in	ADP
dpc-4600	71	35	patients	patient	NOUN
dpc-4600	71	36	aged	age	VERB
dpc-4600	71	37	more	more	ADJ
dpc-4600	71	38	than	than	ADP
dpc-4600	71	39	12	12	NUM
dpc-4600	71	40	years	year	NOUN
dpc-4600	71	41	[	[	X
dpc-4600	71	42	19	19	NUM
dpc-4600	71	43	]	]	PUNCT
dpc-4600	71	44	.	.	PUNCT
dpc-4600	72	1	it	it	PRON
dpc-4600	72	2	is	be	AUX
dpc-4600	72	3	a	a	DET
dpc-4600	72	4	chimeric	chimeric	ADJ
dpc-4600	72	5	antibody	antibody	NOUN
dpc-4600	72	6	that	that	PRON
dpc-4600	72	7	targets	target	VERB
dpc-4600	72	8	cd20	cd20	PROPN
dpc-4600	72	9	cells	cell	NOUN
dpc-4600	72	10	,	,	PUNCT
dpc-4600	72	11	which	which	PRON
dpc-4600	72	12	are	be	AUX
dpc-4600	72	13	preand	preand	VERB
dpc-4600	72	14	mature	mature	ADJ
dpc-4600	72	15	b	b	NOUN
dpc-4600	72	16	lymphocytes	lymphocyte	NOUN
dpc-4600	72	17	.	.	PUNCT
dpc-4600	73	1	it	it	PRON
dpc-4600	73	2	also	also	ADV
dpc-4600	73	3	inhibits	inhibit	VERB
dpc-4600	73	4	cd4	cd4	PROPN
dpc-4600	73	5	+	+	PROPN
dpc-4600	73	6	t	t	NOUN
dpc-4600	73	7	cells	cell	NOUN
dpc-4600	73	8	and	and	CCONJ
dpc-4600	73	9	cd8	cd8	PROPN
dpc-4600	73	10	+	+	PROPN
dpc-4600	73	11	cytotoxic	cytotoxic	ADJ
dpc-4600	73	12	and	and	CCONJ
dpc-4600	73	13	cd8	cd8	PROPN
dpc-4600	73	14	+	+	PROPN
dpc-4600	73	15	antigenspecific	antigenspecific	PROPN
dpc-4600	73	16	t	t	PROPN
dpc-4600	73	17	cell	cell	NOUN
dpc-4600	73	18	responses	response	NOUN
dpc-4600	73	19	as	as	ADV
dpc-4600	73	20	well	well	ADV
dpc-4600	73	21	as	as	ADP
dpc-4600	73	22	human	human	ADJ
dpc-4600	73	23	dendritic	dendritic	ADJ
dpc-4600	73	24	cells	cell	NOUN
dpc-4600	73	25	.	.	PUNCT
dpc-4600	74	1	hamzavi	hamzavi	PROPN
dpc-4600	74	2	et	et	PROPN
dpc-4600	74	3	al	al	PROPN
dpc-4600	74	4	.	.	PROPN
dpc-4600	74	5	tested	test	VERB
dpc-4600	74	6	ruxolitinib	ruxolitinib	NOUN
dpc-4600	74	7	cream	cream	NOUN
dpc-4600	74	8	on	on	ADP
dpc-4600	74	9	157	157	NUM
dpc-4600	74	10	adults	adult	NOUN
dpc-4600	74	11	in	in	ADP
dpc-4600	74	12	a	a	DET
dpc-4600	74	13	phase	phase	NOUN
dpc-4600	74	14	ii	ii	NOUN
dpc-4600	74	15	study	study	NOUN
dpc-4600	74	16	.	.	PUNCT
dpc-4600	75	1	after	after	ADP
dpc-4600	75	2	24	24	NUM
dpc-4600	75	3	weeks	week	NOUN
dpc-4600	75	4	,	,	PUNCT
dpc-4600	75	5	the	the	DET
dpc-4600	75	6	cream	cream	NOUN
dpc-4600	75	7	repigmented	repigmente	VERB
dpc-4600	75	8	facial	facial	ADJ
dpc-4600	75	9	and	and	CCONJ
dpc-4600	75	10	total	total	ADJ
dpc-4600	75	11	body	body	NOUN
dpc-4600	75	12	vitiligo	vitiligo	NOUN
dpc-4600	75	13	lesions	lesion	NOUN
dpc-4600	75	14	,	,	PUNCT
dpc-4600	75	15	improving	improve	VERB
dpc-4600	75	16	until	until	ADP
dpc-4600	75	17	week	week	NOUN
dpc-4600	75	18	52	52	NUM
dpc-4600	75	19	.	.	PUNCT
dpc-4600	76	1	ruxolitinib	ruxolitinib	NOUN
dpc-4600	76	2	cream	cream	PROPN
dpc-4600	76	3	also	also	ADV
dpc-4600	76	4	clinically	clinically	ADV
dpc-4600	76	5	repigmented	repigmente	VERB
dpc-4600	76	6	all	all	DET
dpc-4600	76	7	body	body	NOUN
dpc-4600	76	8	parts	part	NOUN
dpc-4600	76	9	,	,	PUNCT
dpc-4600	76	10	including	include	VERB
dpc-4600	76	11	acral	acral	ADJ
dpc-4600	76	12	areas	area	NOUN
dpc-4600	76	13	,	,	PUNCT
dpc-4600	76	14	which	which	PRON
dpc-4600	76	15	are	be	AUX
dpc-4600	76	16	notoriously	notoriously	ADV
dpc-4600	76	17	difficult	difficult	ADJ
dpc-4600	76	18	to	to	PART
dpc-4600	76	19	treat	treat	VERB
dpc-4600	76	20	.	.	PUNCT
dpc-4600	77	1	milder	mild	ADJ
dpc-4600	77	2	side	side	NOUN
dpc-4600	77	3	effects	effect	NOUN
dpc-4600	77	4	were	be	AUX
dpc-4600	77	5	observed	observe	VERB
dpc-4600	77	6	,	,	PUNCT
dpc-4600	77	7	like	like	ADP
dpc-4600	77	8	acne	acne	NOUN
dpc-4600	77	9	at	at	ADP
dpc-4600	77	10	the	the	DET
dpc-4600	77	11	site	site	NOUN
dpc-4600	77	12	of	of	ADP
dpc-4600	77	13	application	application	NOUN
dpc-4600	77	14	and	and	CCONJ
dpc-4600	77	15	pruritus	pruritus	NOUN
dpc-4600	77	16	[	[	X
dpc-4600	77	17	20	20	NUM
dpc-4600	77	18	]	]	PUNCT
dpc-4600	77	19	.	.	PUNCT
dpc-4600	78	1	ruxolitinib	ruxolitinib	PROPN
dpc-4600	78	2	cream	cream	PROPN
dpc-4600	78	3	has	have	AUX
dpc-4600	78	4	been	be	AUX
dpc-4600	78	5	used	use	VERB
dpc-4600	78	6	in	in	ADP
dpc-4600	78	7	combination	combination	NOUN
dpc-4600	78	8	with	with	ADP
dpc-4600	78	9	narrow	narrow	ADJ
dpc-4600	78	10	-	-	PUNCT
dpc-4600	78	11	band	band	NOUN
dpc-4600	78	12	uvb	uvb	ADJ
dpc-4600	78	13	(	(	PUNCT
dpc-4600	78	14	nb	nb	NOUN
dpc-4600	78	15	-	-	PUNCT
dpc-4600	78	16	uvb	uvb	ADJ
dpc-4600	78	17	)	)	PUNCT
dpc-4600	78	18	phototherapy	phototherapy	NOUN
dpc-4600	78	19	for	for	ADP
dpc-4600	78	20	52	52	NUM
dpc-4600	78	21	weeks	week	NOUN
dpc-4600	78	22	in	in	ADP
dpc-4600	78	23	an	an	DET
dpc-4600	78	24	open	open	ADJ
dpc-4600	78	25	-	-	PUNCT
dpc-4600	78	26	label	label	NOUN
dpc-4600	78	27	phase	phase	NOUN
dpc-4600	78	28	ii	ii	NOUN
dpc-4600	78	29	study	study	NOUN
dpc-4600	78	30	,	,	PUNCT
dpc-4600	78	31	with	with	ADP
dpc-4600	78	32	significant	significant	ADJ
dpc-4600	78	33	repigmentation	repigmentation	NOUN
dpc-4600	78	34	of	of	ADP
dpc-4600	78	35	lesions	lesion	NOUN
dpc-4600	78	36	,	,	PUNCT
dpc-4600	78	37	particularly	particularly	ADV
dpc-4600	78	38	on	on	ADP
dpc-4600	78	39	the	the	DET
dpc-4600	78	40	face	face	NOUN
dpc-4600	78	41	and	and	CCONJ
dpc-4600	78	42	body	body	NOUN
dpc-4600	78	43	[	[	X
dpc-4600	78	44	21	21	NUM
dpc-4600	78	45	]	]	PUNCT
dpc-4600	78	46	.	.	PUNCT
dpc-4600	79	1	however	however	ADV
dpc-4600	79	2	,	,	PUNCT
dpc-4600	79	3	more	more	ADJ
dpc-4600	79	4	studies	study	NOUN
dpc-4600	79	5	are	be	AUX
dpc-4600	79	6	needed	need	VERB
dpc-4600	79	7	on	on	ADP
dpc-4600	79	8	a	a	DET
dpc-4600	79	9	large	large	ADJ
dpc-4600	79	10	number	number	NOUN
dpc-4600	79	11	of	of	ADP
dpc-4600	79	12	patients	patient	NOUN
dpc-4600	79	13	to	to	PART
dpc-4600	79	14	further	far	ADV
dpc-4600	79	15	evaluate	evaluate	VERB
dpc-4600	79	16	its	its	PRON
dpc-4600	79	17	efficacy	efficacy	NOUN
dpc-4600	79	18	and	and	CCONJ
dpc-4600	79	19	safety	safety	NOUN
dpc-4600	79	20	.	.	PUNCT
dpc-4600	80	1	currently	currently	ADV
dpc-4600	80	2	,	,	PUNCT
dpc-4600	80	3	studies	study	NOUN
dpc-4600	80	4	are	be	AUX
dpc-4600	80	5	underway	underway	ADJ
dpc-4600	80	6	on	on	ADP
dpc-4600	80	7	the	the	DET
dpc-4600	80	8	safety	safety	NOUN
dpc-4600	80	9	and	and	CCONJ
dpc-4600	80	10	tolerability	tolerability	NOUN
dpc-4600	80	11	of	of	ADP
dpc-4600	80	12	cerdulatinib	cerdulatinib	NOUN
dpc-4600	80	13	gel	gel	NOUN
dpc-4600	80	14	0.37	0.37	NUM
dpc-4600	80	15	%	%	NOUN
dpc-4600	80	16	bid	bid	NOUN
dpc-4600	80	17	,	,	PUNCT
dpc-4600	80	18	a	a	DET
dpc-4600	80	19	dual	dual	PROPN
dpc-4600	80	20	jak	jak	PROPN
dpc-4600	80	21	and	and	CCONJ
dpc-4600	80	22	spleen	spleen	PROPN
dpc-4600	80	23	tryrosine	tryrosine	PROPN
dpc-4600	80	24	kinase	kinase	PROPN
dpc-4600	80	25	(	(	PUNCT
dpc-4600	80	26	syk	syk	NOUN
dpc-4600	80	27	)	)	PUNCT
dpc-4600	80	28	inhibitor	inhibitor	NOUN
dpc-4600	80	29	,	,	PUNCT
dpc-4600	80	30	in	in	ADP
dpc-4600	80	31	the	the	DET
dpc-4600	80	32	treatment	treatment	NOUN
dpc-4600	80	33	of	of	ADP
dpc-4600	80	34	vitiligo	vitiligo	NOUN
dpc-4600	80	35	[	[	X
dpc-4600	80	36	22	22	NUM
dpc-4600	80	37	]	]	PUNCT
dpc-4600	80	38	.	.	PUNCT
dpc-4600	81	1	oral	oral	PROPN
dpc-4600	81	2	jak	jak	PROPN
dpc-4600	81	3	inhibitors	inhibitor	NOUN
dpc-4600	81	4	baricitinib	baricitinib	NOUN
dpc-4600	81	5	,	,	PUNCT
dpc-4600	81	6	a	a	DET
dpc-4600	81	7	selective	selective	ADJ
dpc-4600	81	8	jak1/2	jak1/2	PROPN
dpc-4600	81	9	inhibitor	inhibitor	NOUN
dpc-4600	81	10	that	that	PRON
dpc-4600	81	11	primarily	primarily	ADV
dpc-4600	81	12	interferes	interfere	VERB
dpc-4600	81	13	with	with	ADP
dpc-4600	81	14	the	the	DET
dpc-4600	81	15	transduction	transduction	NOUN
dpc-4600	81	16	of	of	ADP
dpc-4600	81	17	pro	pro	ADJ
dpc-4600	81	18	-	-	ADJ
dpc-4600	81	19	inflammatory	inflammatory	ADJ
dpc-4600	81	20	cytokines	cytokine	NOUN
dpc-4600	81	21	,	,	PUNCT
dpc-4600	81	22	has	have	AUX
dpc-4600	81	23	been	be	AUX
dpc-4600	81	24	recently	recently	ADV
dpc-4600	81	25	approved	approve	VERB
dpc-4600	81	26	for	for	ADP
dpc-4600	81	27	the	the	DET
dpc-4600	81	28	management	management	NOUN
dpc-4600	81	29	of	of	ADP
dpc-4600	81	30	atopic	atopic	NOUN
dpc-4600	81	31	review	review	NOUN
dpc-4600	81	32	|	|	ADV
dpc-4600	81	33	dermatol	dermatol	ADJ
dpc-4600	81	34	pract	pract	NOUN
dpc-4600	81	35	concept	concept	NOUN
dpc-4600	81	36	.	.	PUNCT
dpc-4600	82	1	2025;15(1):4600	2025;15(1):4600	NUM
dpc-4600	82	2	5	5	NUM
dpc-4600	82	3	prostaglandin	prostaglandin	NOUN
dpc-4600	82	4	analogues	analogue	NOUN
dpc-4600	82	5	prostaglandins	prostaglandin	NOUN
dpc-4600	82	6	can	can	AUX
dpc-4600	82	7	enhance	enhance	VERB
dpc-4600	82	8	the	the	DET
dpc-4600	82	9	expression	expression	NOUN
dpc-4600	82	10	of	of	ADP
dpc-4600	82	11	the	the	DET
dpc-4600	82	12	enzyme	enzyme	NOUN
dpc-4600	82	13	tyrosinase	tyrosinase	NOUN
dpc-4600	82	14	,	,	PUNCT
dpc-4600	82	15	which	which	PRON
dpc-4600	82	16	regulates	regulate	VERB
dpc-4600	82	17	the	the	DET
dpc-4600	82	18	rate	rate	NOUN
dpc-4600	82	19	of	of	ADP
dpc-4600	82	20	melanin	melanin	NOUN
dpc-4600	82	21	production	production	NOUN
dpc-4600	82	22	in	in	ADP
dpc-4600	82	23	the	the	DET
dpc-4600	82	24	skin	skin	NOUN
dpc-4600	82	25	[	[	X
dpc-4600	82	26	28	28	NUM
dpc-4600	82	27	]	]	PUNCT
dpc-4600	82	28	.	.	PUNCT
dpc-4600	83	1	in	in	ADP
dpc-4600	83	2	vitiligo	vitiligo	PROPN
dpc-4600	83	3	,	,	PUNCT
dpc-4600	83	4	there	there	PRON
dpc-4600	83	5	occurs	occur	VERB
dpc-4600	83	6	 	 	SPACE
dpc-4600	83	7	a	a	DET
dpc-4600	83	8	decreased	decreased	ADJ
dpc-4600	83	9	synthesis	synthesis	NOUN
dpc-4600	83	10	of	of	ADP
dpc-4600	83	11	prostaglandins	prostaglandin	NOUN
dpc-4600	83	12	like	like	ADP
dpc-4600	83	13	prostaglandin	prostaglandin	NOUN
dpc-4600	83	14	e2	e2	PROPN
dpc-4600	83	15	(	(	PUNCT
dpc-4600	83	16	pge2	pge2	PROPN
dpc-4600	83	17	)	)	PUNCT
dpc-4600	83	18	and	and	CCONJ
dpc-4600	83	19	prostaglandin	prostaglandin	VERB
dpc-4600	83	20	f2	f2	PROPN
dpc-4600	83	21	(	(	PUNCT
dpc-4600	83	22	pgf2α	pgf2α	X
dpc-4600	83	23	)	)	PUNCT
dpc-4600	83	24	in	in	ADP
dpc-4600	83	25	the	the	DET
dpc-4600	83	26	skin	skin	NOUN
dpc-4600	83	27	in	in	ADP
dpc-4600	83	28	response	response	NOUN
dpc-4600	83	29	to	to	PART
dpc-4600	83	30	oxidative	oxidative	ADJ
dpc-4600	83	31	stress	stress	NOUN
dpc-4600	83	32	[	[	X
dpc-4600	83	33	29	29	NUM
dpc-4600	83	34	]	]	PUNCT
dpc-4600	83	35	.	.	PUNCT
dpc-4600	84	1	pgf2	pgf2	PROPN
dpc-4600	84	2	is	be	AUX
dpc-4600	84	3	a	a	DET
dpc-4600	84	4	well	well	ADV
dpc-4600	84	5	-	-	PUNCT
dpc-4600	84	6	known	know	VERB
dpc-4600	84	7	oxidative	oxidative	ADJ
dpc-4600	84	8	stress	stress	NOUN
dpc-4600	84	9	marker	marker	NOUN
dpc-4600	84	10	,	,	PUNCT
dpc-4600	84	11	and	and	CCONJ
dpc-4600	84	12	its	its	PRON
dpc-4600	84	13	levels	level	NOUN
dpc-4600	84	14	are	be	AUX
dpc-4600	84	15	seen	see	VERB
dpc-4600	84	16	increase	increase	NOUN
dpc-4600	84	17	in	in	ADP
dpc-4600	84	18	the	the	DET
dpc-4600	84	19	skin	skin	NOUN
dpc-4600	84	20	of	of	ADP
dpc-4600	84	21	vitiligo	vitiligo	ADJ
dpc-4600	84	22	patients	patient	NOUN
dpc-4600	84	23	.	.	PUNCT
dpc-4600	85	1	the	the	DET
dpc-4600	85	2	ability	ability	NOUN
dpc-4600	85	3	of	of	ADP
dpc-4600	85	4	topical	topical	ADJ
dpc-4600	85	5	bimatoprost	bimatoprost	NOUN
dpc-4600	85	6	,	,	PUNCT
dpc-4600	85	7	an	an	DET
dpc-4600	85	8	analogue	analogue	NOUN
dpc-4600	85	9	of	of	ADP
dpc-4600	85	10	pgf2	pgf2	PROPN
dpc-4600	85	11	,	,	PUNCT
dpc-4600	85	12	to	to	PART
dpc-4600	85	13	cause	cause	VERB
dpc-4600	85	14	increased	increase	VERB
dpc-4600	85	15	melanogenesis	melanogenesis	NOUN
dpc-4600	85	16	and	and	CCONJ
dpc-4600	85	17	 	 	SPACE
dpc-4600	85	18	peri	peri	NOUN
dpc-4600	85	19	-	-	PUNCT
dpc-4600	85	20	ocular	ocular	ADJ
dpc-4600	85	21	skin	skin	NOUN
dpc-4600	85	22	hyperpigmentation	hyperpigmentation	NOUN
dpc-4600	85	23	in	in	ADP
dpc-4600	85	24	glaucoma	glaucoma	NOUN
dpc-4600	85	25	patients	patient	NOUN
dpc-4600	85	26	is	be	AUX
dpc-4600	85	27	being	be	AUX
dpc-4600	85	28	utilized	utilize	VERB
dpc-4600	85	29	to	to	PART
dpc-4600	85	30	treat	treat	VERB
dpc-4600	85	31	 	 	SPACE
dpc-4600	85	32	vitiligo	vitiligo	NOUN
dpc-4600	85	33	[	[	X
dpc-4600	85	34	29,30	29,30	NUM
dpc-4600	85	35	]	]	PUNCT
dpc-4600	85	36	various	various	ADJ
dpc-4600	85	37	analogues	analogue	NOUN
dpc-4600	85	38	of	of	ADP
dpc-4600	85	39	pgf2α	pgf2α	PROPN
dpc-4600	85	40	,	,	PUNCT
dpc-4600	85	41	like	like	ADP
dpc-4600	85	42	topical	topical	ADJ
dpc-4600	85	43	bimatoprost	bimatoprost	NOUN
dpc-4600	85	44	and	and	CCONJ
dpc-4600	85	45	latanoprost	latanoprost	ADJ
dpc-4600	85	46	,	,	PUNCT
dpc-4600	85	47	have	have	AUX
dpc-4600	85	48	been	be	AUX
dpc-4600	85	49	proven	prove	VERB
dpc-4600	85	50	effective	effective	ADJ
dpc-4600	85	51	in	in	ADP
dpc-4600	85	52	treating	treat	VERB
dpc-4600	85	53	vitiligo	vitiligo	NOUN
dpc-4600	85	54	when	when	SCONJ
dpc-4600	85	55	used	use	VERB
dpc-4600	85	56	with	with	ADP
dpc-4600	85	57	other	other	ADJ
dpc-4600	85	58	modalities	modality	NOUN
dpc-4600	85	59	like	like	ADP
dpc-4600	85	60	topical	topical	ADJ
dpc-4600	85	61	corticosteroids	corticosteroid	NOUN
dpc-4600	85	62	,	,	PUNCT
dpc-4600	85	63	narrow	narrow	ADJ
dpc-4600	85	64	-	-	PUNCT
dpc-4600	85	65	band	band	NOUN
dpc-4600	85	66	phototherapy	phototherapy	NOUN
dpc-4600	85	67	,	,	PUNCT
dpc-4600	85	68	and	and	CCONJ
dpc-4600	85	69	microneedling	microneedle	VERB
dpc-4600	85	70	[	[	X
dpc-4600	85	71	30	30	NUM
dpc-4600	85	72	]	]	PUNCT
dpc-4600	85	73	.	.	PUNCT
dpc-4600	86	1	presently	presently	ADV
dpc-4600	86	2	,	,	PUNCT
dpc-4600	86	3	the	the	DET
dpc-4600	86	4	efficacy	efficacy	NOUN
dpc-4600	86	5	of	of	ADP
dpc-4600	86	6	topical	topical	ADJ
dpc-4600	86	7	latanoprost	latanoprost	ADJ
dpc-4600	86	8	0.005	0.005	NUM
dpc-4600	86	9	%	%	NOUN
dpc-4600	86	10	ophthalmic	ophthalmic	ADJ
dpc-4600	86	11	solution	solution	NOUN
dpc-4600	86	12	and	and	CCONJ
dpc-4600	86	13	5	5	NUM
dpc-4600	86	14	-	-	PUNCT
dpc-4600	86	15	fluorouracil	fluorouracil	NOUN
dpc-4600	86	16	in	in	ADP
dpc-4600	86	17	vitiligo	vitiligo	PROPN
dpc-4600	86	18	is	be	AUX
dpc-4600	86	19	being	be	AUX
dpc-4600	86	20	studied	study	VERB
dpc-4600	86	21	in	in	ADP
dpc-4600	86	22	an	an	DET
dpc-4600	86	23	ongoing	ongoing	ADJ
dpc-4600	86	24	clinical	clinical	ADJ
dpc-4600	86	25	trial	trial	NOUN
dpc-4600	86	26	(	(	PUNCT
dpc-4600	86	27	nct05513924	nct05513924	NOUN
dpc-4600	86	28	)	)	PUNCT
dpc-4600	86	29	.	.	PUNCT
dpc-4600	87	1	hormone	hormone	NOUN
dpc-4600	87	2	analogue	analogue	NOUN
dpc-4600	87	3	afamelanotide	afamelanotide	NOUN
dpc-4600	87	4	afamelanotide	afamelanotide	NOUN
dpc-4600	87	5	is	be	AUX
dpc-4600	87	6	an	an	DET
dpc-4600	87	7	α	α	NOUN
dpc-4600	87	8	-	-	PUNCT
dpc-4600	87	9	melanocyte	melanocyte	NOUN
dpc-4600	87	10	-	-	PUNCT
dpc-4600	87	11	stimulating	stimulate	VERB
dpc-4600	87	12	hormone	hormone	NOUN
dpc-4600	87	13	(	(	PUNCT
dpc-4600	87	14	α	α	NOUN
dpc-4600	87	15	-	-	PUNCT
dpc-4600	87	16	msh	msh	NOUN
dpc-4600	87	17	)	)	PUNCT
dpc-4600	87	18	analogue	analogue	NOUN
dpc-4600	87	19	that	that	PRON
dpc-4600	87	20	binds	bind	VERB
dpc-4600	87	21	to	to	ADP
dpc-4600	87	22	the	the	DET
dpc-4600	87	23	melanocortin	melanocortin	NOUN
dpc-4600	87	24	1	1	NUM
dpc-4600	87	25	receptor	receptor	NOUN
dpc-4600	87	26	(	(	PUNCT
dpc-4600	87	27	mc1r	mc1r	PROPN
dpc-4600	87	28	)	)	PUNCT
dpc-4600	87	29	present	present	ADJ
dpc-4600	87	30	on	on	ADP
dpc-4600	87	31	melanocytes	melanocyte	NOUN
dpc-4600	87	32	and	and	CCONJ
dpc-4600	87	33	that	that	PRON
dpc-4600	87	34	causes	cause	VERB
dpc-4600	87	35	melanogenesis	melanogenesis	NOUN
dpc-4600	87	36	by	by	ADP
dpc-4600	87	37	increasing	increase	VERB
dpc-4600	87	38	the	the	DET
dpc-4600	87	39	uptake	uptake	NOUN
dpc-4600	87	40	of	of	ADP
dpc-4600	87	41	eumelanin	eumelanin	NOUN
dpc-4600	87	42	by	by	ADP
dpc-4600	87	43	melanosomes	melanosome	NOUN
dpc-4600	87	44	.	.	PUNCT
dpc-4600	88	1	since	since	SCONJ
dpc-4600	88	2	the	the	DET
dpc-4600	88	3	mc1r	mc1r	NOUN
dpc-4600	88	4	receptor	receptor	NOUN
dpc-4600	88	5	is	be	AUX
dpc-4600	88	6	also	also	ADV
dpc-4600	88	7	present	present	ADJ
dpc-4600	88	8	on	on	ADP
dpc-4600	88	9	many	many	ADJ
dpc-4600	88	10	inflammatory	inflammatory	ADJ
dpc-4600	88	11	cells	cell	NOUN
dpc-4600	88	12	,	,	PUNCT
dpc-4600	88	13	such	such	ADJ
dpc-4600	88	14	as	as	ADP
dpc-4600	88	15	neutrophils	neutrophil	NOUN
dpc-4600	88	16	and	and	CCONJ
dpc-4600	88	17	lymphocytes	lymphocyte	NOUN
dpc-4600	88	18	,	,	PUNCT
dpc-4600	88	19	afamelanotide	afamelanotide	NOUN
dpc-4600	88	20	has	have	AUX
dpc-4600	88	21	been	be	AUX
dpc-4600	88	22	shown	show	VERB
dpc-4600	88	23	to	to	PART
dpc-4600	88	24	possess	possess	VERB
dpc-4600	88	25	some	some	DET
dpc-4600	88	26	anti	anti	ADJ
dpc-4600	88	27	-	-	ADJ
dpc-4600	88	28	inflammatory	inflammatory	ADJ
dpc-4600	88	29	properties	property	NOUN
dpc-4600	88	30	as	as	ADV
dpc-4600	88	31	well	well	ADV
dpc-4600	88	32	.	.	PUNCT
dpc-4600	89	1	it	it	PRON
dpc-4600	89	2	is	be	AUX
dpc-4600	89	3	used	use	VERB
dpc-4600	89	4	as	as	ADP
dpc-4600	89	5	a	a	DET
dpc-4600	89	6	biodegradable	biodegradable	ADJ
dpc-4600	89	7	,	,	PUNCT
dpc-4600	89	8	sustained	sustain	VERB
dpc-4600	89	9	-	-	PUNCT
dpc-4600	89	10	release	release	NOUN
dpc-4600	89	11	implant	implant	NOUN
dpc-4600	89	12	administered	administer	VERB
dpc-4600	89	13	subcutaneously	subcutaneously	ADV
dpc-4600	89	14	to	to	ADP
dpc-4600	89	15	patients	patient	NOUN
dpc-4600	89	16	with	with	ADP
dpc-4600	89	17	vitiligo	vitiligo	PROPN
dpc-4600	89	18	[	[	X
dpc-4600	89	19	31	31	NUM
dpc-4600	89	20	]	]	PUNCT
dpc-4600	89	21	.	.	PUNCT
dpc-4600	90	1	dermatitis	dermatitis	NOUN
dpc-4600	90	2	and	and	CCONJ
dpc-4600	90	3	rheumatoid	rheumatoid	VERB
dpc-4600	90	4	arthritis	arthritis	NOUN
dpc-4600	90	5	[	[	X
dpc-4600	90	6	23	23	NUM
dpc-4600	90	7	]	]	PUNCT
dpc-4600	90	8	.	.	PUNCT
dpc-4600	91	1	currently	currently	ADV
dpc-4600	91	2	,	,	PUNCT
dpc-4600	91	3	there	there	PRON
dpc-4600	91	4	is	be	VERB
dpc-4600	91	5	only	only	ADV
dpc-4600	91	6	a	a	DET
dpc-4600	91	7	single	single	ADJ
dpc-4600	91	8	clinical	clinical	ADJ
dpc-4600	91	9	case	case	NOUN
dpc-4600	91	10	report	report	NOUN
dpc-4600	91	11	documenting	document	VERB
dpc-4600	91	12	its	its	PRON
dpc-4600	91	13	use	use	NOUN
dpc-4600	91	14	in	in	ADP
dpc-4600	91	15	individuals	individual	NOUN
dpc-4600	91	16	with	with	ADP
dpc-4600	91	17	vitiligo	vitiligo	NOUN
dpc-4600	91	18	,	,	PUNCT
dpc-4600	91	19	who	who	PRON
dpc-4600	91	20	were	be	AUX
dpc-4600	91	21	given	give	VERB
dpc-4600	91	22	4	4	NUM
dpc-4600	91	23	mg	mg	ADP
dpc-4600	91	24	of	of	ADP
dpc-4600	91	25	baricitinib	baricitinib	NOUN
dpc-4600	91	26	daily	daily	ADV
dpc-4600	91	27	.	.	PUNCT
dpc-4600	92	1	the	the	DET
dpc-4600	92	2	effectiveness	effectiveness	NOUN
dpc-4600	92	3	of	of	ADP
dpc-4600	92	4	4	4	NUM
dpc-4600	92	5	mg	mg	NOUN
dpc-4600	92	6	of	of	ADP
dpc-4600	92	7	baricitinib	baricitinib	NOUN
dpc-4600	92	8	in	in	ADP
dpc-4600	92	9	combination	combination	NOUN
dpc-4600	92	10	with	with	ADP
dpc-4600	92	11	phototherapy	phototherapy	NOUN
dpc-4600	92	12	is	be	AUX
dpc-4600	92	13	being	be	AUX
dpc-4600	92	14	studied	study	VERB
dpc-4600	92	15	in	in	ADP
dpc-4600	92	16	various	various	ADJ
dpc-4600	92	17	clinical	clinical	ADJ
dpc-4600	92	18	trials	trial	NOUN
dpc-4600	92	19	[	[	X
dpc-4600	92	20	24	24	NUM
dpc-4600	92	21	]	]	PUNCT
dpc-4600	92	22	.	.	PUNCT
dpc-4600	93	1	ritlecitinib	ritlecitinib	NOUN
dpc-4600	93	2	is	be	AUX
dpc-4600	93	3	another	another	DET
dpc-4600	93	4	jak3	jak3	NOUN
dpc-4600	93	5	inhibitor	inhibitor	NOUN
dpc-4600	93	6	that	that	PRON
dpc-4600	93	7	is	be	AUX
dpc-4600	93	8	used	use	VERB
dpc-4600	93	9	in	in	ADP
dpc-4600	93	10	the	the	DET
dpc-4600	93	11	treatment	treatment	NOUN
dpc-4600	93	12	of	of	ADP
dpc-4600	93	13	active	active	ADJ
dpc-4600	93	14	nsv	nsv	PROPN
dpc-4600	93	15	.	.	PUNCT
dpc-4600	94	1	the	the	DET
dpc-4600	94	2	efficacy	efficacy	NOUN
dpc-4600	94	3	and	and	CCONJ
dpc-4600	94	4	safety	safety	NOUN
dpc-4600	94	5	of	of	ADP
dpc-4600	94	6	ritlecitinib	ritlecitinib	NOUN
dpc-4600	94	7	50	50	NUM
dpc-4600	94	8	mg	mg	NOUN
dpc-4600	94	9	(	(	PUNCT
dpc-4600	94	10	with	with	ADP
dpc-4600	94	11	or	or	CCONJ
dpc-4600	94	12	without	without	ADP
dpc-4600	94	13	loading	loading	NOUN
dpc-4600	94	14	dose	dose	NOUN
dpc-4600	94	15	)	)	PUNCT
dpc-4600	94	16	were	be	AUX
dpc-4600	94	17	studied	study	VERB
dpc-4600	94	18	by	by	ADP
dpc-4600	94	19	khaled	khaled	PROPN
dpc-4600	94	20	ezzedine	ezzedine	PROPN
dpc-4600	94	21	et	et	PROPN
dpc-4600	94	22	al	al	PROPN
dpc-4600	94	23	.	.	PROPN
dpc-4600	95	1	in	in	ADP
dpc-4600	95	2	a	a	DET
dpc-4600	95	3	randomized	randomized	ADJ
dpc-4600	95	4	phase	phase	NOUN
dpc-4600	95	5	iib	iib	NOUN
dpc-4600	95	6	clinical	clinical	ADJ
dpc-4600	95	7	trial	trial	NOUN
dpc-4600	95	8	in	in	ADP
dpc-4600	95	9	which	which	PRON
dpc-4600	95	10	ritlecitinib	ritlecitinib	VERB
dpc-4600	95	11	substantially	substantially	ADV
dpc-4600	95	12	outperformed	outperform	VERB
dpc-4600	95	13	placebo	placebo	NOUN
dpc-4600	95	14	in	in	ADP
dpc-4600	95	15	achieving	achieve	VERB
dpc-4600	95	16	centrally	centrally	ADV
dpc-4600	95	17	read	read	VERB
dpc-4600	95	18	f	f	NOUN
dpc-4600	95	19	-	-	PUNCT
dpc-4600	95	20	vasi75	vasi75	NOUN
dpc-4600	95	21	at	at	ADP
dpc-4600	95	22	24	24	NUM
dpc-4600	95	23	weeks	week	NOUN
dpc-4600	95	24	.	.	PUNCT
dpc-4600	96	1	furthermore	furthermore	ADV
dpc-4600	96	2	,	,	PUNCT
dpc-4600	96	3	during	during	ADP
dpc-4600	96	4	the	the	DET
dpc-4600	96	5	extension	extension	NOUN
dpc-4600	96	6	period	period	NOUN
dpc-4600	96	7	,	,	PUNCT
dpc-4600	96	8	accelerated	accelerate	VERB
dpc-4600	96	9	improvement	improvement	NOUN
dpc-4600	96	10	was	be	AUX
dpc-4600	96	11	seen	see	VERB
dpc-4600	96	12	after	after	ADP
dpc-4600	96	13	28	28	NUM
dpc-4600	96	14	weeks	week	NOUN
dpc-4600	96	15	,	,	PUNCT
dpc-4600	96	16	and	and	CCONJ
dpc-4600	96	17	ritlecitinib	ritlecitinib	NOUN
dpc-4600	96	18	was	be	AUX
dpc-4600	96	19	well	well	ADV
dpc-4600	96	20	tolerated	tolerate	VERB
dpc-4600	96	21	for	for	ADP
dpc-4600	96	22	up	up	ADP
dpc-4600	96	23	to	to	PART
dpc-4600	96	24	48	48	NUM
dpc-4600	96	25	weeks	week	NOUN
dpc-4600	97	1	[	[	X
dpc-4600	97	2	25	25	NUM
dpc-4600	97	3	]	]	PUNCT
dpc-4600	97	4	.	.	PUNCT
dpc-4600	98	1	delgocitinib	delgocitinib	NOUN
dpc-4600	98	2	has	have	AUX
dpc-4600	98	3	shown	show	VERB
dpc-4600	98	4	its	its	PRON
dpc-4600	98	5	effectiveness	effectiveness	NOUN
dpc-4600	98	6	in	in	ADP
dpc-4600	98	7	the	the	DET
dpc-4600	98	8	management	management	NOUN
dpc-4600	98	9	of	of	ADP
dpc-4600	98	10	vitiligo	vitiligo	NOUN
dpc-4600	98	11	in	in	ADP
dpc-4600	98	12	only	only	ADV
dpc-4600	98	13	two	two	NUM
dpc-4600	98	14	reported	report	VERB
dpc-4600	98	15	cases	case	NOUN
dpc-4600	98	16	to	to	ADP
dpc-4600	98	17	date	date	NOUN
dpc-4600	98	18	,	,	PUNCT
dpc-4600	98	19	where	where	SCONJ
dpc-4600	98	20	response	response	NOUN
dpc-4600	98	21	was	be	AUX
dpc-4600	98	22	more	more	ADJ
dpc-4600	98	23	for	for	ADP
dpc-4600	98	24	the	the	DET
dpc-4600	98	25	cervical	cervical	ADJ
dpc-4600	98	26	lesions	lesion	NOUN
dpc-4600	98	27	in	in	ADP
dpc-4600	98	28	comparison	comparison	NOUN
dpc-4600	98	29	to	to	ADP
dpc-4600	98	30	the	the	DET
dpc-4600	98	31	elbows	elbow	NOUN
dpc-4600	98	32	.	.	PUNCT
dpc-4600	99	1	this	this	PRON
dpc-4600	99	2	could	could	AUX
dpc-4600	99	3	be	be	AUX
dpc-4600	99	4	attributed	attribute	VERB
dpc-4600	99	5	to	to	ADP
dpc-4600	99	6	differences	difference	NOUN
dpc-4600	99	7	in	in	ADP
dpc-4600	99	8	skin	skin	NOUN
dpc-4600	99	9	thickness	thickness	NOUN
dpc-4600	99	10	,	,	PUNCT
dpc-4600	99	11	disease	disease	NOUN
dpc-4600	99	12	duration	duration	NOUN
dpc-4600	99	13	,	,	PUNCT
dpc-4600	99	14	and	and	CCONJ
dpc-4600	99	15	sun	sun	NOUN
dpc-4600	99	16	exposure	exposure	NOUN
dpc-4600	99	17	at	at	ADP
dpc-4600	99	18	these	these	DET
dpc-4600	99	19	two	two	NUM
dpc-4600	99	20	sites	site	NOUN
dpc-4600	99	21	[	[	X
dpc-4600	99	22	26	26	NUM
dpc-4600	99	23	]	]	PUNCT
dpc-4600	99	24	.	.	PUNCT
dpc-4600	100	1	ifidancitinib	ifidancitinib	NOUN
dpc-4600	100	2	is	be	AUX
dpc-4600	100	3	a	a	DET
dpc-4600	100	4	jak1/3	jak1/3	PRON
dpc-4600	100	5	inhibitor	inhibitor	NOUN
dpc-4600	100	6	that	that	PRON
dpc-4600	100	7	has	have	AUX
dpc-4600	100	8	been	be	AUX
dpc-4600	100	9	used	use	VERB
dpc-4600	100	10	to	to	PART
dpc-4600	100	11	treat	treat	VERB
dpc-4600	100	12	alopecia	alopecia	NOUN
dpc-4600	100	13	areata	areata	ADJ
dpc-4600	100	14	.	.	PUNCT
dpc-4600	101	1	its	its	PRON
dpc-4600	101	2	efficacy	efficacy	NOUN
dpc-4600	101	3	in	in	ADP
dpc-4600	101	4	the	the	DET
dpc-4600	101	5	treatment	treatment	NOUN
dpc-4600	101	6	of	of	ADP
dpc-4600	101	7	vitiligo	vitiligo	NOUN
dpc-4600	101	8	is	be	AUX
dpc-4600	101	9	being	be	AUX
dpc-4600	101	10	explored	explore	VERB
dpc-4600	101	11	in	in	ADP
dpc-4600	101	12	a	a	DET
dpc-4600	101	13	phase	phase	NOUN
dpc-4600	101	14	ii	ii	NOUN
dpc-4600	101	15	clinical	clinical	ADJ
dpc-4600	101	16	trial	trial	NOUN
dpc-4600	101	17	,	,	PUNCT
dpc-4600	101	18	but	but	CCONJ
dpc-4600	101	19	more	more	ADJ
dpc-4600	101	20	data	datum	NOUN
dpc-4600	101	21	are	be	AUX
dpc-4600	101	22	needed	need	VERB
dpc-4600	101	23	for	for	ADP
dpc-4600	101	24	its	its	PRON
dpc-4600	101	25	safety	safety	NOUN
dpc-4600	101	26	of	of	ADP
dpc-4600	101	27	use	use	NOUN
dpc-4600	101	28	in	in	ADP
dpc-4600	101	29	vitiligo	vitiligo	NOUN
dpc-4600	101	30	[	[	X
dpc-4600	101	31	22	22	NUM
dpc-4600	101	32	]	]	PUNCT
dpc-4600	101	33	.	.	PUNCT
dpc-4600	102	1	an	an	DET
dpc-4600	102	2	interesting	interesting	ADJ
dpc-4600	102	3	52	52	NUM
dpc-4600	102	4	-	-	PUNCT
dpc-4600	102	5	week	week	NOUN
dpc-4600	102	6	phase	phase	NOUN
dpc-4600	102	7	iib	iib	NOUN
dpc-4600	102	8	trial	trial	NOUN
dpc-4600	102	9	on	on	ADP
dpc-4600	102	10	povorcitinib	povorcitinib	NOUN
dpc-4600	102	11	(	(	PUNCT
dpc-4600	102	12	a	a	DET
dpc-4600	102	13	jak-1	jak-1	PUNCT
dpc-4600	102	14	inhibitor	inhibitor	NOUN
dpc-4600	102	15	)	)	PUNCT
dpc-4600	102	16	for	for	ADP
dpc-4600	102	17	extensive	extensive	ADJ
dpc-4600	102	18	nsv	nsv	PROPN
dpc-4600	102	19	with	with	ADP
dpc-4600	102	20	a	a	DET
dpc-4600	102	21	total	total	ADJ
dpc-4600	102	22	body	body	NOUN
dpc-4600	102	23	surface	surface	NOUN
dpc-4600	102	24	area	area	NOUN
dpc-4600	102	25	>	>	PUNCT
dpc-4600	102	26	8	8	NUM
dpc-4600	102	27	%	%	NOUN
dpc-4600	102	28	and	and	CCONJ
dpc-4600	102	29	facial	facial	ADJ
dpc-4600	102	30	involvement	involvement	NOUN
dpc-4600	102	31	>	>	PUNCT
dpc-4600	102	32	0.5	0.5	NUM
dpc-4600	102	33	%	%	NOUN
dpc-4600	102	34	was	be	AUX
dpc-4600	102	35	performed	perform	VERB
dpc-4600	102	36	.	.	PUNCT
dpc-4600	103	1	patients	patient	NOUN
dpc-4600	103	2	showed	show	VERB
dpc-4600	103	3	significant	significant	ADJ
dpc-4600	103	4	repigmentation	repigmentation	NOUN
dpc-4600	103	5	after	after	ADP
dpc-4600	103	6	receiving	receive	VERB
dpc-4600	103	7	povorcitinib	povorcitinib	NOUN
dpc-4600	103	8	once	once	ADV
dpc-4600	103	9	daily	daily	ADV
dpc-4600	103	10	for	for	ADP
dpc-4600	103	11	24	24	NUM
dpc-4600	103	12	weeks	week	NOUN
dpc-4600	103	13	as	as	SCONJ
dpc-4600	103	14	compared	compare	VERB
dpc-4600	103	15	to	to	ADP
dpc-4600	103	16	placebo	placebo	NOUN
dpc-4600	103	17	,	,	PUNCT
dpc-4600	103	18	which	which	PRON
dpc-4600	103	19	continued	continue	VERB
dpc-4600	103	20	through	through	ADP
dpc-4600	103	21	36	36	NUM
dpc-4600	103	22	weeks	week	NOUN
dpc-4600	103	23	during	during	ADP
dpc-4600	103	24	the	the	DET
dpc-4600	103	25	extension	extension	NOUN
dpc-4600	103	26	period	period	NOUN
dpc-4600	103	27	.	.	PUNCT
dpc-4600	104	1	no	no	DET
dpc-4600	104	2	serious	serious	ADJ
dpc-4600	104	3	treatment	treatment	NOUN
dpc-4600	104	4	-	-	PUNCT
dpc-4600	104	5	related	relate	VERB
dpc-4600	104	6	adverse	adverse	ADJ
dpc-4600	104	7	events	event	NOUN
dpc-4600	104	8	were	be	AUX
dpc-4600	104	9	reported	report	VERB
dpc-4600	104	10	[	[	X
dpc-4600	104	11	27	27	NUM
dpc-4600	104	12	]	]	PUNCT
dpc-4600	104	13	.	.	PUNCT
dpc-4600	105	1	figure	figure	VERB
dpc-4600	105	2	4	4	NUM
dpc-4600	105	3	.	.	PUNCT
dpc-4600	106	1	role	role	NOUN
dpc-4600	106	2	of	of	ADP
dpc-4600	106	3	oxidative	oxidative	ADJ
dpc-4600	106	4	stress	stress	NOUN
dpc-4600	106	5	in	in	ADP
dpc-4600	106	6	vitiligo	vitiligo	NOUN
dpc-4600	106	7	.	.	PUNCT
dpc-4600	107	1	6	6	NUM
dpc-4600	107	2	review	review	NOUN
dpc-4600	107	3	|	|	ADV
dpc-4600	107	4	dermatol	dermatol	ADJ
dpc-4600	107	5	pract	pract	NOUN
dpc-4600	107	6	concept	concept	NOUN
dpc-4600	107	7	.	.	PUNCT
dpc-4600	108	1	2025;15(1):4600	2025;15(1):4600	NUM
dpc-4600	108	2	amounts	amount	NOUN
dpc-4600	108	3	[	[	X
dpc-4600	108	4	38	38	NUM
dpc-4600	108	5	]	]	PUNCT
dpc-4600	108	6	.	.	PUNCT
dpc-4600	109	1	as	as	SCONJ
dpc-4600	109	2	it	it	PRON
dpc-4600	109	3	is	be	AUX
dpc-4600	109	4	important	important	ADJ
dpc-4600	109	5	for	for	ADP
dpc-4600	109	6	the	the	DET
dpc-4600	109	7	recycling	recycling	NOUN
dpc-4600	109	8	of	of	ADP
dpc-4600	109	9	the	the	DET
dpc-4600	109	10	antioxidant	antioxidant	ADJ
dpc-4600	109	11	vitamins	vitamin	NOUN
dpc-4600	109	12	c	c	NOUN
dpc-4600	109	13	and	and	CCONJ
dpc-4600	109	14	e	e	NOUN
dpc-4600	109	15	,	,	PUNCT
dpc-4600	109	16	it	it	PRON
dpc-4600	109	17	has	have	AUX
dpc-4600	109	18	been	be	AUX
dpc-4600	109	19	used	use	VERB
dpc-4600	109	20	with	with	ADP
dpc-4600	109	21	these	these	DET
dpc-4600	109	22	vitamins	vitamin	NOUN
dpc-4600	109	23	along	along	ADP
dpc-4600	109	24	with	with	ADP
dpc-4600	109	25	nb	nb	ADJ
dpc-4600	109	26	-	-	ADJ
dpc-4600	109	27	uvb	uvb	ADJ
dpc-4600	109	28	phototherapy	phototherapy	NOUN
dpc-4600	109	29	to	to	PART
dpc-4600	109	30	halt	halt	VERB
dpc-4600	109	31	disease	disease	NOUN
dpc-4600	109	32	progression	progression	NOUN
dpc-4600	109	33	.	.	PUNCT
dpc-4600	110	1	yan	yan	PROPN
dpc-4600	110	2	sun	sun	PROPN
dpc-4600	110	3	assessed	assess	VERB
dpc-4600	110	4	the	the	DET
dpc-4600	110	5	safety	safety	NOUN
dpc-4600	110	6	and	and	CCONJ
dpc-4600	110	7	effectiveness	effectiveness	NOUN
dpc-4600	110	8	of	of	ADP
dpc-4600	110	9	oral	oral	ADJ
dpc-4600	110	10	ala	ala	PROPN
dpc-4600	110	11	and	and	CCONJ
dpc-4600	110	12	nb	nb	NOUN
dpc-4600	110	13	-	-	ADJ
dpc-4600	110	14	uvb	uvb	ADJ
dpc-4600	110	15	phototherapy	phototherapy	NOUN
dpc-4600	110	16	and	and	CCONJ
dpc-4600	110	17	suggested	suggest	VERB
dpc-4600	110	18	that	that	SCONJ
dpc-4600	110	19	the	the	DET
dpc-4600	110	20	use	use	NOUN
dpc-4600	110	21	of	of	ADP
dpc-4600	110	22	alpha	alpha	NOUN
dpc-4600	110	23	-	-	PUNCT
dpc-4600	110	24	lipoic	lipoic	NOUN
dpc-4600	110	25	acid	acid	NOUN
dpc-4600	110	26	did	do	AUX
dpc-4600	110	27	not	not	PART
dpc-4600	110	28	provide	provide	VERB
dpc-4600	110	29	any	any	DET
dpc-4600	110	30	advantage	advantage	NOUN
dpc-4600	110	31	when	when	SCONJ
dpc-4600	110	32	combined	combine	VERB
dpc-4600	110	33	with	with	ADP
dpc-4600	110	34	phototherapy	phototherapy	NOUN
dpc-4600	110	35	[	[	X
dpc-4600	110	36	39	39	NUM
dpc-4600	110	37	]	]	PUNCT
dpc-4600	110	38	.	.	PUNCT
dpc-4600	111	1	polypodium	polypodium	PROPN
dpc-4600	111	2	leucotomos	leucotomos	PROPN
dpc-4600	111	3	polypodium	polypodium	PROPN
dpc-4600	111	4	leucotomos	leucotomos	PROPN
dpc-4600	111	5	(	(	PUNCT
dpc-4600	111	6	pl	pl	NOUN
dpc-4600	111	7	)	)	PUNCT
dpc-4600	111	8	is	be	AUX
dpc-4600	111	9	a	a	DET
dpc-4600	111	10	fern	fern	ADJ
dpc-4600	111	11	native	native	ADJ
dpc-4600	111	12	to	to	ADP
dpc-4600	111	13	central	central	PROPN
dpc-4600	111	14	america	america	PROPN
dpc-4600	111	15	.	.	PUNCT
dpc-4600	112	1	it	it	PRON
dpc-4600	112	2	can	can	AUX
dpc-4600	112	3	be	be	AUX
dpc-4600	112	4	used	use	VERB
dpc-4600	112	5	in	in	ADP
dpc-4600	112	6	the	the	DET
dpc-4600	112	7	treatment	treatment	NOUN
dpc-4600	112	8	of	of	ADP
dpc-4600	112	9	vitiligo	vitiligo	NOUN
dpc-4600	112	10	,	,	PUNCT
dpc-4600	112	11	as	as	SCONJ
dpc-4600	112	12	it	it	PRON
dpc-4600	112	13	prevents	prevent	VERB
dpc-4600	112	14	the	the	DET
dpc-4600	112	15	peroxidation	peroxidation	NOUN
dpc-4600	112	16	of	of	ADP
dpc-4600	112	17	membrane	membrane	NOUN
dpc-4600	112	18	lipids	lipid	NOUN
dpc-4600	112	19	in	in	ADP
dpc-4600	112	20	keratinocytes	keratinocyte	NOUN
dpc-4600	112	21	and	and	CCONJ
dpc-4600	112	22	fibroblasts	fibroblast	NOUN
dpc-4600	112	23	.	.	PUNCT
dpc-4600	113	1	it	it	PRON
dpc-4600	113	2	also	also	ADV
dpc-4600	113	3	prevents	prevent	VERB
dpc-4600	113	4	the	the	DET
dpc-4600	113	5	oxidation	oxidation	NOUN
dpc-4600	113	6	of	of	ADP
dpc-4600	113	7	the	the	DET
dpc-4600	113	8	glutathione	glutathione	NOUN
dpc-4600	113	9	enzyme	enzyme	NOUN
dpc-4600	113	10	and	and	CCONJ
dpc-4600	113	11	directly	directly	ADV
dpc-4600	113	12	absorbs	absorb	VERB
dpc-4600	113	13	many	many	ADJ
dpc-4600	113	14	reactive	reactive	ADJ
dpc-4600	113	15	oxygen	oxygen	NOUN
dpc-4600	113	16	species	specie	NOUN
dpc-4600	113	17	(	(	PUNCT
dpc-4600	113	18	ros	ros	PROPN
dpc-4600	113	19	)	)	PUNCT
dpc-4600	113	20	like	like	ADP
dpc-4600	113	21	peroxide	peroxide	NOUN
dpc-4600	113	22	ions	ion	NOUN
dpc-4600	113	23	,	,	PUNCT
dpc-4600	113	24	hydroxyl	hydroxyl	NOUN
dpc-4600	113	25	ions	ion	NOUN
dpc-4600	113	26	,	,	PUNCT
dpc-4600	113	27	and	and	CCONJ
dpc-4600	113	28	superoxide	superoxide	NOUN
dpc-4600	113	29	ions	ion	NOUN
dpc-4600	113	30	.	.	PUNCT
dpc-4600	114	1	by	by	ADP
dpc-4600	114	2	stimulating	stimulate	VERB
dpc-4600	114	3	the	the	DET
dpc-4600	114	4	production	production	NOUN
dpc-4600	114	5	of	of	ADP
dpc-4600	114	6	inflammatory	inflammatory	ADJ
dpc-4600	114	7	cytokines	cytokine	NOUN
dpc-4600	114	8	like	like	ADP
dpc-4600	114	9	il-10	il-10	PRON
dpc-4600	114	10	,	,	PUNCT
dpc-4600	114	11	it	it	PRON
dpc-4600	114	12	produces	produce	VERB
dpc-4600	114	13	a	a	DET
dpc-4600	114	14	shift	shift	NOUN
dpc-4600	114	15	in	in	ADP
dpc-4600	114	16	cytokine	cytokine	ADJ
dpc-4600	114	17	profile	profile	NOUN
dpc-4600	114	18	from	from	ADP
dpc-4600	114	19	type	type	NOUN
dpc-4600	114	20	1	1	NUM
dpc-4600	114	21	to	to	PART
dpc-4600	114	22	type	type	VERB
dpc-4600	114	23	2	2	NUM
dpc-4600	114	24	t	t	NOUN
dpc-4600	114	25	lymphocytes	lymphocyte	VERB
dpc-4600	114	26	[	[	X
dpc-4600	114	27	40	40	NUM
dpc-4600	114	28	]	]	PUNCT
dpc-4600	114	29	.	.	PUNCT
dpc-4600	115	1	according	accord	VERB
dpc-4600	115	2	to	to	ADP
dpc-4600	115	3	research	research	NOUN
dpc-4600	115	4	by	by	ADP
dpc-4600	115	5	pacifico	pacifico	PROPN
dpc-4600	115	6	et	et	PROPN
dpc-4600	115	7	al	al	PROPN
dpc-4600	115	8	.	.	PROPN
dpc-4600	115	9	,	,	PUNCT
dpc-4600	115	10	patients	patient	NOUN
dpc-4600	115	11	with	with	ADP
dpc-4600	115	12	diffuse	diffuse	ADJ
dpc-4600	115	13	vitiligo	vitiligo	NOUN
dpc-4600	115	14	may	may	AUX
dpc-4600	115	15	experience	experience	VERB
dpc-4600	115	16	faster	fast	ADJ
dpc-4600	115	17	repigmentation	repigmentation	NOUN
dpc-4600	115	18	at	at	ADP
dpc-4600	115	19	lower	low	ADJ
dpc-4600	115	20	cumulative	cumulative	ADJ
dpc-4600	115	21	doses	dose	NOUN
dpc-4600	115	22	with	with	ADP
dpc-4600	115	23	pl	pl	PROPN
dpc-4600	115	24	and	and	CCONJ
dpc-4600	115	25	nb	nb	NOUN
dpc-4600	115	26	-	-	ADJ
dpc-4600	115	27	uvb	uvb	ADJ
dpc-4600	115	28	phototherapy	phototherapy	NOUN
dpc-4600	115	29	treatments	treatment	VERB
dpc-4600	115	30	[	[	X
dpc-4600	115	31	41	41	NUM
dpc-4600	115	32	]	]	PUNCT
dpc-4600	115	33	.	.	PUNCT
dpc-4600	116	1	selenium	selenium	NOUN
dpc-4600	116	2	selenium	selenium	NOUN
dpc-4600	116	3	is	be	AUX
dpc-4600	116	4	an	an	DET
dpc-4600	116	5	important	important	ADJ
dpc-4600	116	6	component	component	NOUN
dpc-4600	116	7	of	of	ADP
dpc-4600	116	8	more	more	ADJ
dpc-4600	116	9	than	than	ADP
dpc-4600	116	10	30	30	NUM
dpc-4600	116	11	selenoproteins	selenoprotein	NOUN
dpc-4600	116	12	in	in	ADP
dpc-4600	116	13	the	the	DET
dpc-4600	116	14	human	human	ADJ
dpc-4600	116	15	body	body	NOUN
dpc-4600	116	16	,	,	PUNCT
dpc-4600	116	17	which	which	PRON
dpc-4600	116	18	makes	make	VERB
dpc-4600	116	19	it	it	PRON
dpc-4600	116	20	an	an	DET
dpc-4600	116	21	essential	essential	ADJ
dpc-4600	116	22	trace	trace	NOUN
dpc-4600	116	23	element	element	NOUN
dpc-4600	116	24	.	.	PUNCT
dpc-4600	117	1	it	it	PRON
dpc-4600	117	2	is	be	AUX
dpc-4600	117	3	required	require	VERB
dpc-4600	117	4	for	for	ADP
dpc-4600	117	5	the	the	DET
dpc-4600	117	6	proper	proper	ADJ
dpc-4600	117	7	functioning	functioning	NOUN
dpc-4600	117	8	of	of	ADP
dpc-4600	117	9	the	the	DET
dpc-4600	117	10	glutathione	glutathione	NOUN
dpc-4600	117	11	peroxidase	peroxidase	NOUN
dpc-4600	117	12	(	(	PUNCT
dpc-4600	117	13	gpx	gpx	NOUN
dpc-4600	117	14	)	)	PUNCT
dpc-4600	117	15	isoenzyme	isoenzyme	NOUN
dpc-4600	117	16	.	.	PUNCT
dpc-4600	118	1	it	it	PRON
dpc-4600	118	2	can	can	AUX
dpc-4600	118	3	be	be	AUX
dpc-4600	118	4	a	a	DET
dpc-4600	118	5	key	key	ADJ
dpc-4600	118	6	player	player	NOUN
dpc-4600	118	7	in	in	ADP
dpc-4600	118	8	redox	redox	ADJ
dpc-4600	118	9	regulation	regulation	NOUN
dpc-4600	118	10	through	through	ADP
dpc-4600	118	11	cascading	cascade	VERB
dpc-4600	118	12	enzyme	enzyme	NOUN
dpc-4600	118	13	systems	system	NOUN
dpc-4600	118	14	and	and	CCONJ
dpc-4600	118	15	protecting	protect	VERB
dpc-4600	118	16	melanocytes	melanocyte	NOUN
dpc-4600	118	17	from	from	ADP
dpc-4600	118	18	the	the	DET
dpc-4600	118	19	damaging	damaging	ADJ
dpc-4600	118	20	effects	effect	NOUN
dpc-4600	118	21	of	of	ADP
dpc-4600	118	22	free	free	ADJ
dpc-4600	118	23	radicals	radical	NOUN
dpc-4600	118	24	.	.	PUNCT
dpc-4600	119	1	studies	study	NOUN
dpc-4600	119	2	have	have	AUX
dpc-4600	119	3	shown	show	VERB
dpc-4600	119	4	elevated	elevated	ADJ
dpc-4600	119	5	serum	serum	NOUN
dpc-4600	119	6	selenium	selenium	NOUN
dpc-4600	119	7	levels	level	NOUN
dpc-4600	119	8	in	in	ADP
dpc-4600	119	9	vitiligo	vitiligo	NOUN
dpc-4600	119	10	patients	patient	NOUN
dpc-4600	119	11	.	.	PUNCT
dpc-4600	120	1	dai	dai	PROPN
dpc-4600	120	2	et	et	PROPN
dpc-4600	120	3	al	al	PROPN
dpc-4600	120	4	.	.	PROPN
dpc-4600	120	5	conducted	conduct	VERB
dpc-4600	120	6	a	a	DET
dpc-4600	120	7	systematic	systematic	ADJ
dpc-4600	120	8	review	review	NOUN
dpc-4600	120	9	to	to	PART
dpc-4600	120	10	evaluate	evaluate	VERB
dpc-4600	120	11	the	the	DET
dpc-4600	120	12	correlation	correlation	NOUN
dpc-4600	120	13	between	between	ADP
dpc-4600	120	14	selenium	selenium	NOUN
dpc-4600	120	15	levels	level	NOUN
dpc-4600	120	16	and	and	CCONJ
dpc-4600	120	17	vitiligo	vitiligo	VERB
dpc-4600	120	18	.	.	PUNCT
dpc-4600	121	1	overall	overall	ADV
dpc-4600	121	2	,	,	PUNCT
dpc-4600	121	3	no	no	DET
dpc-4600	121	4	significant	significant	ADJ
dpc-4600	121	5	difference	difference	NOUN
dpc-4600	121	6	was	be	AUX
dpc-4600	121	7	seen	see	VERB
dpc-4600	121	8	in	in	ADP
dpc-4600	121	9	selenium	selenium	NOUN
dpc-4600	121	10	levels	level	NOUN
dpc-4600	121	11	between	between	ADP
dpc-4600	121	12	vitiligo	vitiligo	NOUN
dpc-4600	121	13	patients	patient	NOUN
dpc-4600	121	14	and	and	CCONJ
dpc-4600	121	15	controls	control	NOUN
dpc-4600	121	16	.	.	PUNCT
dpc-4600	122	1	however	however	ADV
dpc-4600	122	2	,	,	PUNCT
dpc-4600	122	3	a	a	DET
dpc-4600	122	4	subgroup	subgroup	NOUN
dpc-4600	122	5	study	study	NOUN
dpc-4600	122	6	showed	show	VERB
dpc-4600	122	7	decreased	decrease	VERB
dpc-4600	122	8	selenium	selenium	NOUN
dpc-4600	122	9	levels	level	NOUN
dpc-4600	122	10	in	in	ADP
dpc-4600	122	11	the	the	DET
dpc-4600	122	12	asian	asian	ADJ
dpc-4600	122	13	population	population	NOUN
dpc-4600	122	14	in	in	ADP
dpc-4600	122	15	comparison	comparison	NOUN
dpc-4600	122	16	to	to	ADP
dpc-4600	122	17	caucasians	caucasian	NOUN
dpc-4600	122	18	and	and	CCONJ
dpc-4600	122	19	healthy	healthy	ADJ
dpc-4600	122	20	individuals	individual	NOUN
dpc-4600	122	21	.	.	PUNCT
dpc-4600	123	1	it	it	PRON
dpc-4600	123	2	was	be	AUX
dpc-4600	123	3	concluded	conclude	VERB
dpc-4600	123	4	that	that	SCONJ
dpc-4600	123	5	selenium	selenium	NOUN
dpc-4600	123	6	levels	level	NOUN
dpc-4600	123	7	vary	vary	VERB
dpc-4600	123	8	in	in	ADP
dpc-4600	123	9	different	different	ADJ
dpc-4600	123	10	races	race	NOUN
dpc-4600	123	11	,	,	PUNCT
dpc-4600	123	12	and	and	CCONJ
dpc-4600	123	13	its	its	PRON
dpc-4600	123	14	supplementation	supplementation	NOUN
dpc-4600	123	15	might	might	AUX
dpc-4600	123	16	prove	prove	VERB
dpc-4600	123	17	beneficial	beneficial	ADJ
dpc-4600	123	18	in	in	ADP
dpc-4600	123	19	the	the	DET
dpc-4600	123	20	treatment	treatment	NOUN
dpc-4600	123	21	of	of	ADP
dpc-4600	123	22	vitiligo	vitiligo	NOUN
dpc-4600	123	23	in	in	ADP
dpc-4600	123	24	the	the	DET
dpc-4600	123	25	asian	asian	ADJ
dpc-4600	123	26	population	population	NOUN
dpc-4600	124	1	[	[	X
dpc-4600	124	2	42	42	NUM
dpc-4600	124	3	]	]	PUNCT
dpc-4600	124	4	.	.	PUNCT
dpc-4600	125	1	vitamin	vitamin	NOUN
dpc-4600	125	2	d3	d3	PROPN
dpc-4600	125	3	analogues	analogue	NOUN
dpc-4600	125	4	vitamin	vitamin	NOUN
dpc-4600	125	5	d	d	NOUN
dpc-4600	125	6	has	have	VERB
dpc-4600	125	7	a	a	DET
dpc-4600	125	8	role	role	NOUN
dpc-4600	125	9	in	in	ADP
dpc-4600	125	10	differentiation	differentiation	NOUN
dpc-4600	125	11	,	,	PUNCT
dpc-4600	125	12	maturation	maturation	NOUN
dpc-4600	125	13	of	of	ADP
dpc-4600	125	14	keratinocytes	keratinocyte	NOUN
dpc-4600	125	15	,	,	PUNCT
dpc-4600	125	16	and	and	CCONJ
dpc-4600	125	17	maintenance	maintenance	NOUN
dpc-4600	125	18	of	of	ADP
dpc-4600	125	19	the	the	DET
dpc-4600	125	20	integrity	integrity	NOUN
dpc-4600	125	21	of	of	ADP
dpc-4600	125	22	the	the	DET
dpc-4600	125	23	epidermal	epidermal	ADJ
dpc-4600	125	24	barrier	barrier	NOUN
dpc-4600	125	25	.	.	PUNCT
dpc-4600	126	1	additionally	additionally	ADV
dpc-4600	126	2	,	,	PUNCT
dpc-4600	126	3	it	it	PRON
dpc-4600	126	4	has	have	VERB
dpc-4600	126	5	immunomodulatory	immunomodulatory	ADJ
dpc-4600	126	6	effects	effect	NOUN
dpc-4600	126	7	by	by	ADP
dpc-4600	126	8	suppressing	suppress	VERB
dpc-4600	126	9	overactive	overactive	ADJ
dpc-4600	126	10	immunological	immunological	ADJ
dpc-4600	126	11	responses	response	NOUN
dpc-4600	126	12	,	,	PUNCT
dpc-4600	126	13	which	which	PRON
dpc-4600	126	14	can	can	AUX
dpc-4600	126	15	lead	lead	VERB
dpc-4600	126	16	to	to	ADP
dpc-4600	126	17	the	the	DET
dpc-4600	126	18	loss	loss	NOUN
dpc-4600	126	19	of	of	ADP
dpc-4600	126	20	melanocytes	melanocyte	NOUN
dpc-4600	126	21	in	in	ADP
dpc-4600	126	22	vitiligo	vitiligo	NOUN
dpc-4600	126	23	.	.	PUNCT
dpc-4600	127	1	it	it	PRON
dpc-4600	127	2	increases	increase	VERB
dpc-4600	127	3	the	the	DET
dpc-4600	127	4	melanin	melanin	ADJ
dpc-4600	127	5	synthesis	synthesis	NOUN
dpc-4600	127	6	within	within	ADP
dpc-4600	127	7	melanocytes	melanocyte	NOUN
dpc-4600	127	8	and	and	CCONJ
dpc-4600	127	9	may	may	AUX
dpc-4600	127	10	aid	aid	VERB
dpc-4600	127	11	in	in	ADP
dpc-4600	127	12	the	the	DET
dpc-4600	127	13	repigmentation	repigmentation	NOUN
dpc-4600	127	14	process	process	NOUN
dpc-4600	127	15	in	in	ADP
dpc-4600	127	16	vitiligo	vitiligo	NOUN
dpc-4600	127	17	[	[	X
dpc-4600	127	18	43	43	NUM
dpc-4600	127	19	]	]	PUNCT
dpc-4600	127	20	.	.	PUNCT
dpc-4600	128	1	moreover	moreover	ADV
dpc-4600	128	2	,	,	PUNCT
dpc-4600	128	3	vitamin	vitamin	NOUN
dpc-4600	128	4	d	d	NOUN
dpc-4600	128	5	affects	affect	VERB
dpc-4600	128	6	the	the	DET
dpc-4600	128	7	release	release	NOUN
dpc-4600	128	8	of	of	ADP
dpc-4600	128	9	several	several	ADJ
dpc-4600	128	10	cytokines	cytokine	NOUN
dpc-4600	128	11	and	and	CCONJ
dpc-4600	128	12	growth	growth	NOUN
dpc-4600	128	13	factors	factor	NOUN
dpc-4600	128	14	that	that	PRON
dpc-4600	128	15	promote	promote	VERB
dpc-4600	128	16	melanocyte	melanocyte	NOUN
dpc-4600	128	17	survival	survival	NOUN
dpc-4600	128	18	and	and	CCONJ
dpc-4600	128	19	proliferation	proliferation	NOUN
dpc-4600	128	20	.	.	PUNCT
dpc-4600	129	1	topical	topical	ADJ
dpc-4600	129	2	vitamin	vitamin	NOUN
dpc-4600	129	3	d	d	NOUN
dpc-4600	129	4	analogues	analogue	NOUN
dpc-4600	129	5	like	like	ADP
dpc-4600	129	6	calcipotriol	calcipotriol	NOUN
dpc-4600	129	7	and	and	CCONJ
dpc-4600	129	8	tacalcitol	tacalcitol	NOUN
dpc-4600	129	9	are	be	AUX
dpc-4600	129	10	commonly	commonly	ADV
dpc-4600	129	11	used	use	VERB
dpc-4600	129	12	as	as	ADP
dpc-4600	129	13	second	second	ADJ
dpc-4600	129	14	-	-	PUNCT
dpc-4600	129	15	line	line	NOUN
dpc-4600	129	16	therapy	therapy	NOUN
dpc-4600	129	17	for	for	ADP
dpc-4600	129	18	the	the	DET
dpc-4600	129	19	treatment	treatment	NOUN
dpc-4600	129	20	of	of	ADP
dpc-4600	129	21	vitiligo	vitiligo	NOUN
dpc-4600	129	22	[	[	X
dpc-4600	129	23	44	44	NUM
dpc-4600	129	24	]	]	PUNCT
dpc-4600	129	25	.	.	PUNCT
dpc-4600	130	1	a	a	DET
dpc-4600	130	2	comparative	comparative	ADJ
dpc-4600	130	3	randomized	randomized	ADJ
dpc-4600	130	4	study	study	NOUN
dpc-4600	130	5	was	be	AUX
dpc-4600	130	6	conducted	conduct	VERB
dpc-4600	130	7	in	in	ADP
dpc-4600	130	8	numerous	numerous	ADJ
dpc-4600	130	9	clinical	clinical	ADJ
dpc-4600	130	10	trials	trial	NOUN
dpc-4600	130	11	have	have	AUX
dpc-4600	130	12	been	be	AUX
dpc-4600	130	13	done	do	VERB
dpc-4600	130	14	regarding	regard	VERB
dpc-4600	130	15	the	the	DET
dpc-4600	130	16	efficacy	efficacy	NOUN
dpc-4600	130	17	and	and	CCONJ
dpc-4600	130	18	safety	safety	NOUN
dpc-4600	130	19	of	of	ADP
dpc-4600	130	20	afamelanotide	afamelanotide	NOUN
dpc-4600	130	21	in	in	ADP
dpc-4600	130	22	the	the	DET
dpc-4600	130	23	treatment	treatment	NOUN
dpc-4600	130	24	of	of	ADP
dpc-4600	130	25	vitiligo	vitiligo	NOUN
dpc-4600	130	26	.	.	PUNCT
dpc-4600	131	1	lim	lim	PROPN
dpc-4600	131	2	et	et	PROPN
dpc-4600	131	3	al	al	PROPN
dpc-4600	131	4	.	.	PROPN
dpc-4600	131	5	conducted	conduct	VERB
dpc-4600	131	6	a	a	DET
dpc-4600	131	7	randomized	randomized	ADJ
dpc-4600	131	8	comparative	comparative	ADJ
dpc-4600	131	9	study	study	NOUN
dpc-4600	131	10	on	on	ADP
dpc-4600	131	11	patients	patient	NOUN
dpc-4600	131	12	with	with	ADP
dpc-4600	131	13	non	non	ADJ
dpc-4600	131	14	-	-	ADJ
dpc-4600	131	15	segmental	segmental	ADJ
dpc-4600	131	16	vitiligo	vitiligo	NOUN
dpc-4600	131	17	having	have	VERB
dpc-4600	131	18	15	15	NUM
dpc-4600	131	19	%	%	NOUN
dpc-4600	131	20	to	to	PART
dpc-4600	131	21	50	50	NUM
dpc-4600	131	22	%	%	NOUN
dpc-4600	131	23	of	of	ADP
dpc-4600	131	24	total	total	ADJ
dpc-4600	131	25	bsa	bsa	PROPN
dpc-4600	131	26	involvement	involvement	NOUN
dpc-4600	131	27	,	,	PUNCT
dpc-4600	131	28	where	where	SCONJ
dpc-4600	131	29	the	the	DET
dpc-4600	131	30	use	use	NOUN
dpc-4600	131	31	of	of	ADP
dpc-4600	131	32	afamelanotide	afamelanotide	NOUN
dpc-4600	131	33	in	in	ADP
dpc-4600	131	34	combination	combination	NOUN
dpc-4600	131	35	with	with	ADP
dpc-4600	131	36	narrow	narrow	ADJ
dpc-4600	131	37	-	-	PUNCT
dpc-4600	131	38	band	band	NOUN
dpc-4600	131	39	uvb	uvb	ADJ
dpc-4600	131	40	phototherapy	phototherapy	NOUN
dpc-4600	131	41	showed	show	VERB
dpc-4600	131	42	more	more	ADJ
dpc-4600	131	43	effectiveness	effectiveness	NOUN
dpc-4600	131	44	in	in	ADP
dpc-4600	131	45	treating	treat	VERB
dpc-4600	131	46	vitiligo	vitiligo	NOUN
dpc-4600	131	47	than	than	ADP
dpc-4600	131	48	phototherapy	phototherapy	NOUN
dpc-4600	131	49	alone	alone	ADV
dpc-4600	131	50	,	,	PUNCT
dpc-4600	131	51	with	with	ADP
dpc-4600	131	52	a	a	DET
dpc-4600	131	53	faster	fast	ADJ
dpc-4600	131	54	rate	rate	NOUN
dpc-4600	131	55	of	of	ADP
dpc-4600	131	56	repigmentation	repigmentation	NOUN
dpc-4600	131	57	over	over	ADP
dpc-4600	131	58	face	face	NOUN
dpc-4600	131	59	and	and	CCONJ
dpc-4600	131	60	upper	upper	ADJ
dpc-4600	131	61	extremities	extremity	NOUN
dpc-4600	131	62	.	.	PUNCT
dpc-4600	132	1	side	side	ADJ
dpc-4600	132	2	effects	effect	NOUN
dpc-4600	132	3	observed	observe	VERB
dpc-4600	132	4	were	be	AUX
dpc-4600	132	5	erythema	erythema	ADJ
dpc-4600	132	6	and	and	CCONJ
dpc-4600	132	7	nausea	nausea	NOUN
dpc-4600	132	8	[	[	X
dpc-4600	132	9	32	32	NUM
dpc-4600	132	10	]	]	PUNCT
dpc-4600	132	11	.	.	PUNCT
dpc-4600	133	1	the	the	DET
dpc-4600	133	2	safety	safety	NOUN
dpc-4600	133	3	of	of	ADP
dpc-4600	133	4	afamelanotide	afamelanotide	ADJ
dpc-4600	133	5	use	use	NOUN
dpc-4600	133	6	on	on	ADP
dpc-4600	133	7	the	the	DET
dpc-4600	133	8	face	face	NOUN
dpc-4600	133	9	in	in	ADP
dpc-4600	133	10	vitiligo	vitiligo	ADJ
dpc-4600	133	11	patients	patient	NOUN
dpc-4600	133	12	is	be	AUX
dpc-4600	133	13	being	be	AUX
dpc-4600	133	14	studied	study	VERB
dpc-4600	133	15	in	in	ADP
dpc-4600	133	16	various	various	ADJ
dpc-4600	133	17	experimental	experimental	ADJ
dpc-4600	133	18	trials	trial	NOUN
dpc-4600	133	19	(	(	PUNCT
dpc-4600	133	20	nct05210582	nct05210582	NOUN
dpc-4600	133	21	)	)	PUNCT
dpc-4600	133	22	.	.	PUNCT
dpc-4600	134	1	antioxidants	antioxidant	NOUN
dpc-4600	134	2	antioxidants	antioxidant	NOUN
dpc-4600	134	3	play	play	VERB
dpc-4600	134	4	a	a	DET
dpc-4600	134	5	significant	significant	ADJ
dpc-4600	134	6	role	role	NOUN
dpc-4600	134	7	in	in	ADP
dpc-4600	134	8	the	the	DET
dpc-4600	134	9	pathogenesis	pathogenesis	NOUN
dpc-4600	134	10	of	of	ADP
dpc-4600	134	11	vitiligo	vitiligo	NOUN
dpc-4600	134	12	(	(	PUNCT
dpc-4600	134	13	figure	figure	NOUN
dpc-4600	134	14	4	4	NUM
dpc-4600	134	15	)	)	PUNCT
dpc-4600	134	16	.	.	PUNCT
dpc-4600	135	1	various	various	ADJ
dpc-4600	135	2	antioxidants	antioxidant	NOUN
dpc-4600	135	3	have	have	AUX
dpc-4600	135	4	been	be	AUX
dpc-4600	135	5	studied	study	VERB
dpc-4600	135	6	for	for	ADP
dpc-4600	135	7	the	the	DET
dpc-4600	135	8	effective	effective	ADJ
dpc-4600	135	9	treatment	treatment	NOUN
dpc-4600	135	10	of	of	ADP
dpc-4600	135	11	this	this	DET
dpc-4600	135	12	condition	condition	NOUN
dpc-4600	135	13	.	.	PUNCT
dpc-4600	136	1	pseudocatalase	pseudocatalase	NOUN
dpc-4600	136	2	/	/	SYM
dpc-4600	136	3	superoxide	superoxide	NOUN
dpc-4600	136	4	dismutase	dismutase	NOUN
dpc-4600	136	5	in	in	ADP
dpc-4600	136	6	vitiligo	vitiligo	NOUN
dpc-4600	136	7	,	,	PUNCT
dpc-4600	136	8	there	there	PRON
dpc-4600	136	9	is	be	VERB
dpc-4600	136	10	an	an	DET
dpc-4600	136	11	accumulation	accumulation	NOUN
dpc-4600	136	12	of	of	ADP
dpc-4600	136	13	free	free	ADJ
dpc-4600	136	14	radicals	radical	NOUN
dpc-4600	136	15	like	like	ADP
dpc-4600	136	16	h2o2	h2o2	NOUN
dpc-4600	136	17	in	in	ADP
dpc-4600	136	18	melanocytes	melanocyte	NOUN
dpc-4600	136	19	,	,	PUNCT
dpc-4600	136	20	which	which	PRON
dpc-4600	136	21	are	be	AUX
dpc-4600	136	22	lethal	lethal	ADJ
dpc-4600	136	23	to	to	ADP
dpc-4600	136	24	enzymes	enzyme	NOUN
dpc-4600	136	25	such	such	ADJ
dpc-4600	136	26	as	as	ADP
dpc-4600	136	27	tyrosinase	tyrosinase	NOUN
dpc-4600	136	28	and	and	CCONJ
dpc-4600	136	29	catalase	catalase	ADJ
dpc-4600	136	30	[	[	X
dpc-4600	136	31	33	33	NUM
dpc-4600	136	32	]	]	PUNCT
dpc-4600	136	33	.	.	PUNCT
dpc-4600	137	1	the	the	DET
dpc-4600	137	2	catalase	catalase	NOUN
dpc-4600	137	3	enzyme	enzyme	NOUN
dpc-4600	137	4	is	be	AUX
dpc-4600	137	5	responsible	responsible	ADJ
dpc-4600	137	6	for	for	ADP
dpc-4600	137	7	reducing	reduce	VERB
dpc-4600	137	8	h2o2	h2o2	NOUN
dpc-4600	137	9	and	and	CCONJ
dpc-4600	137	10	preventing	prevent	VERB
dpc-4600	137	11	oxidative	oxidative	ADJ
dpc-4600	137	12	stress	stress	NOUN
dpc-4600	137	13	in	in	ADP
dpc-4600	137	14	melanocytes	melanocyte	NOUN
dpc-4600	137	15	.	.	PUNCT
dpc-4600	138	1	alshiyab	alshiyab	PROPN
dpc-4600	138	2	et	et	PROPN
dpc-4600	138	3	al	al	PROPN
dpc-4600	138	4	.	.	PROPN
dpc-4600	138	5	performed	perform	VERB
dpc-4600	138	6	a	a	DET
dpc-4600	138	7	study	study	NOUN
dpc-4600	138	8	on	on	ADP
dpc-4600	138	9	pediatric	pediatric	ADJ
dpc-4600	138	10	vitiligo	vitiligo	NOUN
dpc-4600	138	11	patients	patient	NOUN
dpc-4600	138	12	to	to	PART
dpc-4600	138	13	evaluate	evaluate	VERB
dpc-4600	138	14	the	the	DET
dpc-4600	138	15	efficacy	efficacy	NOUN
dpc-4600	138	16	of	of	ADP
dpc-4600	138	17	pseudocatalase	pseudocatalase	ADJ
dpc-4600	138	18	gel	gel	NOUN
dpc-4600	138	19	in	in	ADP
dpc-4600	138	20	combination	combination	NOUN
dpc-4600	138	21	with	with	ADP
dpc-4600	138	22	topical	topical	ADJ
dpc-4600	138	23	tacrolimus	tacrolimus	NOUN
dpc-4600	138	24	0.1	0.1	NUM
dpc-4600	138	25	%	%	NOUN
dpc-4600	138	26	versus	versus	ADP
dpc-4600	138	27	topical	topical	ADJ
dpc-4600	138	28	tacrolimus	tacrolimus	NOUN
dpc-4600	138	29	0.1	0.1	NUM
dpc-4600	138	30	%	%	NOUN
dpc-4600	138	31	alone	alone	ADV
dpc-4600	138	32	.	.	PUNCT
dpc-4600	139	1	no	no	DET
dpc-4600	139	2	significant	significant	ADJ
dpc-4600	139	3	difference	difference	NOUN
dpc-4600	139	4	in	in	ADP
dpc-4600	139	5	the	the	DET
dpc-4600	139	6	percentages	percentage	NOUN
dpc-4600	139	7	of	of	ADP
dpc-4600	139	8	repigmentation	repigmentation	NOUN
dpc-4600	139	9	was	be	AUX
dpc-4600	139	10	observed	observe	VERB
dpc-4600	139	11	[	[	X
dpc-4600	139	12	34	34	NUM
dpc-4600	139	13	]	]	PUNCT
dpc-4600	139	14	.	.	PUNCT
dpc-4600	140	1	nevertheless	nevertheless	ADV
dpc-4600	140	2	,	,	PUNCT
dpc-4600	140	3	information	information	NOUN
dpc-4600	140	4	regarding	regard	VERB
dpc-4600	140	5	pseudocatalase	pseudocatalase	NOUN
dpc-4600	140	6	’s	’s	PART
dpc-4600	140	7	safety	safety	NOUN
dpc-4600	140	8	profile	profile	NOUN
dpc-4600	140	9	and	and	CCONJ
dpc-4600	140	10	adverse	adverse	ADJ
dpc-4600	140	11	effects	effect	NOUN
dpc-4600	140	12	is	be	AUX
dpc-4600	140	13	scarce	scarce	ADJ
dpc-4600	140	14	.	.	PUNCT
dpc-4600	141	1	ginkgo	ginkgo	NOUN
dpc-4600	141	2	biloba	biloba	PROPN
dpc-4600	141	3	extract	extract	VERB
dpc-4600	141	4	ginkgo	ginkgo	NOUN
dpc-4600	141	5	biloba	biloba	NOUN
dpc-4600	141	6	(	(	PUNCT
dpc-4600	141	7	gb	gb	NOUN
dpc-4600	141	8	)	)	PUNCT
dpc-4600	141	9	extract	extract	NOUN
dpc-4600	141	10	inhibits	inhibit	VERB
dpc-4600	141	11	h2o2	h2o2	ADJ
dpc-4600	141	12	-	-	ADJ
dpc-4600	141	13	induced	induced	ADJ
dpc-4600	141	14	apoptosis	apoptosis	NOUN
dpc-4600	141	15	and	and	CCONJ
dpc-4600	141	16	the	the	DET
dpc-4600	141	17	release	release	NOUN
dpc-4600	141	18	of	of	ADP
dpc-4600	141	19	heat	heat	NOUN
dpc-4600	141	20	shock	shock	NOUN
dpc-4600	141	21	protein	protein	NOUN
dpc-4600	141	22	70	70	NUM
dpc-4600	141	23	(	(	PUNCT
dpc-4600	141	24	hsp70	hsp70	NOUN
dpc-4600	141	25	)	)	PUNCT
dpc-4600	141	26	,	,	PUNCT
dpc-4600	141	27	therefore	therefore	ADV
dpc-4600	141	28	preventing	prevent	VERB
dpc-4600	141	29	oxidative	oxidative	ADJ
dpc-4600	141	30	damage	damage	NOUN
dpc-4600	141	31	to	to	ADP
dpc-4600	141	32	melanocytes	melanocyte	NOUN
dpc-4600	141	33	[	[	X
dpc-4600	141	34	35	35	NUM
dpc-4600	141	35	]	]	PUNCT
dpc-4600	141	36	.	.	PUNCT
dpc-4600	142	1	in	in	ADP
dpc-4600	142	2	addition	addition	NOUN
dpc-4600	142	3	,	,	PUNCT
dpc-4600	142	4	it	it	PRON
dpc-4600	142	5	reduces	reduce	VERB
dpc-4600	142	6	inflammation	inflammation	NOUN
dpc-4600	142	7	by	by	ADP
dpc-4600	142	8	blocking	block	VERB
dpc-4600	142	9	the	the	DET
dpc-4600	142	10	activity	activity	NOUN
dpc-4600	142	11	of	of	ADP
dpc-4600	142	12	the	the	DET
dpc-4600	142	13	cyclooxygenase	cyclooxygenase	NOUN
dpc-4600	142	14	enzyme	enzyme	NOUN
dpc-4600	142	15	,	,	PUNCT
dpc-4600	142	16	proinflammatory	proinflammatory	ADJ
dpc-4600	142	17	interleukins	interleukin	NOUN
dpc-4600	142	18	like	like	ADP
dpc-4600	142	19	il-8	il-8	NOUN
dpc-4600	142	20	,	,	PUNCT
dpc-4600	142	21	and	and	CCONJ
dpc-4600	142	22	vascular	vascular	ADJ
dpc-4600	142	23	endothelial	endothelial	ADJ
dpc-4600	142	24	growth	growth	NOUN
dpc-4600	142	25	factor	factor	NOUN
dpc-4600	142	26	(	(	PUNCT
dpc-4600	142	27	vegf	vegf	PROPN
dpc-4600	142	28	)	)	PUNCT
dpc-4600	143	1	[	[	X
dpc-4600	143	2	36	36	NUM
dpc-4600	143	3	]	]	PUNCT
dpc-4600	143	4	.	.	PUNCT
dpc-4600	144	1	a	a	DET
dpc-4600	144	2	clinical	clinical	ADJ
dpc-4600	144	3	trial	trial	NOUN
dpc-4600	144	4	on	on	ADP
dpc-4600	144	5	vitiligo	vitiligo	NOUN
dpc-4600	144	6	patients	patient	NOUN
dpc-4600	144	7	showed	show	VERB
dpc-4600	144	8	that	that	SCONJ
dpc-4600	144	9	supplementing	supplement	VERB
dpc-4600	144	10	ginkgo	ginkgo	NOUN
dpc-4600	144	11	biloba	biloba	NOUN
dpc-4600	144	12	at	at	ADP
dpc-4600	144	13	a	a	DET
dpc-4600	144	14	dose	dose	NOUN
dpc-4600	144	15	of	of	ADP
dpc-4600	144	16	40	40	NUM
dpc-4600	144	17	mg	mg	NUM
dpc-4600	144	18	three	three	NUM
dpc-4600	144	19	times	time	NOUN
dpc-4600	144	20	a	a	DET
dpc-4600	144	21	day	day	NOUN
dpc-4600	144	22	might	might	AUX
dpc-4600	144	23	induce	induce	VERB
dpc-4600	144	24	repigmentation	repigmentation	NOUN
dpc-4600	144	25	of	of	ADP
dpc-4600	144	26	facial	facial	ADJ
dpc-4600	144	27	lesions	lesion	NOUN
dpc-4600	144	28	in	in	ADP
dpc-4600	144	29	vitiligo	vitiligo	NOUN
dpc-4600	144	30	.	.	PUNCT
dpc-4600	145	1	in	in	ADP
dpc-4600	145	2	another	another	DET
dpc-4600	145	3	study	study	NOUN
dpc-4600	145	4	conducted	conduct	VERB
dpc-4600	145	5	by	by	ADP
dpc-4600	145	6	szczurko	szczurko	PROPN
dpc-4600	145	7	et	et	PROPN
dpc-4600	145	8	al	al	PROPN
dpc-4600	145	9	.	.	PROPN
dpc-4600	145	10	,	,	PUNCT
dpc-4600	145	11	it	it	PRON
dpc-4600	145	12	was	be	AUX
dpc-4600	145	13	seen	see	VERB
dpc-4600	145	14	that	that	SCONJ
dpc-4600	145	15	60	60	NUM
dpc-4600	145	16	mg	mg	NOUN
dpc-4600	145	17	of	of	ADP
dpc-4600	145	18	ginkgo	ginkgo	NOUN
dpc-4600	145	19	biloba	biloba	NOUN
dpc-4600	145	20	twice	twice	ADV
dpc-4600	145	21	daily	daily	ADV
dpc-4600	145	22	also	also	ADV
dpc-4600	145	23	reduced	reduce	VERB
dpc-4600	145	24	the	the	DET
dpc-4600	145	25	severity	severity	NOUN
dpc-4600	145	26	of	of	ADP
dpc-4600	145	27	disease	disease	NOUN
dpc-4600	145	28	in	in	ADP
dpc-4600	145	29	vitiligo	vitiligo	NOUN
dpc-4600	145	30	patients	patient	NOUN
dpc-4600	145	31	.	.	PUNCT
dpc-4600	146	1	gb	gb	PRON
dpc-4600	146	2	may	may	AUX
dpc-4600	146	3	interact	interact	VERB
dpc-4600	146	4	with	with	ADP
dpc-4600	146	5	antiplatelets	antiplatelet	NOUN
dpc-4600	146	6	and	and	CCONJ
dpc-4600	146	7	anticoagulants	anticoagulant	NOUN
dpc-4600	146	8	and	and	CCONJ
dpc-4600	146	9	increase	increase	VERB
dpc-4600	146	10	the	the	DET
dpc-4600	146	11	risk	risk	NOUN
dpc-4600	146	12	of	of	ADP
dpc-4600	146	13	bleeding	bleeding	NOUN
dpc-4600	146	14	.	.	PUNCT
dpc-4600	147	1	hence	hence	ADV
dpc-4600	147	2	,	,	PUNCT
dpc-4600	147	3	the	the	DET
dpc-4600	147	4	hazards	hazard	NOUN
dpc-4600	147	5	of	of	ADP
dpc-4600	147	6	ginkgo	ginkgo	NOUN
dpc-4600	147	7	biloba	biloba	NOUN
dpc-4600	147	8	may	may	AUX
dpc-4600	147	9	outweigh	outweigh	VERB
dpc-4600	147	10	its	its	PRON
dpc-4600	147	11	benefits	benefit	NOUN
dpc-4600	147	12	[	[	X
dpc-4600	147	13	37	37	NUM
dpc-4600	147	14	]	]	PUNCT
dpc-4600	147	15	.	.	PUNCT
dpc-4600	148	1	alpha	alpha	NOUN
dpc-4600	148	2	lipoic	lipoic	ADJ
dpc-4600	148	3	acid	acid	PROPN
dpc-4600	148	4	alpha	alpha	NOUN
dpc-4600	148	5	lipoic	lipoic	NOUN
dpc-4600	148	6	acid	acid	NOUN
dpc-4600	148	7	is	be	AUX
dpc-4600	148	8	a	a	DET
dpc-4600	148	9	lipoxygenase	lipoxygenase	NOUN
dpc-4600	148	10	inhibitor	inhibitor	NOUN
dpc-4600	148	11	.	.	PUNCT
dpc-4600	149	1	it	it	PRON
dpc-4600	149	2	promotes	promote	VERB
dpc-4600	149	3	the	the	DET
dpc-4600	149	4	synthesis	synthesis	NOUN
dpc-4600	149	5	of	of	ADP
dpc-4600	149	6	glutathione	glutathione	NOUN
dpc-4600	149	7	enzymes	enzyme	NOUN
dpc-4600	149	8	and	and	CCONJ
dpc-4600	149	9	scavenges	scavenge	NOUN
dpc-4600	149	10	free	free	ADJ
dpc-4600	149	11	radicals	radical	NOUN
dpc-4600	149	12	like	like	ADP
dpc-4600	149	13	hydroxyl	hydroxyl	NOUN
dpc-4600	149	14	radicles	radicle	NOUN
dpc-4600	149	15	,	,	PUNCT
dpc-4600	149	16	thus	thus	ADV
dpc-4600	149	17	preventing	prevent	VERB
dpc-4600	149	18	oxidative	oxidative	ADJ
dpc-4600	149	19	damage	damage	NOUN
dpc-4600	149	20	in	in	ADP
dpc-4600	149	21	vitiligo	vitiligo	NOUN
dpc-4600	149	22	[	[	X
dpc-4600	149	23	37	37	NUM
dpc-4600	149	24	]	]	PUNCT
dpc-4600	149	25	.	.	PUNCT
dpc-4600	150	1	it	it	PRON
dpc-4600	150	2	is	be	AUX
dpc-4600	150	3	synthesized	synthesize	VERB
dpc-4600	150	4	in	in	ADP
dpc-4600	150	5	the	the	DET
dpc-4600	150	6	liver	liver	NOUN
dpc-4600	150	7	and	and	CCONJ
dpc-4600	150	8	is	be	AUX
dpc-4600	150	9	present	present	ADJ
dpc-4600	150	10	in	in	ADP
dpc-4600	150	11	green	green	ADJ
dpc-4600	150	12	leafy	leafy	ADJ
dpc-4600	150	13	vegetables	vegetable	NOUN
dpc-4600	150	14	like	like	ADP
dpc-4600	150	15	broccoli	broccoli	NOUN
dpc-4600	150	16	and	and	CCONJ
dpc-4600	150	17	spinach	spinach	NOUN
dpc-4600	150	18	in	in	ADP
dpc-4600	150	19	small	small	ADJ
dpc-4600	150	20	review	review	NOUN
dpc-4600	150	21	|	|	ADV
dpc-4600	150	22	dermatol	dermatol	ADJ
dpc-4600	150	23	pract	pract	NOUN
dpc-4600	150	24	concept	concept	NOUN
dpc-4600	150	25	.	.	PUNCT
dpc-4600	151	1	2025;15(1):4600	2025;15(1):4600	NUM
dpc-4600	151	2	7	7	NUM
dpc-4600	151	3	treatment	treatment	NOUN
dpc-4600	151	4	period	period	NOUN
dpc-4600	151	5	,	,	PUNCT
dpc-4600	151	6	but	but	CCONJ
dpc-4600	151	7	post	post	ADJ
dpc-4600	151	8	-	-	ADJ
dpc-4600	151	9	treatment	treatment	ADJ
dpc-4600	151	10	follow	follow	NOUN
dpc-4600	151	11	-	-	PUNCT
dpc-4600	151	12	up	up	NOUN
dpc-4600	151	13	was	be	AUX
dpc-4600	151	14	not	not	PART
dpc-4600	151	15	documented	document	VERB
dpc-4600	151	16	.	.	PUNCT
dpc-4600	152	1	ironically	ironically	ADV
dpc-4600	152	2	,	,	PUNCT
dpc-4600	152	3	some	some	DET
dpc-4600	152	4	people	people	NOUN
dpc-4600	152	5	taking	take	VERB
dpc-4600	152	6	tnf	tnf	PROPN
dpc-4600	152	7	-	-	PUNCT
dpc-4600	152	8	α	α	NOUN
dpc-4600	152	9	inhibitors	inhibitor	NOUN
dpc-4600	152	10	for	for	ADP
dpc-4600	152	11	ailments	ailment	NOUN
dpc-4600	152	12	other	other	ADJ
dpc-4600	152	13	than	than	ADP
dpc-4600	152	14	vitiligo	vitiligo	PROPN
dpc-4600	152	15	have	have	AUX
dpc-4600	152	16	reported	report	VERB
dpc-4600	152	17	worsening	worsen	VERB
dpc-4600	152	18	of	of	ADP
dpc-4600	152	19	their	their	PRON
dpc-4600	152	20	vitiligo	vitiligo	NOUN
dpc-4600	152	21	or	or	CCONJ
dpc-4600	152	22	the	the	DET
dpc-4600	152	23	development	development	NOUN
dpc-4600	152	24	of	of	ADP
dpc-4600	152	25	de	de	X
dpc-4600	152	26	novo	novo	NOUN
dpc-4600	152	27	vitiligo	vitiligo	VERB
dpc-4600	152	28	.	.	PUNCT
dpc-4600	153	1	this	this	DET
dpc-4600	153	2	paradox	paradox	NOUN
dpc-4600	153	3	may	may	AUX
dpc-4600	153	4	be	be	AUX
dpc-4600	153	5	explained	explain	VERB
dpc-4600	153	6	by	by	ADP
dpc-4600	153	7	the	the	DET
dpc-4600	153	8	multifactorial	multifactorial	ADJ
dpc-4600	153	9	pathophysiology	pathophysiology	NOUN
dpc-4600	153	10	of	of	ADP
dpc-4600	153	11	vitiligo	vitiligo	NOUN
dpc-4600	153	12	,	,	PUNCT
dpc-4600	153	13	which	which	PRON
dpc-4600	153	14	includes	include	VERB
dpc-4600	153	15	upregulation	upregulation	NOUN
dpc-4600	153	16	of	of	ADP
dpc-4600	153	17	icam-1	icam-1	NUM
dpc-4600	153	18	molecules	molecule	NOUN
dpc-4600	153	19	on	on	ADP
dpc-4600	153	20	melanocytes	melanocyte	NOUN
dpc-4600	153	21	and	and	CCONJ
dpc-4600	153	22	other	other	ADJ
dpc-4600	153	23	cytokines	cytokine	NOUN
dpc-4600	153	24	like	like	ADP
dpc-4600	153	25	ifn	ifn	PROPN
dpc-4600	153	26	γ	γ	PROPN
dpc-4600	153	27	,	,	PUNCT
dpc-4600	153	28	which	which	PRON
dpc-4600	153	29	attract	attract	VERB
dpc-4600	153	30	more	more	ADJ
dpc-4600	153	31	cytotoxic	cytotoxic	ADJ
dpc-4600	153	32	t	t	NOUN
dpc-4600	153	33	cells	cell	NOUN
dpc-4600	153	34	to	to	ADP
dpc-4600	153	35	the	the	DET
dpc-4600	153	36	lesional	lesional	ADJ
dpc-4600	153	37	skin	skin	NOUN
dpc-4600	153	38	[	[	X
dpc-4600	153	39	53	53	NUM
dpc-4600	153	40	]	]	PUNCT
dpc-4600	153	41	.	.	PUNCT
dpc-4600	154	1	drugs	drug	NOUN
dpc-4600	154	2	targeting	target	VERB
dpc-4600	154	3	interleukins	interleukin	NOUN
dpc-4600	154	4	interleukin-17	interleukin-17	PROPN
dpc-4600	154	5	,	,	PUNCT
dpc-4600	154	6	produced	produce	VERB
dpc-4600	154	7	by	by	ADP
dpc-4600	154	8	t	t	PROPN
dpc-4600	154	9	helper	helper	NOUN
dpc-4600	154	10	17	17	NUM
dpc-4600	154	11	(	(	PUNCT
dpc-4600	154	12	th17	th17	NOUN
dpc-4600	154	13	)	)	PUNCT
dpc-4600	154	14	cells	cell	NOUN
dpc-4600	154	15	,	,	PUNCT
dpc-4600	154	16	is	be	AUX
dpc-4600	154	17	a	a	DET
dpc-4600	154	18	pro	pro	ADJ
dpc-4600	154	19	-	-	ADJ
dpc-4600	154	20	inflammatory	inflammatory	ADJ
dpc-4600	154	21	cytokine	cytokine	NOUN
dpc-4600	154	22	that	that	PRON
dpc-4600	154	23	may	may	AUX
dpc-4600	154	24	stimulate	stimulate	VERB
dpc-4600	154	25	the	the	DET
dpc-4600	154	26	monocytes	monocyte	NOUN
dpc-4600	154	27	to	to	PART
dpc-4600	154	28	release	release	VERB
dpc-4600	154	29	other	other	ADJ
dpc-4600	154	30	inflammatory	inflammatory	ADJ
dpc-4600	154	31	cytokines	cytokine	NOUN
dpc-4600	154	32	like	like	ADP
dpc-4600	154	33	il-1	il-1	ADP
dpc-4600	154	34	,	,	PUNCT
dpc-4600	154	35	il-6	il-6	NUM
dpc-4600	154	36	,	,	PUNCT
dpc-4600	154	37	and	and	CCONJ
dpc-4600	154	38	tnf	tnf	PROPN
dpc-4600	154	39	-	-	PUNCT
dpc-4600	154	40	alpha	alpha	NOUN
dpc-4600	154	41	,	,	PUNCT
dpc-4600	154	42	leading	lead	VERB
dpc-4600	154	43	to	to	ADP
dpc-4600	154	44	the	the	DET
dpc-4600	154	45	persistence	persistence	NOUN
dpc-4600	154	46	of	of	ADP
dpc-4600	154	47	the	the	DET
dpc-4600	154	48	inflammatory	inflammatory	ADJ
dpc-4600	154	49	cascade	cascade	NOUN
dpc-4600	154	50	[	[	X
dpc-4600	154	51	54	54	NUM
dpc-4600	154	52	]	]	PUNCT
dpc-4600	154	53	.	.	PUNCT
dpc-4600	155	1	il-17	il-17	NUM
dpc-4600	155	2	levels	level	NOUN
dpc-4600	155	3	have	have	AUX
dpc-4600	155	4	been	be	AUX
dpc-4600	155	5	found	find	VERB
dpc-4600	155	6	to	to	PART
dpc-4600	155	7	positively	positively	ADV
dpc-4600	155	8	correlate	correlate	VERB
dpc-4600	155	9	with	with	ADP
dpc-4600	155	10	the	the	DET
dpc-4600	155	11	activity	activity	NOUN
dpc-4600	155	12	of	of	ADP
dpc-4600	155	13	disease	disease	NOUN
dpc-4600	155	14	in	in	ADP
dpc-4600	155	15	vitiligo	vitiligo	NOUN
dpc-4600	155	16	[	[	X
dpc-4600	155	17	55	55	NUM
dpc-4600	155	18	]	]	PUNCT
dpc-4600	155	19	.	.	PUNCT
dpc-4600	156	1	treatment	treatment	NOUN
dpc-4600	156	2	with	with	ADP
dpc-4600	156	3	nb	nb	PROPN
dpc-4600	156	4	-	-	ADJ
dpc-4600	156	5	uvb	uvb	ADJ
dpc-4600	156	6	phototherapy	phototherapy	NOUN
dpc-4600	156	7	has	have	AUX
dpc-4600	156	8	been	be	AUX
dpc-4600	156	9	found	find	VERB
dpc-4600	156	10	to	to	PART
dpc-4600	156	11	decrease	decrease	VERB
dpc-4600	156	12	both	both	DET
dpc-4600	156	13	the	the	DET
dpc-4600	156	14	serum	serum	NOUN
dpc-4600	156	15	il-17	il-17	PART
dpc-4600	156	16	levels	level	NOUN
dpc-4600	156	17	and	and	CCONJ
dpc-4600	156	18	th17	th17	NOUN
dpc-4600	156	19	cells	cell	NOUN
dpc-4600	156	20	in	in	ADP
dpc-4600	156	21	the	the	DET
dpc-4600	156	22	skin	skin	NOUN
dpc-4600	156	23	of	of	ADP
dpc-4600	156	24	vitiliginous	vitiliginous	ADJ
dpc-4600	156	25	patients	patient	NOUN
dpc-4600	156	26	,	,	PUNCT
dpc-4600	156	27	suggesting	suggest	VERB
dpc-4600	156	28	that	that	SCONJ
dpc-4600	156	29	the	the	DET
dpc-4600	156	30	th17	th17	PROPN
dpc-4600	156	31	pathway	pathway	NOUN
dpc-4600	156	32	has	have	VERB
dpc-4600	156	33	a	a	DET
dpc-4600	156	34	role	role	NOUN
dpc-4600	156	35	in	in	ADP
dpc-4600	156	36	the	the	DET
dpc-4600	156	37	induction	induction	NOUN
dpc-4600	156	38	as	as	ADV
dpc-4600	156	39	well	well	ADV
dpc-4600	156	40	as	as	ADP
dpc-4600	156	41	the	the	DET
dpc-4600	156	42	progression	progression	NOUN
dpc-4600	156	43	of	of	ADP
dpc-4600	156	44	the	the	DET
dpc-4600	156	45	disease	disease	NOUN
dpc-4600	156	46	[	[	X
dpc-4600	156	47	56	56	NUM
dpc-4600	156	48	]	]	PUNCT
dpc-4600	156	49	.	.	PUNCT
dpc-4600	157	1	in	in	ADP
dpc-4600	157	2	a	a	DET
dpc-4600	157	3	pilot	pilot	NOUN
dpc-4600	157	4	study	study	NOUN
dpc-4600	157	5	done	do	VERB
dpc-4600	157	6	by	by	ADP
dpc-4600	157	7	speeckaert	speeckaert	PROPN
dpc-4600	157	8	et	et	PROPN
dpc-4600	157	9	al	al	PROPN
dpc-4600	157	10	.	.	PROPN
dpc-4600	158	1	on	on	ADP
dpc-4600	158	2	eight	eight	NUM
dpc-4600	158	3	patients	patient	NOUN
dpc-4600	158	4	with	with	ADP
dpc-4600	158	5	active	active	ADJ
dpc-4600	158	6	non	non	ADJ
dpc-4600	158	7	-	-	ADJ
dpc-4600	158	8	segmental	segmental	ADJ
dpc-4600	158	9	vitiligo	vitiligo	NOUN
dpc-4600	158	10	,	,	PUNCT
dpc-4600	158	11	secukinumab	secukinumab	NOUN
dpc-4600	158	12	300	300	NUM
dpc-4600	158	13	mg	mg	NOUN
dpc-4600	158	14	was	be	AUX
dpc-4600	158	15	given	give	VERB
dpc-4600	158	16	at	at	ADP
dpc-4600	158	17	0	0	NUM
dpc-4600	158	18	,	,	PUNCT
dpc-4600	158	19	1	1	NUM
dpc-4600	158	20	,	,	PUNCT
dpc-4600	158	21	2	2	NUM
dpc-4600	158	22	,	,	PUNCT
dpc-4600	158	23	3	3	NUM
dpc-4600	158	24	,	,	PUNCT
dpc-4600	158	25	4	4	NUM
dpc-4600	158	26	,	,	PUNCT
dpc-4600	158	27	followed	follow	VERB
dpc-4600	158	28	by	by	ADP
dpc-4600	158	29	once	once	ADV
dpc-4600	158	30	every	every	DET
dpc-4600	158	31	4	4	NUM
dpc-4600	158	32	weeks	week	NOUN
dpc-4600	158	33	thereafter	thereafter	ADV
dpc-4600	158	34	.	.	PUNCT
dpc-4600	159	1	out	out	ADP
dpc-4600	159	2	of	of	ADP
dpc-4600	159	3	these	these	DET
dpc-4600	159	4	eight	eight	NUM
dpc-4600	159	5	patients	patient	NOUN
dpc-4600	159	6	,	,	PUNCT
dpc-4600	159	7	seven	seven	NUM
dpc-4600	159	8	showed	show	VERB
dpc-4600	159	9	no	no	DET
dpc-4600	159	10	progression	progression	NOUN
dpc-4600	159	11	of	of	ADP
dpc-4600	159	12	disease	disease	NOUN
dpc-4600	159	13	,	,	PUNCT
dpc-4600	159	14	whereas	whereas	SCONJ
dpc-4600	159	15	in	in	ADP
dpc-4600	159	16	one	one	NUM
dpc-4600	159	17	patient	patient	NOUN
dpc-4600	159	18	,	,	PUNCT
dpc-4600	159	19	there	there	PRON
dpc-4600	159	20	was	be	VERB
dpc-4600	159	21	mild	mild	ADJ
dpc-4600	159	22	repigmentation	repigmentation	NOUN
dpc-4600	159	23	in	in	ADP
dpc-4600	159	24	skin	skin	NOUN
dpc-4600	159	25	lesions	lesion	NOUN
dpc-4600	159	26	after	after	ADP
dpc-4600	159	27	seven	seven	NUM
dpc-4600	159	28	months	month	NOUN
dpc-4600	159	29	of	of	ADP
dpc-4600	159	30	treatment	treatment	NOUN
dpc-4600	159	31	with	with	ADP
dpc-4600	159	32	secukunimab	secukunimab	NOUN
dpc-4600	159	33	[	[	X
dpc-4600	159	34	57	57	NUM
dpc-4600	159	35	]	]	PUNCT
dpc-4600	159	36	.	.	PUNCT
dpc-4600	160	1	interleukin	interleukin	NOUN
dpc-4600	160	2	23	23	NUM
dpc-4600	160	3	is	be	AUX
dpc-4600	160	4	believed	believe	VERB
dpc-4600	160	5	to	to	PART
dpc-4600	160	6	play	play	VERB
dpc-4600	160	7	a	a	DET
dpc-4600	160	8	significant	significant	ADJ
dpc-4600	160	9	role	role	NOUN
dpc-4600	160	10	in	in	ADP
dpc-4600	160	11	the	the	DET
dpc-4600	160	12	etiopathogenesis	etiopathogenesis	NOUN
dpc-4600	160	13	of	of	ADP
dpc-4600	160	14	vitiligo	vitiligo	NOUN
dpc-4600	160	15	.	.	PUNCT
dpc-4600	161	1	with	with	ADP
dpc-4600	161	2	the	the	DET
dpc-4600	161	3	help	help	NOUN
dpc-4600	161	4	of	of	ADP
dpc-4600	161	5	tgfβ	tgfβ	NOUN
dpc-4600	161	6	and	and	CCONJ
dpc-4600	161	7	il-6	il-6	NOUN
dpc-4600	161	8	,	,	PUNCT
dpc-4600	161	9	il-23	il-23	PUNCT
dpc-4600	161	10	stimulates	stimulate	VERB
dpc-4600	161	11	the	the	DET
dpc-4600	161	12	differentiation	differentiation	NOUN
dpc-4600	161	13	of	of	ADP
dpc-4600	161	14	th17	th17	PROPN
dpc-4600	161	15	cells	cell	NOUN
dpc-4600	161	16	and	and	CCONJ
dpc-4600	161	17	the	the	DET
dpc-4600	161	18	recruitment	recruitment	NOUN
dpc-4600	161	19	of	of	ADP
dpc-4600	161	20	more	more	ADJ
dpc-4600	161	21	neutrophils	neutrophil	NOUN
dpc-4600	161	22	to	to	ADP
dpc-4600	161	23	the	the	DET
dpc-4600	161	24	epidermis	epidermis	NOUN
dpc-4600	162	1	[	[	X
dpc-4600	162	2	58	58	NUM
dpc-4600	162	3	]	]	PUNCT
dpc-4600	162	4	.	.	PUNCT
dpc-4600	163	1	thus	thus	ADV
dpc-4600	163	2	,	,	PUNCT
dpc-4600	163	3	blocking	block	VERB
dpc-4600	163	4	it	it	PRON
dpc-4600	163	5	may	may	AUX
dpc-4600	163	6	have	have	VERB
dpc-4600	163	7	a	a	DET
dpc-4600	163	8	role	role	NOUN
dpc-4600	163	9	in	in	ADP
dpc-4600	163	10	the	the	DET
dpc-4600	163	11	treatment	treatment	NOUN
dpc-4600	163	12	of	of	ADP
dpc-4600	163	13	this	this	DET
dpc-4600	163	14	disease	disease	NOUN
dpc-4600	163	15	.	.	PUNCT
dpc-4600	164	1	in	in	ADP
dpc-4600	164	2	few	few	ADJ
dpc-4600	164	3	studies	study	NOUN
dpc-4600	164	4	,	,	PUNCT
dpc-4600	164	5	ustekinumab	ustekinumab	NOUN
dpc-4600	164	6	has	have	AUX
dpc-4600	164	7	been	be	AUX
dpc-4600	164	8	found	find	VERB
dpc-4600	164	9	to	to	PART
dpc-4600	164	10	successfully	successfully	ADV
dpc-4600	164	11	induce	induce	VERB
dpc-4600	164	12	stabilization	stabilization	NOUN
dpc-4600	164	13	and	and	CCONJ
dpc-4600	164	14	repigmentation	repigmentation	NOUN
dpc-4600	164	15	of	of	ADP
dpc-4600	164	16	vitiligo	vitiligo	NOUN
dpc-4600	164	17	after	after	ADP
dpc-4600	164	18	16	16	NUM
dpc-4600	164	19	weeks	week	NOUN
dpc-4600	164	20	of	of	ADP
dpc-4600	164	21	continuous	continuous	ADJ
dpc-4600	164	22	use	use	NOUN
dpc-4600	164	23	.	.	PUNCT
dpc-4600	165	1	also	also	ADV
dpc-4600	165	2	,	,	PUNCT
dpc-4600	165	3	one	one	NUM
dpc-4600	165	4	study	study	NOUN
dpc-4600	165	5	has	have	AUX
dpc-4600	165	6	reported	report	VERB
dpc-4600	165	7	that	that	SCONJ
dpc-4600	165	8	it	it	PRON
dpc-4600	165	9	produces	produce	VERB
dpc-4600	165	10	significant	significant	ADJ
dpc-4600	165	11	hair	hair	NOUN
dpc-4600	165	12	repigmentation	repigmentation	NOUN
dpc-4600	165	13	in	in	ADP
dpc-4600	165	14	patients	patient	NOUN
dpc-4600	165	15	as	as	ADV
dpc-4600	165	16	well	well	ADV
dpc-4600	165	17	.	.	PUNCT
dpc-4600	166	1	all	all	DET
dpc-4600	166	2	these	these	DET
dpc-4600	166	3	results	result	NOUN
dpc-4600	166	4	have	have	AUX
dpc-4600	166	5	been	be	AUX
dpc-4600	166	6	attributed	attribute	VERB
dpc-4600	166	7	to	to	ADP
dpc-4600	166	8	its	its	PRON
dpc-4600	166	9	ability	ability	NOUN
dpc-4600	166	10	to	to	PART
dpc-4600	166	11	inhibit	inhibit	VERB
dpc-4600	166	12	interleukin-16	interleukin-16	PROPN
dpc-4600	166	13	,	,	PUNCT
dpc-4600	166	14	which	which	PRON
dpc-4600	166	15	acts	act	VERB
dpc-4600	166	16	as	as	ADP
dpc-4600	166	17	an	an	DET
dpc-4600	166	18	anti	anti	ADJ
dpc-4600	166	19	-	-	ADJ
dpc-4600	166	20	melanogenic	melanogenic	ADJ
dpc-4600	166	21	cytokine	cytokine	NOUN
dpc-4600	166	22	[	[	PUNCT
dpc-4600	166	23	59	59	NUM
dpc-4600	166	24	]	]	PUNCT
dpc-4600	166	25	.	.	PUNCT
dpc-4600	167	1	light	light	ADJ
dpc-4600	167	2	therapy	therapy	NOUN
dpc-4600	167	3	phototherapy	phototherapy	NOUN
dpc-4600	167	4	,	,	PUNCT
dpc-4600	167	5	a	a	DET
dpc-4600	167	6	major	major	ADJ
dpc-4600	167	7	therapeutic	therapeutic	ADJ
dpc-4600	167	8	option	option	NOUN
dpc-4600	167	9	for	for	ADP
dpc-4600	167	10	the	the	DET
dpc-4600	167	11	treatment	treatment	NOUN
dpc-4600	167	12	of	of	ADP
dpc-4600	167	13	vitiligo	vitiligo	NOUN
dpc-4600	167	14	,	,	PUNCT
dpc-4600	167	15	has	have	AUX
dpc-4600	167	16	been	be	AUX
dpc-4600	167	17	used	use	VERB
dpc-4600	167	18	over	over	ADP
dpc-4600	167	19	the	the	DET
dpc-4600	167	20	decades	decade	NOUN
dpc-4600	167	21	.	.	PUNCT
dpc-4600	168	1	narrow	narrow	ADJ
dpc-4600	168	2	-	-	PUNCT
dpc-4600	168	3	band	band	NOUN
dpc-4600	168	4	phototherapy	phototherapy	NOUN
dpc-4600	168	5	(	(	PUNCT
dpc-4600	168	6	nb	nb	INTJ
dpc-4600	168	7	-	-	PUNCT
dpc-4600	168	8	uvb	uvb	NOUN
dpc-4600	168	9	)	)	PUNCT
dpc-4600	168	10	is	be	AUX
dpc-4600	168	11	quite	quite	ADV
dpc-4600	168	12	effective	effective	ADJ
dpc-4600	168	13	and	and	CCONJ
dpc-4600	168	14	relatively	relatively	ADV
dpc-4600	168	15	safe	safe	ADJ
dpc-4600	168	16	,	,	PUNCT
dpc-4600	168	17	making	make	VERB
dpc-4600	168	18	it	it	PRON
dpc-4600	168	19	a	a	DET
dpc-4600	168	20	first	first	ADJ
dpc-4600	168	21	-	-	PUNCT
dpc-4600	168	22	line	line	NOUN
dpc-4600	168	23	treatment	treatment	NOUN
dpc-4600	168	24	option	option	NOUN
dpc-4600	168	25	for	for	ADP
dpc-4600	168	26	vitiligo	vitiligo	NOUN
dpc-4600	168	27	.	.	PUNCT
dpc-4600	169	1	nb	nb	X
dpc-4600	169	2	-	-	ADJ
dpc-4600	169	3	uvb	uvb	ADJ
dpc-4600	169	4	causes	cause	VERB
dpc-4600	169	5	t	t	NOUN
dpc-4600	169	6	cells	cell	NOUN
dpc-4600	169	7	to	to	PART
dpc-4600	169	8	undergo	undergo	VERB
dpc-4600	169	9	apoptosis	apoptosis	NOUN
dpc-4600	169	10	,	,	PUNCT
dpc-4600	169	11	downregulates	downregulate	VERB
dpc-4600	169	12	the	the	DET
dpc-4600	169	13	inflammatory	inflammatory	ADJ
dpc-4600	169	14	signaling	signal	VERB
dpc-4600	169	15	pathway	pathway	NOUN
dpc-4600	169	16	,	,	PUNCT
dpc-4600	169	17	and	and	CCONJ
dpc-4600	169	18	causes	cause	VERB
dpc-4600	169	19	upregulation	upregulation	NOUN
dpc-4600	169	20	of	of	ADP
dpc-4600	169	21	regulatory	regulatory	ADJ
dpc-4600	169	22	t	t	NOUN
dpc-4600	169	23	cells	cell	NOUN
dpc-4600	169	24	.	.	PUNCT
dpc-4600	170	1	furthermore	furthermore	ADV
dpc-4600	170	2	,	,	PUNCT
dpc-4600	170	3	nbuvb	nbuvb	NOUN
dpc-4600	170	4	reduces	reduce	VERB
dpc-4600	170	5	antigen	antigen	ADJ
dpc-4600	170	6	presentation	presentation	NOUN
dpc-4600	170	7	by	by	ADP
dpc-4600	170	8	depleting	deplete	VERB
dpc-4600	170	9	epidermal	epidermal	ADJ
dpc-4600	170	10	langerhans	langerhan	NOUN
dpc-4600	170	11	cells	cell	NOUN
dpc-4600	170	12	[	[	X
dpc-4600	170	13	60	60	NUM
dpc-4600	170	14	]	]	PUNCT
dpc-4600	170	15	.	.	PUNCT
dpc-4600	171	1	in	in	ADP
dpc-4600	171	2	stable	stable	ADJ
dpc-4600	171	3	vitiligo	vitiligo	NOUN
dpc-4600	171	4	,	,	PUNCT
dpc-4600	171	5	it	it	PRON
dpc-4600	171	6	promotes	promote	VERB
dpc-4600	171	7	melanocyte	melanocyte	NOUN
dpc-4600	171	8	proliferation	proliferation	NOUN
dpc-4600	171	9	and	and	CCONJ
dpc-4600	171	10	their	their	PRON
dpc-4600	171	11	migration	migration	NOUN
dpc-4600	171	12	from	from	ADP
dpc-4600	171	13	the	the	DET
dpc-4600	171	14	outer	outer	ADJ
dpc-4600	171	15	root	root	NOUN
dpc-4600	171	16	sheath	sheath	NOUN
dpc-4600	171	17	of	of	ADP
dpc-4600	171	18	the	the	DET
dpc-4600	171	19	hair	hair	NOUN
dpc-4600	171	20	follicle	follicle	VERB
dpc-4600	171	21	to	to	ADP
dpc-4600	171	22	the	the	DET
dpc-4600	171	23	epidermis	epidermis	NOUN
dpc-4600	171	24	of	of	ADP
dpc-4600	171	25	the	the	DET
dpc-4600	171	26	skin	skin	NOUN
dpc-4600	171	27	,	,	PUNCT
dpc-4600	171	28	which	which	PRON
dpc-4600	171	29	causes	cause	VERB
dpc-4600	171	30	islands	island	NOUN
dpc-4600	171	31	of	of	ADP
dpc-4600	171	32	repigmentation	repigmentation	NOUN
dpc-4600	171	33	with	with	ADP
dpc-4600	171	34	a	a	DET
dpc-4600	171	35	speckled	speckle	VERB
dpc-4600	171	36	three	three	NUM
dpc-4600	171	37	groups	group	NOUN
dpc-4600	171	38	of	of	ADP
dpc-4600	171	39	patients	patient	NOUN
dpc-4600	171	40	to	to	PART
dpc-4600	171	41	evaluate	evaluate	VERB
dpc-4600	171	42	the	the	DET
dpc-4600	171	43	efficacy	efficacy	NOUN
dpc-4600	171	44	and	and	CCONJ
dpc-4600	171	45	safety	safety	NOUN
dpc-4600	171	46	of	of	ADP
dpc-4600	171	47	topical	topical	ADJ
dpc-4600	171	48	calcipotriol	calcipotriol	NOUN
dpc-4600	171	49	and	and	CCONJ
dpc-4600	171	50	betamethasone	betamethasone	PROPN
dpc-4600	171	51	ointment	ointment	PROPN
dpc-4600	171	52	.	.	PUNCT
dpc-4600	172	1	group	group	PROPN
dpc-4600	172	2	a	a	DET
dpc-4600	172	3	applied	apply	VERB
dpc-4600	172	4	topical	topical	ADJ
dpc-4600	172	5	calcipotriol	calcipotriol	NOUN
dpc-4600	172	6	ointment	ointment	NOUN
dpc-4600	172	7	only	only	ADV
dpc-4600	172	8	;	;	PUNCT
dpc-4600	172	9	group	group	NOUN
dpc-4600	172	10	b	b	PROPN
dpc-4600	172	11	used	use	VERB
dpc-4600	172	12	topical	topical	ADJ
dpc-4600	172	13	betamethasone	betamethasone	NOUN
dpc-4600	172	14	dipropionate	dipropionate	PROPN
dpc-4600	172	15	ointment	ointment	NOUN
dpc-4600	172	16	;	;	PUNCT
dpc-4600	172	17	group	group	NOUN
dpc-4600	172	18	c	c	PROPN
dpc-4600	172	19	applied	apply	VERB
dpc-4600	172	20	both	both	DET
dpc-4600	172	21	ointments	ointment	NOUN
dpc-4600	172	22	twice	twice	ADV
dpc-4600	172	23	daily	daily	ADV
dpc-4600	172	24	for	for	ADP
dpc-4600	172	25	three	three	NUM
dpc-4600	172	26	months	month	NOUN
dpc-4600	172	27	.	.	PUNCT
dpc-4600	173	1	the	the	DET
dpc-4600	173	2	combination	combination	NOUN
dpc-4600	173	3	of	of	ADP
dpc-4600	173	4	vitamin	vitamin	NOUN
dpc-4600	173	5	d	d	NOUN
dpc-4600	173	6	analogues	analogue	NOUN
dpc-4600	173	7	,	,	PUNCT
dpc-4600	173	8	calcipotriol	calcipotriol	NOUN
dpc-4600	173	9	,	,	PUNCT
dpc-4600	173	10	and	and	CCONJ
dpc-4600	173	11	betamethasone	betamethasone	PROPN
dpc-4600	173	12	steroids	steroid	NOUN
dpc-4600	173	13	proved	prove	VERB
dpc-4600	173	14	superior	superior	ADJ
dpc-4600	173	15	in	in	ADP
dpc-4600	173	16	efficacy	efficacy	NOUN
dpc-4600	173	17	over	over	ADP
dpc-4600	173	18	individual	individual	ADJ
dpc-4600	173	19	preparations	preparation	NOUN
dpc-4600	173	20	[	[	X
dpc-4600	173	21	45	45	NUM
dpc-4600	173	22	]	]	PUNCT
dpc-4600	173	23	.	.	PUNCT
dpc-4600	174	1	to	to	PART
dpc-4600	174	2	enhance	enhance	VERB
dpc-4600	174	3	the	the	DET
dpc-4600	174	4	rates	rate	NOUN
dpc-4600	174	5	of	of	ADP
dpc-4600	174	6	repigmentation	repigmentation	NOUN
dpc-4600	174	7	in	in	ADP
dpc-4600	174	8	patients	patient	NOUN
dpc-4600	174	9	with	with	ADP
dpc-4600	174	10	vitiligo	vitiligo	NOUN
dpc-4600	174	11	,	,	PUNCT
dpc-4600	174	12	vitamin	vitamin	NOUN
dpc-4600	174	13	d	d	NOUN
dpc-4600	174	14	analogues	analogue	NOUN
dpc-4600	174	15	have	have	AUX
dpc-4600	174	16	been	be	AUX
dpc-4600	174	17	used	use	VERB
dpc-4600	174	18	in	in	ADP
dpc-4600	174	19	combination	combination	NOUN
dpc-4600	174	20	with	with	ADP
dpc-4600	174	21	phototherapy	phototherapy	NOUN
dpc-4600	174	22	.	.	PUNCT
dpc-4600	175	1	liu	liu	PROPN
dpc-4600	175	2	x	x	PROPN
dpc-4600	175	3	et	et	PROPN
dpc-4600	175	4	al	al	PROPN
dpc-4600	175	5	.	.	PROPN
dpc-4600	175	6	performed	perform	VERB
dpc-4600	175	7	a	a	DET
dpc-4600	175	8	systematic	systematic	ADJ
dpc-4600	175	9	review	review	NOUN
dpc-4600	175	10	and	and	CCONJ
dpc-4600	175	11	meta	meta	NOUN
dpc-4600	175	12	-	-	PUNCT
dpc-4600	175	13	analysis	analysis	NOUN
dpc-4600	175	14	to	to	PART
dpc-4600	175	15	establish	establish	VERB
dpc-4600	175	16	the	the	DET
dpc-4600	175	17	efficacy	efficacy	NOUN
dpc-4600	175	18	and	and	CCONJ
dpc-4600	175	19	safety	safety	NOUN
dpc-4600	175	20	of	of	ADP
dpc-4600	175	21	the	the	DET
dpc-4600	175	22	combined	combine	VERB
dpc-4600	175	23	use	use	NOUN
dpc-4600	175	24	of	of	ADP
dpc-4600	175	25	narrow	narrow	ADJ
dpc-4600	175	26	-	-	PUNCT
dpc-4600	175	27	band	band	NOUN
dpc-4600	175	28	ultraviolet	ultraviolet	NOUN
dpc-4600	175	29	b	b	PROPN
dpc-4600	175	30	phototherapy	phototherapy	NOUN
dpc-4600	175	31	(	(	PUNCT
dpc-4600	175	32	nb	nb	NOUN
dpc-4600	175	33	-	-	PUNCT
dpc-4600	175	34	uvb	uvb	ADJ
dpc-4600	175	35	)	)	PUNCT
dpc-4600	175	36	and	and	CCONJ
dpc-4600	175	37	vitamin	vitamin	NOUN
dpc-4600	175	38	d	d	NOUN
dpc-4600	175	39	analogues	analogue	NOUN
dpc-4600	175	40	.	.	PUNCT
dpc-4600	176	1	it	it	PRON
dpc-4600	176	2	was	be	AUX
dpc-4600	176	3	found	find	VERB
dpc-4600	176	4	that	that	SCONJ
dpc-4600	176	5	adding	add	VERB
dpc-4600	176	6	topical	topical	ADJ
dpc-4600	176	7	calcipotriol	calcipotriol	NOUN
dpc-4600	176	8	or	or	CCONJ
dpc-4600	176	9	tacalcitol	tacalcitol	NOUN
dpc-4600	176	10	to	to	ADP
dpc-4600	176	11	phototherapy	phototherapy	NOUN
dpc-4600	176	12	may	may	AUX
dpc-4600	176	13	help	help	VERB
dpc-4600	176	14	treat	treat	VERB
dpc-4600	176	15	vitiligo	vitiligo	VERB
dpc-4600	176	16	better	well	ADV
dpc-4600	176	17	,	,	PUNCT
dpc-4600	176	18	with	with	ADP
dpc-4600	176	19	tacalcitol	tacalcitol	NOUN
dpc-4600	176	20	having	have	VERB
dpc-4600	176	21	a	a	DET
dpc-4600	176	22	stronger	strong	ADJ
dpc-4600	176	23	effect	effect	NOUN
dpc-4600	176	24	than	than	ADP
dpc-4600	176	25	calcipotriol	calcipotriol	NOUN
dpc-4600	176	26	[	[	X
dpc-4600	176	27	46	46	NUM
dpc-4600	176	28	]	]	PUNCT
dpc-4600	176	29	.	.	PUNCT
dpc-4600	177	1	vitamin	vitamin	NOUN
dpc-4600	177	2	d	d	PROPN
dpc-4600	177	3	analogues	analogue	NOUN
dpc-4600	177	4	have	have	AUX
dpc-4600	177	5	been	be	AUX
dpc-4600	177	6	used	use	VERB
dpc-4600	177	7	in	in	ADP
dpc-4600	177	8	combination	combination	NOUN
dpc-4600	177	9	with	with	ADP
dpc-4600	177	10	microneedling	microneedling	NOUN
dpc-4600	177	11	as	as	ADV
dpc-4600	177	12	well	well	ADV
dpc-4600	177	13	.	.	PUNCT
dpc-4600	178	1	maha	maha	PROPN
dpc-4600	178	2	wafic	wafic	PROPN
dpc-4600	178	3	et	et	PROPN
dpc-4600	178	4	al	al	PROPN
dpc-4600	178	5	.	.	PROPN
dpc-4600	178	6	evaluated	evaluate	VERB
dpc-4600	178	7	the	the	DET
dpc-4600	178	8	effectiveness	effectiveness	NOUN
dpc-4600	178	9	of	of	ADP
dpc-4600	178	10	topical	topical	ADJ
dpc-4600	178	11	vitamin	vitamin	NOUN
dpc-4600	178	12	d	d	NOUN
dpc-4600	178	13	(	(	PUNCT
dpc-4600	178	14	cholecalciferol	cholecalciferol	NOUN
dpc-4600	178	15	)	)	PUNCT
dpc-4600	178	16	and	and	CCONJ
dpc-4600	178	17	microneedling	microneedle	VERB
dpc-4600	178	18	in	in	ADP
dpc-4600	178	19	25	25	NUM
dpc-4600	178	20	patients	patient	NOUN
dpc-4600	178	21	with	with	ADP
dpc-4600	178	22	stable	stable	ADJ
dpc-4600	178	23	vitiligo	vitiligo	NOUN
dpc-4600	178	24	.	.	PUNCT
dpc-4600	179	1	fifty	fifty	NUM
dpc-4600	179	2	-	-	PUNCT
dpc-4600	179	3	two	two	NUM
dpc-4600	179	4	percent	percent	NOUN
dpc-4600	179	5	of	of	ADP
dpc-4600	179	6	the	the	DET
dpc-4600	179	7	patients	patient	NOUN
dpc-4600	179	8	showed	show	VERB
dpc-4600	179	9	a	a	DET
dpc-4600	179	10	good	good	ADJ
dpc-4600	179	11	-	-	PUNCT
dpc-4600	179	12	to	to	ADP
dpc-4600	179	13	-	-	PUNCT
dpc-4600	179	14	excellent	excellent	ADJ
dpc-4600	179	15	response	response	NOUN
dpc-4600	179	16	to	to	ADP
dpc-4600	179	17	microneedling	microneedle	VERB
dpc-4600	179	18	plus	plus	CCONJ
dpc-4600	179	19	topical	topical	ADJ
dpc-4600	179	20	cholecalciferol	cholecalciferol	NOUN
dpc-4600	179	21	,	,	PUNCT
dpc-4600	179	22	in	in	ADP
dpc-4600	179	23	contrast	contrast	NOUN
dpc-4600	179	24	to	to	ADP
dpc-4600	179	25	40	40	NUM
dpc-4600	179	26	%	%	NOUN
dpc-4600	179	27	of	of	ADP
dpc-4600	179	28	patients	patient	NOUN
dpc-4600	179	29	treated	treat	VERB
dpc-4600	179	30	with	with	ADP
dpc-4600	179	31	microneedling	microneedle	VERB
dpc-4600	179	32	alone	alone	ADV
dpc-4600	179	33	[	[	X
dpc-4600	179	34	47,48	47,48	NOUN
dpc-4600	179	35	]	]	PUNCT
dpc-4600	179	36	.	.	PUNCT
dpc-4600	180	1	statins	statins	PROPN
dpc-4600	180	2	statins	statins	PROPN
dpc-4600	180	3	are	be	AUX
dpc-4600	180	4	the	the	DET
dpc-4600	180	5	drugs	drug	NOUN
dpc-4600	180	6	that	that	PRON
dpc-4600	180	7	lower	low	ADJ
dpc-4600	180	8	plasma	plasma	NOUN
dpc-4600	180	9	lipids	lipid	NOUN
dpc-4600	180	10	.	.	PUNCT
dpc-4600	181	1	it	it	PRON
dpc-4600	181	2	has	have	AUX
dpc-4600	181	3	been	be	AUX
dpc-4600	181	4	reported	report	VERB
dpc-4600	181	5	that	that	SCONJ
dpc-4600	181	6	in	in	ADP
dpc-4600	181	7	individuals	individual	NOUN
dpc-4600	181	8	with	with	ADP
dpc-4600	181	9	active	active	ADJ
dpc-4600	181	10	vitiligo	vitiligo	NOUN
dpc-4600	181	11	,	,	PUNCT
dpc-4600	181	12	the	the	DET
dpc-4600	181	13	dose	dose	ADJ
dpc-4600	181	14	dependent	dependent	ADJ
dpc-4600	181	15	action	action	NOUN
dpc-4600	181	16	of	of	ADP
dpc-4600	181	17	simvastatin	simvastatin	PROPN
dpc-4600	181	18	significantly	significantly	ADV
dpc-4600	181	19	inhibits	inhibit	VERB
dpc-4600	181	20	the	the	DET
dpc-4600	181	21	inf	inf	VERB
dpc-4600	181	22	-	-	PUNCT
dpc-4600	181	23	γ	γ	NOUN
dpc-4600	181	24	-	-	ADJ
dpc-4600	181	25	dependent	dependent	ADJ
dpc-4600	181	26	mhc	mhc	PROPN
dpc-4600	181	27	-	-	PUNCT
dpc-4600	181	28	ii	ii	PROPN
dpc-4600	181	29	expressions	expression	NOUN
dpc-4600	181	30	,	,	PUNCT
dpc-4600	181	31	which	which	PRON
dpc-4600	181	32	in	in	ADP
dpc-4600	181	33	turn	turn	NOUN
dpc-4600	181	34	inhibit	inhibit	VERB
dpc-4600	181	35	activated	activate	VERB
dpc-4600	181	36	t	t	NOUN
dpc-4600	181	37	lymphocytes	lymphocyte	VERB
dpc-4600	181	38	[	[	X
dpc-4600	181	39	49	49	NUM
dpc-4600	181	40	]	]	PUNCT
dpc-4600	181	41	.	.	PUNCT
dpc-4600	182	1	various	various	ADJ
dpc-4600	182	2	studies	study	NOUN
dpc-4600	182	3	showed	show	VERB
dpc-4600	182	4	significant	significant	ADJ
dpc-4600	182	5	improvement	improvement	NOUN
dpc-4600	182	6	in	in	ADP
dpc-4600	182	7	the	the	DET
dpc-4600	182	8	vitiligo	vitiligo	NOUN
dpc-4600	182	9	disease	disease	NOUN
dpc-4600	182	10	activity	activity	NOUN
dpc-4600	182	11	(	(	PUNCT
dpc-4600	182	12	vida	vida	NOUN
dpc-4600	182	13	)	)	PUNCT
dpc-4600	182	14	score	score	NOUN
dpc-4600	182	15	and	and	CCONJ
dpc-4600	182	16	lipid	lipid	NOUN
dpc-4600	182	17	profile	profile	NOUN
dpc-4600	182	18	in	in	ADP
dpc-4600	182	19	patients	patient	NOUN
dpc-4600	182	20	who	who	PRON
dpc-4600	182	21	received	receive	VERB
dpc-4600	182	22	80	80	NUM
dpc-4600	182	23	mg	mg	NOUN
dpc-4600	182	24	of	of	ADP
dpc-4600	182	25	simvastatin	simvastatin	PROPN
dpc-4600	182	26	daily	daily	PROPN
dpc-4600	182	27	.	.	PUNCT
dpc-4600	183	1	thus	thus	ADV
dpc-4600	183	2	,	,	PUNCT
dpc-4600	183	3	simvastatin	simvastatin	PROPN
dpc-4600	183	4	has	have	AUX
dpc-4600	183	5	shown	show	VERB
dpc-4600	183	6	a	a	DET
dpc-4600	183	7	potentially	potentially	ADV
dpc-4600	183	8	beneficial	beneficial	ADJ
dpc-4600	183	9	role	role	NOUN
dpc-4600	183	10	in	in	ADP
dpc-4600	183	11	vitiligo	vitiligo	ADJ
dpc-4600	183	12	patients	patient	NOUN
dpc-4600	183	13	with	with	ADP
dpc-4600	183	14	dyslipidemia	dyslipidemia	NOUN
dpc-4600	183	15	and	and	CCONJ
dpc-4600	183	16	reduces	reduce	VERB
dpc-4600	183	17	cardiovascular	cardiovascular	ADJ
dpc-4600	183	18	morbidity	morbidity	NOUN
dpc-4600	183	19	[	[	X
dpc-4600	183	20	50	50	NUM
dpc-4600	183	21	]	]	PUNCT
dpc-4600	183	22	.	.	PUNCT
dpc-4600	184	1	tnf	tnf	PROPN
dpc-4600	184	2	-	-	PUNCT
dpc-4600	184	3	α	α	PROPN
dpc-4600	184	4	inhibitors	inhibitor	NOUN
dpc-4600	184	5	tnf	tnf	PROPN
dpc-4600	184	6	-	-	PUNCT
dpc-4600	184	7	α	α	PROPN
dpc-4600	184	8	is	be	AUX
dpc-4600	184	9	an	an	DET
dpc-4600	184	10	anti	anti	ADJ
dpc-4600	184	11	-	-	ADJ
dpc-4600	184	12	inflammatory	inflammatory	ADJ
dpc-4600	184	13	mediator	mediator	NOUN
dpc-4600	184	14	that	that	PRON
dpc-4600	184	15	induces	induce	VERB
dpc-4600	184	16	b	b	PRON
dpc-4600	184	17	cell	cell	NOUN
dpc-4600	184	18	activation	activation	NOUN
dpc-4600	184	19	,	,	PUNCT
dpc-4600	184	20	inhibits	inhibit	VERB
dpc-4600	184	21	melanogenesis	melanogenesis	NOUN
dpc-4600	184	22	,	,	PUNCT
dpc-4600	184	23	promotes	promote	VERB
dpc-4600	184	24	apoptosis	apoptosis	NOUN
dpc-4600	184	25	in	in	ADP
dpc-4600	184	26	melanocytes	melanocyte	NOUN
dpc-4600	184	27	,	,	PUNCT
dpc-4600	184	28	and	and	CCONJ
dpc-4600	184	29	increases	increase	NOUN
dpc-4600	184	30	autoantibody	autoantibody	VERB
dpc-4600	184	31	production	production	NOUN
dpc-4600	184	32	in	in	ADP
dpc-4600	184	33	vitiligo	vitiligo	NOUN
dpc-4600	184	34	[	[	X
dpc-4600	184	35	51	51	NUM
dpc-4600	184	36	]	]	PUNCT
dpc-4600	184	37	.	.	PUNCT
dpc-4600	185	1	recent	recent	ADJ
dpc-4600	185	2	studies	study	NOUN
dpc-4600	185	3	have	have	AUX
dpc-4600	185	4	shown	show	VERB
dpc-4600	185	5	a	a	DET
dpc-4600	185	6	significantly	significantly	ADV
dpc-4600	185	7	higher	high	ADJ
dpc-4600	185	8	expression	expression	NOUN
dpc-4600	185	9	of	of	ADP
dpc-4600	185	10	tnf	tnf	PROPN
dpc-4600	185	11	-	-	PUNCT
dpc-4600	185	12	α	α	PROPN
dpc-4600	185	13	in	in	ADP
dpc-4600	185	14	vitiligo	vitiligo	NOUN
dpc-4600	185	15	,	,	PUNCT
dpc-4600	185	16	especially	especially	ADV
dpc-4600	185	17	in	in	ADP
dpc-4600	185	18	the	the	DET
dpc-4600	185	19	lesional	lesional	ADJ
dpc-4600	185	20	skin	skin	NOUN
dpc-4600	185	21	.	.	PUNCT
dpc-4600	186	1	it	it	PRON
dpc-4600	186	2	is	be	AUX
dpc-4600	186	3	postulated	postulate	VERB
dpc-4600	186	4	that	that	SCONJ
dpc-4600	186	5	tnf	tnf	PROPN
dpc-4600	186	6	-	-	PUNCT
dpc-4600	186	7	α	α	PROPN
dpc-4600	186	8	prevents	prevent	VERB
dpc-4600	186	9	repigmentation	repigmentation	NOUN
dpc-4600	186	10	since	since	SCONJ
dpc-4600	186	11	it	it	PRON
dpc-4600	186	12	dose	dose	VERB
dpc-4600	186	13	-	-	PUNCT
dpc-4600	186	14	dependently	dependently	ADV
dpc-4600	186	15	inhibits	inhibit	VERB
dpc-4600	186	16	tyrosinase	tyrosinase	NOUN
dpc-4600	186	17	activity	activity	NOUN
dpc-4600	186	18	and	and	CCONJ
dpc-4600	186	19	suppresses	suppress	VERB
dpc-4600	186	20	melanocyte	melanocyte	NOUN
dpc-4600	186	21	proliferation	proliferation	NOUN
dpc-4600	186	22	.	.	PUNCT
dpc-4600	187	1	it	it	PRON
dpc-4600	187	2	has	have	AUX
dpc-4600	187	3	been	be	AUX
dpc-4600	187	4	also	also	ADV
dpc-4600	187	5	observed	observe	VERB
dpc-4600	187	6	that	that	SCONJ
dpc-4600	187	7	tnf	tnf	PROPN
dpc-4600	187	8	-	-	PUNCT
dpc-4600	187	9	α	α	PROPN
dpc-4600	187	10	may	may	AUX
dpc-4600	187	11	hinder	hinder	VERB
dpc-4600	187	12	the	the	DET
dpc-4600	187	13	development	development	NOUN
dpc-4600	187	14	of	of	ADP
dpc-4600	187	15	melanocyte	melanocyte	NOUN
dpc-4600	187	16	stem	stem	NOUN
dpc-4600	187	17	cells	cell	NOUN
dpc-4600	187	18	and	and	CCONJ
dpc-4600	187	19	facilitate	facilitate	VERB
dpc-4600	187	20	melanocyte	melanocyte	NOUN
dpc-4600	187	21	death	death	NOUN
dpc-4600	187	22	,	,	PUNCT
dpc-4600	187	23	hence	hence	ADV
dpc-4600	187	24	impeding	impede	VERB
dpc-4600	187	25	repigmentation	repigmentation	NOUN
dpc-4600	187	26	in	in	ADP
dpc-4600	187	27	skin	skin	NOUN
dpc-4600	187	28	affected	affect	VERB
dpc-4600	187	29	by	by	ADP
dpc-4600	187	30	vitiligo	vitiligo	NOUN
dpc-4600	188	1	[	[	X
dpc-4600	188	2	52	52	NUM
dpc-4600	188	3	]	]	PUNCT
dpc-4600	188	4	.	.	PUNCT
dpc-4600	189	1	thus	thus	ADV
dpc-4600	189	2	,	,	PUNCT
dpc-4600	189	3	inhibition	inhibition	NOUN
dpc-4600	189	4	of	of	ADP
dpc-4600	189	5	tnf	tnf	PROPN
dpc-4600	189	6	-	-	PUNCT
dpc-4600	189	7	α	α	PROPN
dpc-4600	189	8	may	may	AUX
dpc-4600	189	9	play	play	VERB
dpc-4600	189	10	a	a	DET
dpc-4600	189	11	pivotal	pivotal	ADJ
dpc-4600	189	12	role	role	NOUN
dpc-4600	189	13	in	in	ADP
dpc-4600	189	14	the	the	DET
dpc-4600	189	15	treatment	treatment	NOUN
dpc-4600	189	16	of	of	ADP
dpc-4600	189	17	vitiligo	vitiligo	NOUN
dpc-4600	189	18	.	.	PUNCT
dpc-4600	190	1	in	in	ADP
dpc-4600	190	2	a	a	DET
dpc-4600	190	3	pilot	pilot	NOUN
dpc-4600	190	4	study	study	NOUN
dpc-4600	190	5	,	,	PUNCT
dpc-4600	190	6	the	the	DET
dpc-4600	190	7	tnf	tnf	PROPN
dpc-4600	190	8	-	-	PUNCT
dpc-4600	190	9	α	α	PROPN
dpc-4600	190	10	inhibitor	inhibitor	NOUN
dpc-4600	190	11	etanercept	etanercept	NOUN
dpc-4600	190	12	was	be	AUX
dpc-4600	190	13	administered	administer	VERB
dpc-4600	190	14	for	for	ADP
dpc-4600	190	15	16	16	NUM
dpc-4600	190	16	weeks	week	NOUN
dpc-4600	190	17	to	to	ADP
dpc-4600	190	18	four	four	NUM
dpc-4600	190	19	individuals	individual	NOUN
dpc-4600	190	20	who	who	PRON
dpc-4600	190	21	had	have	VERB
dpc-4600	190	22	vitiligo	vitiligo	NOUN
dpc-4600	190	23	.	.	PUNCT
dpc-4600	191	1	all	all	DET
dpc-4600	191	2	these	these	DET
dpc-4600	191	3	patients	patient	NOUN
dpc-4600	191	4	achieved	achieve	VERB
dpc-4600	191	5	disease	disease	NOUN
dpc-4600	191	6	stabilization	stabilization	NOUN
dpc-4600	191	7	during	during	ADP
dpc-4600	191	8	the	the	DET
dpc-4600	191	9	8	8	NUM
dpc-4600	191	10	review	review	NOUN
dpc-4600	191	11	|	|	ADV
dpc-4600	191	12	dermatol	dermatol	ADJ
dpc-4600	191	13	pract	pract	NOUN
dpc-4600	191	14	concept	concept	NOUN
dpc-4600	191	15	.	.	PUNCT
dpc-4600	192	1	2025;15(1):4600	2025;15(1):4600	NUM
dpc-4600	192	2	future	future	ADJ
dpc-4600	192	3	directions	direction	NOUN
dpc-4600	192	4	vitiligo	vitiligo	VERB
dpc-4600	192	5	is	be	AUX
dpc-4600	192	6	a	a	DET
dpc-4600	192	7	disease	disease	NOUN
dpc-4600	192	8	that	that	PRON
dpc-4600	192	9	has	have	AUX
dpc-4600	192	10	been	be	AUX
dpc-4600	192	11	known	know	VERB
dpc-4600	192	12	to	to	ADP
dpc-4600	192	13	mankind	mankind	NOUN
dpc-4600	192	14	for	for	ADP
dpc-4600	192	15	years	year	NOUN
dpc-4600	192	16	;	;	PUNCT
dpc-4600	192	17	however	however	ADV
dpc-4600	192	18	,	,	PUNCT
dpc-4600	192	19	recent	recent	ADJ
dpc-4600	192	20	advancements	advancement	NOUN
dpc-4600	192	21	in	in	ADP
dpc-4600	192	22	the	the	DET
dpc-4600	192	23	etiopathogenesis	etiopathogenesis	NOUN
dpc-4600	192	24	of	of	ADP
dpc-4600	192	25	the	the	DET
dpc-4600	192	26	disease	disease	NOUN
dpc-4600	192	27	could	could	AUX
dpc-4600	192	28	lead	lead	VERB
dpc-4600	192	29	to	to	ADP
dpc-4600	192	30	more	more	ADV
dpc-4600	192	31	precise	precise	ADJ
dpc-4600	192	32	,	,	PUNCT
dpc-4600	192	33	efficient	efficient	ADJ
dpc-4600	192	34	,	,	PUNCT
dpc-4600	192	35	and	and	CCONJ
dpc-4600	192	36	secure	secure	VERB
dpc-4600	192	37	treatment	treatment	NOUN
dpc-4600	192	38	for	for	ADP
dpc-4600	192	39	those	those	PRON
dpc-4600	192	40	who	who	PRON
dpc-4600	192	41	experience	experience	VERB
dpc-4600	192	42	this	this	DET
dpc-4600	192	43	debilitating	debilitate	VERB
dpc-4600	192	44	condition	condition	NOUN
dpc-4600	192	45	.	.	PUNCT
dpc-4600	193	1	the	the	DET
dpc-4600	193	2	management	management	NOUN
dpc-4600	193	3	of	of	ADP
dpc-4600	193	4	vitiligo	vitiligo	NOUN
dpc-4600	193	5	with	with	ADP
dpc-4600	193	6	il-15	il-15	PUNCT
dpc-4600	193	7	inhibitors	inhibitor	NOUN
dpc-4600	193	8	or	or	CCONJ
dpc-4600	193	9	il-15	il-15	NOUN
dpc-4600	193	10	receptor	receptor	NOUN
dpc-4600	193	11	blocking	block	VERB
dpc-4600	193	12	agents	agent	NOUN
dpc-4600	193	13	appears	appear	VERB
dpc-4600	193	14	alluring	alluring	ADJ
dpc-4600	193	15	due	due	ADP
dpc-4600	193	16	to	to	ADP
dpc-4600	193	17	its	its	PRON
dpc-4600	193	18	significant	significant	ADJ
dpc-4600	193	19	contribution	contribution	NOUN
dpc-4600	193	20	to	to	ADP
dpc-4600	193	21	the	the	DET
dpc-4600	193	22	promotion	promotion	NOUN
dpc-4600	193	23	of	of	ADP
dpc-4600	193	24	tissueresident	tissueresident	NOUN
dpc-4600	193	25	lymphocytes	lymphocyte	NOUN
dpc-4600	193	26	(	(	PUNCT
dpc-4600	193	27	trm	trm	NOUN
dpc-4600	193	28	)	)	PUNCT
dpc-4600	193	29	and	and	CCONJ
dpc-4600	193	30	the	the	DET
dpc-4600	193	31	persistence	persistence	NOUN
dpc-4600	193	32	of	of	ADP
dpc-4600	193	33	the	the	DET
dpc-4600	193	34	lesions	lesion	NOUN
dpc-4600	193	35	[	[	X
dpc-4600	193	36	67	67	NUM
dpc-4600	193	37	]	]	PUNCT
dpc-4600	193	38	.	.	PUNCT
dpc-4600	194	1	the	the	DET
dpc-4600	194	2	role	role	NOUN
dpc-4600	194	3	of	of	ADP
dpc-4600	194	4	cxcl9	cxcl9	NOUN
dpc-4600	194	5	and	and	CCONJ
dpc-4600	194	6	cxcl10	cxcl10	NOUN
dpc-4600	194	7	chemokines	chemokine	NOUN
dpc-4600	194	8	in	in	ADP
dpc-4600	194	9	vitiligo	vitiligo	PROPN
dpc-4600	194	10	has	have	AUX
dpc-4600	194	11	been	be	AUX
dpc-4600	194	12	defined	define	VERB
dpc-4600	194	13	to	to	PART
dpc-4600	194	14	induce	induce	VERB
dpc-4600	194	15	cytotoxic	cytotoxic	ADJ
dpc-4600	194	16	t	t	NOUN
dpc-4600	194	17	cell	cell	NOUN
dpc-4600	194	18	production	production	NOUN
dpc-4600	194	19	and	and	CCONJ
dpc-4600	194	20	migration	migration	NOUN
dpc-4600	194	21	to	to	ADP
dpc-4600	194	22	the	the	DET
dpc-4600	194	23	basal	basal	ADJ
dpc-4600	194	24	layer	layer	NOUN
dpc-4600	194	25	of	of	ADP
dpc-4600	194	26	the	the	DET
dpc-4600	194	27	epidermis	epidermis	NOUN
dpc-4600	194	28	,	,	PUNCT
dpc-4600	194	29	where	where	SCONJ
dpc-4600	194	30	they	they	PRON
dpc-4600	194	31	target	target	VERB
dpc-4600	194	32	melanocytes	melanocyte	NOUN
dpc-4600	194	33	,	,	PUNCT
dpc-4600	194	34	cause	cause	VERB
dpc-4600	194	35	their	their	PRON
dpc-4600	194	36	apoptosis	apoptosis	NOUN
dpc-4600	194	37	,	,	PUNCT
dpc-4600	194	38	and	and	CCONJ
dpc-4600	194	39	decrease	decrease	VERB
dpc-4600	194	40	melanin	melanin	NOUN
dpc-4600	194	41	production	production	NOUN
dpc-4600	195	1	[	[	X
dpc-4600	195	2	68	68	NUM
dpc-4600	195	3	]	]	PUNCT
dpc-4600	195	4	.	.	PUNCT
dpc-4600	196	1	since	since	SCONJ
dpc-4600	196	2	there	there	PRON
dpc-4600	196	3	is	be	VERB
dpc-4600	196	4	a	a	DET
dpc-4600	196	5	significant	significant	ADJ
dpc-4600	196	6	role	role	NOUN
dpc-4600	196	7	of	of	ADP
dpc-4600	196	8	cd8	cd8	PROPN
dpc-4600	196	9	+	+	PROPN
dpc-4600	196	10	t	t	PROPN
dpc-4600	196	11	lymphocytes	lymphocyte	VERB
dpc-4600	196	12	in	in	ADP
dpc-4600	196	13	the	the	DET
dpc-4600	196	14	production	production	NOUN
dpc-4600	196	15	of	of	ADP
dpc-4600	196	16	vitiligo	vitiligo	NOUN
dpc-4600	196	17	,	,	PUNCT
dpc-4600	196	18	it	it	PRON
dpc-4600	196	19	may	may	AUX
dpc-4600	196	20	be	be	AUX
dpc-4600	196	21	worthwhile	worthwhile	ADJ
dpc-4600	196	22	to	to	PART
dpc-4600	196	23	investigate	investigate	VERB
dpc-4600	196	24	and	and	CCONJ
dpc-4600	196	25	test	test	NOUN
dpc-4600	196	26	therapeutics	therapeutic	NOUN
dpc-4600	196	27	that	that	PRON
dpc-4600	196	28	block	block	VERB
dpc-4600	196	29	the	the	DET
dpc-4600	196	30	cxcl9	cxcl9	NOUN
dpc-4600	196	31	and	and	CCONJ
dpc-4600	196	32	cxcl10	cxcl10	NOUN
dpc-4600	196	33	chemokines	chemokine	NOUN
dpc-4600	196	34	and	and	CCONJ
dpc-4600	196	35	their	their	PRON
dpc-4600	196	36	receptor	receptor	NOUN
dpc-4600	196	37	,	,	PUNCT
dpc-4600	196	38	cxcr3	cxcr3	PROPN
dpc-4600	196	39	,	,	PUNCT
dpc-4600	196	40	involved	involve	VERB
dpc-4600	196	41	in	in	ADP
dpc-4600	196	42	the	the	DET
dpc-4600	196	43	ifn	ifn	PROPN
dpc-4600	196	44	-	-	PUNCT
dpc-4600	196	45	γ	γ	NOUN
dpc-4600	196	46	signaling	signal	VERB
dpc-4600	196	47	pathway	pathway	NOUN
dpc-4600	196	48	[	[	X
dpc-4600	196	49	69	69	NUM
dpc-4600	196	50	]	]	PUNCT
dpc-4600	196	51	.	.	PUNCT
dpc-4600	197	1	as	as	SCONJ
dpc-4600	197	2	mentioned	mention	VERB
dpc-4600	197	3	earlier	early	ADV
dpc-4600	197	4	,	,	PUNCT
dpc-4600	197	5	damage	damage	NOUN
dpc-4600	197	6	-	-	PUNCT
dpc-4600	197	7	associated	associate	VERB
dpc-4600	197	8	molecular	molecular	ADJ
dpc-4600	197	9	patterns	pattern	NOUN
dpc-4600	197	10	(	(	PUNCT
dpc-4600	197	11	damps	damps	VERB
dpc-4600	197	12	)	)	PUNCT
dpc-4600	197	13	have	have	VERB
dpc-4600	197	14	a	a	DET
dpc-4600	197	15	role	role	NOUN
dpc-4600	197	16	in	in	ADP
dpc-4600	197	17	autoantigen	autoantigen	PROPN
dpc-4600	197	18	recognition	recognition	PROPN
dpc-4600	197	19	,	,	PUNCT
dpc-4600	197	20	regulation	regulation	NOUN
dpc-4600	197	21	of	of	ADP
dpc-4600	197	22	immune	immune	ADJ
dpc-4600	197	23	responses	response	NOUN
dpc-4600	197	24	,	,	PUNCT
dpc-4600	197	25	and	and	CCONJ
dpc-4600	197	26	induction	induction	NOUN
dpc-4600	197	27	of	of	ADP
dpc-4600	197	28	melanocyte	melanocyte	NOUN
dpc-4600	197	29	apoptosis	apoptosis	NOUN
dpc-4600	197	30	.	.	PUNCT
dpc-4600	198	1	the	the	DET
dpc-4600	198	2	primary	primary	ADJ
dpc-4600	198	3	damp	damp	ADJ
dpc-4600	198	4	molecule	molecule	NOUN
dpc-4600	198	5	,	,	PUNCT
dpc-4600	198	6	i.e.	i.e.	X
dpc-4600	198	7	,	,	PUNCT
dpc-4600	198	8	heat	heat	NOUN
dpc-4600	198	9	shock	shock	NOUN
dpc-4600	198	10	protein	protein	NOUN
dpc-4600	198	11	(	(	PUNCT
dpc-4600	198	12	hsp70i	hsp70i	PROPN
dpc-4600	198	13	)	)	PUNCT
dpc-4600	198	14	,	,	PUNCT
dpc-4600	198	15	plays	play	VERB
dpc-4600	198	16	a	a	DET
dpc-4600	198	17	central	central	ADJ
dpc-4600	198	18	role	role	NOUN
dpc-4600	198	19	in	in	ADP
dpc-4600	198	20	the	the	DET
dpc-4600	198	21	pathogenesis	pathogenesis	NOUN
dpc-4600	198	22	of	of	ADP
dpc-4600	198	23	vitiligo	vitiligo	NOUN
dpc-4600	198	24	[	[	X
dpc-4600	198	25	9	9	NUM
dpc-4600	198	26	]	]	PUNCT
dpc-4600	198	27	.	.	PUNCT
dpc-4600	199	1	by	by	ADP
dpc-4600	199	2	blocking	block	VERB
dpc-4600	199	3	hsp70i	hsp70i	NOUN
dpc-4600	199	4	,	,	PUNCT
dpc-4600	199	5	there	there	PRON
dpc-4600	199	6	could	could	AUX
dpc-4600	199	7	be	be	AUX
dpc-4600	199	8	downregulation	downregulation	NOUN
dpc-4600	199	9	of	of	ADP
dpc-4600	199	10	the	the	DET
dpc-4600	199	11	th-1	th-1	X
dpc-4600	199	12	lymphocytes	lymphocyte	NOUN
dpc-4600	199	13	in	in	ADP
dpc-4600	199	14	active	active	ADJ
dpc-4600	199	15	vitiliginous	vitiliginous	ADJ
dpc-4600	199	16	lesions	lesion	NOUN
dpc-4600	199	17	.	.	PUNCT
dpc-4600	200	1	another	another	DET
dpc-4600	200	2	potential	potential	ADJ
dpc-4600	200	3	target	target	NOUN
dpc-4600	200	4	among	among	ADP
dpc-4600	200	5	damps	damp	NOUN
dpc-4600	200	6	is	be	AUX
dpc-4600	200	7	the	the	DET
dpc-4600	200	8	high	high	ADJ
dpc-4600	200	9	-	-	PUNCT
dpc-4600	200	10	mobility	mobility	NOUN
dpc-4600	200	11	group	group	NOUN
dpc-4600	200	12	box	box	NOUN
dpc-4600	200	13	protein	protein	NOUN
dpc-4600	200	14	b1	b1	NOUN
dpc-4600	200	15	(	(	PUNCT
dpc-4600	200	16	hmgb1	hmgb1	PROPN
dpc-4600	200	17	)	)	PUNCT
dpc-4600	200	18	whose	whose	DET
dpc-4600	200	19	levels	level	NOUN
dpc-4600	200	20	have	have	AUX
dpc-4600	200	21	been	be	AUX
dpc-4600	200	22	found	find	VERB
dpc-4600	200	23	to	to	PART
dpc-4600	200	24	be	be	AUX
dpc-4600	200	25	increased	increase	VERB
dpc-4600	200	26	in	in	ADP
dpc-4600	200	27	the	the	DET
dpc-4600	200	28	serum	serum	NOUN
dpc-4600	200	29	of	of	ADP
dpc-4600	200	30	the	the	DET
dpc-4600	200	31	patients	patient	NOUN
dpc-4600	200	32	[	[	X
dpc-4600	200	33	70	70	NUM
dpc-4600	200	34	]	]	PUNCT
dpc-4600	200	35	.	.	PUNCT
dpc-4600	201	1	it	it	PRON
dpc-4600	201	2	may	may	AUX
dpc-4600	201	3	be	be	AUX
dpc-4600	201	4	worthwhile	worthwhile	ADJ
dpc-4600	201	5	to	to	PART
dpc-4600	201	6	investigate	investigate	VERB
dpc-4600	201	7	thoroughly	thoroughly	ADV
dpc-4600	201	8	the	the	DET
dpc-4600	201	9	role	role	NOUN
dpc-4600	201	10	of	of	ADP
dpc-4600	201	11	hmgb1	hmgb1	NOUN
dpc-4600	201	12	in	in	ADP
dpc-4600	201	13	causing	cause	VERB
dpc-4600	201	14	toxicity	toxicity	NOUN
dpc-4600	201	15	to	to	ADP
dpc-4600	201	16	melanocytes	melanocyte	NOUN
dpc-4600	201	17	to	to	PART
dpc-4600	201	18	enhance	enhance	VERB
dpc-4600	201	19	our	our	PRON
dpc-4600	201	20	knowledge	knowledge	NOUN
dpc-4600	201	21	of	of	ADP
dpc-4600	201	22	vitiligo	vitiligo	NOUN
dpc-4600	201	23	and	and	CCONJ
dpc-4600	201	24	develop	develop	VERB
dpc-4600	201	25	newer	new	ADJ
dpc-4600	201	26	therapeutic	therapeutic	ADJ
dpc-4600	201	27	options	option	NOUN
dpc-4600	201	28	(	(	PUNCT
dpc-4600	201	29	table	table	NOUN
dpc-4600	201	30	2	2	NUM
dpc-4600	201	31	)	)	PUNCT
dpc-4600	201	32	.	.	PUNCT
dpc-4600	202	1	appearance	appearance	NOUN
dpc-4600	203	1	[	[	X
dpc-4600	203	2	61	61	NUM
dpc-4600	203	3	]	]	PUNCT
dpc-4600	203	4	.	.	PUNCT
dpc-4600	204	1	in	in	ADP
dpc-4600	204	2	addition	addition	NOUN
dpc-4600	204	3	,	,	PUNCT
dpc-4600	204	4	it	it	PRON
dpc-4600	204	5	also	also	ADV
dpc-4600	204	6	upregulates	upregulate	VERB
dpc-4600	204	7	the	the	DET
dpc-4600	204	8	tyrosinase	tyrosinase	NOUN
dpc-4600	204	9	enzyme	enzyme	NOUN
dpc-4600	204	10	and	and	CCONJ
dpc-4600	204	11	increases	increase	VERB
dpc-4600	204	12	the	the	DET
dpc-4600	204	13	synthesis	synthesis	NOUN
dpc-4600	204	14	of	of	ADP
dpc-4600	204	15	melanin	melanin	NOUN
dpc-4600	204	16	.	.	PUNCT
dpc-4600	205	1	according	accord	VERB
dpc-4600	205	2	to	to	ADP
dpc-4600	205	3	the	the	DET
dpc-4600	205	4	global	global	ADJ
dpc-4600	205	5	vitiligo	vitiligo	PROPN
dpc-4600	205	6	foundation	foundation	NOUN
dpc-4600	205	7	recommendations	recommendation	NOUN
dpc-4600	205	8	,	,	PUNCT
dpc-4600	205	9	phototherapy	phototherapy	NOUN
dpc-4600	205	10	is	be	AUX
dpc-4600	205	11	to	to	PART
dpc-4600	205	12	be	be	AUX
dpc-4600	205	13	given	give	VERB
dpc-4600	205	14	2–3	2–3	NUM
dpc-4600	205	15	times	time	NOUN
dpc-4600	205	16	a	a	DET
dpc-4600	205	17	week	week	NOUN
dpc-4600	205	18	,	,	PUNCT
dpc-4600	205	19	starting	start	VERB
dpc-4600	205	20	at	at	ADP
dpc-4600	205	21	a	a	DET
dpc-4600	205	22	dose	dose	NOUN
dpc-4600	205	23	of	of	ADP
dpc-4600	205	24	200	200	NUM
dpc-4600	205	25	mj	mj	NOUN
dpc-4600	205	26	/	/	SYM
dpc-4600	205	27	cm2	cm2	NOUN
dpc-4600	205	28	,	,	PUNCT
dpc-4600	205	29	with	with	ADP
dpc-4600	205	30	subsequent	subsequent	ADJ
dpc-4600	205	31	increments	increment	NOUN
dpc-4600	205	32	of	of	ADP
dpc-4600	205	33	10	10	NUM
dpc-4600	205	34	%	%	NOUN
dpc-4600	205	35	to	to	PART
dpc-4600	205	36	20	20	NUM
dpc-4600	205	37	%	%	NOUN
dpc-4600	205	38	if	if	SCONJ
dpc-4600	205	39	no	no	DET
dpc-4600	205	40	erythema	erythema	ADV
dpc-4600	205	41	occurs	occur	VERB
dpc-4600	205	42	.	.	PUNCT
dpc-4600	205	43	 	 	SPACE
dpc-4600	206	1	after	after	ADP
dpc-4600	206	2	12	12	NUM
dpc-4600	206	3	months	month	NOUN
dpc-4600	206	4	of	of	ADP
dpc-4600	206	5	therapy	therapy	NOUN
dpc-4600	206	6	,	,	PUNCT
dpc-4600	206	7	more	more	ADJ
dpc-4600	206	8	than	than	ADP
dpc-4600	206	9	75	75	NUM
dpc-4600	206	10	%	%	NOUN
dpc-4600	206	11	repigmentation	repigmentation	NOUN
dpc-4600	206	12	is	be	AUX
dpc-4600	206	13	generally	generally	ADV
dpc-4600	206	14	expected	expect	VERB
dpc-4600	206	15	to	to	PART
dpc-4600	206	16	occur	occur	VERB
dpc-4600	206	17	.	.	PUNCT
dpc-4600	207	1	patients	patient	NOUN
dpc-4600	207	2	should	should	AUX
dpc-4600	207	3	be	be	AUX
dpc-4600	207	4	informed	inform	VERB
dpc-4600	207	5	of	of	ADP
dpc-4600	207	6	the	the	DET
dpc-4600	207	7	longterm	longterm	ADJ
dpc-4600	207	8	nature	nature	NOUN
dpc-4600	207	9	of	of	ADP
dpc-4600	207	10	phototherapy	phototherapy	NOUN
dpc-4600	207	11	at	at	ADP
dpc-4600	207	12	the	the	DET
dpc-4600	207	13	outset	outset	NOUN
dpc-4600	207	14	only	only	ADV
dpc-4600	207	15	for	for	ADP
dpc-4600	207	16	better	well	ADJ
dpc-4600	207	17	compliance	compliance	NOUN
dpc-4600	207	18	and	and	CCONJ
dpc-4600	207	19	effective	effective	ADJ
dpc-4600	207	20	results	result	NOUN
dpc-4600	207	21	[	[	X
dpc-4600	207	22	62	62	NUM
dpc-4600	207	23	]	]	PUNCT
dpc-4600	207	24	.	.	PUNCT
dpc-4600	208	1	the	the	DET
dpc-4600	208	2	excimer	excimer	NOUN
dpc-4600	208	3	laser	laser	NOUN
dpc-4600	208	4	(	(	PUNCT
dpc-4600	208	5	exls	exls	NOUN
dpc-4600	208	6	)	)	PUNCT
dpc-4600	208	7	offers	offer	VERB
dpc-4600	208	8	a	a	DET
dpc-4600	208	9	suitable	suitable	ADJ
dpc-4600	208	10	option	option	NOUN
dpc-4600	208	11	for	for	ADP
dpc-4600	208	12	vitiligo	vitiligo	NOUN
dpc-4600	208	13	patients	patient	NOUN
dpc-4600	208	14	who	who	PRON
dpc-4600	208	15	have	have	VERB
dpc-4600	208	16	limited	limit	VERB
dpc-4600	208	17	skin	skin	NOUN
dpc-4600	208	18	involvement	involvement	NOUN
dpc-4600	208	19	.	.	PUNCT
dpc-4600	209	1	it	it	PRON
dpc-4600	209	2	has	have	VERB
dpc-4600	209	3	a	a	DET
dpc-4600	209	4	wavelength	wavelength	NOUN
dpc-4600	209	5	of	of	ADP
dpc-4600	209	6	308	308	NUM
dpc-4600	209	7	nm	nm	NOUN
dpc-4600	209	8	,	,	PUNCT
dpc-4600	209	9	which	which	PRON
dpc-4600	209	10	is	be	AUX
dpc-4600	209	11	produced	produce	VERB
dpc-4600	209	12	by	by	ADP
dpc-4600	209	13	combining	combine	VERB
dpc-4600	209	14	xenon	xenon	NOUN
dpc-4600	209	15	and	and	CCONJ
dpc-4600	209	16	chlorine	chlorine	NOUN
dpc-4600	209	17	gases	gas	NOUN
dpc-4600	209	18	.	.	PUNCT
dpc-4600	210	1	it	it	PRON
dpc-4600	210	2	has	have	VERB
dpc-4600	210	3	certain	certain	ADJ
dpc-4600	210	4	advantages	advantage	NOUN
dpc-4600	210	5	,	,	PUNCT
dpc-4600	210	6	like	like	ADP
dpc-4600	210	7	accessibility	accessibility	NOUN
dpc-4600	210	8	to	to	ADP
dpc-4600	210	9	hard	hard	ADJ
dpc-4600	210	10	-	-	PUNCT
dpc-4600	210	11	to	to	PART
dpc-4600	210	12	-	-	PUNCT
dpc-4600	210	13	reach	reach	VERB
dpc-4600	210	14	areas	area	NOUN
dpc-4600	210	15	,	,	PUNCT
dpc-4600	210	16	a	a	DET
dpc-4600	210	17	lower	low	ADJ
dpc-4600	210	18	cumulative	cumulative	ADJ
dpc-4600	210	19	dose	dose	NOUN
dpc-4600	210	20	,	,	PUNCT
dpc-4600	210	21	and	and	CCONJ
dpc-4600	210	22	limited	limited	ADJ
dpc-4600	210	23	exposure	exposure	NOUN
dpc-4600	210	24	of	of	ADP
dpc-4600	210	25	uvb	uvb	ADJ
dpc-4600	210	26	to	to	PART
dpc-4600	210	27	target	target	VERB
dpc-4600	210	28	areas	area	NOUN
dpc-4600	210	29	[	[	X
dpc-4600	210	30	63	63	NUM
dpc-4600	210	31	]	]	PUNCT
dpc-4600	210	32	.	.	PUNCT
dpc-4600	211	1	it	it	PRON
dpc-4600	211	2	has	have	VERB
dpc-4600	211	3	certain	certain	ADJ
dpc-4600	211	4	adverse	adverse	ADJ
dpc-4600	211	5	effects	effect	NOUN
dpc-4600	211	6	like	like	ADP
dpc-4600	211	7	erythema	erythema	ADV
dpc-4600	211	8	,	,	PUNCT
dpc-4600	211	9	blistering	blister	VERB
dpc-4600	211	10	,	,	PUNCT
dpc-4600	211	11	hypo	hypo	ADJ
dpc-4600	211	12	and	and	CCONJ
dpc-4600	211	13	hyperpigmentation	hyperpigmentation	NOUN
dpc-4600	211	14	of	of	ADP
dpc-4600	211	15	the	the	DET
dpc-4600	211	16	skin	skin	NOUN
dpc-4600	211	17	,	,	PUNCT
dpc-4600	211	18	and	and	CCONJ
dpc-4600	211	19	pruritus	pruritus	PROPN
dpc-4600	211	20	.	.	PUNCT
dpc-4600	212	1	however	however	ADV
dpc-4600	212	2	,	,	PUNCT
dpc-4600	212	3	these	these	PRON
dpc-4600	212	4	are	be	AUX
dpc-4600	212	5	localized	localize	VERB
dpc-4600	212	6	to	to	ADP
dpc-4600	212	7	the	the	DET
dpc-4600	212	8	treatment	treatment	NOUN
dpc-4600	212	9	area	area	NOUN
dpc-4600	212	10	only	only	ADV
dpc-4600	212	11	in	in	ADP
dpc-4600	212	12	comparison	comparison	NOUN
dpc-4600	212	13	to	to	ADP
dpc-4600	212	14	the	the	DET
dpc-4600	212	15	whole	whole	ADJ
dpc-4600	212	16	body	body	NOUN
dpc-4600	212	17	in	in	ADP
dpc-4600	212	18	nbuvb	nbuvb	ADJ
dpc-4600	212	19	phototherapy	phototherapy	NOUN
dpc-4600	212	20	.	.	PUNCT
dpc-4600	213	1	exls	exls	NOUN
dpc-4600	213	2	costs	cost	VERB
dpc-4600	213	3	more	more	ADJ
dpc-4600	213	4	than	than	ADP
dpc-4600	213	5	alternative	alternative	ADJ
dpc-4600	213	6	phototherapy	phototherapy	NOUN
dpc-4600	213	7	equipment	equipment	NOUN
dpc-4600	213	8	.	.	PUNCT
dpc-4600	214	1	another	another	DET
dpc-4600	214	2	device	device	NOUN
dpc-4600	214	3	that	that	PRON
dpc-4600	214	4	has	have	AUX
dpc-4600	214	5	been	be	AUX
dpc-4600	214	6	widely	widely	ADV
dpc-4600	214	7	used	use	VERB
dpc-4600	214	8	to	to	PART
dpc-4600	214	9	induce	induce	VERB
dpc-4600	214	10	repigmentation	repigmentation	NOUN
dpc-4600	214	11	in	in	ADP
dpc-4600	214	12	vitiligo	vitiligo	NOUN
dpc-4600	214	13	is	be	AUX
dpc-4600	214	14	monochromatic	monochromatic	ADJ
dpc-4600	214	15	excimer	excimer	NOUN
dpc-4600	214	16	light	light	NOUN
dpc-4600	214	17	lamps	lamp	NOUN
dpc-4600	214	18	(	(	PUNCT
dpc-4600	214	19	exlp	exlp	NOUN
dpc-4600	214	20	)	)	PUNCT
dpc-4600	214	21	.	.	PUNCT
dpc-4600	215	1	it	it	PRON
dpc-4600	215	2	emits	emit	VERB
dpc-4600	215	3	a	a	DET
dpc-4600	215	4	wavelength	wavelength	NOUN
dpc-4600	215	5	of	of	ADP
dpc-4600	215	6	308	308	NUM
dpc-4600	215	7	nm	nm	NOUN
dpc-4600	215	8	.	.	PUNCT
dpc-4600	216	1	compared	compare	VERB
dpc-4600	216	2	to	to	ADP
dpc-4600	216	3	excimer	excimer	NOUN
dpc-4600	216	4	lasers	laser	NOUN
dpc-4600	216	5	,	,	PUNCT
dpc-4600	216	6	it	it	PRON
dpc-4600	216	7	gives	give	VERB
dpc-4600	216	8	faster	fast	ADJ
dpc-4600	216	9	repigmentation	repigmentation	NOUN
dpc-4600	216	10	as	as	SCONJ
dpc-4600	216	11	it	it	PRON
dpc-4600	216	12	has	have	VERB
dpc-4600	216	13	a	a	DET
dpc-4600	216	14	broader	broad	ADJ
dpc-4600	216	15	field	field	NOUN
dpc-4600	216	16	of	of	ADP
dpc-4600	216	17	treatment	treatment	NOUN
dpc-4600	216	18	[	[	X
dpc-4600	216	19	64	64	NUM
dpc-4600	216	20	]	]	PUNCT
dpc-4600	216	21	.	.	PUNCT
dpc-4600	217	1	it	it	PRON
dpc-4600	217	2	is	be	AUX
dpc-4600	217	3	far	far	ADV
dpc-4600	217	4	less	less	ADV
dpc-4600	217	5	expensive	expensive	ADJ
dpc-4600	217	6	than	than	ADP
dpc-4600	217	7	other	other	ADJ
dpc-4600	217	8	laser	laser	NOUN
dpc-4600	217	9	devices	device	NOUN
dpc-4600	217	10	available	available	ADJ
dpc-4600	217	11	on	on	ADP
dpc-4600	217	12	the	the	DET
dpc-4600	217	13	market	market	NOUN
dpc-4600	217	14	.	.	PUNCT
dpc-4600	218	1	many	many	ADJ
dpc-4600	218	2	studies	study	NOUN
dpc-4600	218	3	have	have	AUX
dpc-4600	218	4	been	be	AUX
dpc-4600	218	5	done	do	VERB
dpc-4600	218	6	to	to	PART
dpc-4600	218	7	compare	compare	VERB
dpc-4600	218	8	the	the	DET
dpc-4600	218	9	efficacy	efficacy	NOUN
dpc-4600	218	10	of	of	ADP
dpc-4600	218	11	nbuvb	nbuvb	NOUN
dpc-4600	218	12	,	,	PUNCT
dpc-4600	218	13	exls	exls	NOUN
dpc-4600	218	14	,	,	PUNCT
dpc-4600	218	15	and	and	CCONJ
dpc-4600	218	16	exlp	exlp	NOUN
dpc-4600	218	17	in	in	ADP
dpc-4600	218	18	treating	treat	VERB
dpc-4600	218	19	vitiligo	vitiligo	NOUN
dpc-4600	218	20	[	[	X
dpc-4600	218	21	65	65	NUM
dpc-4600	218	22	]	]	PUNCT
dpc-4600	218	23	.	.	PUNCT
dpc-4600	219	1	according	accord	VERB
dpc-4600	219	2	to	to	ADP
dpc-4600	219	3	recent	recent	ADJ
dpc-4600	219	4	meta	meta	ADJ
dpc-4600	219	5	-	-	PUNCT
dpc-4600	219	6	analyses	analysis	NOUN
dpc-4600	219	7	,	,	PUNCT
dpc-4600	219	8	the	the	DET
dpc-4600	219	9	excimer	excimer	NOUN
dpc-4600	219	10	treatment	treatment	NOUN
dpc-4600	219	11	has	have	VERB
dpc-4600	219	12	a	a	DET
dpc-4600	219	13	better	well	ADJ
dpc-4600	219	14	degree	degree	NOUN
dpc-4600	219	15	of	of	ADP
dpc-4600	219	16	repigmentation	repigmentation	NOUN
dpc-4600	219	17	and	and	CCONJ
dpc-4600	219	18	a	a	DET
dpc-4600	219	19	quicker	quick	ADJ
dpc-4600	219	20	result	result	NOUN
dpc-4600	219	21	than	than	ADP
dpc-4600	219	22	nb	nb	NOUN
dpc-4600	219	23	-	-	ADJ
dpc-4600	219	24	uvb	uvb	ADJ
dpc-4600	219	25	[	[	X
dpc-4600	219	26	66	66	NUM
dpc-4600	219	27	]	]	PUNCT
dpc-4600	219	28	.	.	PUNCT
dpc-4600	220	1	table	table	NOUN
dpc-4600	220	2	2	2	NUM
dpc-4600	220	3	.	.	PUNCT
dpc-4600	221	1	future	future	ADJ
dpc-4600	221	2	drug	drug	NOUN
dpc-4600	221	3	targets	target	NOUN
dpc-4600	221	4	in	in	ADP
dpc-4600	221	5	vitiligo	vitiligo	PROPN
dpc-4600	221	6	.	.	PUNCT
dpc-4600	222	1	drug	drug	NOUN
dpc-4600	222	2	class	class	NOUN
dpc-4600	222	3	treatments	treatment	NOUN
dpc-4600	222	4	mechanism	mechanism	NOUN
dpc-4600	222	5	treatment	treatment	NOUN
dpc-4600	222	6	goal	goal	NOUN
dpc-4600	222	7	anti	anti	X
dpc-4600	222	8	il-15	il-15	ADJ
dpc-4600	222	9	biologics	biologic	NOUN
dpc-4600	222	10	anti	anti	X
dpc-4600	222	11	il-15	il-15	ADJ
dpc-4600	222	12	antibody	antibody	NOUN
dpc-4600	222	13	anti	anti	ADJ
dpc-4600	222	14	-	-	ADJ
dpc-4600	222	15	cd	cd	ADJ
dpc-4600	222	16	122	122	NUM
dpc-4600	222	17	antibody	antibody	NOUN
dpc-4600	222	18	blocking	blocking	NOUN
dpc-4600	222	19	of	of	ADP
dpc-4600	222	20	interleukin	interleukin	NOUN
dpc-4600	222	21	15	15	NUM
dpc-4600	222	22	signaling	signal	VERB
dpc-4600	222	23	immunosuppression	immunosuppression	NOUN
dpc-4600	222	24	and	and	CCONJ
dpc-4600	222	25	trm	trm	ADJ
dpc-4600	222	26	cell	cell	NOUN
dpc-4600	222	27	elimination	elimination	NOUN
dpc-4600	222	28	phosphodiesterase	phosphodiesterase	NOUN
dpc-4600	222	29	4	4	NUM
dpc-4600	222	30	inhibitor	inhibitor	NOUN
dpc-4600	222	31	apremilast	apremilast	NOUN
dpc-4600	222	32	roflumilast	roflumilast	NOUN
dpc-4600	222	33	inhibition	inhibition	NOUN
dpc-4600	222	34	of	of	ADP
dpc-4600	222	35	pde-4	pde-4	NOUN
dpc-4600	222	36	,	,	PUNCT
dpc-4600	222	37	increasing	increase	VERB
dpc-4600	222	38	camp	camp	NOUN
dpc-4600	222	39	and	and	CCONJ
dpc-4600	222	40	decreasing	decrease	VERB
dpc-4600	222	41	expression	expression	NOUN
dpc-4600	222	42	of	of	ADP
dpc-4600	222	43	inflammatory	inflammatory	ADJ
dpc-4600	222	44	mediators	mediator	NOUN
dpc-4600	222	45	immunosuppression	immunosuppression	NOUN
dpc-4600	222	46	plasmid	plasmid	ADJ
dpc-4600	222	47	hsp70i	hsp70i	PROPN
dpc-4600	222	48	gene	gene	NOUN
dpc-4600	222	49	therapy	therapy	NOUN
dpc-4600	222	50	hsp70iq435a	hsp70iq435a	VERB
dpc-4600	222	51	hsp70i	hsp70i	PROPN
dpc-4600	222	52	in	in	ADP
dpc-4600	222	53	mutant	mutant	ADJ
dpc-4600	222	54	form	form	NOUN
dpc-4600	222	55	may	may	AUX
dpc-4600	222	56	inhibit	inhibit	VERB
dpc-4600	222	57	endogenous	endogenous	ADJ
dpc-4600	222	58	hsp70i	hsp70i	NOUN
dpc-4600	222	59	-	-	PUNCT
dpc-4600	222	60	induced	induce	VERB
dpc-4600	222	61	immune	immune	ADJ
dpc-4600	222	62	system	system	NOUN
dpc-4600	222	63	activation	activation	NOUN
dpc-4600	222	64	blocks	block	VERB
dpc-4600	222	65	endogenous	endogenous	ADJ
dpc-4600	222	66	innate	innate	ADJ
dpc-4600	222	67	immune	immune	ADJ
dpc-4600	222	68	activation	activation	NOUN
dpc-4600	222	69	agonists	agonist	NOUN
dpc-4600	222	70	of	of	ADP
dpc-4600	222	71	wnt	wnt	NOUN
dpc-4600	222	72	signaling	signal	VERB
dpc-4600	222	73	pathway	pathway	NOUN
dpc-4600	222	74	skl2001	skl2001	VERB
dpc-4600	222	75	stimulation	stimulation	NOUN
dpc-4600	222	76	of	of	ADP
dpc-4600	222	77	melanoblast	melanoblast	ADJ
dpc-4600	222	78	proliferation	proliferation	NOUN
dpc-4600	222	79	and	and	CCONJ
dpc-4600	222	80	migration	migration	NOUN
dpc-4600	222	81	production	production	NOUN
dpc-4600	222	82	of	of	ADP
dpc-4600	222	83	more	more	ADJ
dpc-4600	222	84	melanocytes	melanocyte	NOUN
dpc-4600	222	85	melanocyte	melanocyte	NOUN
dpc-4600	222	86	regeneration	regeneration	NOUN
dpc-4600	222	87	tricholoroacetic	tricholoroacetic	ADJ
dpc-4600	222	88	acid	acid	NOUN
dpc-4600	222	89	70	70	NUM
dpc-4600	222	90	%	%	NOUN
dpc-4600	222	91	tca	tca	NOUN
dpc-4600	222	92	along	along	ADP
dpc-4600	222	93	with	with	ADP
dpc-4600	222	94	microneedling	microneedle	VERB
dpc-4600	222	95	tca	tca	PROPN
dpc-4600	222	96	-	-	PUNCT
dpc-4600	222	97	induced	induce	VERB
dpc-4600	222	98	necrosis	necrosis	NOUN
dpc-4600	222	99	stimulates	stimulate	VERB
dpc-4600	222	100	the	the	DET
dpc-4600	222	101	proliferation	proliferation	NOUN
dpc-4600	222	102	of	of	ADP
dpc-4600	222	103	melanocytes	melanocyte	NOUN
dpc-4600	222	104	through	through	ADP
dpc-4600	222	105	synthesis	synthesis	NOUN
dpc-4600	222	106	of	of	ADP
dpc-4600	222	107	melanocortins	melanocortin	NOUN
dpc-4600	222	108	and	and	CCONJ
dpc-4600	222	109	their	their	PRON
dpc-4600	222	110	precursor	precursor	NOUN
dpc-4600	222	111	moleculeproopiomelanocortin	moleculeproopiomelanocortin	NOUN
dpc-4600	222	112	(	(	PUNCT
dpc-4600	222	113	pomc	pomc	NOUN
dpc-4600	222	114	)	)	PUNCT
dpc-4600	222	115	release	release	NOUN
dpc-4600	222	116	of	of	ADP
dpc-4600	222	117	growth	growth	NOUN
dpc-4600	222	118	factors	factor	NOUN
dpc-4600	222	119	and	and	CCONJ
dpc-4600	222	120	inflammatory	inflammatory	ADJ
dpc-4600	222	121	mediators	mediator	NOUN
dpc-4600	222	122	platelet	platelet	ADJ
dpc-4600	222	123	-	-	PUNCT
dpc-4600	222	124	rich	rich	ADJ
dpc-4600	222	125	plasma	plasma	NOUN
dpc-4600	222	126	used	use	VERB
dpc-4600	222	127	in	in	ADP
dpc-4600	222	128	conjunction	conjunction	NOUN
dpc-4600	222	129	with	with	ADP
dpc-4600	222	130	laser	laser	NOUN
dpc-4600	222	131	,	,	PUNCT
dpc-4600	222	132	phototherapy	phototherapy	NOUN
dpc-4600	222	133	,	,	PUNCT
dpc-4600	222	134	and	and	CCONJ
dpc-4600	222	135	surgical	surgical	ADJ
dpc-4600	222	136	treatments	treatment	NOUN
dpc-4600	222	137	restores	restore	VERB
dpc-4600	222	138	normal	normal	ADJ
dpc-4600	222	139	cellular	cellular	ADJ
dpc-4600	222	140	function	function	NOUN
dpc-4600	222	141	and	and	CCONJ
dpc-4600	222	142	promotes	promote	VERB
dpc-4600	222	143	growth	growth	NOUN
dpc-4600	222	144	and	and	CCONJ
dpc-4600	222	145	maturation	maturation	NOUN
dpc-4600	222	146	of	of	ADP
dpc-4600	222	147	keratinocytes	keratinocyte	NOUN
dpc-4600	222	148	and	and	CCONJ
dpc-4600	222	149	melanocytes	melanocyte	NOUN
dpc-4600	222	150	in	in	ADP
dpc-4600	223	1	skin	skin	NOUN
dpc-4600	223	2	epidermal	epidermal	ADJ
dpc-4600	223	3	repigmentation	repigmentation	NOUN
dpc-4600	223	4	review	review	NOUN
dpc-4600	224	1	|	|	ADV
dpc-4600	224	2	dermatol	dermatol	ADJ
dpc-4600	224	3	pract	pract	NOUN
dpc-4600	224	4	concept	concept	NOUN
dpc-4600	224	5	.	.	PUNCT
dpc-4600	225	1	2025;15(1):4600	2025;15(1):4600	NUM
dpc-4600	225	2	9	9	NUM
dpc-4600	225	3	12	12	NUM
dpc-4600	225	4	.	.	PUNCT
dpc-4600	226	1	oparaugo	oparaugo	PROPN
dpc-4600	226	2	nc	nc	PROPN
dpc-4600	226	3	,	,	PUNCT
dpc-4600	226	4	ouyang	ouyang	PROPN
dpc-4600	226	5	k	k	PROPN
dpc-4600	226	6	,	,	PUNCT
dpc-4600	226	7	nguyen	nguyen	PROPN
dpc-4600	226	8	npn	npn	PROPN
dpc-4600	226	9	,	,	PUNCT
dpc-4600	226	10	nelson	nelson	PROPN
dpc-4600	226	11	am	am	PROPN
dpc-4600	226	12	,	,	PUNCT
dpc-4600	226	13	agak	agak	PROPN
dpc-4600	226	14	gw	gw	PROPN
dpc-4600	226	15	.	.	PUNCT
dpc-4600	227	1	human	human	ADJ
dpc-4600	227	2	regulatory	regulatory	ADJ
dpc-4600	227	3	t	t	PROPN
dpc-4600	227	4	cells	cell	NOUN
dpc-4600	227	5	:	:	PUNCT
dpc-4600	227	6	understanding	understand	VERB
dpc-4600	227	7	the	the	DET
dpc-4600	227	8	role	role	NOUN
dpc-4600	227	9	of	of	ADP
dpc-4600	227	10	tregs	treg	NOUN
dpc-4600	227	11	in	in	ADP
dpc-4600	227	12	select	select	ADJ
dpc-4600	227	13	autoimmune	autoimmune	ADJ
dpc-4600	227	14	skin	skin	NOUN
dpc-4600	227	15	diseases	disease	NOUN
dpc-4600	227	16	and	and	CCONJ
dpc-4600	227	17	post	post	ADJ
dpc-4600	227	18	-	-	ADJ
dpc-4600	227	19	transplant	transplant	ADJ
dpc-4600	227	20	nonmelanoma	nonmelanoma	ADJ
dpc-4600	227	21	skin	skin	NOUN
dpc-4600	227	22	cancers	cancer	NOUN
dpc-4600	227	23	.	.	PUNCT
dpc-4600	228	1	int	int	PROPN
dpc-4600	228	2	j	j	PROPN
dpc-4600	228	3	mol	mol	ADP
dpc-4600	228	4	sci	sci	PROPN
dpc-4600	228	5	.	.	PUNCT
dpc-4600	229	1	2023;24(2):1527	2023;24(2):1527	PROPN
dpc-4600	229	2	.	.	PUNCT
dpc-4600	230	1	doi	doi	NOUN
dpc-4600	230	2	:	:	PUNCT
dpc-4600	230	3	10.3390	10.3390	NUM
dpc-4600	230	4	/	/	SYM
dpc-4600	230	5	ijms24021527	ijms24021527	PROPN
dpc-4600	230	6	.	.	PUNCT
dpc-4600	231	1	pmid	pmid	NOUN
dpc-4600	231	2	:	:	PUNCT
dpc-4600	231	3	36675037	36675037	NUM
dpc-4600	231	4	.	.	PUNCT
dpc-4600	232	1	13	13	NUM
dpc-4600	232	2	.	.	PUNCT
dpc-4600	233	1	richmond	richmond	PROPN
dpc-4600	233	2	jm	jm	PROPN
dpc-4600	233	3	,	,	PUNCT
dpc-4600	233	4	strassner	strassner	PROPN
dpc-4600	233	5	jp	jp	PROPN
dpc-4600	233	6	,	,	PUNCT
dpc-4600	233	7	rashighi	rashighi	PROPN
dpc-4600	233	8	m	m	PROPN
dpc-4600	233	9	,	,	PUNCT
dpc-4600	233	10	et	et	PROPN
dpc-4600	233	11	al	al	PROPN
dpc-4600	233	12	.	.	PROPN
dpc-4600	233	13	resident	resident	PROPN
dpc-4600	233	14	memory	memory	NOUN
dpc-4600	233	15	and	and	CCONJ
dpc-4600	233	16	recirculating	recirculating	NOUN
dpc-4600	233	17	memory	memory	NOUN
dpc-4600	233	18	t	t	PROPN
dpc-4600	233	19	cells	cell	NOUN
dpc-4600	233	20	cooperate	cooperate	VERB
dpc-4600	233	21	to	to	PART
dpc-4600	233	22	maintain	maintain	VERB
dpc-4600	233	23	disease	disease	NOUN
dpc-4600	233	24	in	in	ADP
dpc-4600	233	25	a	a	DET
dpc-4600	233	26	mouse	mouse	NOUN
dpc-4600	233	27	model	model	NOUN
dpc-4600	233	28	of	of	ADP
dpc-4600	233	29	vitiligo	vitiligo	PROPN
dpc-4600	233	30	.	.	PUNCT
dpc-4600	234	1	j	j	PROPN
dpc-4600	234	2	invest	invest	VERB
dpc-4600	234	3	dermatol	dermatol	NOUN
dpc-4600	234	4	.	.	PUNCT
dpc-4600	235	1	2019;139(4):769	2019;139(4):769	NUM
dpc-4600	235	2	-	-	SYM
dpc-4600	235	3	778	778	NUM
dpc-4600	235	4	.	.	PUNCT
dpc-4600	236	1	doi	doi	NOUN
dpc-4600	236	2	:	:	PUNCT
dpc-4600	236	3	10.1016	10.1016	NUM
dpc-4600	236	4	/	/	SYM
dpc-4600	236	5	j.jid.2018.10.032	j.jid.2018.10.032	PROPN
dpc-4600	236	6	.	.	PUNCT
dpc-4600	237	1	epub	epub	PROPN
dpc-4600	237	2	2018	2018	NUM
dpc-4600	237	3	nov	nov	PROPN
dpc-4600	237	4	10	10	NUM
dpc-4600	237	5	.	.	PUNCT
dpc-4600	238	1	pmid	pmid	NOUN
dpc-4600	238	2	:	:	PUNCT
dpc-4600	238	3	30423329	30423329	NUM
dpc-4600	238	4	.	.	PUNCT
dpc-4600	239	1	14	14	NUM
dpc-4600	239	2	.	.	PUNCT
dpc-4600	240	1	xuan	xuan	PROPN
dpc-4600	240	2	y	y	PROPN
dpc-4600	240	3	,	,	PUNCT
dpc-4600	240	4	yang	yang	PROPN
dpc-4600	240	5	y	y	PROPN
dpc-4600	240	6	,	,	PUNCT
dpc-4600	240	7	xiang	xiang	PROPN
dpc-4600	240	8	l	l	PROPN
dpc-4600	240	9	,	,	PUNCT
dpc-4600	240	10	zhang	zhang	PROPN
dpc-4600	240	11	c.	c.	PROPN
dpc-4600	241	1	the	the	DET
dpc-4600	241	2	role	role	NOUN
dpc-4600	241	3	of	of	ADP
dpc-4600	241	4	oxidative	oxidative	ADJ
dpc-4600	241	5	stress	stress	NOUN
dpc-4600	241	6	in	in	ADP
dpc-4600	241	7	the	the	DET
dpc-4600	241	8	pathogenesis	pathogenesis	NOUN
dpc-4600	241	9	of	of	ADP
dpc-4600	241	10	vitiligo	vitiligo	NOUN
dpc-4600	241	11	:	:	PUNCT
dpc-4600	241	12	a	a	DET
dpc-4600	241	13	culprit	culprit	NOUN
dpc-4600	241	14	for	for	ADP
dpc-4600	241	15	melanocyte	melanocyte	NOUN
dpc-4600	241	16	death	death	NOUN
dpc-4600	241	17	.	.	PUNCT
dpc-4600	242	1	oxid	oxid	PROPN
dpc-4600	242	2	med	med	PROPN
dpc-4600	242	3	cell	cell	NOUN
dpc-4600	242	4	longev	longev	NOUN
dpc-4600	242	5	.	.	PUNCT
dpc-4600	243	1	2022;2022:8498472	2022;2022:8498472	NUM
dpc-4600	243	2	.	.	PUNCT
dpc-4600	244	1	doi	doi	NOUN
dpc-4600	244	2	:	:	PUNCT
dpc-4600	244	3	10.1155/2022/8498472	10.1155/2022/8498472	NUM
dpc-4600	244	4	.	.	PUNCT
dpc-4600	245	1	pmid	pmid	NOUN
dpc-4600	245	2	:	:	PUNCT
dpc-4600	245	3	35103096	35103096	NUM
dpc-4600	245	4	.	.	PUNCT
dpc-4600	246	1	15	15	NUM
dpc-4600	246	2	.	.	X
dpc-4600	246	3	yang	yang	PROPN
dpc-4600	246	4	rl	rl	PROPN
dpc-4600	246	5	,	,	PUNCT
dpc-4600	246	6	chen	chen	PROPN
dpc-4600	246	7	sy	sy	PROPN
dpc-4600	246	8	,	,	PUNCT
dpc-4600	246	9	fu	fu	PROPN
dpc-4600	246	10	sp	sp	NOUN
dpc-4600	246	11	,	,	PUNCT
dpc-4600	246	12	at	at	ADP
dpc-4600	246	13	al	al	PROPN
dpc-4600	246	14	.	.	PROPN
dpc-4600	246	15	antioxidant	antioxidant	ADJ
dpc-4600	246	16	mechanisms	mechanism	NOUN
dpc-4600	246	17	of	of	ADP
dpc-4600	246	18	mesenchymal	mesenchymal	NOUN
dpc-4600	246	19	stem	stem	NOUN
dpc-4600	246	20	cells	cell	NOUN
dpc-4600	246	21	and	and	CCONJ
dpc-4600	246	22	their	their	PRON
dpc-4600	246	23	therapeutic	therapeutic	ADJ
dpc-4600	246	24	potential	potential	NOUN
dpc-4600	246	25	in	in	ADP
dpc-4600	246	26	vitiligo	vitiligo	PROPN
dpc-4600	246	27	.	.	PUNCT
dpc-4600	247	1	front	front	ADJ
dpc-4600	247	2	cell	cell	NOUN
dpc-4600	247	3	dev	dev	PROPN
dpc-4600	247	4	biol	biol	NOUN
dpc-4600	247	5	.	.	PUNCT
dpc-4600	248	1	2023;11:1293101	2023;11:1293101	NUM
dpc-4600	248	2	.	.	PUNCT
dpc-4600	249	1	doi	doi	NOUN
dpc-4600	249	2	:	:	PUNCT
dpc-4600	249	3	10.3389	10.3389	NUM
dpc-4600	249	4	/fcell.2023.1293101	/fcell.2023.1293101	NOUN
dpc-4600	249	5	.	.	PUNCT
dpc-4600	250	1	pmid	pmid	NOUN
dpc-4600	250	2	:	:	PUNCT
dpc-4600	250	3	38178870	38178870	NUM
dpc-4600	250	4	.	.	PUNCT
dpc-4600	251	1	16	16	NUM
dpc-4600	251	2	.	.	PUNCT
dpc-4600	252	1	roy	roy	PROPN
dpc-4600	252	2	t	t	PROPN
dpc-4600	252	3	,	,	PUNCT
dpc-4600	252	4	boateng	boateng	PROPN
dpc-4600	252	5	st	st	PROPN
dpc-4600	252	6	,	,	PUNCT
dpc-4600	252	7	uddin	uddin	PROPN
dpc-4600	252	8	mb	mb	NOUN
dpc-4600	252	9	,	,	PUNCT
dpc-4600	252	10	et	et	PROPN
dpc-4600	252	11	al	al	PROPN
dpc-4600	252	12	.	.	PUNCT
dpc-4600	253	1	the	the	DET
dpc-4600	253	2	pi3k	pi3k	PROPN
dpc-4600	253	3	-	-	PUNCT
dpc-4600	253	4	akt	akt	PROPN
dpc-4600	253	5	-	-	PUNCT
dpc-4600	253	6	mtor	mtor	PROPN
dpc-4600	253	7	and	and	CCONJ
dpc-4600	253	8	associated	associate	VERB
dpc-4600	253	9	signaling	signal	VERB
dpc-4600	253	10	pathways	pathway	NOUN
dpc-4600	253	11	as	as	ADP
dpc-4600	253	12	molecular	molecular	ADJ
dpc-4600	253	13	drivers	driver	NOUN
dpc-4600	253	14	of	of	ADP
dpc-4600	253	15	immune	immune	NOUN
dpc-4600	253	16	-	-	PUNCT
dpc-4600	253	17	mediated	mediate	VERB
dpc-4600	253	18	inflammatory	inflammatory	ADJ
dpc-4600	253	19	skin	skin	NOUN
dpc-4600	253	20	diseases	disease	NOUN
dpc-4600	253	21	:	:	PUNCT
dpc-4600	253	22	update	update	NOUN
dpc-4600	253	23	on	on	ADP
dpc-4600	253	24	therapeutic	therapeutic	ADJ
dpc-4600	253	25	strategy	strategy	NOUN
dpc-4600	253	26	using	use	VERB
dpc-4600	253	27	natural	natural	ADJ
dpc-4600	253	28	and	and	CCONJ
dpc-4600	253	29	synthetic	synthetic	ADJ
dpc-4600	253	30	compounds	compound	NOUN
dpc-4600	253	31	.	.	PUNCT
dpc-4600	254	1	cells	cell	NOUN
dpc-4600	254	2	.	.	PUNCT
dpc-4600	255	1	2023;12(12):1671	2023;12(12):1671	X
dpc-4600	255	2	.	.	X
dpc-4600	255	3	doi	doi	NOUN
dpc-4600	255	4	:	:	PUNCT
dpc-4600	255	5	10.3390	10.3390	NUM
dpc-4600	255	6	/	/	SYM
dpc-4600	255	7	cells12121671	cells12121671	PROPN
dpc-4600	255	8	.	.	PUNCT
dpc-4600	256	1	pmid	pmid	NOUN
dpc-4600	256	2	:	:	PUNCT
dpc-4600	256	3	37371141	37371141	NUM
dpc-4600	256	4	.	.	PUNCT
dpc-4600	257	1	17	17	NUM
dpc-4600	257	2	.	.	PUNCT
dpc-4600	258	1	al	al	PROPN
dpc-4600	258	2	abadie	abadie	PROPN
dpc-4600	258	3	ms	ms	PROPN
dpc-4600	258	4	,	,	PUNCT
dpc-4600	258	5	gawkrodger	gawkrodger	NOUN
dpc-4600	258	6	dj	dj	PROPN
dpc-4600	258	7	.	.	PUNCT
dpc-4600	258	8	integrating	integrate	VERB
dpc-4600	258	9	neuronal	neuronal	ADJ
dpc-4600	258	10	involvement	involvement	NOUN
dpc-4600	258	11	into	into	ADP
dpc-4600	258	12	the	the	DET
dpc-4600	258	13	immune	immune	ADJ
dpc-4600	258	14	and	and	CCONJ
dpc-4600	258	15	genetic	genetic	ADJ
dpc-4600	258	16	paradigm	paradigm	NOUN
dpc-4600	258	17	of	of	ADP
dpc-4600	258	18	vitiligo	vitiligo	PROPN
dpc-4600	258	19	.	.	PUNCT
dpc-4600	259	1	clin	clin	PROPN
dpc-4600	259	2	exp	exp	NOUN
dpc-4600	259	3	dermatol	dermatol	NOUN
dpc-4600	259	4	.	.	PUNCT
dpc-4600	260	1	2021;46(4):646	2021;46(4):646	NUM
dpc-4600	260	2	-	-	SYM
dpc-4600	260	3	650	650	NUM
dpc-4600	260	4	.	.	PUNCT
dpc-4600	261	1	doi	doi	NOUN
dpc-4600	261	2	:	:	PUNCT
dpc-4600	261	3	10.1111	10.1111	NUM
dpc-4600	261	4	/	/	SYM
dpc-4600	261	5	ced.14490	ced.14490	NUM
dpc-4600	261	6	.	.	PUNCT
dpc-4600	262	1	pmid	pmid	NOUN
dpc-4600	262	2	:	:	PUNCT
dpc-4600	262	3	33098692	33098692	NUM
dpc-4600	262	4	.	.	PUNCT
dpc-4600	263	1	18	18	NUM
dpc-4600	263	2	.	.	PUNCT
dpc-4600	264	1	nada	nada	PROPN
dpc-4600	264	2	hr	hr	PROPN
dpc-4600	264	3	,	,	PUNCT
dpc-4600	264	4	el	el	PROPN
dpc-4600	264	5	sharkawy	sharkawy	PROPN
dpc-4600	264	6	da	da	PROPN
dpc-4600	264	7	,	,	PUNCT
dpc-4600	264	8	elmasry	elmasry	PROPN
dpc-4600	264	9	mf	mf	NOUN
dpc-4600	264	10	,	,	PUNCT
dpc-4600	264	11	rashed	rashe	VERB
dpc-4600	264	12	la	la	PROPN
dpc-4600	264	13	,	,	PUNCT
dpc-4600	264	14	mamdouh	mamdouh	NOUN
dpc-4600	264	15	s.	s.	PROPN
dpc-4600	264	16	expression	expression	NOUN
dpc-4600	264	17	of	of	ADP
dpc-4600	264	18	janus	janus	PROPN
dpc-4600	264	19	kinase	kinase	PROPN
dpc-4600	264	20	1	1	NUM
dpc-4600	264	21	in	in	ADP
dpc-4600	264	22	vitiligo	vitiligo	NOUN
dpc-4600	264	23	&	&	CCONJ
dpc-4600	264	24	psoriasis	psoriasis	NOUN
dpc-4600	264	25	before	before	ADV
dpc-4600	264	26	and	and	CCONJ
dpc-4600	264	27	after	after	ADP
dpc-4600	264	28	narrow	narrow	ADJ
dpc-4600	264	29	band	band	NOUN
dpc-4600	264	30	uvb	uvb	ADJ
dpc-4600	264	31	:	:	PUNCT
dpc-4600	264	32	a	a	DET
dpc-4600	264	33	case	case	NOUN
dpc-4600	264	34	-	-	PUNCT
dpc-4600	264	35	control	control	NOUN
dpc-4600	264	36	study	study	NOUN
dpc-4600	264	37	.	.	PUNCT
dpc-4600	265	1	arch	arch	ADJ
dpc-4600	265	2	dermatol	dermatol	NOUN
dpc-4600	265	3	res	re	NOUN
dpc-4600	265	4	.	.	PUNCT
dpc-4600	265	5	2018;310(1):39	2018;310(1):39	NUM
dpc-4600	265	6	-	-	SYM
dpc-4600	265	7	46	46	NUM
dpc-4600	265	8	.	.	PUNCT
dpc-4600	266	1	doi	doi	NOUN
dpc-4600	266	2	:	:	PUNCT
dpc-4600	266	3	10.1007	10.1007	NUM
dpc-4600	266	4	/	/	SYM
dpc-4600	266	5	s00403	s00403	NOUN
dpc-4600	266	6	-	-	PUNCT
dpc-4600	266	7	017	017	NUM
dpc-4600	266	8	-	-	PUNCT
dpc-4600	266	9	1792	1792	NUM
dpc-4600	266	10	-	-	SYM
dpc-4600	266	11	6	6	NUM
dpc-4600	266	12	.	.	PUNCT
dpc-4600	267	1	pmid	pmid	NOUN
dpc-4600	267	2	:	:	PUNCT
dpc-4600	267	3	29127481	29127481	NUM
dpc-4600	267	4	.	.	PUNCT
dpc-4600	268	1	19	19	NUM
dpc-4600	268	2	.	.	PUNCT
dpc-4600	269	1	cunningham	cunningham	PROPN
dpc-4600	269	2	kn	kn	PROPN
dpc-4600	269	3	,	,	PUNCT
dpc-4600	269	4	rosmarin	rosmarin	PROPN
dpc-4600	269	5	d.	d.	PROPN
dpc-4600	269	6	vitiligo	vitiligo	PROPN
dpc-4600	269	7	treatments	treatment	NOUN
dpc-4600	269	8	:	:	PUNCT
dpc-4600	269	9	review	review	NOUN
dpc-4600	269	10	of	of	ADP
dpc-4600	269	11	current	current	ADJ
dpc-4600	269	12	therapeutic	therapeutic	ADJ
dpc-4600	269	13	modalities	modality	NOUN
dpc-4600	269	14	and	and	CCONJ
dpc-4600	269	15	jak	jak	PROPN
dpc-4600	269	16	inhibitors	inhibitor	NOUN
dpc-4600	269	17	.	.	PUNCT
dpc-4600	270	1	am	be	AUX
dpc-4600	270	2	j	j	PROPN
dpc-4600	270	3	clin	clin	PROPN
dpc-4600	270	4	dermatol	dermatol	NOUN
dpc-4600	270	5	.	.	PUNCT
dpc-4600	271	1	2023;24(2):165	2023;24(2):165	NUM
dpc-4600	271	2	-	-	SYM
dpc-4600	271	3	186	186	NUM
dpc-4600	271	4	.	.	PUNCT
dpc-4600	272	1	doi	doi	NOUN
dpc-4600	272	2	:	:	PUNCT
dpc-4600	272	3	10.1007	10.1007	NUM
dpc-4600	272	4	/	/	SYM
dpc-4600	272	5	s40257	s40257	NOUN
dpc-4600	272	6	-	-	PUNCT
dpc-4600	272	7	02200752	02200752	NUM
dpc-4600	272	8	-	-	SYM
dpc-4600	272	9	6	6	NUM
dpc-4600	272	10	.	.	PUNCT
dpc-4600	273	1	pmid	pmid	NOUN
dpc-4600	273	2	:	:	PUNCT
dpc-4600	273	3	36715849	36715849	NUM
dpc-4600	273	4	.	.	PUNCT
dpc-4600	274	1	20	20	NUM
dpc-4600	274	2	.	.	PUNCT
dpc-4600	275	1	hamzavi	hamzavi	PROPN
dpc-4600	275	2	i	i	PRON
dpc-4600	275	3	,	,	PUNCT
dpc-4600	275	4	rosmarin	rosmarin	PROPN
dpc-4600	275	5	d	d	PROPN
dpc-4600	275	6	,	,	PUNCT
dpc-4600	275	7	harris	harris	PROPN
dpc-4600	275	8	je	je	PROPN
dpc-4600	275	9	,	,	PUNCT
dpc-4600	275	10	et	et	PROPN
dpc-4600	275	11	al	al	PROPN
dpc-4600	275	12	.	.	PROPN
dpc-4600	275	13	efficacy	efficacy	PROPN
dpc-4600	275	14	of	of	ADP
dpc-4600	275	15	ruxolitinib	ruxolitinib	PROPN
dpc-4600	275	16	cream	cream	NOUN
dpc-4600	275	17	in	in	ADP
dpc-4600	275	18	vitiligo	vitiligo	NOUN
dpc-4600	275	19	by	by	ADP
dpc-4600	275	20	patient	patient	ADJ
dpc-4600	275	21	characteristics	characteristic	NOUN
dpc-4600	275	22	and	and	CCONJ
dpc-4600	275	23	affected	affect	VERB
dpc-4600	275	24	body	body	NOUN
dpc-4600	275	25	areas	area	NOUN
dpc-4600	275	26	:	:	PUNCT
dpc-4600	275	27	descriptive	descriptive	ADJ
dpc-4600	275	28	subgroup	subgroup	NOUN
dpc-4600	275	29	analyses	analyse	VERB
dpc-4600	275	30	from	from	ADP
dpc-4600	275	31	a	a	DET
dpc-4600	275	32	phase	phase	NOUN
dpc-4600	275	33	2	2	NUM
dpc-4600	275	34	,	,	PUNCT
dpc-4600	275	35	randomized	randomize	VERB
dpc-4600	275	36	,	,	PUNCT
dpc-4600	275	37	double	double	ADJ
dpc-4600	275	38	-	-	PUNCT
dpc-4600	275	39	blind	blind	ADJ
dpc-4600	275	40	trial	trial	NOUN
dpc-4600	275	41	.	.	PUNCT
dpc-4600	276	1	j	j	PROPN
dpc-4600	276	2	am	be	AUX
dpc-4600	276	3	acad	acad	ADJ
dpc-4600	276	4	dermatol	dermatol	NOUN
dpc-4600	276	5	.	.	PUNCT
dpc-4600	277	1	2022;86(6):1398	2022;86(6):1398	PROPN
dpc-4600	277	2	-	-	PUNCT
dpc-4600	277	3	1401	1401	NUM
dpc-4600	277	4	.	.	PUNCT
dpc-4600	278	1	doi	doi	NOUN
dpc-4600	278	2	:	:	PUNCT
dpc-4600	278	3	10.1016	10.1016	NUM
dpc-4600	278	4	/	/	SYM
dpc-4600	278	5	j.jaad.2021.05.047	j.jaad.2021.05.047	PROPN
dpc-4600	278	6	.	.	PUNCT
dpc-4600	279	1	pmid	pmid	NOUN
dpc-4600	279	2	:	:	PUNCT
dpc-4600	279	3	34089797	34089797	NUM
dpc-4600	279	4	.	.	PUNCT
dpc-4600	280	1	21	21	NUM
dpc-4600	280	2	.	.	PUNCT
dpc-4600	281	1	tavoletti	tavoletti	PROPN
dpc-4600	281	2	g	g	PROPN
dpc-4600	281	3	,	,	PUNCT
dpc-4600	281	4	avallone	avallone	NOUN
dpc-4600	281	5	g	g	PROPN
dpc-4600	281	6	,	,	PUNCT
dpc-4600	281	7	conforti	conforti	PROPN
dpc-4600	281	8	c	c	PROPN
dpc-4600	281	9	,	,	PUNCT
dpc-4600	281	10	et	et	PROPN
dpc-4600	281	11	al	al	PROPN
dpc-4600	281	12	.	.	PUNCT
dpc-4600	281	13	topical	topical	ADJ
dpc-4600	281	14	ruxolitinib	ruxolitinib	NOUN
dpc-4600	281	15	:	:	PUNCT
dpc-4600	281	16	a	a	DET
dpc-4600	281	17	new	new	ADJ
dpc-4600	281	18	treatment	treatment	NOUN
dpc-4600	281	19	for	for	ADP
dpc-4600	281	20	vitiligo	vitiligo	NOUN
dpc-4600	281	21	.	.	PUNCT
dpc-4600	282	1	j	j	PROPN
dpc-4600	282	2	eur	eur	PROPN
dpc-4600	282	3	acad	acad	PROPN
dpc-4600	282	4	dermatol	dermatol	NOUN
dpc-4600	282	5	venereol	venereol	NOUN
dpc-4600	282	6	.	.	PUNCT
dpc-4600	283	1	2023	2023	NUM
dpc-4600	283	2	nov;37(11):2222	nov;37(11):2222	NOUN
dpc-4600	283	3	-	-	SYM
dpc-4600	283	4	2230	2230	NUM
dpc-4600	283	5	.	.	PUNCT
dpc-4600	284	1	doi	doi	NOUN
dpc-4600	284	2	:	:	PUNCT
dpc-4600	284	3	10.1111	10.1111	NUM
dpc-4600	284	4	/	/	SYM
dpc-4600	284	5	jdv.19162	jdv.19162	NOUN
dpc-4600	284	6	.	.	PUNCT
dpc-4600	285	1	pmid	pmid	NOUN
dpc-4600	285	2	:	:	PUNCT
dpc-4600	285	3	37147856	37147856	NUM
dpc-4600	285	4	.	.	PUNCT
dpc-4600	286	1	22	22	NUM
dpc-4600	286	2	.	.	PUNCT
dpc-4600	287	1	feng	feng	PROPN
dpc-4600	287	2	y	y	PROPN
dpc-4600	287	3	,	,	PUNCT
dpc-4600	287	4	lu	lu	PROPN
dpc-4600	287	5	y.	y.	PROPN
dpc-4600	287	6	advances	advance	VERB
dpc-4600	287	7	in	in	ADP
dpc-4600	287	8	vitiligo	vitiligo	NOUN
dpc-4600	287	9	:	:	PUNCT
dpc-4600	287	10	update	update	NOUN
dpc-4600	287	11	on	on	ADP
dpc-4600	287	12	therapeutic	therapeutic	ADJ
dpc-4600	287	13	targets	target	NOUN
dpc-4600	287	14	.	.	PUNCT
dpc-4600	288	1	front	front	ADJ
dpc-4600	288	2	immunol	immunol	NOUN
dpc-4600	288	3	.	.	PUNCT
dpc-4600	289	1	2022;13:986918	2022;13:986918	X
dpc-4600	289	2	.	.	PUNCT
dpc-4600	289	3	doi	doi	NOUN
dpc-4600	289	4	:	:	PUNCT
dpc-4600	289	5	10.3389	10.3389	NUM
dpc-4600	289	6	/	/	SYM
dpc-4600	289	7	fimmu	fimmu	ADJ
dpc-4600	289	8	.2022.986918	.2022.986918	PROPN
dpc-4600	289	9	.	.	PUNCT
dpc-4600	290	1	pmid	pmid	NOUN
dpc-4600	290	2	:	:	PUNCT
dpc-4600	290	3	36119071	36119071	NUM
dpc-4600	290	4	.	.	PUNCT
dpc-4600	291	1	23	23	NUM
dpc-4600	291	2	.	.	PUNCT
dpc-4600	291	3	radi	radi	NOUN
dpc-4600	291	4	g	g	PROPN
dpc-4600	291	5	,	,	PUNCT
dpc-4600	291	6	simonetti	simonetti	NOUN
dpc-4600	291	7	o	o	NOUN
dpc-4600	291	8	,	,	PUNCT
dpc-4600	291	9	rizzetto	rizzetto	NOUN
dpc-4600	291	10	g	g	PROPN
dpc-4600	291	11	,	,	PUNCT
dpc-4600	291	12	diotallevi	diotallevi	ADJ
dpc-4600	291	13	f	f	PROPN
dpc-4600	291	14	,	,	PUNCT
dpc-4600	291	15	molinelli	molinelli	NOUN
dpc-4600	291	16	e	e	NOUN
dpc-4600	291	17	,	,	PUNCT
dpc-4600	291	18	offidani	offidani	ADJ
dpc-4600	291	19	a.	a.	NOUN
dpc-4600	291	20	baricitinib	baricitinib	PROPN
dpc-4600	291	21	:	:	PUNCT
dpc-4600	291	22	the	the	DET
dpc-4600	291	23	first	first	PROPN
dpc-4600	291	24	jak	jak	PROPN
dpc-4600	291	25	inhibitor	inhibitor	NOUN
dpc-4600	291	26	approved	approve	VERB
dpc-4600	291	27	in	in	ADP
dpc-4600	291	28	europe	europe	PROPN
dpc-4600	291	29	for	for	ADP
dpc-4600	291	30	the	the	DET
dpc-4600	291	31	treatment	treatment	NOUN
dpc-4600	291	32	of	of	ADP
dpc-4600	291	33	moderate	moderate	ADJ
dpc-4600	291	34	to	to	ADP
dpc-4600	291	35	severe	severe	ADJ
dpc-4600	291	36	atopic	atopic	NOUN
dpc-4600	291	37	dermatitis	dermatitis	NOUN
dpc-4600	291	38	in	in	ADP
dpc-4600	291	39	adult	adult	NOUN
dpc-4600	291	40	patients	patient	NOUN
dpc-4600	291	41	.	.	PUNCT
dpc-4600	292	1	healthcare	healthcare	NOUN
dpc-4600	292	2	(	(	PUNCT
dpc-4600	292	3	basel	basel	PROPN
dpc-4600	292	4	)	)	PUNCT
dpc-4600	292	5	.	.	PUNCT
dpc-4600	293	1	2021;9(11):1575	2021;9(11):1575	X
dpc-4600	293	2	.	.	PUNCT
dpc-4600	294	1	doi	doi	NOUN
dpc-4600	294	2	:	:	PUNCT
dpc-4600	294	3	10.3390	10.3390	NUM
dpc-4600	294	4	/	/	SYM
dpc-4600	294	5	healthcare9111575	healthcare9111575	PROPN
dpc-4600	294	6	.	.	PUNCT
dpc-4600	295	1	pmid	pmid	NOUN
dpc-4600	295	2	:	:	PUNCT
dpc-4600	295	3	34828623	34828623	NUM
dpc-4600	295	4	.	.	PUNCT
dpc-4600	296	1	24	24	NUM
dpc-4600	296	2	.	.	PUNCT
dpc-4600	297	1	dong	dong	PROPN
dpc-4600	297	2	j	j	PROPN
dpc-4600	297	3	,	,	PUNCT
dpc-4600	297	4	huang	huang	PROPN
dpc-4600	297	5	x	x	PROPN
dpc-4600	297	6	,	,	PUNCT
dpc-4600	297	7	ma	ma	PROPN
dpc-4600	297	8	lp	lp	PROPN
dpc-4600	297	9	,	,	PUNCT
dpc-4600	297	10	et	et	PROPN
dpc-4600	297	11	al	al	PROPN
dpc-4600	297	12	.	.	PROPN
dpc-4600	297	13	baricitinib	baricitinib	NOUN
dpc-4600	297	14	is	be	AUX
dpc-4600	297	15	effective	effective	ADJ
dpc-4600	297	16	in	in	ADP
dpc-4600	297	17	treating	treat	VERB
dpc-4600	297	18	progressing	progress	VERB
dpc-4600	297	19	vitiligo	vitiligo	NOUN
dpc-4600	297	20	in	in	ADP
dpc-4600	297	21	vivo	vivo	NOUN
dpc-4600	297	22	and	and	CCONJ
dpc-4600	297	23	in	in	ADP
dpc-4600	297	24	vitro	vitro	X
dpc-4600	297	25	.	.	PUNCT
dpc-4600	298	1	dose	dose	NOUN
dpc-4600	298	2	response	response	NOUN
dpc-4600	298	3	.	.	PUNCT
dpc-4600	299	1	2022;20(2):15593258221105370	2022;20(2):15593258221105370	X
dpc-4600	299	2	.	.	PUNCT
dpc-4600	300	1	doi	doi	NOUN
dpc-4600	300	2	:	:	PUNCT
dpc-4600	300	3	10.1177/155932582211	10.1177/155932582211	NUM
dpc-4600	300	4	05370	05370	NUM
dpc-4600	300	5	.	.	PUNCT
dpc-4600	301	1	pmid	pmid	NOUN
dpc-4600	301	2	:	:	PUNCT
dpc-4600	301	3	35663493	35663493	NUM
dpc-4600	301	4	.	.	PUNCT
dpc-4600	302	1	25	25	NUM
dpc-4600	302	2	.	.	PUNCT
dpc-4600	302	3	ezzedine	ezzedine	PROPN
dpc-4600	302	4	k	k	PROPN
dpc-4600	302	5	,	,	PUNCT
dpc-4600	302	6	peeva	peeva	PROPN
dpc-4600	302	7	e	e	PROPN
dpc-4600	302	8	,	,	PUNCT
dpc-4600	302	9	yamaguchi	yamaguchi	PROPN
dpc-4600	302	10	y	y	PROPN
dpc-4600	302	11	,	,	PUNCT
dpc-4600	302	12	et	et	PROPN
dpc-4600	302	13	al	al	PROPN
dpc-4600	302	14	.	.	PROPN
dpc-4600	302	15	efficacy	efficacy	NOUN
dpc-4600	302	16	and	and	CCONJ
dpc-4600	302	17	safety	safety	NOUN
dpc-4600	302	18	of	of	ADP
dpc-4600	302	19	oral	oral	ADJ
dpc-4600	302	20	ritlecitinib	ritlecitinib	NOUN
dpc-4600	302	21	for	for	ADP
dpc-4600	302	22	the	the	DET
dpc-4600	302	23	treatment	treatment	NOUN
dpc-4600	302	24	of	of	ADP
dpc-4600	302	25	active	active	ADJ
dpc-4600	302	26	nonsegmental	nonsegmental	NOUN
dpc-4600	302	27	vitiligo	vitiligo	NOUN
dpc-4600	302	28	:	:	PUNCT
dpc-4600	302	29	conclusion	conclusion	NOUN
dpc-4600	302	30	vitiligo	vitiligo	NOUN
dpc-4600	302	31	is	be	AUX
dpc-4600	302	32	a	a	DET
dpc-4600	302	33	debilitating	debilitate	VERB
dpc-4600	302	34	disease	disease	NOUN
dpc-4600	302	35	that	that	PRON
dpc-4600	302	36	affects	affect	VERB
dpc-4600	302	37	an	an	DET
dpc-4600	302	38	individual	individual	NOUN
dpc-4600	302	39	’s	’s	PART
dpc-4600	302	40	health	health	NOUN
dpc-4600	302	41	,	,	PUNCT
dpc-4600	302	42	psychosocial	psychosocial	ADJ
dpc-4600	302	43	well	well	ADV
dpc-4600	302	44	-	-	PUNCT
dpc-4600	302	45	being	being	NOUN
dpc-4600	302	46	,	,	PUNCT
dpc-4600	302	47	and	and	CCONJ
dpc-4600	302	48	quality	quality	NOUN
dpc-4600	302	49	of	of	ADP
dpc-4600	302	50	life	life	NOUN
dpc-4600	302	51	.	.	PUNCT
dpc-4600	303	1	since	since	SCONJ
dpc-4600	303	2	the	the	DET
dpc-4600	303	3	pathogenesis	pathogenesis	NOUN
dpc-4600	303	4	of	of	ADP
dpc-4600	303	5	vitiligo	vitiligo	NOUN
dpc-4600	303	6	is	be	AUX
dpc-4600	303	7	complex	complex	ADJ
dpc-4600	303	8	,	,	PUNCT
dpc-4600	303	9	with	with	ADP
dpc-4600	303	10	multiple	multiple	ADJ
dpc-4600	303	11	pathways	pathway	NOUN
dpc-4600	303	12	that	that	PRON
dpc-4600	303	13	are	be	AUX
dpc-4600	303	14	intricately	intricately	ADV
dpc-4600	303	15	involved	involve	VERB
dpc-4600	303	16	,	,	PUNCT
dpc-4600	303	17	using	use	VERB
dpc-4600	303	18	combination	combination	NOUN
dpc-4600	303	19	therapies	therapy	NOUN
dpc-4600	303	20	for	for	ADP
dpc-4600	303	21	its	its	PRON
dpc-4600	303	22	treatment	treatment	NOUN
dpc-4600	303	23	rather	rather	ADV
dpc-4600	303	24	than	than	ADP
dpc-4600	303	25	targeting	target	VERB
dpc-4600	303	26	a	a	DET
dpc-4600	303	27	single	single	ADJ
dpc-4600	303	28	pathway	pathway	NOUN
dpc-4600	303	29	can	can	AUX
dpc-4600	303	30	be	be	AUX
dpc-4600	303	31	suggested	suggest	VERB
dpc-4600	303	32	.	.	PUNCT
dpc-4600	304	1	use	use	NOUN
dpc-4600	304	2	of	of	ADP
dpc-4600	304	3	biologicals	biological	NOUN
dpc-4600	304	4	along	along	ADP
dpc-4600	304	5	with	with	ADP
dpc-4600	304	6	other	other	ADJ
dpc-4600	304	7	novel	novel	ADJ
dpc-4600	304	8	drugs	drug	NOUN
dpc-4600	304	9	may	may	AUX
dpc-4600	304	10	prove	prove	VERB
dpc-4600	304	11	beneficial	beneficial	ADJ
dpc-4600	304	12	to	to	PART
dpc-4600	304	13	target	target	VERB
dpc-4600	304	14	the	the	DET
dpc-4600	304	15	complex	complex	ADJ
dpc-4600	304	16	cytokine	cytokine	NOUN
dpc-4600	304	17	network	network	NOUN
dpc-4600	304	18	involved	involve	VERB
dpc-4600	304	19	in	in	ADP
dpc-4600	304	20	this	this	DET
dpc-4600	304	21	disease	disease	NOUN
dpc-4600	304	22	.	.	PUNCT
dpc-4600	305	1	in	in	ADP
dpc-4600	305	2	the	the	DET
dpc-4600	305	3	pursuit	pursuit	NOUN
dpc-4600	305	4	of	of	ADP
dpc-4600	305	5	conquering	conquer	VERB
dpc-4600	305	6	vitiligo	vitiligo	NOUN
dpc-4600	305	7	,	,	PUNCT
dpc-4600	305	8	understanding	understand	VERB
dpc-4600	305	9	it	it	PRON
dpc-4600	305	10	at	at	ADP
dpc-4600	305	11	a	a	DET
dpc-4600	305	12	molecular	molecular	ADJ
dpc-4600	305	13	,	,	PUNCT
dpc-4600	305	14	cellular	cellular	ADJ
dpc-4600	305	15	,	,	PUNCT
dpc-4600	305	16	and	and	CCONJ
dpc-4600	305	17	systemic	systemic	ADJ
dpc-4600	305	18	level	level	NOUN
dpc-4600	305	19	is	be	AUX
dpc-4600	305	20	crucial	crucial	ADJ
dpc-4600	305	21	to	to	ADP
dpc-4600	305	22	developing	develop	VERB
dpc-4600	305	23	effective	effective	ADJ
dpc-4600	305	24	therapeutic	therapeutic	ADJ
dpc-4600	305	25	strategies	strategy	NOUN
dpc-4600	305	26	.	.	PUNCT
dpc-4600	306	1	references	reference	NOUN
dpc-4600	306	2	1	1	NUM
dpc-4600	306	3	.	.	PUNCT
dpc-4600	307	1	gandhi	gandhi	PROPN
dpc-4600	307	2	k	k	PROPN
dpc-4600	307	3	,	,	PUNCT
dpc-4600	307	4	ezzedine	ezzedine	PROPN
dpc-4600	307	5	k	k	NOUN
dpc-4600	307	6	,	,	PUNCT
dpc-4600	307	7	anastassopoulos	anastassopoulo	NOUN
dpc-4600	307	8	kp	kp	PROPN
dpc-4600	307	9	,	,	PUNCT
dpc-4600	307	10	et	et	PROPN
dpc-4600	307	11	al	al	PROPN
dpc-4600	307	12	.	.	PUNCT
dpc-4600	308	1	prevalence	prevalence	NOUN
dpc-4600	308	2	of	of	ADP
dpc-4600	308	3	vitiligo	vitiligo	NOUN
dpc-4600	308	4	among	among	ADP
dpc-4600	308	5	adults	adult	NOUN
dpc-4600	308	6	in	in	ADP
dpc-4600	308	7	the	the	DET
dpc-4600	308	8	united	united	PROPN
dpc-4600	308	9	states	states	PROPN
dpc-4600	308	10	.	.	PUNCT
dpc-4600	309	1	jama	jama	PROPN
dpc-4600	309	2	dermatol	dermatol	NOUN
dpc-4600	309	3	.	.	PUNCT
dpc-4600	310	1	2022	2022	NUM
dpc-4600	310	2	;	;	PUNCT
dpc-4600	310	3	158(1):43	158(1):43	NUM
dpc-4600	310	4	-	-	SYM
dpc-4600	310	5	50	50	NUM
dpc-4600	310	6	.	.	PUNCT
dpc-4600	311	1	doi	doi	NOUN
dpc-4600	311	2	:	:	PUNCT
dpc-4600	311	3	10.1001	10.1001	NUM
dpc-4600	311	4	/	/	SYM
dpc-4600	311	5	jamadermatol.2021.4724	jamadermatol.2021.4724	NOUN
dpc-4600	311	6	.	.	PUNCT
dpc-4600	312	1	pmid	pmid	NOUN
dpc-4600	312	2	:	:	PUNCT
dpc-4600	312	3	34787670	34787670	NUM
dpc-4600	312	4	2	2	NUM
dpc-4600	312	5	.	.	PUNCT
dpc-4600	312	6	iwanowski	iwanowski	PROPN
dpc-4600	312	7	t	t	PROPN
dpc-4600	312	8	,	,	PUNCT
dpc-4600	312	9	szlązak	szlązak	NOUN
dpc-4600	312	10	p	p	NOUN
dpc-4600	312	11	,	,	PUNCT
dpc-4600	312	12	zabłotna	zabłotna	PROPN
dpc-4600	312	13	m	m	PROPN
dpc-4600	312	14	,	,	PUNCT
dpc-4600	312	15	olszewska	olszewska	PROPN
dpc-4600	312	16	b	b	NUM
dpc-4600	312	17	,	,	PUNCT
dpc-4600	312	18	sokołowska	sokołowska	ADJ
dpc-4600	312	19	wojdyło	wojdyło	NOUN
dpc-4600	312	20	m.	m.	PROPN
dpc-4600	312	21	translation	translation	PROPN
dpc-4600	312	22	,	,	PUNCT
dpc-4600	312	23	cross	cross	ADJ
dpc-4600	312	24	-	-	ADJ
dpc-4600	312	25	cultural	cultural	ADJ
dpc-4600	312	26	adaptation	adaptation	NOUN
dpc-4600	312	27	and	and	CCONJ
dpc-4600	312	28	validation	validation	NOUN
dpc-4600	312	29	of	of	ADP
dpc-4600	312	30	the	the	DET
dpc-4600	312	31	vitiligo	vitiligo	NOUN
dpc-4600	312	32	-	-	PUNCT
dpc-4600	312	33	specific	specific	ADJ
dpc-4600	312	34	health	health	NOUN
dpc-4600	312	35	-	-	PUNCT
dpc-4600	312	36	related	relate	VERB
dpc-4600	312	37	quality	quality	NOUN
dpc-4600	312	38	of	of	ADP
dpc-4600	312	39	life	life	NOUN
dpc-4600	312	40	instrument	instrument	NOUN
dpc-4600	312	41	(	(	PUNCT
dpc-4600	312	42	vitiqol	vitiqol	NOUN
dpc-4600	312	43	)	)	PUNCT
dpc-4600	312	44	into	into	ADP
dpc-4600	312	45	polish	polish	PROPN
dpc-4600	312	46	.	.	PUNCT
dpc-4600	313	1	postepy	postepy	PROPN
dpc-4600	313	2	dermatol	dermatol	NOUN
dpc-4600	313	3	alergol	alergol	NOUN
dpc-4600	313	4	.	.	PUNCT
dpc-4600	314	1	2021;38(4	2021;38(4	NUM
dpc-4600	314	2	):	):	PUNCT
dpc-4600	314	3	636	636	NUM
dpc-4600	314	4	-	-	SYM
dpc-4600	314	5	643	643	NUM
dpc-4600	314	6	.	.	PUNCT
dpc-4600	315	1	doi	doi	NOUN
dpc-4600	315	2	:	:	PUNCT
dpc-4600	315	3	10.5114	10.5114	NUM
dpc-4600	315	4	/	/	SYM
dpc-4600	315	5	ada.2021.108896	ada.2021.108896	PROPN
dpc-4600	315	6	.	.	PUNCT
dpc-4600	316	1	pmid	pmid	PROPN
dpc-4600	316	2	:	:	PUNCT
dpc-4600	316	3	34658707	34658707	NUM
dpc-4600	316	4	3	3	NUM
dpc-4600	316	5	.	.	PUNCT
dpc-4600	316	6	ezzedine	ezzedine	PROPN
dpc-4600	317	1	k	k	PROPN
dpc-4600	317	2	,	,	PUNCT
dpc-4600	317	3	lim	lim	PROPN
dpc-4600	317	4	hw	hw	PROPN
dpc-4600	317	5	,	,	PUNCT
dpc-4600	317	6	suzuki	suzuki	PROPN
dpc-4600	317	7	t	t	PROPN
dpc-4600	317	8	,	,	PUNCT
dpc-4600	317	9	et	et	PROPN
dpc-4600	317	10	al	al	PROPN
dpc-4600	317	11	.	.	PROPN
dpc-4600	318	1	vitiligo	vitiligo	PROPN
dpc-4600	318	2	global	global	ADJ
dpc-4600	318	3	issue	issue	NOUN
dpc-4600	318	4	consensus	consensus	NOUN
dpc-4600	318	5	conference	conference	NOUN
dpc-4600	318	6	panelists	panelist	NOUN
dpc-4600	318	7	.	.	PUNCT
dpc-4600	319	1	revised	revise	VERB
dpc-4600	319	2	classification	classification	NOUN
dpc-4600	319	3	/	/	SYM
dpc-4600	319	4	nomenclature	nomenclature	NOUN
dpc-4600	319	5	of	of	ADP
dpc-4600	319	6	vitiligo	vitiligo	ADJ
dpc-4600	319	7	and	and	CCONJ
dpc-4600	319	8	related	related	ADJ
dpc-4600	319	9	issues	issue	NOUN
dpc-4600	319	10	:	:	PUNCT
dpc-4600	319	11	the	the	DET
dpc-4600	319	12	vitiligo	vitiligo	ADJ
dpc-4600	319	13	global	global	ADJ
dpc-4600	319	14	issues	issue	NOUN
dpc-4600	319	15	consensus	consensus	NOUN
dpc-4600	319	16	conference	conference	NOUN
dpc-4600	319	17	.	.	PUNCT
dpc-4600	320	1	pigment	pigment	ADJ
dpc-4600	320	2	cell	cell	NOUN
dpc-4600	320	3	melanoma	melanoma	NOUN
dpc-4600	320	4	res	re	NOUN
dpc-4600	320	5	.	.	PUNCT
dpc-4600	321	1	2012;25(3):e1	2012;25(3):e1	NUM
dpc-4600	321	2	-	-	SYM
dpc-4600	321	3	13	13	NUM
dpc-4600	321	4	.	.	PUNCT
dpc-4600	322	1	doi	doi	NOUN
dpc-4600	322	2	:	:	PUNCT
dpc-4600	322	3	10.1111	10.1111	NUM
dpc-4600	322	4	/	/	SYM
dpc-4600	322	5	j.1755	j.1755	NOUN
dpc-4600	322	6	-	-	PUNCT
dpc-4600	322	7	148x.2012.00997.x	148x.2012.00997.x	NOUN
dpc-4600	322	8	.	.	PUNCT
dpc-4600	323	1	pmid	pmid	NOUN
dpc-4600	323	2	:	:	PUNCT
dpc-4600	323	3	22417114	22417114	NUM
dpc-4600	323	4	4	4	NUM
dpc-4600	323	5	.	.	PUNCT
dpc-4600	323	6	bergqvist	bergqvist	PROPN
dpc-4600	323	7	c	c	PROPN
dpc-4600	323	8	,	,	PUNCT
dpc-4600	323	9	ezzedine	ezzedine	PROPN
dpc-4600	323	10	k.	k.	PROPN
dpc-4600	323	11	vitiligo	vitiligo	PROPN
dpc-4600	323	12	:	:	PUNCT
dpc-4600	323	13	a	a	DET
dpc-4600	323	14	review	review	NOUN
dpc-4600	323	15	.	.	PUNCT
dpc-4600	324	1	dermatology	dermatology	NOUN
dpc-4600	324	2	.	.	PUNCT
dpc-4600	325	1	2020	2020	NUM
dpc-4600	325	2	;	;	PUNCT
dpc-4600	325	3	236(6):571	236(6):571	NUM
dpc-4600	325	4	-	-	SYM
dpc-4600	325	5	592	592	NUM
dpc-4600	325	6	.	.	PUNCT
dpc-4600	326	1	doi	doi	NOUN
dpc-4600	326	2	:	:	PUNCT
dpc-4600	326	3	10.1159/000506103	10.1159/000506103	NUM
dpc-4600	326	4	.	.	PUNCT
dpc-4600	327	1	pmid	pmid	NOUN
dpc-4600	327	2	:	:	PUNCT
dpc-4600	327	3	32155629	32155629	NUM
dpc-4600	327	4	.	.	X
dpc-4600	328	1	5	5	NUM
dpc-4600	328	2	.	.	X
dpc-4600	328	3	kundu	kundu	PROPN
dpc-4600	328	4	rv	rv	PROPN
dpc-4600	328	5	,	,	PUNCT
dpc-4600	328	6	mhlaba	mhlaba	PROPN
dpc-4600	328	7	jm	jm	PROPN
dpc-4600	328	8	,	,	PUNCT
dpc-4600	328	9	rangel	rangel	PROPN
dpc-4600	328	10	sm	sm	PROPN
dpc-4600	328	11	,	,	PUNCT
dpc-4600	328	12	le	le	PROPN
dpc-4600	328	13	poole	poole	PROPN
dpc-4600	328	14	ic	ic	PROPN
dpc-4600	328	15	.	.	PUNCT
dpc-4600	329	1	the	the	DET
dpc-4600	329	2	convergence	convergence	NOUN
dpc-4600	329	3	theory	theory	NOUN
dpc-4600	329	4	for	for	ADP
dpc-4600	329	5	vitiligo	vitiligo	NOUN
dpc-4600	329	6	:	:	PUNCT
dpc-4600	329	7	a	a	DET
dpc-4600	329	8	reappraisal	reappraisal	NOUN
dpc-4600	329	9	.	.	PUNCT
dpc-4600	330	1	exp	exp	NOUN
dpc-4600	330	2	dermatol	dermatol	NOUN
dpc-4600	330	3	.	.	PUNCT
dpc-4600	331	1	2019;28(6	2019;28(6	NUM
dpc-4600	331	2	):	):	PUNCT
dpc-4600	332	1	647	647	NUM
dpc-4600	332	2	-	-	SYM
dpc-4600	332	3	655	655	NUM
dpc-4600	332	4	.	.	PUNCT
dpc-4600	332	5	doi	doi	NOUN
dpc-4600	332	6	:	:	PUNCT
dpc-4600	332	7	10.1111	10.1111	NUM
dpc-4600	332	8	/	/	SYM
dpc-4600	332	9	exd.13677	exd.13677	PROPN
dpc-4600	332	10	.	.	PUNCT
dpc-4600	333	1	pmid	pmid	NOUN
dpc-4600	333	2	:	:	PUNCT
dpc-4600	333	3	29704874	29704874	NUM
dpc-4600	333	4	6	6	NUM
dpc-4600	333	5	.	.	PUNCT
dpc-4600	333	6	spritz	spritz	PROPN
dpc-4600	333	7	ra	ra	PROPN
dpc-4600	333	8	,	,	PUNCT
dpc-4600	333	9	santorico	santorico	PROPN
dpc-4600	333	10	sa	sa	PROPN
dpc-4600	333	11	.	.	PUNCT
dpc-4600	334	1	the	the	DET
dpc-4600	334	2	genetic	genetic	ADJ
dpc-4600	334	3	basis	basis	NOUN
dpc-4600	334	4	of	of	ADP
dpc-4600	334	5	vitiligo	vitiligo	NOUN
dpc-4600	334	6	.	.	PUNCT
dpc-4600	335	1	j	j	PROPN
dpc-4600	335	2	invest	invest	VERB
dpc-4600	335	3	dermatol	dermatol	NOUN
dpc-4600	335	4	.	.	PUNCT
dpc-4600	336	1	2021;141(2):265	2021;141(2):265	NUM
dpc-4600	336	2	-	-	SYM
dpc-4600	336	3	273	273	NUM
dpc-4600	336	4	.	.	PUNCT
dpc-4600	337	1	doi	doi	NOUN
dpc-4600	337	2	:	:	PUNCT
dpc-4600	337	3	10.1016	10.1016	NUM
dpc-4600	337	4	/	/	SYM
dpc-4600	337	5	j.jid.2020	j.jid.2020	PROPN
dpc-4600	337	6	.06.004	.06.004	NOUN
dpc-4600	337	7	.	.	PUNCT
dpc-4600	338	1	pmid	pmid	NOUN
dpc-4600	338	2	:	:	PUNCT
dpc-4600	338	3	32778407	32778407	NUM
dpc-4600	338	4	.	.	PUNCT
dpc-4600	339	1	7	7	X
dpc-4600	339	2	.	.	X
dpc-4600	339	3	dahir	dahir	PROPN
dpc-4600	339	4	am	am	PROPN
dpc-4600	339	5	,	,	PUNCT
dpc-4600	339	6	thomsen	thomsen	PROPN
dpc-4600	339	7	sf	sf	PROPN
dpc-4600	339	8	.	.	PROPN
dpc-4600	339	9	comorbidities	comorbiditie	NOUN
dpc-4600	339	10	in	in	ADP
dpc-4600	339	11	vitiligo	vitiligo	NOUN
dpc-4600	339	12	:	:	PUNCT
dpc-4600	339	13	comprehensive	comprehensive	ADJ
dpc-4600	339	14	review	review	NOUN
dpc-4600	339	15	.	.	PUNCT
dpc-4600	340	1	int	int	NOUN
dpc-4600	340	2	j	j	PROPN
dpc-4600	340	3	dermatol	dermatol	NOUN
dpc-4600	340	4	.	.	PUNCT
dpc-4600	341	1	2018;57(10):1157	2018;57(10):1157	NUM
dpc-4600	341	2	-	-	SYM
dpc-4600	341	3	1164	1164	NUM
dpc-4600	341	4	.	.	PUNCT
dpc-4600	342	1	doi	doi	NOUN
dpc-4600	342	2	:	:	PUNCT
dpc-4600	342	3	10.1111	10.1111	NUM
dpc-4600	342	4	/	/	SYM
dpc-4600	342	5	ijd.14055	ijd.14055	PROPN
dpc-4600	342	6	.	.	PUNCT
dpc-4600	343	1	pmid	pmid	NOUN
dpc-4600	343	2	:	:	PUNCT
dpc-4600	343	3	29808541	29808541	NUM
dpc-4600	343	4	.	.	PUNCT
dpc-4600	344	1	8	8	X
dpc-4600	344	2	.	.	PUNCT
dpc-4600	345	1	roberts	roberts	PROPN
dpc-4600	345	2	ghl	ghl	PROPN
dpc-4600	345	3	,	,	PUNCT
dpc-4600	345	4	paul	paul	PROPN
dpc-4600	345	5	s	s	PROPN
dpc-4600	345	6	,	,	PUNCT
dpc-4600	345	7	yorgov	yorgov	PROPN
dpc-4600	345	8	d	d	PROPN
dpc-4600	345	9	,	,	PUNCT
dpc-4600	345	10	santorico	santorico	PROPN
dpc-4600	345	11	sa	sa	PROPN
dpc-4600	345	12	,	,	PUNCT
dpc-4600	345	13	spritz	spritz	PROPN
dpc-4600	345	14	ra	ra	PROPN
dpc-4600	345	15	.	.	PUNCT
dpc-4600	346	1	family	family	NOUN
dpc-4600	346	2	clustering	clustering	NOUN
dpc-4600	346	3	of	of	ADP
dpc-4600	346	4	autoimmune	autoimmune	ADJ
dpc-4600	346	5	vitiligo	vitiligo	NOUN
dpc-4600	346	6	results	result	NOUN
dpc-4600	346	7	principally	principally	ADV
dpc-4600	346	8	from	from	ADP
dpc-4600	346	9	polygenic	polygenic	ADJ
dpc-4600	346	10	inheritance	inheritance	NOUN
dpc-4600	346	11	of	of	ADP
dpc-4600	346	12	common	common	ADJ
dpc-4600	346	13	risk	risk	NOUN
dpc-4600	346	14	alleles	allele	NOUN
dpc-4600	346	15	.	.	PUNCT
dpc-4600	347	1	am	be	AUX
dpc-4600	347	2	j	j	PROPN
dpc-4600	347	3	hum	hum	PROPN
dpc-4600	347	4	genet	genet	PROPN
dpc-4600	347	5	.	.	PUNCT
dpc-4600	348	1	2019;105(2):364	2019;105(2):364	NUM
dpc-4600	348	2	-	-	SYM
dpc-4600	348	3	372	372	NUM
dpc-4600	348	4	.	.	PUNCT
dpc-4600	348	5	doi	doi	NOUN
dpc-4600	348	6	:	:	PUNCT
dpc-4600	348	7	10.1016	10.1016	NUM
dpc-4600	348	8	/	/	SYM
dpc-4600	348	9	j.ajhg.2019.06.013	j.ajhg.2019.06.013	PROPN
dpc-4600	348	10	.	.	PUNCT
dpc-4600	349	1	pmid	pmid	NOUN
dpc-4600	349	2	:	:	PUNCT
dpc-4600	349	3	31327509	31327509	NUM
dpc-4600	349	4	.	.	PUNCT
dpc-4600	350	1	9	9	X
dpc-4600	350	2	.	.	X
dpc-4600	350	3	wong	wong	PROPN
dpc-4600	350	4	pm	pm	PROPN
dpc-4600	350	5	,	,	PUNCT
dpc-4600	350	6	yang	yang	PROPN
dpc-4600	350	7	l	l	PROPN
dpc-4600	350	8	,	,	PUNCT
dpc-4600	350	9	yang	yang	PROPN
dpc-4600	350	10	l	l	PROPN
dpc-4600	350	11	,	,	PUNCT
dpc-4600	350	12	et	et	PROPN
dpc-4600	350	13	al	al	PROPN
dpc-4600	350	14	.	.	PUNCT
dpc-4600	351	1	new	new	ADJ
dpc-4600	351	2	insight	insight	NOUN
dpc-4600	351	3	into	into	ADP
dpc-4600	351	4	the	the	DET
dpc-4600	351	5	role	role	NOUN
dpc-4600	351	6	of	of	ADP
dpc-4600	351	7	exosomes	exosome	NOUN
dpc-4600	351	8	in	in	ADP
dpc-4600	351	9	vitiligo	vitiligo	PROPN
dpc-4600	351	10	.	.	PUNCT
dpc-4600	352	1	autoimmun	autoimmun	PROPN
dpc-4600	352	2	rev	rev	PROPN
dpc-4600	352	3	.	.	PUNCT
dpc-4600	353	1	2020;19(11):102664	2020;19(11):102664	X
dpc-4600	353	2	.	.	X
dpc-4600	353	3	doi	doi	NOUN
dpc-4600	353	4	:	:	PUNCT
dpc-4600	353	5	10.1016	10.1016	NUM
dpc-4600	353	6	/	/	SYM
dpc-4600	353	7	j.autrev.2020.102664	j.autrev.2020.102664	PROPN
dpc-4600	353	8	.	.	PUNCT
dpc-4600	354	1	pmid	pmid	NOUN
dpc-4600	354	2	:	:	PUNCT
dpc-4600	354	3	32942029	32942029	NUM
dpc-4600	354	4	.	.	PUNCT
dpc-4600	355	1	10	10	NUM
dpc-4600	355	2	.	.	PUNCT
dpc-4600	356	1	abdallah	abdallah	PROPN
dpc-4600	356	2	m	m	PROPN
dpc-4600	356	3	,	,	PUNCT
dpc-4600	356	4	el	el	PROPN
dpc-4600	356	5	-	-	PUNCT
dpc-4600	356	6	mofty	mofty	PROPN
dpc-4600	356	7	m	m	PROPN
dpc-4600	356	8	,	,	PUNCT
dpc-4600	356	9	anbar	anbar	PROPN
dpc-4600	356	10	t	t	PROPN
dpc-4600	356	11	,	,	PUNCT
dpc-4600	356	12	et	et	PROPN
dpc-4600	356	13	al	al	PROPN
dpc-4600	356	14	.	.	PUNCT
dpc-4600	357	1	egyptian	egyptian	PROPN
dpc-4600	357	2	vitiligo	vitiligo	PROPN
dpc-4600	357	3	group	group	NOUN
dpc-4600	357	4	.	.	PUNCT
dpc-4600	358	1	cxcl-10	cxcl-10	PROPN
dpc-4600	358	2	and	and	CCONJ
dpc-4600	358	3	interleukin-6	interleukin-6	NOUN
dpc-4600	358	4	are	be	AUX
dpc-4600	358	5	reliable	reliable	ADJ
dpc-4600	358	6	serum	serum	NOUN
dpc-4600	358	7	markers	marker	NOUN
dpc-4600	358	8	for	for	ADP
dpc-4600	358	9	vitiligo	vitiligo	NOUN
dpc-4600	358	10	activity	activity	NOUN
dpc-4600	358	11	:	:	PUNCT
dpc-4600	358	12	a	a	DET
dpc-4600	358	13	multicenter	multicenter	ADJ
dpc-4600	358	14	cross	cross	ADJ
dpc-4600	358	15	-	-	ADJ
dpc-4600	358	16	sectional	sectional	ADJ
dpc-4600	358	17	study	study	NOUN
dpc-4600	358	18	.	.	PUNCT
dpc-4600	359	1	pigment	pigment	ADJ
dpc-4600	359	2	cell	cell	NOUN
dpc-4600	359	3	melanoma	melanoma	NOUN
dpc-4600	359	4	res	re	NOUN
dpc-4600	359	5	.	.	PUNCT
dpc-4600	360	1	2018;31(2):330	2018;31(2):330	NUM
dpc-4600	360	2	-	-	PUNCT
dpc-4600	360	3	336	336	NUM
dpc-4600	360	4	.	.	PUNCT
dpc-4600	361	1	doi	doi	NOUN
dpc-4600	361	2	:	:	PUNCT
dpc-4600	361	3	10.1111	10.1111	NUM
dpc-4600	361	4	/	/	SYM
dpc-4600	361	5	pcmr	pcmr	PROPN
dpc-4600	361	6	.12667	.12667	PROPN
dpc-4600	361	7	.	.	PUNCT
dpc-4600	362	1	pmid	pmid	NOUN
dpc-4600	362	2	:	:	PUNCT
dpc-4600	362	3	29094481	29094481	NUM
dpc-4600	362	4	.	.	PUNCT
dpc-4600	363	1	11	11	NUM
dpc-4600	363	2	.	.	PUNCT
dpc-4600	363	3	abdou	abdou	PROPN
dpc-4600	363	4	ag	ag	PROPN
dpc-4600	363	5	,	,	PUNCT
dpc-4600	363	6	maraee	maraee	PROPN
dpc-4600	363	7	a	a	PRON
dpc-4600	363	8	,	,	PUNCT
dpc-4600	363	9	yassien	yassien	PROPN
dpc-4600	363	10	h	h	NOUN
dpc-4600	363	11	,	,	PUNCT
dpc-4600	363	12	sarhan	sarhan	ADP
dpc-4600	363	13	m.	m.	NOUN
dpc-4600	363	14	immunohistochemistry	immunohistochemistry	NOUN
dpc-4600	363	15	of	of	ADP
dpc-4600	363	16	janus	janus	PROPN
dpc-4600	363	17	kinase	kinase	PROPN
dpc-4600	363	18	1	1	NUM
dpc-4600	363	19	(	(	PUNCT
dpc-4600	363	20	jak1	jak1	NOUN
dpc-4600	363	21	)	)	PUNCT
dpc-4600	363	22	expression	expression	NOUN
dpc-4600	363	23	in	in	ADP
dpc-4600	363	24	vitiligo	vitiligo	NOUN
dpc-4600	363	25	.	.	PUNCT
dpc-4600	364	1	j	j	PROPN
dpc-4600	364	2	pathol	pathol	PROPN
dpc-4600	364	3	transl	transl	PROPN
dpc-4600	364	4	med	med	PROPN
dpc-4600	364	5	.	.	PUNCT
dpc-4600	365	1	2018;52(6):363	2018;52(6):363	NUM
dpc-4600	365	2	-	-	PUNCT
dpc-4600	365	3	368	368	NUM
dpc-4600	365	4	.	.	PUNCT
dpc-4600	366	1	doi	doi	NOUN
dpc-4600	366	2	:	:	PUNCT
dpc-4600	366	3	10.4132	10.4132	NUM
dpc-4600	366	4	/	/	SYM
dpc-4600	366	5	jptm	jptm	PROPN
dpc-4600	366	6	.2018.09.18	.2018.09.18	PROPN
dpc-4600	366	7	.	.	PUNCT
dpc-4600	367	1	pmid	pmid	NOUN
dpc-4600	367	2	:	:	PUNCT
dpc-4600	367	3	30347972	30347972	NUM
dpc-4600	367	4	.	.	PUNCT
dpc-4600	368	1	10	10	NUM
dpc-4600	368	2	review	review	NOUN
dpc-4600	368	3	|	|	ADV
dpc-4600	368	4	dermatol	dermatol	ADJ
dpc-4600	368	5	pract	pract	NOUN
dpc-4600	368	6	concept	concept	NOUN
dpc-4600	368	7	.	.	PUNCT
dpc-4600	369	1	2025;15(1):4600	2025;15(1):4600	NUM
dpc-4600	369	2	40	40	NUM
dpc-4600	369	3	.	.	PUNCT
dpc-4600	370	1	calzari	calzari	PROPN
dpc-4600	370	2	p	p	NOUN
dpc-4600	370	3	,	,	PUNCT
dpc-4600	370	4	vaienti	vaienti	NOUN
dpc-4600	370	5	s	s	PROPN
dpc-4600	370	6	,	,	PUNCT
dpc-4600	370	7	nazzaro	nazzaro	ADJ
dpc-4600	370	8	g.	g.	PROPN
dpc-4600	370	9	uses	use	VERB
dpc-4600	370	10	of	of	ADP
dpc-4600	370	11	  	  	SPACE
dpc-4600	370	12	polypodium	polypodium	NOUN
dpc-4600	370	13	leucotomos	leucotomos	PROPN
dpc-4600	370	14	 	 	SPACE
dpc-4600	370	15	extract	extract	NOUN
dpc-4600	370	16	in	in	ADP
dpc-4600	370	17	oncodermatology	oncodermatology	NOUN
dpc-4600	370	18	.	.	PUNCT
dpc-4600	371	1	j	j	PROPN
dpc-4600	371	2	clin	clin	PROPN
dpc-4600	371	3	med	med	PROPN
dpc-4600	371	4	.	.	PUNCT
dpc-4600	372	1	2023;12(2):673	2023;12(2):673	PROPN
dpc-4600	372	2	.	.	PUNCT
dpc-4600	373	1	doi	doi	NOUN
dpc-4600	373	2	:	:	PUNCT
dpc-4600	373	3	10.3390	10.3390	NUM
dpc-4600	373	4	/	/	SYM
dpc-4600	373	5	jcm12020673	jcm12020673	NOUN
dpc-4600	373	6	.	.	PUNCT
dpc-4600	374	1	pmid	pmid	NOUN
dpc-4600	374	2	:	:	PUNCT
dpc-4600	374	3	36675602	36675602	NUM
dpc-4600	374	4	.	.	PUNCT
dpc-4600	375	1	41	41	NUM
dpc-4600	375	2	.	.	PUNCT
dpc-4600	376	1	pacifico	pacifico	PROPN
dpc-4600	376	2	a	a	PRON
dpc-4600	376	3	,	,	PUNCT
dpc-4600	376	4	damiani	damiani	PROPN
dpc-4600	376	5	g	g	PROPN
dpc-4600	376	6	,	,	PUNCT
dpc-4600	376	7	iacovelli	iacovelli	NOUN
dpc-4600	376	8	p	p	NOUN
dpc-4600	376	9	,	,	PUNCT
dpc-4600	376	10	conic	conic	ADJ
dpc-4600	376	11	rrz	rrz	NOUN
dpc-4600	376	12	;	;	PUNCT
dpc-4600	376	13	young	young	ADJ
dpc-4600	376	14	dermatologists	dermatologist	NOUN
dpc-4600	376	15	italian	italian	ADJ
dpc-4600	376	16	network	network	NOUN
dpc-4600	376	17	(	(	PUNCT
dpc-4600	376	18	ydin	ydin	PROPN
dpc-4600	376	19	)	)	PUNCT
dpc-4600	376	20	;	;	PUNCT
dpc-4600	376	21	gonzalez	gonzalez	PROPN
dpc-4600	376	22	s	s	PROPN
dpc-4600	376	23	,	,	PUNCT
dpc-4600	376	24	morrone	morrone	NOUN
dpc-4600	376	25	a.	a.	NOUN
dpc-4600	376	26	nb	nb	PROPN
dpc-4600	376	27	-	-	PUNCT
dpc-4600	376	28	uvb	uvb	ADJ
dpc-4600	376	29	plus	plus	CCONJ
dpc-4600	376	30	oral	oral	ADJ
dpc-4600	376	31	polypodium	polypodium	NOUN
dpc-4600	376	32	leucotomos	leucotomos	PROPN
dpc-4600	376	33	extract	extract	NOUN
dpc-4600	376	34	display	display	VERB
dpc-4600	376	35	higher	high	ADJ
dpc-4600	376	36	efficacy	efficacy	NOUN
dpc-4600	376	37	than	than	ADP
dpc-4600	376	38	nb	nb	NOUN
dpc-4600	376	39	-	-	ADJ
dpc-4600	376	40	uvb	uvb	ADJ
dpc-4600	376	41	alone	alone	ADJ
dpc-4600	376	42	in	in	ADP
dpc-4600	376	43	patients	patient	NOUN
dpc-4600	376	44	with	with	ADP
dpc-4600	376	45	vitiligo	vitiligo	NOUN
dpc-4600	376	46	.	.	PUNCT
dpc-4600	377	1	dermatol	dermatol	NOUN
dpc-4600	377	2	ther	ther	ADV
dpc-4600	377	3	.	.	PUNCT
dpc-4600	378	1	2021;34(2):e14776	2021;34(2):e14776	X
dpc-4600	378	2	.	.	PUNCT
dpc-4600	378	3	doi	doi	NOUN
dpc-4600	378	4	:	:	PUNCT
dpc-4600	378	5	10.1111	10.1111	NUM
dpc-4600	378	6	/	/	SYM
dpc-4600	378	7	dth.14776	dth.14776	NOUN
dpc-4600	378	8	.	.	PUNCT
dpc-4600	379	1	pmid	pmid	NOUN
dpc-4600	379	2	:	:	PUNCT
dpc-4600	379	3	33433041	33433041	NUM
dpc-4600	379	4	.	.	PUNCT
dpc-4600	380	1	42	42	NUM
dpc-4600	380	2	.	.	PUNCT
dpc-4600	381	1	dai	dai	PROPN
dpc-4600	381	2	t	t	PROPN
dpc-4600	381	3	,	,	PUNCT
dpc-4600	381	4	xiaoying	xiaoye	VERB
dpc-4600	381	5	s	s	PROPN
dpc-4600	381	6	,	,	PUNCT
dpc-4600	381	7	li	li	PROPN
dpc-4600	381	8	x	x	PROPN
dpc-4600	381	9	,	,	PUNCT
dpc-4600	381	10	hongjin	hongjin	NOUN
dpc-4600	381	11	l	l	PROPN
dpc-4600	381	12	,	,	PUNCT
dpc-4600	381	13	yaqiong	yaqiong	PROPN
dpc-4600	381	14	z	z	PROPN
dpc-4600	381	15	,	,	PUNCT
dpc-4600	381	16	bo	bo	PROPN
dpc-4600	381	17	l.	l.	PROPN
dpc-4600	381	18	selenium	selenium	NOUN
dpc-4600	381	19	level	level	NOUN
dpc-4600	381	20	in	in	ADP
dpc-4600	381	21	patients	patient	NOUN
dpc-4600	381	22	with	with	ADP
dpc-4600	381	23	vitiligo	vitiligo	NOUN
dpc-4600	381	24	:	:	PUNCT
dpc-4600	381	25	a	a	DET
dpc-4600	381	26	meta	meta	ADJ
dpc-4600	381	27	-	-	PUNCT
dpc-4600	381	28	analysis	analysis	NOUN
dpc-4600	381	29	.	.	PUNCT
dpc-4600	381	30	biomed	biome	VERB
dpc-4600	381	31	res	re	NOUN
dpc-4600	381	32	int	int	NOUN
dpc-4600	381	33	.	.	PUNCT
dpc-4600	382	1	2020;2020:7580939	2020;2020:7580939	NUM
dpc-4600	382	2	.	.	PUNCT
dpc-4600	383	1	doi	doi	NOUN
dpc-4600	383	2	:	:	PUNCT
dpc-4600	383	3	10.1155/2020/7580939	10.1155/2020/7580939	NUM
dpc-4600	383	4	.	.	PUNCT
dpc-4600	384	1	pmid	pmid	NOUN
dpc-4600	384	2	:	:	PUNCT
dpc-4600	384	3	32626761	32626761	NUM
dpc-4600	384	4	.	.	PUNCT
dpc-4600	385	1	43	43	NUM
dpc-4600	385	2	.	.	PUNCT
dpc-4600	386	1	beyzaee	beyzaee	ADJ
dpc-4600	386	2	am	am	PROPN
dpc-4600	386	3	,	,	PUNCT
dpc-4600	386	4	goldust	goldust	PROPN
dpc-4600	386	5	m	m	PROPN
dpc-4600	386	6	,	,	PUNCT
dpc-4600	386	7	patil	patil	PROPN
dpc-4600	386	8	a	a	PRON
dpc-4600	386	9	,	,	PUNCT
dpc-4600	386	10	rokni	rokni	NOUN
dpc-4600	386	11	gr	gr	NUM
dpc-4600	386	12	,	,	PUNCT
dpc-4600	386	13	beyzaee	beyzaee	VERB
dpc-4600	386	14	s.	s.	PROPN
dpc-4600	386	15	the	the	DET
dpc-4600	386	16	role	role	NOUN
dpc-4600	386	17	of	of	ADP
dpc-4600	386	18	cytokines	cytokine	NOUN
dpc-4600	386	19	and	and	CCONJ
dpc-4600	386	20	vitamin	vitamin	NOUN
dpc-4600	386	21	d	d	NOUN
dpc-4600	386	22	in	in	ADP
dpc-4600	386	23	vitiligo	vitiligo	NOUN
dpc-4600	386	24	pathogenesis	pathogenesis	NOUN
dpc-4600	386	25	.	.	PUNCT
dpc-4600	387	1	j	j	PROPN
dpc-4600	387	2	cosmet	cosmet	PROPN
dpc-4600	387	3	dermatol	dermatol	NOUN
dpc-4600	387	4	.	.	PUNCT
dpc-4600	388	1	2022;21(11):6314	2022;21(11):6314	NUM
dpc-4600	388	2	-	-	SYM
dpc-4600	388	3	6325	6325	NUM
dpc-4600	388	4	.	.	PUNCT
dpc-4600	389	1	doi	doi	NOUN
dpc-4600	389	2	:	:	PUNCT
dpc-4600	389	3	10.1111	10.1111	NUM
dpc-4600	389	4	/	/	SYM
dpc-4600	389	5	jocd.15272	jocd.15272	PROPN
dpc-4600	389	6	.	.	PUNCT
dpc-4600	390	1	pmid	pmid	NOUN
dpc-4600	390	2	:	:	PUNCT
dpc-4600	390	3	35871394	35871394	NUM
dpc-4600	390	4	.	.	PUNCT
dpc-4600	391	1	44	44	NUM
dpc-4600	391	2	.	.	PUNCT
dpc-4600	392	1	agarwal	agarwal	PROPN
dpc-4600	392	2	k	k	PROPN
dpc-4600	392	3	,	,	PUNCT
dpc-4600	392	4	podder	podder	PROPN
dpc-4600	392	5	i	i	PROPN
dpc-4600	392	6	,	,	PUNCT
dpc-4600	392	7	kassir	kassir	PROPN
dpc-4600	392	8	m	m	PROPN
dpc-4600	392	9	,	,	PUNCT
dpc-4600	392	10	et	et	PROPN
dpc-4600	392	11	al	al	PROPN
dpc-4600	392	12	.	.	PUNCT
dpc-4600	393	1	therapeutic	therapeutic	ADJ
dpc-4600	393	2	options	option	NOUN
dpc-4600	393	3	in	in	ADP
dpc-4600	393	4	vitiligo	vitiligo	NOUN
dpc-4600	393	5	with	with	ADP
dpc-4600	393	6	special	special	ADJ
dpc-4600	393	7	emphasis	emphasis	NOUN
dpc-4600	393	8	on	on	ADP
dpc-4600	393	9	immunomodulators	immunomodulator	NOUN
dpc-4600	393	10	:	:	PUNCT
dpc-4600	393	11	a	a	DET
dpc-4600	393	12	comprehensive	comprehensive	ADJ
dpc-4600	393	13	update	update	NOUN
dpc-4600	393	14	with	with	ADP
dpc-4600	393	15	review	review	NOUN
dpc-4600	393	16	of	of	ADP
dpc-4600	393	17	literature	literature	NOUN
dpc-4600	393	18	.	.	PUNCT
dpc-4600	394	1	dermatol	dermatol	NOUN
dpc-4600	394	2	ther	ther	ADV
dpc-4600	394	3	.	.	PUNCT
dpc-4600	395	1	2020;33(2):e13215	2020;33(2):e13215	X
dpc-4600	395	2	.	.	PUNCT
dpc-4600	395	3	doi	doi	PROPN
dpc-4600	395	4	:	:	PUNCT
dpc-4600	395	5	10.1111	10.1111	NUM
dpc-4600	395	6	/	/	SYM
dpc-4600	395	7	dth.13215	dth.13215	PROPN
dpc-4600	395	8	.	.	PUNCT
dpc-4600	396	1	pmid	pmid	NOUN
dpc-4600	396	2	:	:	PUNCT
dpc-4600	396	3	31891450	31891450	NUM
dpc-4600	396	4	.	.	PUNCT
dpc-4600	397	1	45	45	NUM
dpc-4600	397	2	.	.	PUNCT
dpc-4600	398	1	zahoor	zahoor	PROPN
dpc-4600	398	2	m	m	PROPN
dpc-4600	398	3	,	,	PUNCT
dpc-4600	398	4	shaukat	shaukat	PROPN
dpc-4600	398	5	s	s	PROPN
dpc-4600	398	6	,	,	PUNCT
dpc-4600	398	7	khan	khan	PROPN
dpc-4600	398	8	ms	ms	PROPN
dpc-4600	398	9	,	,	PUNCT
dpc-4600	398	10	ahmad	ahmad	PROPN
dpc-4600	398	11	tj	tj	PROPN
dpc-4600	398	12	.	.	PROPN
dpc-4600	398	13	comparison	comparison	NOUN
dpc-4600	398	14	of	of	ADP
dpc-4600	398	15	efficacy	efficacy	NOUN
dpc-4600	398	16	and	and	CCONJ
dpc-4600	398	17	safety	safety	NOUN
dpc-4600	398	18	of	of	ADP
dpc-4600	398	19	0.005	0.005	NUM
dpc-4600	398	20	%	%	NOUN
dpc-4600	398	21	calcipotriol	calcipotriol	NOUN
dpc-4600	398	22	ointment	ointment	NOUN
dpc-4600	398	23	versus	versus	ADP
dpc-4600	398	24	0.05	0.05	NUM
dpc-4600	398	25	%	%	NOUN
dpc-4600	398	26	betamethasone	betamethasone	NOUN
dpc-4600	398	27	dipropionate	dipropionate	PROPN
dpc-4600	398	28	ointment	ointment	NOUN
dpc-4600	398	29	versus	versus	ADP
dpc-4600	398	30	calcipotriol	calcipotriol	PROPN
dpc-4600	398	31	plus	plus	CCONJ
dpc-4600	398	32	betamethasone	betamethasone	NOUN
dpc-4600	398	33	ointment	ointment	NOUN
dpc-4600	398	34	for	for	ADP
dpc-4600	398	35	the	the	DET
dpc-4600	398	36	treatment	treatment	NOUN
dpc-4600	398	37	of	of	ADP
dpc-4600	398	38	vitiligo	vitiligo	NOUN
dpc-4600	398	39	.	.	PUNCT
dpc-4600	399	1	j	j	PROPN
dpc-4600	399	2	pak	pak	PROPN
dpc-4600	399	3	assoc	assoc	PROPN
dpc-4600	399	4	dermatol	dermatol	NOUN
dpc-4600	400	1	[	[	X
dpc-4600	400	2	internet	internet	NOUN
dpc-4600	400	3	]	]	PUNCT
dpc-4600	400	4	.	.	PUNCT
dpc-4600	401	1	2017;27(1):30	2017;27(1):30	NUM
dpc-4600	401	2	-	-	SYM
dpc-4600	401	3	6	6	NUM
dpc-4600	401	4	.	.	PUNCT
dpc-4600	401	5	available	available	ADJ
dpc-4600	401	6	from	from	ADP
dpc-4600	401	7	:	:	PUNCT
dpc-4600	401	8	http://	http://	PROPN
dpc-4600	401	9	jpad.com.pk/index.php/jpad/article/view/1023	jpad.com.pk/index.php/jpad/article/view/1023	PROPN
dpc-4600	401	10	46	46	NUM
dpc-4600	401	11	.	.	PUNCT
dpc-4600	402	1	liu	liu	PROPN
dpc-4600	402	2	x	x	PROPN
dpc-4600	402	3	,	,	PUNCT
dpc-4600	402	4	yao	yao	PROPN
dpc-4600	402	5	z	z	PROPN
dpc-4600	402	6	,	,	PUNCT
dpc-4600	402	7	wang	wang	PROPN
dpc-4600	402	8	y	y	PROPN
dpc-4600	402	9	,	,	PUNCT
dpc-4600	402	10	chai	chai	NOUN
dpc-4600	402	11	l	l	NOUN
dpc-4600	402	12	,	,	PUNCT
dpc-4600	402	13	zhou	zhou	PROPN
dpc-4600	402	14	x.	x.	PROPN
dpc-4600	402	15	vitamin	vitamin	PROPN
dpc-4600	402	16	d	d	NOUN
dpc-4600	402	17	analogs	analog	NOUN
dpc-4600	402	18	combined	combine	VERB
dpc-4600	402	19	with	with	ADP
dpc-4600	402	20	different	different	ADJ
dpc-4600	402	21	types	type	NOUN
dpc-4600	402	22	of	of	ADP
dpc-4600	402	23	phototherapy	phototherapy	NOUN
dpc-4600	402	24	in	in	ADP
dpc-4600	402	25	the	the	DET
dpc-4600	402	26	treatment	treatment	NOUN
dpc-4600	402	27	of	of	ADP
dpc-4600	402	28	vitiligo	vitiligo	NOUN
dpc-4600	402	29	:	:	PUNCT
dpc-4600	402	30	a	a	DET
dpc-4600	402	31	systematic	systematic	ADJ
dpc-4600	402	32	review	review	NOUN
dpc-4600	402	33	of	of	ADP
dpc-4600	402	34	randomized	randomized	ADJ
dpc-4600	402	35	trials	trial	NOUN
dpc-4600	402	36	and	and	CCONJ
dpc-4600	402	37	within	within	ADP
dpc-4600	402	38	-	-	PUNCT
dpc-4600	402	39	patient	patient	NOUN
dpc-4600	402	40	studies	study	NOUN
dpc-4600	402	41	.	.	PUNCT
dpc-4600	403	1	int	int	PROPN
dpc-4600	403	2	immunopharmacol	immunopharmacol	PROPN
dpc-4600	403	3	.	.	PUNCT
dpc-4600	404	1	2022;109:108789	2022;109:108789	X
dpc-4600	404	2	.	.	PUNCT
dpc-4600	405	1	doi	doi	NOUN
dpc-4600	405	2	:	:	PUNCT
dpc-4600	405	3	10.1016	10.1016	NUM
dpc-4600	405	4	/	/	SYM
dpc-4600	405	5	j.intimp.2022.108789.pmid	j.intimp.2022.108789.pmid	PROPN
dpc-4600	405	6	:	:	PUNCT
dpc-4600	405	7	35468365	35468365	NUM
dpc-4600	405	8	.	.	PUNCT
dpc-4600	406	1	47	47	NUM
dpc-4600	406	2	.	.	PUNCT
dpc-4600	407	1	salloum	salloum	PROPN
dpc-4600	407	2	a	a	DET
dpc-4600	407	3	,	,	PUNCT
dpc-4600	407	4	bazzi	bazzi	NOUN
dpc-4600	407	5	n	n	CCONJ
dpc-4600	407	6	,	,	PUNCT
dpc-4600	407	7	maalouf	maalouf	PROPN
dpc-4600	407	8	d	d	NOUN
dpc-4600	407	9	,	,	PUNCT
dpc-4600	407	10	habre	habre	NOUN
dpc-4600	407	11	m.	m.	NOUN
dpc-4600	407	12	microneedling	microneedle	VERB
dpc-4600	407	13	in	in	ADP
dpc-4600	407	14	vitiligo	vitiligo	NOUN
dpc-4600	407	15	:	:	PUNCT
dpc-4600	407	16	a	a	DET
dpc-4600	407	17	systematic	systematic	ADJ
dpc-4600	407	18	review	review	NOUN
dpc-4600	407	19	.	.	PUNCT
dpc-4600	408	1	dermatol	dermatol	NOUN
dpc-4600	408	2	ther	ther	ADV
dpc-4600	408	3	.	.	PUNCT
dpc-4600	409	1	2020;33(6):e14297	2020;33(6):e14297	X
dpc-4600	409	2	.	.	PUNCT
dpc-4600	409	3	doi	doi	NOUN
dpc-4600	409	4	:	:	PUNCT
dpc-4600	409	5	10.1111	10.1111	NUM
dpc-4600	409	6	/	/	SYM
dpc-4600	409	7	dth.14297	dth.14297	PROPN
dpc-4600	409	8	.	.	PUNCT
dpc-4600	410	1	pmid	pmid	NOUN
dpc-4600	410	2	:	:	PUNCT
dpc-4600	410	3	32940387	32940387	NUM
dpc-4600	410	4	.	.	PUNCT
dpc-4600	411	1	48	48	NUM
dpc-4600	411	2	.	.	PUNCT
dpc-4600	412	1	salem	salem	PROPN
dpc-4600	412	2	mw	mw	PROPN
dpc-4600	412	3	,	,	PUNCT
dpc-4600	412	4	adel	adel	PROPN
dpc-4600	412	5	abd	abd	PROPN
dpc-4600	412	6	el	el	PROPN
dpc-4600	412	7	azim	azim	PROPN
dpc-4600	412	8	a	a	PROPN
dpc-4600	412	9	,	,	PUNCT
dpc-4600	412	10	galal	galal	PROPN
dpc-4600	412	11	sa	sa	PROPN
dpc-4600	412	12	.	.	PUNCT
dpc-4600	413	1	efficacy	efficacy	NOUN
dpc-4600	413	2	of	of	ADP
dpc-4600	413	3	topical	topical	ADJ
dpc-4600	413	4	vitamin	vitamin	NOUN
dpc-4600	413	5	d	d	NOUN
dpc-4600	413	6	combined	combine	VERB
dpc-4600	413	7	with	with	ADP
dpc-4600	413	8	microneedling	microneedle	VERB
dpc-4600	413	9	in	in	ADP
dpc-4600	413	10	the	the	DET
dpc-4600	413	11	treatment	treatment	NOUN
dpc-4600	413	12	of	of	ADP
dpc-4600	413	13	vitiligo	vitiligo	NOUN
dpc-4600	413	14	:	:	PUNCT
dpc-4600	413	15	a	a	DET
dpc-4600	413	16	comparative	comparative	ADJ
dpc-4600	413	17	study	study	NOUN
dpc-4600	413	18	.	.	PUNCT
dpc-4600	414	1	j	j	PROPN
dpc-4600	414	2	cosmet	cosmet	PROPN
dpc-4600	414	3	dermatol	dermatol	NOUN
dpc-4600	414	4	.	.	PUNCT
dpc-4600	415	1	2023;22(5	2023;22(5	NOUN
dpc-4600	415	2	):	):	PUNCT
dpc-4600	415	3	1521	1521	NUM
dpc-4600	415	4	-	-	SYM
dpc-4600	415	5	1527	1527	NUM
dpc-4600	415	6	.	.	PUNCT
dpc-4600	416	1	doi	doi	NOUN
dpc-4600	416	2	:	:	PUNCT
dpc-4600	416	3	10.1111	10.1111	NUM
dpc-4600	416	4	/	/	SYM
dpc-4600	416	5	jocd.15621	jocd.15621	PROPN
dpc-4600	416	6	.	.	PUNCT
dpc-4600	417	1	pmid	pmid	NOUN
dpc-4600	417	2	:	:	PUNCT
dpc-4600	417	3	36718834	36718834	NUM
dpc-4600	417	4	.	.	PUNCT
dpc-4600	418	1	49	49	NUM
dpc-4600	418	2	.	.	PUNCT
dpc-4600	419	1	al	al	PROPN
dpc-4600	419	2	-	-	PUNCT
dpc-4600	419	3	kuraishy	kuraishy	PROPN
dpc-4600	419	4	,	,	PUNCT
dpc-4600	419	5	hayder	hayder	NOUN
dpc-4600	419	6	m.	m.	NOUN
dpc-4600	419	7	;	;	PUNCT
dpc-4600	419	8	hussian	hussian	PROPN
dpc-4600	419	9	,	,	PUNCT
dpc-4600	419	10	nawar	nawar	PROPN
dpc-4600	419	11	r.	r.	PROPN
dpc-4600	419	12	;	;	PUNCT
dpc-4600	419	13	al	al	PROPN
dpc-4600	419	14	-	-	PUNCT
dpc-4600	419	15	naimi	naimi	PROPN
dpc-4600	419	16	,	,	PUNCT
dpc-4600	419	17	marwa	marwa	PROPN
dpc-4600	419	18	s.	s.	PROPN
dpc-4600	419	19	;	;	PUNCT
dpc-4600	419	20	al	al	PROPN
dpc-4600	419	21	-	-	PUNCT
dpc-4600	419	22	gareeb	gareeb	PROPN
dpc-4600	419	23	,	,	PUNCT
dpc-4600	419	24	ali	ali	PROPN
dpc-4600	419	25	i.	i.	PROPN
dpc-4600	419	26	statins	statins	PROPN
dpc-4600	419	27	role	role	NOUN
dpc-4600	419	28	in	in	ADP
dpc-4600	419	29	vitiligo	vitiligo	NOUN
dpc-4600	419	30	:	:	PUNCT
dpc-4600	419	31	a	a	DET
dpc-4600	419	32	mini	mini	NOUN
dpc-4600	419	33	-	-	NOUN
dpc-4600	419	34	review	review	NOUN
dpc-4600	419	35	.	.	PUNCT
dpc-4600	420	1	turkish	turkish	ADJ
dpc-4600	420	2	journal	journal	NOUN
dpc-4600	420	3	of	of	ADP
dpc-4600	420	4	dermatology	dermatology	NOUN
dpc-4600	420	5	,	,	PUNCT
dpc-4600	420	6	14(1):p	14(1):p	NUM
dpc-4600	420	7	1	1	NUM
dpc-4600	420	8	-	-	SYM
dpc-4600	420	9	7	7	NUM
dpc-4600	420	10	,	,	PUNCT
dpc-4600	420	11	jan	jan	PROPN
dpc-4600	420	12	–	–	PROPN
dpc-4600	420	13	mar	mar	PROPN
dpc-4600	420	14	2020	2020	NUM
dpc-4600	420	15	.	.	PUNCT
dpc-4600	421	1	doi	doi	NOUN
dpc-4600	421	2	:	:	PUNCT
dpc-4600	421	3	10.4103	10.4103	NUM
dpc-4600	421	4	/	/	SYM
dpc-4600	422	1	tjd.tjd_38_19	tjd.tjd_38_19	PROPN
dpc-4600	422	2	.	.	PUNCT
dpc-4600	423	1	50	50	NUM
dpc-4600	423	2	.	.	X
dpc-4600	423	3	shaker	shaker	NOUN
dpc-4600	423	4	ese	ese	PROPN
dpc-4600	423	5	,	,	PUNCT
dpc-4600	423	6	allam	allam	PROPN
dpc-4600	423	7	sh	sh	PROPN
dpc-4600	423	8	,	,	PUNCT
dpc-4600	423	9	mabrouk	mabrouk	X
dpc-4600	423	10	mm	mm	PROPN
dpc-4600	423	11	,	,	PUNCT
dpc-4600	423	12	elgharbawy	elgharbawy	PROPN
dpc-4600	423	13	nm	nm	PROPN
dpc-4600	423	14	,	,	PUNCT
dpc-4600	423	15	salaam	salaam	PROPN
dpc-4600	423	16	sfa	sfa	PROPN
dpc-4600	423	17	.	.	PUNCT
dpc-4600	424	1	simvastatin	simvastatin	PROPN
dpc-4600	424	2	and	and	CCONJ
dpc-4600	424	3	non	non	ADJ
dpc-4600	424	4	-	-	ADJ
dpc-4600	424	5	segmental	segmental	ADJ
dpc-4600	424	6	vitiligo	vitiligo	NOUN
dpc-4600	424	7	:	:	PUNCT
dpc-4600	424	8	a	a	DET
dpc-4600	424	9	new	new	ADJ
dpc-4600	424	10	potential	potential	ADJ
dpc-4600	424	11	treatment	treatment	NOUN
dpc-4600	424	12	option	option	NOUN
dpc-4600	424	13	?	?	PUNCT
dpc-4600	425	1	dermatol	dermatol	NOUN
dpc-4600	425	2	ther	ther	ADV
dpc-4600	425	3	.	.	PUNCT
dpc-4600	426	1	2022;35(12):e15969	2022;35(12):e15969	NOUN
dpc-4600	426	2	.	.	PUNCT
dpc-4600	427	1	doi	doi	NOUN
dpc-4600	427	2	:	:	PUNCT
dpc-4600	427	3	10.1111	10.1111	NUM
dpc-4600	427	4	/	/	SYM
dpc-4600	427	5	dth.15969	dth.15969	PROPN
dpc-4600	427	6	.	.	PUNCT
dpc-4600	428	1	pmid	pmid	NOUN
dpc-4600	428	2	:	:	PUNCT
dpc-4600	428	3	36346030	36346030	NUM
dpc-4600	428	4	.	.	PUNCT
dpc-4600	429	1	51	51	NUM
dpc-4600	429	2	.	.	PUNCT
dpc-4600	430	1	feng	feng	PROPN
dpc-4600	430	2	y	y	PROPN
dpc-4600	430	3	,	,	PUNCT
dpc-4600	430	4	lu	lu	PROPN
dpc-4600	430	5	y.	y.	PROPN
dpc-4600	430	6	advances	advance	VERB
dpc-4600	430	7	in	in	ADP
dpc-4600	430	8	vitiligo	vitiligo	NOUN
dpc-4600	430	9	:	:	PUNCT
dpc-4600	430	10	update	update	NOUN
dpc-4600	430	11	on	on	ADP
dpc-4600	430	12	therapeutic	therapeutic	ADJ
dpc-4600	430	13	targets	target	NOUN
dpc-4600	430	14	.	.	PUNCT
dpc-4600	431	1	front	front	ADJ
dpc-4600	431	2	immunol	immunol	NOUN
dpc-4600	431	3	.	.	PUNCT
dpc-4600	432	1	2022;13:986918	2022;13:986918	X
dpc-4600	432	2	.	.	PUNCT
dpc-4600	432	3	doi	doi	NOUN
dpc-4600	432	4	:	:	PUNCT
dpc-4600	432	5	10.3389	10.3389	NUM
dpc-4600	432	6	/	/	SYM
dpc-4600	432	7	fimmu	fimmu	ADJ
dpc-4600	432	8	.2022.986918	.2022.986918	PROPN
dpc-4600	432	9	.	.	PUNCT
dpc-4600	433	1	pmid	pmid	NOUN
dpc-4600	433	2	:	:	PUNCT
dpc-4600	433	3	36119071	36119071	NUM
dpc-4600	433	4	.	.	PUNCT
dpc-4600	434	1	52	52	NUM
dpc-4600	434	2	.	.	PUNCT
dpc-4600	435	1	karagaiah	karagaiah	PROPN
dpc-4600	435	2	p	p	PROPN
dpc-4600	435	3	,	,	PUNCT
dpc-4600	435	4	schwartz	schwartz	PROPN
dpc-4600	435	5	ra	ra	PROPN
dpc-4600	435	6	,	,	PUNCT
dpc-4600	435	7	lotti	lotti	PROPN
dpc-4600	435	8	t	t	PROPN
dpc-4600	435	9	,	,	PUNCT
dpc-4600	435	10	wollina	wollina	NOUN
dpc-4600	435	11	u	u	PROPN
dpc-4600	435	12	,	,	PUNCT
dpc-4600	435	13	grabbe	grabbe	PROPN
dpc-4600	435	14	s	s	PROPN
dpc-4600	435	15	,	,	PUNCT
dpc-4600	435	16	goldust	goldust	PROPN
dpc-4600	435	17	m.	m.	NOUN
dpc-4600	435	18	biologic	biologic	NOUN
dpc-4600	435	19	and	and	CCONJ
dpc-4600	435	20	targeted	target	VERB
dpc-4600	435	21	therapeutics	therapeutic	NOUN
dpc-4600	435	22	in	in	ADP
dpc-4600	435	23	vitiligo	vitiligo	NOUN
dpc-4600	435	24	.	.	PUNCT
dpc-4600	436	1	j	j	PROPN
dpc-4600	436	2	cosmet	cosmet	PROPN
dpc-4600	436	3	dermatol	dermatol	NOUN
dpc-4600	436	4	.	.	PUNCT
dpc-4600	437	1	2023;22(1):64	2023;22(1):64	NUM
dpc-4600	437	2	-	-	SYM
dpc-4600	437	3	73	73	NUM
dpc-4600	437	4	.	.	PUNCT
dpc-4600	438	1	doi	doi	NOUN
dpc-4600	438	2	:	:	PUNCT
dpc-4600	438	3	10.1111	10.1111	NUM
dpc-4600	438	4	/	/	SYM
dpc-4600	438	5	jocd.14770	jocd.14770	NOUN
dpc-4600	438	6	.	.	PUNCT
dpc-4600	439	1	pmid	pmid	NOUN
dpc-4600	439	2	:	:	PUNCT
dpc-4600	439	3	35029034	35029034	NUM
dpc-4600	439	4	.	.	PUNCT
dpc-4600	440	1	53	53	NUM
dpc-4600	440	2	.	.	PUNCT
dpc-4600	441	1	custurone	custurone	NOUN
dpc-4600	441	2	p	p	NOUN
dpc-4600	441	3	,	,	PUNCT
dpc-4600	441	4	di	di	X
dpc-4600	441	5	bartolomeo	bartolomeo	PROPN
dpc-4600	441	6	l	l	PROPN
dpc-4600	441	7	,	,	PUNCT
dpc-4600	441	8	irrera	irrera	NOUN
dpc-4600	441	9	n	n	CCONJ
dpc-4600	441	10	,	,	PUNCT
dpc-4600	441	11	et	et	PROPN
dpc-4600	441	12	al	al	PROPN
dpc-4600	441	13	.	.	PUNCT
dpc-4600	441	14	role	role	NOUN
dpc-4600	441	15	of	of	ADP
dpc-4600	441	16	cytokines	cytokine	NOUN
dpc-4600	441	17	in	in	ADP
dpc-4600	441	18	vitiligo	vitiligo	NOUN
dpc-4600	441	19	:	:	PUNCT
dpc-4600	441	20	pathogenesis	pathogenesis	NOUN
dpc-4600	441	21	and	and	CCONJ
dpc-4600	441	22	possible	possible	ADJ
dpc-4600	441	23	targets	target	NOUN
dpc-4600	441	24	for	for	ADP
dpc-4600	441	25	old	old	ADJ
dpc-4600	441	26	and	and	CCONJ
dpc-4600	441	27	new	new	ADJ
dpc-4600	441	28	treatments	treatment	NOUN
dpc-4600	441	29	.	.	PUNCT
dpc-4600	442	1	int	int	PROPN
dpc-4600	442	2	j	j	PROPN
dpc-4600	442	3	mol	mol	ADP
dpc-4600	442	4	sci	sci	PROPN
dpc-4600	442	5	.	.	PUNCT
dpc-4600	443	1	2021;22(21):11429	2021;22(21):11429	NUM
dpc-4600	443	2	.	.	PUNCT
dpc-4600	443	3	doi	doi	NOUN
dpc-4600	443	4	:	:	PUNCT
dpc-4600	443	5	10.3390	10.3390	NUM
dpc-4600	443	6	/ijms222111429	/ijms222111429	PUNCT
dpc-4600	443	7	.	.	PUNCT
dpc-4600	444	1	pmid	pmid	PROPN
dpc-4600	444	2	:	:	PUNCT
dpc-4600	444	3	34768860	34768860	NUM
dpc-4600	444	4	.	.	PUNCT
dpc-4600	445	1	54	54	NUM
dpc-4600	445	2	.	.	PUNCT
dpc-4600	446	1	mikhael	mikhael	PROPN
dpc-4600	446	2	nw	nw	PROPN
dpc-4600	446	3	,	,	PUNCT
dpc-4600	446	4	hamed	hamed	PROPN
dpc-4600	446	5	am	am	PROPN
dpc-4600	446	6	,	,	PUNCT
dpc-4600	446	7	elfallah	elfallah	PROPN
dpc-4600	446	8	aa	aa	PROPN
dpc-4600	446	9	,	,	PUNCT
dpc-4600	446	10	ahmed	ahmed	PROPN
dpc-4600	446	11	aa	aa	PROPN
dpc-4600	446	12	.	.	PROPN
dpc-4600	447	1	assessment	assessment	NOUN
dpc-4600	447	2	of	of	ADP
dpc-4600	447	3	serum	serum	NOUN
dpc-4600	447	4	level	level	NOUN
dpc-4600	447	5	of	of	ADP
dpc-4600	447	6	interleukin-17	interleukin-17	PROPN
dpc-4600	447	7	in	in	ADP
dpc-4600	447	8	patients	patient	NOUN
dpc-4600	447	9	with	with	ADP
dpc-4600	447	10	vitiligo	vitiligo	PROPN
dpc-4600	447	11	.	.	PUNCT
dpc-4600	448	1	benha	benha	NOUN
dpc-4600	448	2	journal	journal	PROPN
dpc-4600	448	3	of	of	ADP
dpc-4600	448	4	applied	apply	VERB
dpc-4600	448	5	sciences	science	NOUN
dpc-4600	448	6	.	.	PUNCT
dpc-4600	449	1	2021	2021	NUM
dpc-4600	450	1	may	may	AUX
dpc-4600	450	2	1;6(3):173	1;6(3):173	PROPN
dpc-4600	450	3	-	-	PUNCT
dpc-4600	450	4	6	6	NUM
dpc-4600	450	5	.	.	PUNCT
dpc-4600	450	6	doi	doi	NOUN
dpc-4600	450	7	:	:	PUNCT
dpc-4600	450	8	10.21608	10.21608	NUM
dpc-4600	450	9	/	/	SYM
dpc-4600	450	10	bjas.2021.188835	bjas.2021.188835	NOUN
dpc-4600	450	11	.	.	PUNCT
dpc-4600	451	1	a	a	DET
dpc-4600	451	2	randomized	randomized	ADJ
dpc-4600	451	3	phase	phase	NOUN
dpc-4600	451	4	2b	2b	NUM
dpc-4600	451	5	clinical	clinical	ADJ
dpc-4600	451	6	trial	trial	NOUN
dpc-4600	451	7	.	.	PUNCT
dpc-4600	452	1	j	j	PROPN
dpc-4600	452	2	am	be	AUX
dpc-4600	452	3	acad	acad	ADJ
dpc-4600	452	4	dermatol	dermatol	NOUN
dpc-4600	452	5	.	.	PUNCT
dpc-4600	453	1	2023	2023	NUM
dpc-4600	453	2	feb;88(2):395	feb;88(2):395	NOUN
dpc-4600	453	3	-	-	SYM
dpc-4600	453	4	403	403	NUM
dpc-4600	453	5	.	.	PUNCT
dpc-4600	454	1	doi	doi	NOUN
dpc-4600	454	2	:	:	PUNCT
dpc-4600	454	3	10.1016	10.1016	NUM
dpc-4600	454	4	/	/	SYM
dpc-4600	454	5	j.jaad.2022.11.005	j.jaad.2022.11.005	PROPN
dpc-4600	454	6	.	.	PUNCT
dpc-4600	455	1	epub	epub	PROPN
dpc-4600	455	2	2022	2022	NUM
dpc-4600	455	3	nov	nov	PROPN
dpc-4600	455	4	9	9	NUM
dpc-4600	455	5	.	.	PUNCT
dpc-4600	455	6	erratum	erratum	PROPN
dpc-4600	455	7	in	in	ADP
dpc-4600	455	8	:	:	PUNCT
dpc-4600	455	9	j	j	PROPN
dpc-4600	455	10	am	be	AUX
dpc-4600	455	11	acad	acad	ADJ
dpc-4600	455	12	dermatol	dermatol	NOUN
dpc-4600	455	13	.	.	PUNCT
dpc-4600	456	1	2023;89(3):639	2023;89(3):639	NUM
dpc-4600	456	2	.	.	PUNCT
dpc-4600	457	1	doi	doi	NOUN
dpc-4600	457	2	:	:	PUNCT
dpc-4600	457	3	10.1016	10.1016	NUM
dpc-4600	457	4	/	/	SYM
dpc-4600	457	5	j.jaad.2023.04.001	j.jaad.2023.04.001	PROPN
dpc-4600	457	6	.	.	PUNCT
dpc-4600	458	1	pmid	pmid	NOUN
dpc-4600	458	2	:	:	PUNCT
dpc-4600	458	3	36370907	36370907	NUM
dpc-4600	458	4	.	.	PUNCT
dpc-4600	459	1	26	26	NUM
dpc-4600	459	2	.	.	PUNCT
dpc-4600	460	1	yagi	yagi	PROPN
dpc-4600	460	2	k	k	PROPN
dpc-4600	460	3	,	,	PUNCT
dpc-4600	460	4	ishida	ishida	PROPN
dpc-4600	460	5	y	y	PROPN
dpc-4600	460	6	,	,	PUNCT
dpc-4600	460	7	otsuka	otsuka	PROPN
dpc-4600	460	8	a	a	PROPN
dpc-4600	460	9	,	,	PUNCT
dpc-4600	460	10	kabashima	kabashima	PROPN
dpc-4600	460	11	k.	k.	PROPN
dpc-4600	460	12	two	two	NUM
dpc-4600	460	13	cases	case	NOUN
dpc-4600	460	14	of	of	ADP
dpc-4600	460	15	vitiligo	vitiligo	ADJ
dpc-4600	460	16	vulgaris	vulgaris	NOUN
dpc-4600	460	17	treated	treat	VERB
dpc-4600	460	18	with	with	ADP
dpc-4600	460	19	topical	topical	ADJ
dpc-4600	460	20	janus	janus	PROPN
dpc-4600	460	21	kinase	kinase	PROPN
dpc-4600	460	22	inhibitor	inhibitor	NOUN
dpc-4600	460	23	delgocitinib	delgocitinib	NOUN
dpc-4600	460	24	.	.	PUNCT
dpc-4600	461	1	australas	australas	PROPN
dpc-4600	461	2	j	j	PROPN
dpc-4600	461	3	dermatol	dermatol	NOUN
dpc-4600	461	4	.	.	PUNCT
dpc-4600	462	1	2021;62(3):433	2021;62(3):433	NUM
dpc-4600	462	2	-	-	PUNCT
dpc-4600	462	3	434	434	NUM
dpc-4600	462	4	.	.	PUNCT
dpc-4600	463	1	doi	doi	NOUN
dpc-4600	463	2	:	:	PUNCT
dpc-4600	463	3	10.1111	10.1111	NUM
dpc-4600	463	4	/ajd.13572.pmid	/ajd.13572.pmid	NOUN
dpc-4600	463	5	:	:	PUNCT
dpc-4600	463	6	33667323	33667323	NUM
dpc-4600	463	7	.	.	PUNCT
dpc-4600	464	1	27	27	NUM
dpc-4600	464	2	.	.	PUNCT
dpc-4600	464	3	https://investor.incyte.com/news-releases/news-release-details	https://investor.incyte.com/news-releases/news-release-detail	VERB
dpc-4600	464	4	/incyte	/incyte	NOUN
dpc-4600	464	5	-	-	PUNCT
dpc-4600	464	6	announces	announce	NOUN
dpc-4600	464	7	-	-	PUNCT
dpc-4600	464	8	positive-52	positive-52	ADJ
dpc-4600	464	9	-	-	PUNCT
dpc-4600	464	10	week	week	NOUN
dpc-4600	464	11	-	-	PUNCT
dpc-4600	464	12	data	data	NOUN
dpc-4600	464	13	-	-	PUNCT
dpc-4600	464	14	phase-2b	phase-2b	NOUN
dpc-4600	464	15	-	-	PUNCT
dpc-4600	464	16	study	study	NOUN
dpc-4600	464	17	evaluating	evaluating	NOUN
dpc-4600	464	18	.	.	PUNCT
dpc-4600	465	1	28	28	NUM
dpc-4600	465	2	.	.	PUNCT
dpc-4600	466	1	diotallevi	diotallevi	PROPN
dpc-4600	466	2	f	f	PROPN
dpc-4600	466	3	,	,	PUNCT
dpc-4600	466	4	gioacchini	gioacchini	NOUN
dpc-4600	466	5	h	h	NOUN
dpc-4600	466	6	,	,	PUNCT
dpc-4600	466	7	de	de	X
dpc-4600	466	8	simoni	simoni	PROPN
dpc-4600	466	9	e	e	PROPN
dpc-4600	466	10	,	,	PUNCT
dpc-4600	466	11	et	et	PROPN
dpc-4600	466	12	al	al	PROPN
dpc-4600	466	13	.	.	PROPN
dpc-4600	466	14	vitiligo	vitiligo	PROPN
dpc-4600	466	15	,	,	PUNCT
dpc-4600	466	16	from	from	ADP
dpc-4600	466	17	pathogenesis	pathogenesis	NOUN
dpc-4600	466	18	to	to	ADP
dpc-4600	466	19	therapeutic	therapeutic	ADJ
dpc-4600	466	20	advances	advance	NOUN
dpc-4600	466	21	:	:	PUNCT
dpc-4600	466	22	state	state	NOUN
dpc-4600	466	23	of	of	ADP
dpc-4600	466	24	the	the	DET
dpc-4600	466	25	art	art	NOUN
dpc-4600	466	26	.	.	PUNCT
dpc-4600	467	1	int	int	PROPN
dpc-4600	467	2	j	j	PROPN
dpc-4600	467	3	mol	mol	ADP
dpc-4600	467	4	sci	sci	PROPN
dpc-4600	467	5	.	.	PUNCT
dpc-4600	468	1	2023;24(5):4910	2023;24(5):4910	NUM
dpc-4600	468	2	.	.	PUNCT
dpc-4600	469	1	doi	doi	NOUN
dpc-4600	469	2	:	:	PUNCT
dpc-4600	469	3	10.3390	10.3390	NUM
dpc-4600	469	4	/	/	SYM
dpc-4600	469	5	ijms24054910	ijms24054910	PROPN
dpc-4600	469	6	.	.	PUNCT
dpc-4600	470	1	pmid	pmid	NOUN
dpc-4600	470	2	:	:	PUNCT
dpc-4600	470	3	36902341	36902341	NUM
dpc-4600	470	4	.	.	PUNCT
dpc-4600	471	1	29	29	NUM
dpc-4600	471	2	.	.	X
dpc-4600	471	3	nagui	nagui	PROPN
dpc-4600	471	4	na	na	PROPN
dpc-4600	471	5	,	,	PUNCT
dpc-4600	471	6	el	el	PROPN
dpc-4600	471	7	-	-	PUNCT
dpc-4600	471	8	tartoushy	tartoushy	ADJ
dpc-4600	471	9	sa	sa	PROPN
dpc-4600	471	10	,	,	PUNCT
dpc-4600	471	11	rashed	rashe	VERB
dpc-4600	471	12	la	la	PROPN
dpc-4600	471	13	,	,	PUNCT
dpc-4600	471	14	elmasry	elmasry	PROPN
dpc-4600	471	15	mf	mf	NOUN
dpc-4600	471	16	.	.	PROPN
dpc-4600	471	17	assessment	assessment	NOUN
dpc-4600	471	18	of	of	ADP
dpc-4600	471	19	prostaglandin	prostaglandin	VERB
dpc-4600	471	20	f2	f2	NOUN
dpc-4600	471	21	-	-	PUNCT
dpc-4600	471	22	alpha	alpha	NOUN
dpc-4600	471	23	(	(	PUNCT
dpc-4600	471	24	pgf2α	pgf2α	X
dpc-4600	471	25	)	)	PUNCT
dpc-4600	471	26	in	in	ADP
dpc-4600	471	27	lesional	lesional	ADJ
dpc-4600	471	28	and	and	CCONJ
dpc-4600	471	29	nonlesional	nonlesional	ADJ
dpc-4600	471	30	skin	skin	NOUN
dpc-4600	471	31	of	of	ADP
dpc-4600	471	32	vitiligo	vitiligo	ADJ
dpc-4600	471	33	patients	patient	NOUN
dpc-4600	471	34	.	.	PUNCT
dpc-4600	472	1	int	int	NOUN
dpc-4600	472	2	j	j	PROPN
dpc-4600	472	3	dermatol	dermatol	NOUN
dpc-4600	472	4	.	.	PUNCT
dpc-4600	473	1	2022;61(11):1390	2022;61(11):1390	NUM
dpc-4600	473	2	-	-	SYM
dpc-4600	473	3	1396	1396	NUM
dpc-4600	473	4	.	.	PUNCT
dpc-4600	474	1	doi	doi	NOUN
dpc-4600	474	2	:	:	PUNCT
dpc-4600	474	3	10.1111	10.1111	NUM
dpc-4600	474	4	/	/	SYM
dpc-4600	474	5	ijd.16307.pmid	ijd.16307.pmid	ADJ
dpc-4600	474	6	:	:	PUNCT
dpc-4600	474	7	35726457	35726457	NUM
dpc-4600	474	8	.	.	PUNCT
dpc-4600	475	1	30	30	NUM
dpc-4600	475	2	.	.	PUNCT
dpc-4600	476	1	jha	jha	PROPN
dpc-4600	476	2	ak	ak	PROPN
dpc-4600	476	3	,	,	PUNCT
dpc-4600	476	4	prasad	prasad	PROPN
dpc-4600	476	5	s	s	PROPN
dpc-4600	476	6	,	,	PUNCT
dpc-4600	476	7	sinha	sinha	PROPN
dpc-4600	476	8	r.	r.	PROPN
dpc-4600	476	9	bimatoprost	bimatoprost	ADJ
dpc-4600	476	10	ophthalmic	ophthalmic	ADJ
dpc-4600	476	11	solution	solution	NOUN
dpc-4600	476	12	in	in	ADP
dpc-4600	476	13	facial	facial	ADJ
dpc-4600	476	14	vitiligo	vitiligo	NOUN
dpc-4600	476	15	.	.	PUNCT
dpc-4600	477	1	j	j	PROPN
dpc-4600	477	2	cosmet	cosmet	PROPN
dpc-4600	477	3	dermatol	dermatol	NOUN
dpc-4600	477	4	.	.	PUNCT
dpc-4600	478	1	2018;17(3):437	2018;17(3):437	NUM
dpc-4600	478	2	-	-	SYM
dpc-4600	478	3	440	440	NUM
dpc-4600	478	4	.	.	PUNCT
dpc-4600	479	1	doi	doi	NOUN
dpc-4600	479	2	:	:	PUNCT
dpc-4600	479	3	10.1111	10.1111	NUM
dpc-4600	479	4	/	/	SYM
dpc-4600	479	5	jocd.12443	jocd.12443	PROPN
dpc-4600	479	6	.	.	PUNCT
dpc-4600	480	1	pmid	pmid	PROPN
dpc-4600	480	2	:	:	PUNCT
dpc-4600	480	3	29034590	29034590	NUM
dpc-4600	480	4	.	.	PUNCT
dpc-4600	481	1	31	31	NUM
dpc-4600	481	2	.	.	PUNCT
dpc-4600	482	1	kanti	kanti	PROPN
dpc-4600	482	2	v	v	PROPN
dpc-4600	482	3	,	,	PUNCT
dpc-4600	482	4	puder	puder	PROPN
dpc-4600	482	5	l	l	PROPN
dpc-4600	482	6	,	,	PUNCT
dpc-4600	482	7	jahnke	jahnke	PROPN
dpc-4600	482	8	i	i	PRON
dpc-4600	482	9	,	,	PUNCT
dpc-4600	482	10	et	et	PROPN
dpc-4600	482	11	al	al	PROPN
dpc-4600	482	12	.	.	PUNCT
dpc-4600	483	1	a	a	DET
dpc-4600	483	2	melanocortin-4	melanocortin-4	NUM
dpc-4600	483	3	receptor	receptor	NOUN
dpc-4600	483	4	agonist	agonist	NOUN
dpc-4600	483	5	induces	induce	VERB
dpc-4600	483	6	skin	skin	NOUN
dpc-4600	483	7	and	and	CCONJ
dpc-4600	483	8	hair	hair	NOUN
dpc-4600	483	9	pigmentation	pigmentation	NOUN
dpc-4600	483	10	in	in	ADP
dpc-4600	483	11	patients	patient	NOUN
dpc-4600	483	12	with	with	ADP
dpc-4600	483	13	monogenic	monogenic	ADJ
dpc-4600	483	14	mutations	mutation	NOUN
dpc-4600	483	15	in	in	ADP
dpc-4600	483	16	the	the	DET
dpc-4600	483	17	leptin	leptin	NOUN
dpc-4600	483	18	-	-	PUNCT
dpc-4600	483	19	melanocortin	melanocortin	NOUN
dpc-4600	483	20	pathway	pathway	NOUN
dpc-4600	483	21	.	.	PUNCT
dpc-4600	484	1	skin	skin	NOUN
dpc-4600	484	2	pharmacol	pharmacol	PROPN
dpc-4600	484	3	physiol	physiol	PROPN
dpc-4600	484	4	.	.	PUNCT
dpc-4600	485	1	2021;34(6):307	2021;34(6):307	NUM
dpc-4600	485	2	-	-	SYM
dpc-4600	485	3	316	316	NUM
dpc-4600	485	4	.	.	PUNCT
dpc-4600	485	5	doi	doi	NOUN
dpc-4600	485	6	:	:	PUNCT
dpc-4600	485	7	10.1159	10.1159	NUM
dpc-4600	485	8	/000516282	/000516282	PUNCT
dpc-4600	485	9	.	.	PUNCT
dpc-4600	486	1	pmid	pmid	NOUN
dpc-4600	486	2	:	:	PUNCT
dpc-4600	486	3	34058738	34058738	NUM
dpc-4600	486	4	.	.	PUNCT
dpc-4600	487	1	32	32	NUM
dpc-4600	487	2	.	.	PUNCT
dpc-4600	488	1	stiegler	stiegler	PROPN
dpc-4600	488	2	j	j	PROPN
dpc-4600	488	3	,	,	PUNCT
dpc-4600	488	4	brickley	brickley	PROPN
dpc-4600	488	5	s.	s.	PROPN
dpc-4600	488	6	vitiligo	vitiligo	VERB
dpc-4600	488	7	:	:	PUNCT
dpc-4600	488	8	a	a	DET
dpc-4600	488	9	comprehensive	comprehensive	ADJ
dpc-4600	488	10	overview	overview	NOUN
dpc-4600	488	11	.	.	PUNCT
dpc-4600	489	1	journal	journal	NOUN
dpc-4600	489	2	of	of	ADP
dpc-4600	489	3	the	the	DET
dpc-4600	489	4	dermatology	dermatology	NOUN
dpc-4600	489	5	nurses	nurse	NOUN
dpc-4600	489	6	’	'	PUNCT
dpc-4600	489	7	association	association	NOUN
dpc-4600	489	8	.	.	PUNCT
dpc-4600	490	1	2021	2021	NUM
dpc-4600	490	2	;	;	PUNCT
dpc-4600	490	3	13:18	13:18	NUM
dpc-4600	490	4	-	-	SYM
dpc-4600	490	5	27	27	NUM
dpc-4600	490	6	.	.	PUNCT
dpc-4600	491	1	doi	doi	NOUN
dpc-4600	491	2	:	:	PUNCT
dpc-4600	491	3	 	 	SPACE
dpc-4600	491	4	10.1097	10.1097	NUM
dpc-4600	491	5	/	/	SYM
dpc-4600	491	6	jdn.0000000000000589	jdn.0000000000000589	NUM
dpc-4600	491	7	33	33	NUM
dpc-4600	491	8	.	.	PUNCT
dpc-4600	492	1	kubelis	kubelis	PROPN
dpc-4600	492	2	-	-	PUNCT
dpc-4600	492	3	lópez	lópez	PROPN
dpc-4600	492	4	de	de	X
dpc-4600	492	5	,	,	PUNCT
dpc-4600	492	6	zapata	zapata	NOUN
dpc-4600	492	7	-	-	PUNCT
dpc-4600	492	8	salazar	salazar	PROPN
dpc-4600	492	9	na	na	NOUN
dpc-4600	492	10	,	,	PUNCT
dpc-4600	492	11	said	say	VERB
dpc-4600	492	12	-	-	PUNCT
dpc-4600	492	13	fernández	fernández	PROPN
dpc-4600	492	14	sl	sl	INTJ
dpc-4600	492	15	,	,	PUNCT
dpc-4600	492	16	et	et	PROPN
dpc-4600	492	17	al	al	PROPN
dpc-4600	492	18	.	.	PROPN
dpc-4600	493	1	updates	update	NOUN
dpc-4600	493	2	and	and	CCONJ
dpc-4600	493	3	new	new	ADJ
dpc-4600	493	4	medical	medical	ADJ
dpc-4600	493	5	treatments	treatment	NOUN
dpc-4600	493	6	for	for	ADP
dpc-4600	493	7	vitiligo	vitiligo	NOUN
dpc-4600	493	8	(	(	PUNCT
dpc-4600	493	9	review	review	NOUN
dpc-4600	493	10	)	)	PUNCT
dpc-4600	493	11	.	.	PUNCT
dpc-4600	494	1	exp	exp	NOUN
dpc-4600	494	2	ther	ther	PROPN
dpc-4600	494	3	med	me	VERB
dpc-4600	494	4	.	.	PUNCT
dpc-4600	495	1	2021	2021	NUM
dpc-4600	495	2	aug;22(2):797	aug;22(2):797	NOUN
dpc-4600	495	3	.	.	PUNCT
dpc-4600	496	1	doi	doi	NOUN
dpc-4600	496	2	:	:	PUNCT
dpc-4600	496	3	10.3892	10.3892	NUM
dpc-4600	496	4	/	/	SYM
dpc-4600	496	5	etm.2021.10229	etm.2021.10229	PROPN
dpc-4600	496	6	.	.	PUNCT
dpc-4600	497	1	pmid	pmid	NOUN
dpc-4600	497	2	:	:	PUNCT
dpc-4600	497	3	34093753	34093753	NUM
dpc-4600	497	4	.	.	PUNCT
dpc-4600	498	1	34	34	NUM
dpc-4600	498	2	.	.	PUNCT
dpc-4600	499	1	alshiyab	alshiyab	PROPN
dpc-4600	499	2	dm	dm	PROPN
dpc-4600	499	3	,	,	PUNCT
dpc-4600	499	4	al	al	PROPN
dpc-4600	499	5	-	-	PUNCT
dpc-4600	499	6	qarqaz	qarqaz	X
dpc-4600	499	7	fa	fa	PROPN
dpc-4600	499	8	,	,	PUNCT
dpc-4600	499	9	muhaidat	muhaidat	PROPN
dpc-4600	499	10	jm	jm	PROPN
dpc-4600	499	11	,	,	PUNCT
dpc-4600	499	12	alkhader	alkhader	PROPN
dpc-4600	499	13	ys	ys	PROPN
dpc-4600	499	14	,	,	PUNCT
dpc-4600	499	15	al	al	PROPN
dpc-4600	499	16	-	-	PUNCT
dpc-4600	499	17	sheyab	sheyab	PROPN
dpc-4600	499	18	rf	rf	PROPN
dpc-4600	499	19	,	,	PUNCT
dpc-4600	499	20	jafaar	jafaar	NOUN
dpc-4600	499	21	si	si	PROPN
dpc-4600	499	22	.	.	PROPN
dpc-4600	499	23	comparison	comparison	NOUN
dpc-4600	499	24	of	of	ADP
dpc-4600	499	25	the	the	DET
dpc-4600	499	26	efficacy	efficacy	NOUN
dpc-4600	499	27	of	of	ADP
dpc-4600	499	28	tacrolimus	tacrolimus	NOUN
dpc-4600	499	29	0.1	0.1	NUM
dpc-4600	499	30	%	%	NOUN
dpc-4600	499	31	ointment	ointment	NOUN
dpc-4600	499	32	and	and	CCONJ
dpc-4600	499	33	tacrolimus	tacrolimus	NOUN
dpc-4600	499	34	0.1	0.1	NUM
dpc-4600	499	35	%	%	NOUN
dpc-4600	499	36	plus	plus	CCONJ
dpc-4600	499	37	topical	topical	ADJ
dpc-4600	499	38	pseudocatalase	pseudocatalase	NOUN
dpc-4600	499	39	/	/	SYM
dpc-4600	499	40	superoxide	superoxide	NOUN
dpc-4600	499	41	dismutase	dismutase	NOUN
dpc-4600	499	42	gel	gel	NOUN
dpc-4600	499	43	in	in	ADP
dpc-4600	499	44	children	child	NOUN
dpc-4600	499	45	with	with	ADP
dpc-4600	499	46	limited	limited	ADJ
dpc-4600	499	47	vitiligo	vitiligo	NOUN
dpc-4600	499	48	:	:	PUNCT
dpc-4600	499	49	a	a	DET
dpc-4600	499	50	randomized	randomized	ADJ
dpc-4600	499	51	controlled	control	VERB
dpc-4600	499	52	trial	trial	NOUN
dpc-4600	499	53	.	.	PUNCT
dpc-4600	500	1	j	j	PROPN
dpc-4600	500	2	dermatolog	dermatolog	PROPN
dpc-4600	500	3	treat	treat	NOUN
dpc-4600	500	4	.	.	PUNCT
dpc-4600	501	1	2022;33(1):146	2022;33(1):146	NUM
dpc-4600	501	2	-	-	PUNCT
dpc-4600	501	3	149	149	NUM
dpc-4600	501	4	.	.	PUNCT
dpc-4600	502	1	doi	doi	NOUN
dpc-4600	502	2	:	:	PUNCT
dpc-4600	502	3	10.1080/09546634.2020.1729952	10.1080/09546634.2020.1729952	NUM
dpc-4600	502	4	.	.	PUNCT
dpc-4600	503	1	pmid	pmid	NOUN
dpc-4600	503	2	:	:	PUNCT
dpc-4600	503	3	32048900	32048900	NUM
dpc-4600	503	4	.	.	PUNCT
dpc-4600	504	1	35	35	NUM
dpc-4600	504	2	.	.	PUNCT
dpc-4600	505	1	liu	liu	PROPN
dpc-4600	505	2	j	j	PROPN
dpc-4600	505	3	,	,	PUNCT
dpc-4600	505	4	li	li	PROPN
dpc-4600	505	5	jy	jy	PROPN
dpc-4600	505	6	,	,	PUNCT
dpc-4600	505	7	xu	xu	PROPN
dpc-4600	505	8	jj	jj	PROPN
dpc-4600	505	9	,	,	PUNCT
dpc-4600	505	10	et	et	PROPN
dpc-4600	505	11	al	al	PROPN
dpc-4600	505	12	.	.	PROPN
dpc-4600	505	13	advances	advance	NOUN
dpc-4600	505	14	in	in	ADP
dpc-4600	505	15	the	the	DET
dpc-4600	505	16	function	function	NOUN
dpc-4600	505	17	of	of	ADP
dpc-4600	505	18	traditional	traditional	ADJ
dpc-4600	505	19	medicine	medicine	NOUN
dpc-4600	505	20	for	for	ADP
dpc-4600	505	21	vitiligo	vitiligo	ADJ
dpc-4600	505	22	treatment	treatment	NOUN
dpc-4600	505	23	.	.	PUNCT
dpc-4600	506	1	tradit	tradit	PROPN
dpc-4600	506	2	med	med	ADJ
dpc-4600	506	3	res	re	NOUN
dpc-4600	506	4	.	.	PUNCT
dpc-4600	507	1	2024;9(3):17	2024;9(3):17	NUM
dpc-4600	507	2	.	.	PUNCT
dpc-4600	507	3	doi	doi	NOUN
dpc-4600	507	4	:	:	PUNCT
dpc-4600	507	5	10.53388	10.53388	NUM
dpc-4600	507	6	/	/	SYM
dpc-4600	507	7	tmr20230815002	tmr20230815002	NOUN
dpc-4600	507	8	.	.	PUNCT
dpc-4600	508	1	36	36	NUM
dpc-4600	508	2	.	.	PUNCT
dpc-4600	509	1	białczyk	białczyk	PROPN
dpc-4600	509	2	a	a	PRON
dpc-4600	509	3	,	,	PUNCT
dpc-4600	509	4	wełniak	wełniak	NOUN
dpc-4600	509	5	a	a	PRON
dpc-4600	509	6	,	,	PUNCT
dpc-4600	509	7	kamińska	kamińska	PROPN
dpc-4600	509	8	b	b	PROPN
dpc-4600	509	9	,	,	PUNCT
dpc-4600	509	10	czajkowski	czajkowski	PROPN
dpc-4600	509	11	r.	r.	PROPN
dpc-4600	509	12	oxidative	oxidative	ADJ
dpc-4600	509	13	stress	stress	NOUN
dpc-4600	509	14	and	and	CCONJ
dpc-4600	509	15	potential	potential	ADJ
dpc-4600	509	16	antioxidant	antioxidant	ADJ
dpc-4600	509	17	therapies	therapy	NOUN
dpc-4600	509	18	in	in	ADP
dpc-4600	509	19	vitiligo	vitiligo	NOUN
dpc-4600	509	20	:	:	PUNCT
dpc-4600	509	21	a	a	DET
dpc-4600	509	22	narrative	narrative	NOUN
dpc-4600	509	23	review	review	NOUN
dpc-4600	509	24	.	.	PUNCT
dpc-4600	510	1	mol	mol	ADP
dpc-4600	510	2	diagn	diagn	PROPN
dpc-4600	510	3	ther	ther	PROPN
dpc-4600	510	4	.	.	PUNCT
dpc-4600	511	1	2023;27(6):723	2023;27(6):723	PROPN
dpc-4600	511	2	-	-	SYM
dpc-4600	511	3	739	739	NUM
dpc-4600	511	4	.	.	PUNCT
dpc-4600	511	5	doi	doi	NOUN
dpc-4600	511	6	:	:	PUNCT
dpc-4600	511	7	10.1007	10.1007	NUM
dpc-4600	511	8	/s40291	/s40291	ADJ
dpc-4600	511	9	-	-	PUNCT
dpc-4600	511	10	023	023	NUM
dpc-4600	511	11	-	-	PUNCT
dpc-4600	511	12	00672	00672	NUM
dpc-4600	511	13	-	-	PUNCT
dpc-4600	511	14	z.	z.	NOUN
dpc-4600	511	15	pmid	pmid	PROPN
dpc-4600	511	16	:	:	PUNCT
dpc-4600	511	17	37737953	37737953	NUM
dpc-4600	511	18	.	.	PUNCT
dpc-4600	512	1	37	37	NUM
dpc-4600	512	2	.	.	PUNCT
dpc-4600	512	3	shakhbazova	shakhbazova	PROPN
dpc-4600	512	4	a	a	DET
dpc-4600	512	5	,	,	PUNCT
dpc-4600	512	6	wu	wu	PROPN
dpc-4600	512	7	h	h	PROPN
dpc-4600	512	8	,	,	PUNCT
dpc-4600	512	9	chambers	chambers	PROPN
dpc-4600	512	10	cj	cj	NUM
dpc-4600	512	11	,	,	PUNCT
dpc-4600	512	12	sivamani	sivamani	PROPN
dpc-4600	512	13	rk	rk	NOUN
dpc-4600	512	14	.	.	PUNCT
dpc-4600	513	1	a	a	DET
dpc-4600	513	2	systematic	systematic	ADJ
dpc-4600	513	3	review	review	NOUN
dpc-4600	513	4	of	of	ADP
dpc-4600	513	5	nutrition	nutrition	NOUN
dpc-4600	513	6	,	,	PUNCT
dpc-4600	513	7	supplement	supplement	NOUN
dpc-4600	513	8	,	,	PUNCT
dpc-4600	513	9	and	and	CCONJ
dpc-4600	513	10	herbal	herbal	ADV
dpc-4600	513	11	-	-	PUNCT
dpc-4600	513	12	based	base	VERB
dpc-4600	513	13	adjunctive	adjunctive	ADJ
dpc-4600	513	14	therapies	therapy	NOUN
dpc-4600	513	15	for	for	ADP
dpc-4600	513	16	vitiligo	vitiligo	NOUN
dpc-4600	513	17	.	.	PUNCT
dpc-4600	514	1	j	j	PROPN
dpc-4600	514	2	altern	altern	PROPN
dpc-4600	514	3	complement	complement	PROPN
dpc-4600	514	4	med	me	VERB
dpc-4600	514	5	.	.	PUNCT
dpc-4600	515	1	2021;27(4	2021;27(4	NUM
dpc-4600	515	2	):	):	PUNCT
dpc-4600	515	3	294	294	NUM
dpc-4600	515	4	-	-	SYM
dpc-4600	515	5	311	311	NUM
dpc-4600	515	6	.	.	PUNCT
dpc-4600	516	1	doi	doi	NOUN
dpc-4600	516	2	:	:	PUNCT
dpc-4600	516	3	10.1089	10.1089	NUM
dpc-4600	516	4	/	/	SYM
dpc-4600	516	5	acm.2020.0292.pmid	acm.2020.0292.pmid	NOUN
dpc-4600	516	6	:	:	PUNCT
dpc-4600	516	7	33337930	33337930	NUM
dpc-4600	516	8	.	.	PUNCT
dpc-4600	517	1	38	38	NUM
dpc-4600	517	2	.	.	PUNCT
dpc-4600	518	1	tóth	tóth	PROPN
dpc-4600	518	2	f	f	PROPN
dpc-4600	518	3	,	,	PUNCT
dpc-4600	518	4	cseh	cseh	PROPN
dpc-4600	518	5	ek	ek	PROPN
dpc-4600	518	6	,	,	PUNCT
dpc-4600	518	7	vécsei	vécsei	PROPN
dpc-4600	518	8	l.	l.	PROPN
dpc-4600	518	9	natural	natural	ADJ
dpc-4600	518	10	molecules	molecule	NOUN
dpc-4600	518	11	and	and	CCONJ
dpc-4600	518	12	neuroprotection	neuroprotection	NOUN
dpc-4600	518	13	:	:	PUNCT
dpc-4600	518	14	kynurenic	kynurenic	ADJ
dpc-4600	518	15	acid	acid	NOUN
dpc-4600	518	16	,	,	PUNCT
dpc-4600	518	17	pantethine	pantethine	NOUN
dpc-4600	518	18	and	and	CCONJ
dpc-4600	518	19	α	α	NOUN
dpc-4600	518	20	-	-	PUNCT
dpc-4600	518	21	lipoic	lipoic	ADJ
dpc-4600	518	22	acid	acid	NOUN
dpc-4600	518	23	.	.	PUNCT
dpc-4600	519	1	int	int	PROPN
dpc-4600	519	2	j	j	PROPN
dpc-4600	519	3	mol	mol	ADP
dpc-4600	519	4	sci	sci	PROPN
dpc-4600	519	5	.	.	PUNCT
dpc-4600	520	1	2021;22(1):403	2021;22(1):403	NOUN
dpc-4600	520	2	.	.	PUNCT
dpc-4600	521	1	doi	doi	NOUN
dpc-4600	521	2	:	:	PUNCT
dpc-4600	521	3	10.3390	10.3390	NUM
dpc-4600	521	4	/	/	SYM
dpc-4600	521	5	ijms22010403	ijms22010403	NOUN
dpc-4600	521	6	.	.	PUNCT
dpc-4600	522	1	pmid	pmid	NOUN
dpc-4600	522	2	:	:	PUNCT
dpc-4600	522	3	33401674	33401674	NUM
dpc-4600	522	4	.	.	PUNCT
dpc-4600	523	1	39	39	NUM
dpc-4600	523	2	.	.	PUNCT
dpc-4600	524	1	sun	sun	PROPN
dpc-4600	524	2	y	y	PROPN
dpc-4600	524	3	,	,	PUNCT
dpc-4600	524	4	guan	guan	PROPN
dpc-4600	524	5	x	x	PROPN
dpc-4600	524	6	,	,	PUNCT
dpc-4600	524	7	wang	wang	PROPN
dpc-4600	524	8	h	h	PROPN
dpc-4600	524	9	,	,	PUNCT
dpc-4600	524	10	et	et	PROPN
dpc-4600	524	11	al	al	PROPN
dpc-4600	524	12	.	.	PROPN
dpc-4600	524	13	randomized	randomize	VERB
dpc-4600	524	14	clinical	clinical	ADJ
dpc-4600	524	15	trial	trial	NOUN
dpc-4600	524	16	of	of	ADP
dpc-4600	524	17	combined	combine	VERB
dpc-4600	524	18	therapy	therapy	NOUN
dpc-4600	524	19	with	with	ADP
dpc-4600	524	20	oral	oral	ADJ
dpc-4600	524	21	α	α	PRON
dpc-4600	524	22	-	-	ADJ
dpc-4600	524	23	lipoic	lipoic	ADJ
dpc-4600	524	24	acid	acid	NOUN
dpc-4600	524	25	and	and	CCONJ
dpc-4600	524	26	nb	nb	NOUN
dpc-4600	524	27	-	-	PUNCT
dpc-4600	524	28	uvb	uvb	ADJ
dpc-4600	524	29	for	for	ADP
dpc-4600	524	30	nonsegmental	nonsegmental	ADJ
dpc-4600	524	31	stable	stable	ADJ
dpc-4600	524	32	vitiligo	vitiligo	NOUN
dpc-4600	524	33	.	.	PUNCT
dpc-4600	525	1	dermatol	dermatol	NOUN
dpc-4600	525	2	ther	ther	ADV
dpc-4600	525	3	.	.	PUNCT
dpc-4600	526	1	2021;34(1):e14610	2021;34(1):e14610	X
dpc-4600	526	2	.	.	PUNCT
dpc-4600	526	3	doi	doi	NOUN
dpc-4600	526	4	:	:	PUNCT
dpc-4600	526	5	10.1111	10.1111	NUM
dpc-4600	526	6	/	/	SYM
dpc-4600	526	7	dth.14610	dth.14610	PROPN
dpc-4600	526	8	.	.	PUNCT
dpc-4600	527	1	pmid	pmid	NOUN
dpc-4600	527	2	:	:	PUNCT
dpc-4600	527	3	33258534	33258534	NUM
dpc-4600	527	4	.	.	PUNCT
dpc-4600	528	1	review	review	VERB
dpc-4600	528	2	|	|	ADV
dpc-4600	528	3	dermatol	dermatol	ADJ
dpc-4600	528	4	pract	pract	NOUN
dpc-4600	528	5	concept	concept	NOUN
dpc-4600	528	6	.	.	PUNCT
dpc-4600	529	1	2025;15(1):4600	2025;15(1):4600	NUM
dpc-4600	529	2	11	11	NUM
dpc-4600	529	3	63	63	NUM
dpc-4600	529	4	.	.	PUNCT
dpc-4600	530	1	li	li	PROPN
dpc-4600	530	2	c	c	PROPN
dpc-4600	530	3	,	,	PUNCT
dpc-4600	530	4	hu	hu	PROPN
dpc-4600	530	5	y	y	PROPN
dpc-4600	530	6	,	,	PUNCT
dpc-4600	530	7	mu	mu	PROPN
dpc-4600	530	8	z	z	PROPN
dpc-4600	530	9	,	,	PUNCT
dpc-4600	530	10	et	et	PROPN
dpc-4600	530	11	al	al	PROPN
dpc-4600	530	12	.	.	PROPN
dpc-4600	530	13	comparison	comparison	NOUN
dpc-4600	530	14	of	of	ADP
dpc-4600	530	15	various	various	ADJ
dpc-4600	530	16	excimer	excimer	NOUN
dpc-4600	530	17	laser	laser	NOUN
dpc-4600	530	18	(	(	PUNCT
dpc-4600	530	19	el	el	NOUN
dpc-4600	530	20	)	)	PUNCT
dpc-4600	530	21	combination	combination	NOUN
dpc-4600	530	22	therapies	therapy	NOUN
dpc-4600	530	23	for	for	ADP
dpc-4600	530	24	vitiligo	vitiligo	NOUN
dpc-4600	530	25	:	:	PUNCT
dpc-4600	530	26	a	a	DET
dpc-4600	530	27	systematic	systematic	ADJ
dpc-4600	530	28	review	review	NOUN
dpc-4600	530	29	and	and	CCONJ
dpc-4600	530	30	network	network	NOUN
dpc-4600	530	31	meta	meta	ADJ
dpc-4600	530	32	-	-	PUNCT
dpc-4600	530	33	analysis	analysis	NOUN
dpc-4600	530	34	.	.	PUNCT
dpc-4600	531	1	j	j	PROPN
dpc-4600	531	2	dermatolog	dermatolog	PROPN
dpc-4600	531	3	treat	treat	NOUN
dpc-4600	531	4	.	.	PUNCT
dpc-4600	532	1	2024;35(1):2302064	2024;35(1):2302064	NUM
dpc-4600	532	2	.	.	PUNCT
dpc-4600	533	1	doi	doi	NOUN
dpc-4600	533	2	:	:	PUNCT
dpc-4600	533	3	10.1080/09546634.2024.2302064.pmid	10.1080/09546634.2024.2302064.pmid	NUM
dpc-4600	533	4	:	:	PUNCT
dpc-4600	533	5	38230424	38230424	NUM
dpc-4600	533	6	.	.	PUNCT
dpc-4600	534	1	64	64	NUM
dpc-4600	534	2	.	.	PUNCT
dpc-4600	535	1	do	do	VERB
dpc-4600	535	2	ht	ht	PROPN
dpc-4600	535	3	,	,	PUNCT
dpc-4600	535	4	nguyen	nguyen	PROPN
dpc-4600	535	5	ht	ht	PROPN
dpc-4600	535	6	,	,	PUNCT
dpc-4600	535	7	kanekura	kanekura	NOUN
dpc-4600	535	8	t.	t.	PROPN
dpc-4600	535	9	efficacy	efficacy	NOUN
dpc-4600	535	10	of	of	ADP
dpc-4600	535	11	308	308	NUM
dpc-4600	535	12	-	-	PUNCT
dpc-4600	535	13	nm	nm	ADV
dpc-4600	535	14	monochromatic	monochromatic	ADJ
dpc-4600	535	15	excimer	excimer	NOUN
dpc-4600	535	16	lamp	lamp	NOUN
dpc-4600	535	17	and	and	CCONJ
dpc-4600	535	18	topical	topical	ADJ
dpc-4600	535	19	tacrolimus	tacrolimus	NOUN
dpc-4600	535	20	combination	combination	NOUN
dpc-4600	535	21	therapy	therapy	NOUN
dpc-4600	535	22	in	in	ADP
dpc-4600	535	23	localized	localized	ADJ
dpc-4600	535	24	vitiligo	vitiligo	NOUN
dpc-4600	535	25	:	:	PUNCT
dpc-4600	535	26	a	a	DET
dpc-4600	535	27	study	study	NOUN
dpc-4600	535	28	in	in	ADP
dpc-4600	535	29	vietnam	vietnam	PROPN
dpc-4600	535	30	.	.	PUNCT
dpc-4600	536	1	international	international	ADJ
dpc-4600	536	2	journal	journal	PROPN
dpc-4600	536	3	of	of	ADP
dpc-4600	536	4	dermatology	dermatology	NOUN
dpc-4600	536	5	and	and	CCONJ
dpc-4600	536	6	venereology	venereology	NOUN
dpc-4600	536	7	.	.	PUNCT
dpc-4600	537	1	2023;6:224	2023;6:224	NUM
dpc-4600	537	2	-	-	SYM
dpc-4600	537	3	8	8	NUM
dpc-4600	537	4	.	.	PUNCT
dpc-4600	537	5	doi	doi	NOUN
dpc-4600	537	6	:	:	PUNCT
dpc-4600	537	7	 	 	SPACE
dpc-4600	537	8	10.1097	10.1097	NUM
dpc-4600	537	9	/	/	SYM
dpc-4600	537	10	jd9.0000000000000326	jd9.0000000000000326	NOUN
dpc-4600	537	11	.	.	NOUN
dpc-4600	538	1	65	65	NUM
dpc-4600	538	2	.	.	PUNCT
dpc-4600	538	3	dellatorre	dellatorre	PROPN
dpc-4600	538	4	g	g	PROPN
dpc-4600	538	5	,	,	PUNCT
dpc-4600	538	6	antelo	antelo	ADJ
dpc-4600	538	7	dap	dap	PROPN
dpc-4600	538	8	,	,	PUNCT
dpc-4600	538	9	bedrikow	bedrikow	NOUN
dpc-4600	538	10	rb	rb	PROPN
dpc-4600	538	11	,	,	PUNCT
dpc-4600	538	12	et	et	PROPN
dpc-4600	538	13	al	al	PROPN
dpc-4600	538	14	.	.	PUNCT
dpc-4600	538	15	consensus	consensus	NOUN
dpc-4600	538	16	on	on	ADP
dpc-4600	538	17	the	the	DET
dpc-4600	538	18	treatment	treatment	NOUN
dpc-4600	538	19	of	of	ADP
dpc-4600	538	20	vitiligo	vitiligo	ADJ
dpc-4600	538	21	brazilian	brazilian	ADJ
dpc-4600	538	22	society	society	NOUN
dpc-4600	538	23	of	of	ADP
dpc-4600	538	24	dermatology	dermatology	NOUN
dpc-4600	538	25	.	.	PUNCT
dpc-4600	539	1	an	an	DET
dpc-4600	539	2	bras	bras	NOUN
dpc-4600	539	3	dermatol	dermatol	NOUN
dpc-4600	539	4	.	.	PUNCT
dpc-4600	540	1	2020;95	2020;95	NUM
dpc-4600	541	1	suppl	suppl	ADJ
dpc-4600	541	2	1(suppl	1(suppl	PRON
dpc-4600	541	3	1):70	1):70	NUM
dpc-4600	541	4	-	-	SYM
dpc-4600	541	5	82	82	NUM
dpc-4600	541	6	.	.	PUNCT
dpc-4600	541	7	doi	doi	NOUN
dpc-4600	541	8	:	:	PUNCT
dpc-4600	541	9	10.1016	10.1016	NUM
dpc-4600	541	10	/j.abd.2020.05.007	/j.abd.2020.05.007	PUNCT
dpc-4600	541	11	.	.	PUNCT
dpc-4600	542	1	pmid	pmid	NOUN
dpc-4600	542	2	:	:	PUNCT
dpc-4600	542	3	33153826	33153826	NUM
dpc-4600	542	4	.	.	PUNCT
dpc-4600	543	1	66	66	NUM
dpc-4600	543	2	.	.	PUNCT
dpc-4600	544	1	gharib	gharib	PROPN
dpc-4600	544	2	k	k	PROPN
dpc-4600	544	3	,	,	PUNCT
dpc-4600	544	4	ibrahim	ibrahim	PROPN
dpc-4600	544	5	a	a	X
dpc-4600	544	6	,	,	PUNCT
dpc-4600	544	7	el	el	PROPN
dpc-4600	544	8	sharkawi	sharkawi	PROPN
dpc-4600	544	9	y	y	PROPN
dpc-4600	544	10	,	,	PUNCT
dpc-4600	544	11	elmegrab	elmegrab	NOUN
dpc-4600	544	12	n	n	SYM
dpc-4600	544	13	,	,	PUNCT
dpc-4600	544	14	attia	attia	PROPN
dpc-4600	544	15	m.	m.	PROPN
dpc-4600	544	16	methotrexate	methotrexate	PROPN
dpc-4600	544	17	gel	gel	PROPN
dpc-4600	544	18	either	either	CCONJ
dpc-4600	544	19	alone	alone	ADV
dpc-4600	544	20	or	or	CCONJ
dpc-4600	544	21	combined	combine	VERB
dpc-4600	544	22	with	with	ADP
dpc-4600	544	23	narrow	narrow	ADJ
dpc-4600	544	24	band	band	NOUN
dpc-4600	544	25	ultraviolet	ultraviolet	PROPN
dpc-4600	544	26	b	b	PROPN
dpc-4600	544	27	or	or	CCONJ
dpc-4600	544	28	excimer	excimer	NOUN
dpc-4600	544	29	light	light	NOUN
dpc-4600	544	30	for	for	ADP
dpc-4600	544	31	the	the	DET
dpc-4600	544	32	treatment	treatment	NOUN
dpc-4600	544	33	of	of	ADP
dpc-4600	544	34	vitiligo	vitiligo	NOUN
dpc-4600	544	35	.	.	PUNCT
dpc-4600	545	1	j	j	PROPN
dpc-4600	545	2	clin	clin	PROPN
dpc-4600	545	3	aesthet	aesthet	PROPN
dpc-4600	545	4	dermatol	dermatol	PROPN
dpc-4600	545	5	.	.	PUNCT
dpc-4600	546	1	2023;16(3):32	2023;16(3):32	NUM
dpc-4600	546	2	-	-	SYM
dpc-4600	546	3	36	36	NUM
dpc-4600	546	4	.	.	PUNCT
dpc-4600	547	1	pmid	pmid	NOUN
dpc-4600	547	2	:	:	PUNCT
dpc-4600	547	3	36950044	36950044	NUM
dpc-4600	547	4	.	.	PUNCT
dpc-4600	548	1	67	67	NUM
dpc-4600	548	2	.	.	PUNCT
dpc-4600	549	1	frączek	frączek	PROPN
dpc-4600	549	2	a	a	PRON
dpc-4600	549	3	,	,	PUNCT
dpc-4600	549	4	owczarczyk	owczarczyk	ADJ
dpc-4600	549	5	-	-	PUNCT
dpc-4600	549	6	saczonek	saczonek	NOUN
dpc-4600	549	7	a	a	PRON
dpc-4600	549	8	,	,	PUNCT
dpc-4600	549	9	placek	placek	PROPN
dpc-4600	549	10	w.	w.	NOUN
dpc-4600	550	1	the	the	DET
dpc-4600	550	2	role	role	NOUN
dpc-4600	550	3	of	of	ADP
dpc-4600	550	4	trm	trm	ADJ
dpc-4600	550	5	cells	cell	NOUN
dpc-4600	550	6	in	in	ADP
dpc-4600	550	7	the	the	DET
dpc-4600	550	8	pathogenesis	pathogenesis	NOUN
dpc-4600	550	9	of	of	ADP
dpc-4600	550	10	vitiligo	vitiligo	NOUN
dpc-4600	550	11	-	-	PUNCT
dpc-4600	550	12	a	a	DET
dpc-4600	550	13	review	review	NOUN
dpc-4600	550	14	of	of	ADP
dpc-4600	550	15	the	the	DET
dpc-4600	550	16	current	current	ADJ
dpc-4600	550	17	state	state	NOUN
dpc-4600	550	18	-	-	PUNCT
dpc-4600	550	19	of	of	ADP
dpc-4600	550	20	-	-	PUNCT
dpc-4600	550	21	the	the	DET
dpc-4600	550	22	-	-	PUNCT
dpc-4600	550	23	art	art	NOUN
dpc-4600	550	24	.	.	PUNCT
dpc-4600	551	1	int	int	PROPN
dpc-4600	551	2	j	j	PROPN
dpc-4600	551	3	mol	mol	ADP
dpc-4600	551	4	sci	sci	PROPN
dpc-4600	551	5	.	.	PUNCT
dpc-4600	552	1	2020;21(10):3552	2020;21(10):3552	X
dpc-4600	552	2	.	.	PUNCT
dpc-4600	552	3	doi	doi	PROPN
dpc-4600	552	4	:	:	PUNCT
dpc-4600	552	5	10.3390	10.3390	NUM
dpc-4600	552	6	/	/	SYM
dpc-4600	552	7	ijms21103552	ijms21103552	PROPN
dpc-4600	552	8	.	.	PUNCT
dpc-4600	553	1	pmid	pmid	NOUN
dpc-4600	553	2	:	:	PUNCT
dpc-4600	553	3	32443482	32443482	NUM
dpc-4600	553	4	.	.	PUNCT
dpc-4600	554	1	68	68	NUM
dpc-4600	554	2	.	.	PUNCT
dpc-4600	555	1	yang	yang	PROPN
dpc-4600	555	2	l	l	PROPN
dpc-4600	555	3	,	,	PUNCT
dpc-4600	555	4	yang	yang	PROPN
dpc-4600	555	5	s	s	PROPN
dpc-4600	555	6	,	,	PUNCT
dpc-4600	555	7	lei	lei	PROPN
dpc-4600	555	8	j	j	PROPN
dpc-4600	555	9	,	,	PUNCT
dpc-4600	555	10	et	et	PROPN
dpc-4600	555	11	al	al	PROPN
dpc-4600	555	12	.	.	PUNCT
dpc-4600	555	13	role	role	NOUN
dpc-4600	555	14	of	of	ADP
dpc-4600	555	15	chemokines	chemokine	NOUN
dpc-4600	555	16	and	and	CCONJ
dpc-4600	555	17	the	the	DET
dpc-4600	555	18	corresponding	corresponding	ADJ
dpc-4600	555	19	receptors	receptor	NOUN
dpc-4600	555	20	in	in	ADP
dpc-4600	555	21	vitiligo	vitiligo	NOUN
dpc-4600	555	22	:	:	PUNCT
dpc-4600	555	23	a	a	DET
dpc-4600	555	24	pilot	pilot	NOUN
dpc-4600	555	25	study	study	NOUN
dpc-4600	555	26	.	.	PUNCT
dpc-4600	556	1	j	j	PROPN
dpc-4600	556	2	dermatol	dermatol	NOUN
dpc-4600	556	3	.	.	PUNCT
dpc-4600	557	1	2018;45(1	2018;45(1	NUM
dpc-4600	557	2	):	):	PUNCT
dpc-4600	557	3	31	31	NUM
dpc-4600	557	4	-	-	SYM
dpc-4600	557	5	38	38	NUM
dpc-4600	557	6	.	.	PUNCT
dpc-4600	558	1	doi	doi	NOUN
dpc-4600	558	2	:	:	PUNCT
dpc-4600	558	3	10.1111/1346	10.1111/1346	NUM
dpc-4600	558	4	-	-	SYM
dpc-4600	558	5	8138.14004	8138.14004	NOUN
dpc-4600	558	6	.	.	PUNCT
dpc-4600	559	1	pmid	pmid	NOUN
dpc-4600	559	2	:	:	PUNCT
dpc-4600	559	3	29115683	29115683	NUM
dpc-4600	559	4	.	.	PUNCT
dpc-4600	560	1	69	69	NUM
dpc-4600	560	2	.	.	PUNCT
dpc-4600	561	1	migayron	migayron	NOUN
dpc-4600	561	2	l	l	NOUN
dpc-4600	561	3	,	,	PUNCT
dpc-4600	561	4	boniface	boniface	PROPN
dpc-4600	561	5	k	k	PROPN
dpc-4600	561	6	,	,	PUNCT
dpc-4600	561	7	seneschal	seneschal	PROPN
dpc-4600	561	8	j.	j.	PROPN
dpc-4600	561	9	vitiligo	vitiligo	PROPN
dpc-4600	561	10	,	,	PUNCT
dpc-4600	561	11	from	from	ADP
dpc-4600	561	12	physiopathology	physiopathology	NOUN
dpc-4600	561	13	to	to	ADP
dpc-4600	561	14	emerging	emerge	VERB
dpc-4600	561	15	treatments	treatment	NOUN
dpc-4600	561	16	:	:	PUNCT
dpc-4600	561	17	a	a	DET
dpc-4600	561	18	review	review	NOUN
dpc-4600	561	19	.	.	PUNCT
dpc-4600	562	1	dermatol	dermatol	NOUN
dpc-4600	562	2	ther	ther	ADV
dpc-4600	562	3	(	(	PUNCT
dpc-4600	562	4	heidelb	heidelb	NOUN
dpc-4600	562	5	)	)	PUNCT
dpc-4600	562	6	.	.	PUNCT
dpc-4600	563	1	2020;10(6):1185	2020;10(6):1185	NUM
dpc-4600	563	2	-	-	SYM
dpc-4600	563	3	1198	1198	NUM
dpc-4600	563	4	.	.	PUNCT
dpc-4600	564	1	doi	doi	NOUN
dpc-4600	564	2	:	:	PUNCT
dpc-4600	564	3	10.1007	10.1007	NUM
dpc-4600	564	4	/	/	SYM
dpc-4600	564	5	s13555	s13555	PROPN
dpc-4600	564	6	-	-	PUNCT
dpc-4600	564	7	02000447	02000447	NUM
dpc-4600	564	8	-	-	PUNCT
dpc-4600	564	9	y.	y.	NOUN
dpc-4600	564	10	pmid	pmid	PROPN
dpc-4600	564	11	:	:	PUNCT
dpc-4600	564	12	32949337	32949337	NUM
dpc-4600	564	13	.	.	PUNCT
dpc-4600	565	1	70	70	NUM
dpc-4600	565	2	.	.	PUNCT
dpc-4600	566	1	lambert	lambert	PROPN
dpc-4600	566	2	c	c	PROPN
dpc-4600	566	3	,	,	PUNCT
dpc-4600	566	4	zappia	zappia	PROPN
dpc-4600	566	5	j	j	PROPN
dpc-4600	566	6	,	,	PUNCT
dpc-4600	566	7	sanchez	sanchez	PROPN
dpc-4600	566	8	c	c	PROPN
dpc-4600	566	9	,	,	PUNCT
dpc-4600	566	10	florin	florin	PROPN
dpc-4600	566	11	a	a	PROPN
dpc-4600	566	12	,	,	PUNCT
dpc-4600	566	13	dubuc	dubuc	ADJ
dpc-4600	566	14	je	je	PROPN
dpc-4600	566	15	,	,	PUNCT
dpc-4600	566	16	henrotin	henrotin	AUX
dpc-4600	566	17	y.	y.	VERB
dpc-4600	566	18	the	the	DET
dpc-4600	566	19	damage	damage	NOUN
dpc-4600	566	20	-	-	PUNCT
dpc-4600	566	21	associated	associate	VERB
dpc-4600	566	22	molecular	molecular	ADJ
dpc-4600	566	23	patterns	pattern	NOUN
dpc-4600	566	24	(	(	PUNCT
dpc-4600	566	25	damps	damps	VERB
dpc-4600	566	26	)	)	PUNCT
dpc-4600	566	27	as	as	ADP
dpc-4600	566	28	potential	potential	ADJ
dpc-4600	566	29	targets	target	NOUN
dpc-4600	566	30	to	to	PART
dpc-4600	566	31	treat	treat	VERB
dpc-4600	566	32	osteoarthritis	osteoarthritis	NOUN
dpc-4600	566	33	:	:	PUNCT
dpc-4600	566	34	perspectives	perspective	NOUN
dpc-4600	566	35	from	from	ADP
dpc-4600	566	36	a	a	DET
dpc-4600	566	37	review	review	NOUN
dpc-4600	566	38	of	of	ADP
dpc-4600	566	39	the	the	DET
dpc-4600	566	40	literature	literature	NOUN
dpc-4600	566	41	.	.	PUNCT
dpc-4600	567	1	front	front	PROPN
dpc-4600	567	2	med	med	PROPN
dpc-4600	567	3	(	(	PUNCT
dpc-4600	567	4	lausanne	lausanne	PROPN
dpc-4600	567	5	)	)	PUNCT
dpc-4600	567	6	.	.	PUNCT
dpc-4600	568	1	2021;7:607186	2021;7:607186	NOUN
dpc-4600	568	2	.	.	PUNCT
dpc-4600	569	1	doi	doi	NOUN
dpc-4600	569	2	:	:	PUNCT
dpc-4600	569	3	10.3389	10.3389	NUM
dpc-4600	569	4	/	/	SYM
dpc-4600	569	5	fmed.2020.607186	fmed.2020.607186	PROPN
dpc-4600	569	6	.	.	PUNCT
dpc-4600	570	1	pmid	pmid	NOUN
dpc-4600	570	2	:	:	PUNCT
dpc-4600	570	3	33537330	33537330	NUM
dpc-4600	570	4	.	.	PUNCT
dpc-4600	571	1	55	55	NUM
dpc-4600	571	2	.	.	PUNCT
dpc-4600	572	1	karagün	karagün	PROPN
dpc-4600	572	2	e	e	NOUN
dpc-4600	572	3	,	,	PUNCT
dpc-4600	572	4	baysak	baysak	PROPN
dpc-4600	572	5	s.	s.	PROPN
dpc-4600	572	6	levels	levels	PROPN
dpc-4600	572	7	of	of	ADP
dpc-4600	572	8	tnf	tnf	PROPN
dpc-4600	572	9	-	-	PUNCT
dpc-4600	572	10	α	α	PROPN
dpc-4600	572	11	,	,	PUNCT
dpc-4600	572	12	il-6	il-6	NUM
dpc-4600	572	13	,	,	PUNCT
dpc-4600	572	14	il-17	il-17	X
dpc-4600	572	15	,	,	PUNCT
dpc-4600	572	16	il-37	il-37	NOUN
dpc-4600	572	17	cytokines	cytokine	NOUN
dpc-4600	572	18	in	in	ADP
dpc-4600	572	19	patients	patient	NOUN
dpc-4600	572	20	with	with	ADP
dpc-4600	572	21	active	active	ADJ
dpc-4600	572	22	vitiligo	vitiligo	NOUN
dpc-4600	572	23	.	.	PUNCT
dpc-4600	573	1	aging	age	VERB
dpc-4600	573	2	male	male	NOUN
dpc-4600	573	3	.	.	PUNCT
dpc-4600	574	1	2020	2020	NUM
dpc-4600	574	2	;	;	PUNCT
dpc-4600	574	3	23(5):1487	23(5):1487	NUM
dpc-4600	574	4	-	-	SYM
dpc-4600	574	5	1492	1492	NUM
dpc-4600	574	6	.	.	PUNCT
dpc-4600	575	1	doi:10.1080/13685538.2020.1806814	doi:10.1080/13685538.2020.1806814	PROPN
dpc-4600	575	2	.	.	PUNCT
dpc-4600	576	1	pmid	pmid	NOUN
dpc-4600	576	2	:	:	PUNCT
dpc-4600	576	3	33191834	33191834	NUM
dpc-4600	576	4	.	.	PUNCT
dpc-4600	577	1	56	56	NUM
dpc-4600	577	2	.	.	X
dpc-4600	578	1	el	el	PROPN
dpc-4600	578	2	sohafy	sohafy	PROPN
dpc-4600	578	3	m	m	PROPN
dpc-4600	578	4	,	,	PUNCT
dpc-4600	578	5	ghanem	ghanem	PROPN
dpc-4600	578	6	b	b	PROPN
dpc-4600	578	7	,	,	PUNCT
dpc-4600	578	8	mitwally	mitwally	ADV
dpc-4600	578	9	s	s	NOUN
dpc-4600	578	10	,	,	PUNCT
dpc-4600	578	11	state	state	NOUN
dpc-4600	578	12	a	a	X
dpc-4600	578	13	,	,	PUNCT
dpc-4600	578	14	elshawaf	elshawaf	PROPN
dpc-4600	578	15	r.	r.	PROPN
dpc-4600	578	16	effect	effect	PROPN
dpc-4600	578	17	of	of	ADP
dpc-4600	578	18	narrow	narrow	ADJ
dpc-4600	578	19	band	band	NOUN
dpc-4600	578	20	–	–	PUNCT
dpc-4600	578	21	uvb	uvb	ADJ
dpc-4600	578	22	phototherapy	phototherapy	NOUN
dpc-4600	578	23	on	on	ADP
dpc-4600	578	24	circulating	circulate	VERB
dpc-4600	578	25	tregulatory	tregulatory	ADJ
dpc-4600	578	26	cells	cell	NOUN
dpc-4600	578	27	and	and	CCONJ
dpc-4600	578	28	serum	serum	NOUN
dpc-4600	578	29	il-17	il-17	ADV
dpc-4600	578	30	level	level	NOUN
dpc-4600	578	31	in	in	ADP
dpc-4600	578	32	egyptian	egyptian	ADJ
dpc-4600	578	33	patients	patient	NOUN
dpc-4600	578	34	with	with	ADP
dpc-4600	578	35	non	non	ADJ
dpc-4600	578	36	segmental	segmental	ADJ
dpc-4600	578	37	vitiligo	vitiligo	NOUN
dpc-4600	578	38	.	.	PUNCT
dpc-4600	579	1	the	the	DET
dpc-4600	579	2	egyptian	egyptian	ADJ
dpc-4600	579	3	journal	journal	PROPN
dpc-4600	579	4	of	of	ADP
dpc-4600	579	5	hospital	hospital	NOUN
dpc-4600	579	6	medicine	medicine	NOUN
dpc-4600	579	7	,	,	PUNCT
dpc-4600	579	8	2021	2021	NUM
dpc-4600	579	9	;	;	PUNCT
dpc-4600	579	10	85(1	85(1	NUM
dpc-4600	579	11	):	):	PUNCT
dpc-4600	579	12	3098	3098	NUM
dpc-4600	579	13	-	-	SYM
dpc-4600	579	14	3103	3103	NUM
dpc-4600	579	15	.	.	PUNCT
dpc-4600	580	1	doi	doi	NOUN
dpc-4600	580	2	:	:	PUNCT
dpc-4600	580	3	10.21608	10.21608	NUM
dpc-4600	580	4	/	/	SYM
dpc-4600	580	5	ejhm.2021.194064	ejhm.2021.194064	NOUN
dpc-4600	580	6	.	.	PUNCT
dpc-4600	581	1	57	57	NUM
dpc-4600	581	2	.	.	PUNCT
dpc-4600	581	3	elkady	elkady	PROPN
dpc-4600	581	4	a	a	PRON
dpc-4600	581	5	,	,	PUNCT
dpc-4600	581	6	bonomo	bonomo	NOUN
dpc-4600	581	7	l	l	NOUN
dpc-4600	581	8	,	,	PUNCT
dpc-4600	581	9	amir	amir	PROPN
dpc-4600	581	10	y	y	PROPN
dpc-4600	581	11	,	,	PUNCT
dpc-4600	581	12	vekaria	vekaria	NOUN
dpc-4600	581	13	as	as	ADP
dpc-4600	581	14	,	,	PUNCT
dpc-4600	581	15	guttman	guttman	ADJ
dpc-4600	581	16	-	-	PUNCT
dpc-4600	581	17	yassky	yassky	NOUN
dpc-4600	581	18	e.	e.	PROPN
dpc-4600	581	19	effective	effective	ADJ
dpc-4600	581	20	use	use	NOUN
dpc-4600	581	21	of	of	ADP
dpc-4600	581	22	ustekinumab	ustekinumab	NOUN
dpc-4600	581	23	in	in	ADP
dpc-4600	581	24	a	a	DET
dpc-4600	581	25	patient	patient	NOUN
dpc-4600	581	26	with	with	ADP
dpc-4600	581	27	concomitant	concomitant	ADJ
dpc-4600	581	28	psoriasis	psoriasis	NOUN
dpc-4600	581	29	,	,	PUNCT
dpc-4600	581	30	vitiligo	vitiligo	VERB
dpc-4600	581	31	,	,	PUNCT
dpc-4600	581	32	and	and	CCONJ
dpc-4600	581	33	alopecia	alopecia	NOUN
dpc-4600	581	34	areata	areata	ADJ
dpc-4600	581	35	.	.	PUNCT
dpc-4600	582	1	jaad	jaad	NOUN
dpc-4600	582	2	case	case	NOUN
dpc-4600	582	3	rep	rep	PROPN
dpc-4600	582	4	.	.	PROPN
dpc-4600	582	5	2017;3(6	2017;3(6	NUM
dpc-4600	582	6	):	):	PUNCT
dpc-4600	582	7	477	477	NUM
dpc-4600	582	8	-	-	SYM
dpc-4600	582	9	479	479	NUM
dpc-4600	582	10	.	.	PUNCT
dpc-4600	583	1	doi	doi	NOUN
dpc-4600	583	2	:	:	PUNCT
dpc-4600	583	3	10.1016	10.1016	NUM
dpc-4600	583	4	/	/	SYM
dpc-4600	583	5	j.jdcr.2017.07.009	j.jdcr.2017.07.009	PROPN
dpc-4600	583	6	.	.	PUNCT
dpc-4600	584	1	pmid	pmid	NOUN
dpc-4600	584	2	:	:	PUNCT
dpc-4600	584	3	28971137	28971137	NUM
dpc-4600	584	4	.	.	PUNCT
dpc-4600	585	1	58	58	NUM
dpc-4600	585	2	.	.	PUNCT
dpc-4600	586	1	liu	liu	PROPN
dpc-4600	586	2	t	t	PROPN
dpc-4600	586	3	,	,	PUNCT
dpc-4600	586	4	li	li	PROPN
dpc-4600	586	5	s	s	PROPN
dpc-4600	586	6	,	,	PUNCT
dpc-4600	586	7	ying	ying	PROPN
dpc-4600	586	8	s	s	PROPN
dpc-4600	586	9	,	,	PUNCT
dpc-4600	586	10	et	et	PROPN
dpc-4600	586	11	al	al	PROPN
dpc-4600	586	12	.	.	PUNCT
dpc-4600	587	1	the	the	DET
dpc-4600	587	2	il-23	il-23	NOUN
dpc-4600	587	3	/	/	SYM
dpc-4600	587	4	il-17	il-17	NUM
dpc-4600	587	5	pathway	pathway	NOUN
dpc-4600	587	6	in	in	ADP
dpc-4600	587	7	inflammatory	inflammatory	ADJ
dpc-4600	587	8	skin	skin	NOUN
dpc-4600	587	9	diseases	disease	NOUN
dpc-4600	587	10	:	:	PUNCT
dpc-4600	587	11	from	from	ADP
dpc-4600	587	12	bench	bench	NOUN
dpc-4600	587	13	to	to	ADP
dpc-4600	587	14	bedside	bedside	NOUN
dpc-4600	587	15	.	.	PUNCT
dpc-4600	588	1	front	front	ADJ
dpc-4600	588	2	immunol	immunol	NOUN
dpc-4600	588	3	.	.	PUNCT
dpc-4600	589	1	2020;11:594735	2020;11:594735	NUM
dpc-4600	589	2	.	.	PUNCT
dpc-4600	589	3	doi	doi	NOUN
dpc-4600	589	4	:	:	PUNCT
dpc-4600	589	5	10.3389	10.3389	NUM
dpc-4600	589	6	/	/	SYM
dpc-4600	589	7	fimmu.2020.594735	fimmu.2020.594735	NOUN
dpc-4600	589	8	.	.	PUNCT
dpc-4600	590	1	pmid	pmid	NOUN
dpc-4600	590	2	:	:	PUNCT
dpc-4600	590	3	33281823	33281823	NUM
dpc-4600	590	4	.	.	X
dpc-4600	591	1	59	59	NUM
dpc-4600	591	2	.	.	PUNCT
dpc-4600	591	3	park	park	NOUN
dpc-4600	591	4	sj	sj	PROPN
dpc-4600	591	5	,	,	PUNCT
dpc-4600	591	6	ahn	ahn	PROPN
dpc-4600	591	7	gr	gr	PROPN
dpc-4600	591	8	,	,	PUNCT
dpc-4600	591	9	park	park	NOUN
dpc-4600	591	10	jw	jw	PROPN
dpc-4600	591	11	,	,	PUNCT
dpc-4600	591	12	seo	seo	NOUN
dpc-4600	591	13	sj	sj	PROPN
dpc-4600	591	14	.	.	PUNCT
dpc-4600	592	1	the	the	DET
dpc-4600	592	2	first	first	ADJ
dpc-4600	592	3	case	case	NOUN
dpc-4600	592	4	of	of	ADP
dpc-4600	592	5	ustekinumab	ustekinumab	NOUN
dpc-4600	592	6	associated	associate	VERB
dpc-4600	592	7	hair	hair	NOUN
dpc-4600	592	8	repigmentation	repigmentation	NOUN
dpc-4600	592	9	and	and	CCONJ
dpc-4600	592	10	a	a	DET
dpc-4600	592	11	proposed	propose	VERB
dpc-4600	592	12	mechanism	mechanism	NOUN
dpc-4600	592	13	of	of	ADP
dpc-4600	592	14	action	action	NOUN
dpc-4600	592	15	.	.	PUNCT
dpc-4600	593	1	ann	ann	PROPN
dpc-4600	593	2	dermatol	dermatol	NOUN
dpc-4600	593	3	.	.	PUNCT
dpc-4600	594	1	2021;33(3):300	2021;33(3):300	NUM
dpc-4600	594	2	-	-	SYM
dpc-4600	594	3	301	301	NUM
dpc-4600	594	4	.	.	PUNCT
dpc-4600	595	1	doi	doi	NOUN
dpc-4600	595	2	:	:	PUNCT
dpc-4600	595	3	10.5021	10.5021	NUM
dpc-4600	595	4	/ad.2021.33.3.300.pmid	/ad.2021.33.3.300.pmid	SYM
dpc-4600	595	5	:	:	PUNCT
dpc-4600	595	6	34079196	34079196	NUM
dpc-4600	595	7	.	.	PUNCT
dpc-4600	596	1	60	60	NUM
dpc-4600	596	2	.	.	PUNCT
dpc-4600	596	3	yu	yu	PROPN
dpc-4600	597	1	z	z	PROPN
dpc-4600	597	2	,	,	PUNCT
dpc-4600	597	3	wolf	wolf	PROPN
dpc-4600	597	4	p.	p.	NOUN
dpc-4600	598	1	how	how	SCONJ
dpc-4600	598	2	it	it	PRON
dpc-4600	598	3	works	work	VERB
dpc-4600	598	4	:	:	PUNCT
dpc-4600	598	5	the	the	DET
dpc-4600	598	6	immunology	immunology	NOUN
dpc-4600	598	7	underlying	underlie	VERB
dpc-4600	598	8	phototherapy	phototherapy	NOUN
dpc-4600	598	9	.	.	PUNCT
dpc-4600	599	1	dermatol	dermatol	NOUN
dpc-4600	599	2	clin	clin	PROPN
dpc-4600	599	3	.	.	PUNCT
dpc-4600	600	1	2020;38(1):37	2020;38(1):37	NUM
dpc-4600	600	2	-	-	SYM
dpc-4600	600	3	53	53	NUM
dpc-4600	600	4	.	.	PUNCT
dpc-4600	600	5	doi	doi	NOUN
dpc-4600	600	6	:	:	PUNCT
dpc-4600	600	7	10.1016	10.1016	NUM
dpc-4600	600	8	/j.det.2019.08.004	/j.det.2019.08.004	PROPN
dpc-4600	600	9	.	.	PUNCT
dpc-4600	601	1	pmid	pmid	NOUN
dpc-4600	601	2	:	:	PUNCT
dpc-4600	601	3	31753191	31753191	NUM
dpc-4600	601	4	.	.	PUNCT
dpc-4600	602	1	61	61	NUM
dpc-4600	602	2	.	.	PUNCT
dpc-4600	603	1	grochocka	grochocka	PROPN
dpc-4600	603	2	m	m	PROPN
dpc-4600	603	3	,	,	PUNCT
dpc-4600	603	4	wełniak	wełniak	PROPN
dpc-4600	603	5	a	a	X
dpc-4600	603	6	,	,	PUNCT
dpc-4600	603	7	białczyk	białczyk	NOUN
dpc-4600	603	8	a	a	PRON
dpc-4600	603	9	,	,	PUNCT
dpc-4600	603	10	marek	marek	PROPN
dpc-4600	603	11	-	-	PUNCT
dpc-4600	603	12	jozefowicz	jozefowicz	NOUN
dpc-4600	603	13	l	l	PROPN
dpc-4600	603	14	,	,	PUNCT
dpc-4600	603	15	tadrowski	tadrowski	PROPN
dpc-4600	603	16	t	t	PROPN
dpc-4600	603	17	,	,	PUNCT
dpc-4600	603	18	czajkowski	czajkowski	PROPN
dpc-4600	603	19	r.	r.	PROPN
dpc-4600	603	20	management	management	NOUN
dpc-4600	603	21	of	of	ADP
dpc-4600	603	22	stable	stable	ADJ
dpc-4600	603	23	vitiligo	vitiligo	NOUN
dpc-4600	603	24	-	-	PUNCT
dpc-4600	603	25	a	a	DET
dpc-4600	603	26	review	review	NOUN
dpc-4600	603	27	of	of	ADP
dpc-4600	603	28	the	the	DET
dpc-4600	603	29	surgical	surgical	ADJ
dpc-4600	603	30	approach	approach	NOUN
dpc-4600	603	31	.	.	PUNCT
dpc-4600	604	1	j	j	PROPN
dpc-4600	604	2	clin	clin	PROPN
dpc-4600	604	3	med	med	PROPN
dpc-4600	604	4	.	.	PUNCT
dpc-4600	605	1	2023;12(5):1984	2023;12(5):1984	PROPN
dpc-4600	605	2	.	.	PUNCT
dpc-4600	606	1	doi	doi	NOUN
dpc-4600	606	2	:	:	PUNCT
dpc-4600	606	3	10.3390	10.3390	NUM
dpc-4600	606	4	/	/	SYM
dpc-4600	606	5	jcm12051984	jcm12051984	NOUN
dpc-4600	606	6	.	.	PUNCT
dpc-4600	607	1	pmid	pmid	NOUN
dpc-4600	607	2	:	:	PUNCT
dpc-4600	607	3	36902772	36902772	NUM
dpc-4600	607	4	.	.	PUNCT
dpc-4600	608	1	62	62	NUM
dpc-4600	608	2	.	.	PUNCT
dpc-4600	609	1	mohammad	mohammad	PROPN
dpc-4600	609	2	tf	tf	PROPN
dpc-4600	609	3	,	,	PUNCT
dpc-4600	609	4	al	al	PROPN
dpc-4600	609	5	-	-	PROPN
dpc-4600	609	6	jamal	jamal	PROPN
dpc-4600	609	7	m	m	PROPN
dpc-4600	609	8	,	,	PUNCT
dpc-4600	609	9	hamzavi	hamzavi	PROPN
dpc-4600	609	10	ih	ih	PRON
dpc-4600	609	11	,	,	PUNCT
dpc-4600	609	12	et	et	PROPN
dpc-4600	609	13	al	al	PROPN
dpc-4600	609	14	.	.	PUNCT
dpc-4600	610	1	the	the	DET
dpc-4600	610	2	vitiligo	vitiligo	PROPN
dpc-4600	610	3	working	working	NOUN
dpc-4600	610	4	group	group	NOUN
dpc-4600	610	5	recommendations	recommendation	NOUN
dpc-4600	610	6	for	for	ADP
dpc-4600	610	7	narrowband	narrowband	PROPN
dpc-4600	610	8	ultraviolet	ultraviolet	PROPN
dpc-4600	611	1	b	b	PROPN
dpc-4600	611	2	light	light	ADJ
dpc-4600	611	3	phototherapy	phototherapy	NOUN
dpc-4600	611	4	treatment	treatment	NOUN
dpc-4600	611	5	of	of	ADP
dpc-4600	611	6	vitiligo	vitiligo	NOUN
dpc-4600	611	7	.	.	PUNCT
dpc-4600	612	1	j	j	PROPN
dpc-4600	612	2	am	be	AUX
dpc-4600	612	3	acad	acad	ADJ
dpc-4600	612	4	dermatol	dermatol	NOUN
dpc-4600	612	5	.	.	PUNCT
dpc-4600	613	1	2017;76(5):879	2017;76(5):879	NUM
dpc-4600	613	2	-	-	PUNCT
dpc-4600	613	3	888	888	NUM
dpc-4600	613	4	.	.	PUNCT
dpc-4600	613	5	doi	doi	NOUN
dpc-4600	613	6	:	:	PUNCT
dpc-4600	613	7	10.1016	10.1016	NUM
dpc-4600	613	8	/	/	SYM
dpc-4600	613	9	j.jaad.2016.12.041	j.jaad.2016.12.041	PROPN
dpc-4600	613	10	.	.	PUNCT
dpc-4600	614	1	pmid	pmid	NOUN
dpc-4600	614	2	:	:	PUNCT
dpc-4600	614	3	28216034	28216034	NUM
dpc-4600	614	4	.	.	PUNCT